
<html lang="en"     class="pb-page"  data-request-id="20bc436e-f245-41b1-8e4f-40d2603c3456"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.1c00917"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents" /></meta><meta name="dc.Creator" content="Antonino Nicolò  Fallica" /></meta><meta name="dc.Creator" content="Carla  Barbaraci" /></meta><meta name="dc.Creator" content="Emanuele  Amata" /></meta><meta name="dc.Creator" content="Lorella  Pasquinucci" /></meta><meta name="dc.Creator" content="Rita  Turnaturi" /></meta><meta name="dc.Creator" content="Maria  Dichiara" /></meta><meta name="dc.Creator" content="Sebastiano  Intagliata" /></meta><meta name="dc.Creator" content="Marzia Bruna  Gariboldi" /></meta><meta name="dc.Creator" content="Emanuela  Marras" /></meta><meta name="dc.Creator" content="Viviana Teresa  Orlandi" /></meta><meta name="dc.Creator" content="Claudia  Ferroni" /></meta><meta name="dc.Creator" content="Cecilia  Martini" /></meta><meta name="dc.Creator" content="Antonio  Rescifina" /></meta><meta name="dc.Creator" content="Davide  Gentile" /></meta><meta name="dc.Creator" content="Greta  Varchi" /></meta><meta name="dc.Creator" content="Agostino  Marrazzo" /></meta><meta name="dc.Description" content="The potential anticancer effect of fluoroquinolone antibiotics has been recently unveiled and related to their ability to interfere with DNA topoisomerase II. We herein envisioned the design and sy..." /></meta><meta name="Description" content="The potential anticancer effect of fluoroquinolone antibiotics has been recently unveiled and related to their ability to interfere with DNA topoisomerase II. We herein envisioned the design and sy..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 28, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00917" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00917" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00917" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00917" /></link>
        
    
    

<title>Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00917" /></meta><meta property="og:title" content="Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0016.jpeg" /></meta><meta property="og:description" content="The potential anticancer effect of fluoroquinolone antibiotics has been recently unveiled and related to their ability to interfere with DNA topoisomerase II. We herein envisioned the design and synthesis of novel Ciprofloxacin and Norfloxacin nitric oxide (NO) photo-donor hybrids to explore the potential synergistic antitumor effect exerted by the fluoroquinolone scaffold and NO eventually produced upon light irradiation. Anticancer activity, evaluated on a panel of tumor cell lines, showed encouraging results with IC50 values in the low micromolar range. Some compounds displayed intense antiproliferative activity on triple-negative and doxorubicin-resistant breast cancer cell lines, paving the way for their potential use to treat aggressive, refractory and multidrug-resistant breast cancer. No significant additive effect was observed on PC3 and DU145 cells following NO release. Conversely, antimicrobial photodynamic experiments on both Gram-negative and Gram-positive microorganisms displayed a significant killing rate in Staphylococcus aureus, accounting for their potential effectiveness as selective antimicrobial photosensitizers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00917"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00917">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00917&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00917&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00917&amp;href=/doi/10.1021/acs.jmedchem.1c00917" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, XXXX</span><span class="cit-fg-issue">, XXX</span><span class="cit-fg-pageRange">, XXX-XXX</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/0/0" title="Return to Articles ASAP" id="returnToASAP" class="content-navigation__btn--return"><span>RETURN TO ARTICLES ASAP</span></a><a href="/doi/10.1021/acs.jmedchem.1c00895" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00665" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Antonino Nicolò Fallica</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonino Nicolò Fallica</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonino+Nicol%C3%B2++Fallica">Antonino Nicolò Fallica</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1899-8414" title="Orcid link">https://orcid.org/0000-0003-1899-8414</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carla Barbaraci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carla Barbaraci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carla++Barbaraci">Carla Barbaraci</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-6155-6702" title="Orcid link">https://orcid.org/0000-0002-6155-6702</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emanuele Amata</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emanuele Amata</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emanuele++Amata">Emanuele Amata</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-4750-3479" title="Orcid link">https://orcid.org/0000-0002-4750-3479</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lorella Pasquinucci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lorella Pasquinucci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lorella++Pasquinucci">Lorella Pasquinucci</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1309-3368" title="Orcid link">https://orcid.org/0000-0003-1309-3368</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rita Turnaturi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rita Turnaturi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rita++Turnaturi">Rita Turnaturi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-5895-7820" title="Orcid link">https://orcid.org/0000-0002-5895-7820</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Dichiara</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Dichiara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Dichiara">Maria Dichiara</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sebastiano Intagliata</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sebastiano Intagliata</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sebastiano++Intagliata">Sebastiano Intagliata</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-0201-1745" title="Orcid link">https://orcid.org/0000-0002-0201-1745</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marzia Bruna Gariboldi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marzia Bruna Gariboldi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology and Life Sciences (DBSV), University of Insubria, Via JH Dunant 3, 21100 Varese, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marzia+Bruna++Gariboldi">Marzia Bruna Gariboldi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-5683-0885" title="Orcid link">https://orcid.org/0000-0002-5683-0885</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emanuela Marras</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emanuela Marras</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology and Life Sciences (DBSV), University of Insubria, Via JH Dunant 3, 21100 Varese, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emanuela++Marras">Emanuela Marras</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Viviana Teresa Orlandi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Viviana Teresa Orlandi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology and Life Sciences (DBSV), University of Insubria, Via JH Dunant 3, 21100 Varese, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Viviana+Teresa++Orlandi">Viviana Teresa Orlandi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudia Ferroni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudia Ferroni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for the Organic Synthesis and Photoreactivity − ISOF, Via Piero Gobetti, 101, 40129 Bologna, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Ferroni">Claudia Ferroni</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-7386-1624" title="Orcid link">https://orcid.org/0000-0002-7386-1624</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cecilia Martini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cecilia Martini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for the Organic Synthesis and Photoreactivity − ISOF, Via Piero Gobetti, 101, 40129 Bologna, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cecilia++Martini">Cecilia Martini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio Rescifina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio Rescifina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Rescifina">Antonio Rescifina</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-5039-2151" title="Orcid link">https://orcid.org/0000-0001-5039-2151</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Davide Gentile</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Davide Gentile</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Davide++Gentile">Davide Gentile</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Greta Varchi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Greta Varchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for the Organic Synthesis and Photoreactivity − ISOF, Via Piero Gobetti, 101, 40129 Bologna, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#bed9ccdbcadf90c8dfccddd6d7fed7cdd1d890ddd0cc90d7ca"><span class="__cf_email__" data-cfemail="d9beabbcadb8f7afb8abbab1b099b0aab6bff7bab7abf7b0ad">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Greta++Varchi">Greta Varchi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8358-3437" title="Orcid link">https://orcid.org/0000-0002-8358-3437</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Agostino Marrazzo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Agostino Marrazzo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug and Health Sciences (DSFS), University of Catania, Viale A. Doria, 6, 95125 Catania, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#b5d8d4c7c7d4cfcfdaf5c0dbdcd6c19bdcc1"><span class="__cf_email__" data-cfemail="0568647777647f7f6a45706b6c66712b6c71">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Agostino++Marrazzo">Agostino Marrazzo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8728-8857" title="Orcid link">https://orcid.org/0000-0002-8728-8857</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00917&amp;href=/doi/10.1021%2Facs.jmedchem.1c00917" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, XXXX</span><span class="cit-issue">, XXX</span><span class="cit-pageRange">, XXX-XXX</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 28, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 May 2021</li><li><span class="item_label"><b>Published</b> online</span>28 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00917" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00917</a></div><div class="article_header-article-copyright"><strong>© 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAntonino%2BNicol%25C3%25B2%2BFallica%252C%2BCarla%2BBarbaraci%252C%2BEmanuele%2BAmata%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D0%26issueNum%3D0%26contentID%3Dacs.jmedchem.1c00917%26title%3DNitric%2BOxide%2BPhoto-Donor%2BHybrids%2Bof%2BCiprofloxacin%2Band%2BNorfloxacin%253A%2BA%2BShift%2Bin%2BActivity%2Bfrom%2BAntimicrobial%2Bto%2BAnticancer%2BAgents%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D17%26publicationDate%3DJuly%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by"><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00917"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">390</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00917" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Antonino&quot;,&quot;last_name&quot;:&quot;Nicolò Fallica&quot;},{&quot;first_name&quot;:&quot;Carla&quot;,&quot;last_name&quot;:&quot;Barbaraci&quot;},{&quot;first_name&quot;:&quot;Emanuele&quot;,&quot;last_name&quot;:&quot;Amata&quot;},{&quot;first_name&quot;:&quot;Lorella&quot;,&quot;last_name&quot;:&quot;Pasquinucci&quot;},{&quot;first_name&quot;:&quot;Rita&quot;,&quot;last_name&quot;:&quot;Turnaturi&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Dichiara&quot;},{&quot;first_name&quot;:&quot;Sebastiano&quot;,&quot;last_name&quot;:&quot;Intagliata&quot;},{&quot;first_name&quot;:&quot;Marzia&quot;,&quot;last_name&quot;:&quot;Bruna Gariboldi&quot;},{&quot;first_name&quot;:&quot;Emanuela&quot;,&quot;last_name&quot;:&quot;Marras&quot;},{&quot;first_name&quot;:&quot;Viviana&quot;,&quot;last_name&quot;:&quot;Teresa Orlandi&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Ferroni&quot;},{&quot;first_name&quot;:&quot;Cecilia&quot;,&quot;last_name&quot;:&quot;Martini&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Rescifina&quot;},{&quot;first_name&quot;:&quot;Davide&quot;,&quot;last_name&quot;:&quot;Gentile&quot;},{&quot;first_name&quot;:&quot;Greta&quot;,&quot;last_name&quot;:&quot;Varchi&quot;},{&quot;first_name&quot;:&quot;Agostino&quot;,&quot;last_name&quot;:&quot;Marrazzo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;0&quot;,&quot;volume&quot;:&quot;0&quot;,&quot;pages&quot;:&quot;&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00917&quot;},&quot;abstract&quot;:&quot;The potential anticancer effect of fluoroquinolone antibiotics has been recently unveiled and related to their ability to interfere with DNA topoisomerase II. We herein envisioned the design and synthesis of novel Ciprofloxacin and Norfloxacin nitric oxide (NO) photo-donor hybrids to explore the potential synergistic antitumor effect exerted by the fluoroquinolone scaffold and NO eventually produced upon light irradiation. Anticancer activity, evaluated on a panel of tumor cell lines, showed encouraging results with IC50 values in the low micromolar range. Some compounds displayed intense antiproliferative activity on triple-negative and doxorubicin-resistant breast cancer cell lines, paving the way for their potential use to treat aggressive, refractory and multidrug-resistant breast cancer. No significant additive effect was observed on PC3 and DU145 cells following NO release. Conversely, antimicrobial photodynamic experiments on both Gram-negative and Gram-positive microorganisms displayed a significant k&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00917&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00917" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00917&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00917" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00917&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00917" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00917&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00917&amp;href=/doi/10.1021/acs.jmedchem.1c00917" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00917" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00917" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00917%26sid%3Dliteratum%253Aachs%26pmid%3D34319100%26genre%3Darticle%26aulast%3DFallica%26date%3D2021%26atitle%3DNitric%2BOxide%2BPhoto-Donor%2BHybrids%2Bof%2BCiprofloxacin%2Band%2BNorfloxacin%253A%2BA%2BShift%2Bin%2BActivity%2Bfrom%2BAntimicrobial%2Bto%2BAnticancer%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D0%26issue%3D0%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290619" title="Irradiation">Irradiation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/0/0" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The potential anticancer effect of fluoroquinolone antibiotics has been recently unveiled and related to their ability to interfere with DNA topoisomerase II. We herein envisioned the design and synthesis of novel Ciprofloxacin and Norfloxacin nitric oxide (NO) photo-donor hybrids to explore the potential synergistic antitumor effect exerted by the fluoroquinolone scaffold and NO eventually produced upon light irradiation. Anticancer activity, evaluated on a panel of tumor cell lines, showed encouraging results with IC<sub>50</sub> values in the low micromolar range. Some compounds displayed intense antiproliferative activity on triple-negative and doxorubicin-resistant breast cancer cell lines, paving the way for their potential use to treat aggressive, refractory and multidrug-resistant breast cancer. No significant additive effect was observed on PC3 and DU145 cells following NO release. Conversely, antimicrobial photodynamic experiments on both Gram-negative and Gram-positive microorganisms displayed a significant killing rate in <i>Staphylococcus aureus</i>, accounting for their potential effectiveness as selective antimicrobial photosensitizers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50717" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50717" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since their early discovery as byproducts of chloroquine synthesis,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> quinolones have represented one of the most important classes of antibiotics for urinary and respiratory infection treatment.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> Quinolones exert their bactericidal activity by interfering with DNA gyrase in Gram-negative bacteria and topoisomerase IV in Gram-positive bacteria.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Both enzymes belong to the topoisomerase family, which plays an essential role in the regulation of the DNA topological state, in DNA replication, and in the condensation and segregation of chromosomes.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> In the presence of quinolone, the enzyme forms a DNA/enzyme/drug ternary complex that perturbs DNA replication, leading to bacterial death or eukaryotic cell apoptosis.</div><div class="NLM_p">Structural modifications of the first marketed compound of this class of molecules, nalidixic acid, generated compounds with greater potency, a broader spectrum of activity, improved pharmacokinetics, and lower frequency of acquired resistance. In particular, Norfloxacin (Nor) and Ciprofloxacin (Cip), belonging to the second-generation fluoroquinolones (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), displayed increased potency and affinity for Gram-negative bacteria due to the introduction of a fluorine atom at position 6. Subsequent structure modifications led to third- and fourth-generation fluoroquinolones, with improved efficacy against Gram-positive organisms.<a onclick="showRef(event, 'ref2 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref2 ref8 ref9">(2,8,9)</a> Also, structure–activity relationship (SAR) studies highlighted the importance of the <i>N-</i>1 substituent on the quinolone core together with the presence of either a carboxylic acid function in position 3 and a ketone function in position 4. Furthermore, to expand their spectrum of action and improve pharmacokinetics, a saturated heterocyclic ring containing an amine function was introduced at the 7-position from the second-generation fluoroquinolones.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of Ciprofloxacin, Norfloxacin, and Vosaroxin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Of note, recent evidence indicates that higher doses of these drugs exert anticancer effects,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> and as expected, this effect is related to their ability to interfere with DNA topoisomerase II, the gyrase human counterpart, which is a well-known target of several anticancer drugs, such as epipodophyllotoxins (etoposide), anthracyclines (doxorubicin and daunorubicin), amsacrine, and mitoxantrone. In this view, we envisioned the design and synthesis of a novel class of 4-quinolone-based topoisomerase II inhibitors endowing the enhancement of their cytotoxic activity.</div><div class="NLM_p">SAR studies on anticancer quinolones (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B)<a onclick="showRef(event, 'ref4 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref4 ref13 ref14 ref15">(4,13−15)</a> allowed identifying the types of structure modifications boosting anticancer activity, such as the reduction of their zwitterionic character by modifying the carboxylic group at the 3-position or by adding a proper substituent on the aliphatic heterocyclic amine at the 7-position. Out of these studies, Vosaroxin<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> has reached phase III clinical trial investigation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Interestingly, Vosaroxin, such as other molecules of the same class, appears to be devoid of the typical side effects of topoisomerase II inhibitors, namely, significant cardiotoxicity and cross-resistance with other topoisomerase II inhibitors, while preserving the cytotoxic effect in multidrug-resistant (MDR) or inactivated p53 cell lines.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Antimicrobial (A) and antitumoral (B) structure–activity relationships of 4-quinolones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The combination of different therapeutic functionalities with synergic or additive features within the same molecular scaffold represents a fascinating opportunity to improve the overall treatment efficacy. Furthermore, the possibility of administering a single drug bearing multiple biological “effectors” could allow higher control on pharmacokinetic and side effects while boosting the treatment outcome.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22">(18−22)</a></div><div class="NLM_p">In this context, the use of molecules able to release nitric oxide (NO) under the exclusive control of light, <i>e</i>.<i>g</i>., NO photo-donors, has been recently described for antibacterial and anticancer treatment.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> NO is physiologically produced by the NO synthase enzyme family from <span class="smallcaps smallerCapital">l</span>-arginine and O<sub>2</sub><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and performs multiple physiological roles ranging from the control of the vascular tone to neurotransmission.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Moreover, NO possesses antimicrobial properties<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and has been shown to be a key player in cancer biology, where its role seems to be regulated by several factors, such as the tumor cell subtype, NO cell sensitivity, exposure time, and cellular concentration.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In fact, unlike pico- and nanomolar NO concentrations are known to boost cancer progression and invasiveness, micromolar NO concentrations promote cytotoxicity<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and interfere with P-glycoprotein activity,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> thus representing a promising option to tackle MDR phenomena. Due to the intrinsic difficulties posed by the direct administration of gaseous NO, specific NO donors,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> alone or included in nanomaterials, have been actively investigated.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> In particular, molecules able to release NO upon the application of an external stimulus, such as light, have attracted increasing attention due to the possibility of precisely controlling the NO production and release only at the site of interest.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42">(35−42)</a></div><div class="NLM_p last">Based on the above, we herein report the design, synthesis, characterization, and molecular modeling studies of 12 Cip and Nor derivatives, endowed with a 4-nitro-3-trifluoromethyl-aniline moiety for the light-triggered release of NO. The new derivatives’ biological activity has also been evaluated, both in prokaryotic and tumor cells, along with the effect of NO release on cell viability and compared with Cip and Nor.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design and Synthesis of Novel Ciprofloxacin and Norfloxacin Hybrids</h3><div class="NLM_p">The new Cip and Nor derivatives are characterized by a carboxylic or a methyl ester group at the 3-position and a NO photo-donor directly linked to the <i>N</i>-4 atom of the piperazine ring (compounds <b>1a</b>, <b>1b</b>, <b>3a</b>, and <b>3b</b>) or connected through an alkyl spacer made of two or three methylene units (compounds <b>6a</b>–<b>6d</b> and <b>7a</b>–<b>7d</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. General Structure of Novel Ciprofloxacin and Norfloxacin NO Photo-Donor Hybrids</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0014.gif" alt="" id="gr13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0015.gif" alt="" id="gr14" /></img><div></div></div><div class="NLM_p">The strategy developed for synthesizing final compounds <b>1a</b>, <b>1b</b>, <b>3a</b>, and <b>3b</b> is depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Carboxylic acids <b>1a</b> and <b>1b</b> were prepared following a one-step procedure involving an aromatic nucleophilic substitution between 4-fluoro-1-nitro-2-(trifluoromethyl)benzene and Cip or Nor in DMSO at 120 °C for 1 h. Methyl esters <b>3a</b> and <b>3b</b> were synthesized in two steps, including a Fisher esterification between Cip or Nor with refluxing methanol, and <i>p</i>-toluenesulfonic acid (22 h) to afford esters <b>2a</b> and <b>2b</b> that were subsequently reacted with 4-fluoro-1-nitro-2-(trifluoromethyl)benzene in refluxing acetonitrile overnight to provide final compounds <b>3a</b> and <b>3b</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Strategy for the Synthesis of Compounds <b>1</b>–<b>3a,b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 4-fluoro-1-nitro-2-(trifluoromethyl)benzene, DMSO, 120 °C, 1 h; (ii) CH<sub>3</sub>OH, <i>p</i>-TsOH, 70 °C, 22 h; (iii) 4-fluoro-1-nitro-2-(trifluoromethyl)benzene, CH<sub>3</sub>CN, 80 °C, overnight.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> reports the synthetic pathway to achieve final compounds <b>6a</b>–<b>6d</b> and <b>7a</b>–<b>7d</b>. Starting from 4-fluoro-1-nitro-2-(trifluoromethyl)benzene, intermediates <b>4a</b> and <b>4b</b> were prepared through an aromatic nucleophilic substitution with 2-aminoethanol or 3-aminopropan-1-ol in acetonitrile at 60 °C overnight. Mesylation of the alcoholic function of compounds <b>4a</b> and <b>4b</b> provided the intermediates <b>5a</b> and <b>5b</b> that were reacted with derivatives <b>2a</b> and <b>2b</b> in refluxing acetonitrile overnight. The obtained methyl esters <b>6a</b>–<b>6d</b> were hydrolyzed with a refluxing NaOH aqueous solution (2 M) for 24 h to afford the corresponding carboxylic acids <b>7a</b>–<b>7d</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Strategy for the Synthesis of Final Compounds <b>6a–6d</b> and <b>7a–7d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 1-aminoethanol or 1-aminopropan-3-ol, CH<sub>3</sub>CN, 60 °C, overnight; (ii) CH<sub>3</sub>SO<sub>2</sub>Cl, TEA, dry CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, then room temperature, 1 h; (iii) <b>2a</b> and <b>2b</b>, CH<sub>3</sub>CN, reflux, overnight; (iv) aqueous NaOH 2 M, reflux, 24 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Spectroscopic and Photochemical Characterization of Novel Ciprofloxacin and Norfloxacin Derivatives</h3><div class="NLM_p">To investigate the spectroscopic behavior of the synthesized compounds, carboxylic acids <b>1a</b>, <b>1b</b>, and <b>7a</b>–<b>7d</b> were selected for recording absorption and fluorescence spectra, showing the characteristic peaks at 400 and 450 nm, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf" class="ext-link">Figure S25</a>). The amount of NO released from the selected compounds upon light irradiation was quantified using the Griess assay, in which NO<sub>2</sub>, generated upon the reaction of released NO with oxygen, reacts with the Griess reagent, generating a purple azo dye that can be spectroscopically monitored following its absorption peak at ∼540 nm.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Therefore, aqueous solutions of compounds <b>1a</b>, <b>1b</b>, and <b>7a</b>–<b>7d</b> (80 μM) were treated with the Griess reagent and irradiated with a white lamp for different time intervals (15 min, 1 h, and 2 h). All performed analyses showed the development of a light purple coloration, confirming a weak NO release, especially after 1 h irradiation time. Although the absorption peak of the analyte solution may weakly skew absorbance measurements at 540 nm, the obtained data indicate a trend in NO production; in particular, the amount of NO released seems to be in the order <b>7b</b> > <b>1b</b> > <b>7d</b> > <b>1a</b> = <b>7a</b> > <b>7c</b>. Furthermore, the nitrite concentration was quantified by measuring the absorbance at 540 nm with respect to a standard curve of NaNO<sub>2</sub> in H<sub>2</sub>O. Data reported in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> confirmed a significant nitrite production by <b>7b</b>, <b>1b</b>, and <b>7d</b> following 1 h irradiation, particularly evident for <b>7b</b> ([NO<sub>2</sub><sup>–</sup>] = 6.2 μM), while the extent of NO<sub>2</sub> generated by other compounds was almost negligible. Except for compound <b>1b</b>, these results suggest that longer spacers between the piperazine ring and the NO-donor moiety might favor the NO production yield.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. NO detection by a Griess test. Effects of 80 μM solution of <b>1a</b>, <b>1b</b>, and <b>7a</b>–<b>7d</b> on NO production after 1 h of white light irradiation (mean ± SD of three independent experiments). Nitrite concentration was determined by comparing the test samples’ absorbance values to a standard curve generated by serial dilution of 50 μM NaNO<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vitro</i> Antitumor Activity Evaluation of Novel Fluoroquinolone Derivatives</h3><div class="NLM_p">The effect of the novel hybrid derivatives on cellular viability of a panel of tumor cell lines of different tissue origins (DU145 and PC3: prostate; MCF-7, MCF7/ADR, and MDA-MB231: breast; HCT116: colon) was investigated through the MTT assay following 3 days treatment with the compounds. Histograms reported in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> represent the IC<sub>50</sub> values extrapolated from the corresponding concentration–response curves. In each graph, IC<sub>50</sub> values of new derivatives were compared to the reference compounds, <i>e.g.</i>, Cip or Nor. All compounds showed effects at micromolar concentrations (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf" class="ext-link">Tables S1 and S2</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IC<sub>50</sub> values obtained following 72 h treatment with Ciprofloxacin (C) and its derivatives in the MTT assay (mean ± ES 4/5 independent experiments; *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 <i>vs</i> Cip).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. IC<sub>50</sub> values obtained following 72 h treatment with Norfloxacin (N) and its derivatives in the MTT assay (mean ± ES 4/5 independent experiments; °<i>p</i> < 0.05, °°<i>p</i> < 0.01, °°°<i>p</i> < 0.001 <i>vs</i> Nor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows that all Cip derivatives were significantly more potent than the parent compound in DU145 and PC3 prostate cancer cells in HCT116 colorectal cancer cells (the more potent being compound <b>7b</b>, with an IC<sub>50</sub> = 1.83 μM) and in MDA-MB231 breast cancer cells (IC<sub>50</sub> values lower than 2.50 μM for compounds <b>7a</b> and <b>7b</b>) while only compounds <b>7a</b> and <b>7b</b> were more potent than Cip in MCF7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf" class="ext-link">Table S1</a>). In general, carboxylic acids <b>7a</b> and <b>7b</b>, where the alkyl linker connects the fluoroquinolone scaffold to the NO photo-donor moiety, showed lower IC<sub>50</sub> values when compared to their corresponding methyl esters <b>6a</b> and <b>6b</b>. Specifically, this trend was more pronounced for compound <b>7a</b>, which was 2- to 7-fold more potent than <b>6a</b> in the tested cell lines. In contrast, the difference in potency was lower when comparing <b>6b</b> and <b>7b</b>. These data indicate that a shorter alkyl bridge improves the cytotoxic effect (<b>7a</b><i>vs</i><b>7b</b>). On the other hand, results obtained for methyl esters <b>6a</b> and <b>6b</b> suggest that a longer alkyl chain provides better cytotoxic properties. Finally, compounds lacking the alkyl bridge (<b>1a</b> and <b>3a</b>) displayed an ambiguous trend on the tested cell lines. Indeed, DU145 and HCT116 cell lines were more sensitive to the methyl ester <b>3a</b>, whereas the PC3 and MDA-MB231 cell lines displayed a slight susceptibility toward the carboxylic acid <b>1a</b>.</div><div class="NLM_p">A similar trend was observed for the SAR of the novel Nor hybrids, except for the better activity of carboxylic acid <b>1b</b> in all the tested cell lines when compared to its methyl ester analog <b>3b</b>. In particular, results obtained in DU145 and PC3 cells showed that all Nor derivatives were significantly more potent than the reference compound, with best results obtained for <b>7d</b> in the DU145 cell line (IC<sub>50</sub> = 1.56 μM) and <b>7c</b> in the PC3 cell line (IC<sub>50</sub> = 2.33 μM). In MCF7 and MDA-MB231 cells, compounds <b>1b</b> and <b>7d</b> showed a significantly lower IC<sub>50</sub> than Nor, while <b>7c</b> was the most potent among all the novel hybrids in both breast cancer cell lines (IC<sub>50</sub> = 2.27 and 1.52 μM for MCF7 and MDA-MB231, respectively). Interestingly, in HCT116 cells, only <b>7c</b> and <b>7d</b> resulted to be more potent than Nor (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf" class="ext-link">Table S2</a>).</div><div class="NLM_p">Last, the effects of all the newly synthesized compounds on cell viability were not limited to cancer cell lines; indeed, as shown on <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, which report the IC<sub>50</sub> values obtained by the MTT assay following 72 h treatment with the compounds, also the non-tumorigenic HBL100 and the WH1 fibroblast cell lines responded to Cip, Nor, and to their derivatives at similar extent compared to cancer cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values Obtained with the MTT Assay following 72 h Treatment with Ciprofloxacin (Cip), Norfloxacin (Nor), and Their Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (μM) ± ES<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (μM) ± ES<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center" char="±">WH1</th><th class="colsep0 rowsep0" align="center" char="±">HBL100</th><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center" char="±">WH1</th><th class="colsep0 rowsep0" align="center" char="±">HBL100</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char="±">9.17 ± 0.60</td><td class="colsep0 rowsep0" align="char" char="±">7.79 ± 0.66</td><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char="±">5.35 ± 1.14<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">9.26 ± 1.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char="±">8.38 ± 1.20</td><td class="colsep0 rowsep0" align="char" char="±">10.57 ± 2.40</td><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="char" char="±">9.00 ± 1.91</td><td class="colsep0 rowsep0" align="char" char="±">11.95 ± 1.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char="±">10.5 ± 2.50</td><td class="colsep0 rowsep0" align="char" char="±">9.76 ± 0.90</td><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="char" char="±">10.63 ± 1.90</td><td class="colsep0 rowsep0" align="char" char="±">10.85 ± 0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="char" char="±">13.2 ± 3.40</td><td class="colsep0 rowsep0" align="char" char="±">12.21 ± 2.00</td><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="char" char="±">9.67 ± 1.65</td><td class="colsep0 rowsep0" align="char" char="±">3.68 ± 0.20<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char="±">5.70 ± 0.92</td><td class="colsep0 rowsep0" align="char" char="±">9.14 ± 0.44</td><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="char" char="±">3.51 ± 0.40<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">11.09 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char="±">7.05 ± 1.20</td><td class="colsep0 rowsep0" align="char" char="±">9.19 ± 0.66</td><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="char" char="±">8.94 ± 0.91</td><td class="colsep0 rowsep0" align="char" char="±">10.40 ± 0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cip</td><td class="colsep0 rowsep0" align="char" char="±">14.2 ± 2.10</td><td class="colsep0 rowsep0" align="char" char="±">10.28 ± 1.00</td><td class="colsep0 rowsep0" align="left">Nor</td><td class="colsep0 rowsep0" align="char" char="±">14.07 ± 2.10</td><td class="colsep0 rowsep0" align="char" char="±">12.43 ± 0.80</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Mean ± ES 4/5 independent experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>p</i> < 0.05 <i>vs</i> Nor.</p></div></div></div><div class="NLM_p">To evaluate if NO released upon light irradiation could affect cell viability, the MTT assay was performed on DU145 and PC3 cells following treatment with two compounds that showed interesting potency against the two prostate cancer cell lines and different degrees of NO release. Specifically, the Cip and the Nor derivative that showed to develop the highest and the lowest NO levels by the Griess assay, namely, <b>7b</b> and <b>7c</b>, respectively, were selected for this experiment. Treatment was followed by 1 h irradiation with white or blue light and 48 h incubation in a drug-free medium. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, no differences in IC<sub>50</sub> values were observed in cells treated with <b>7b</b> and <b>7c</b> and irradiated (both with white or blue light) with respect to cells treated and kept in the dark. However, compound <b>7c</b> seems to be more active on DU145 cells when irradiated under blue light with respect to white light.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. IC<sub>50</sub> values obtained following 24 h treatment with compound <b>7b</b> or <b>7c</b> with 1 h irradiation and 48 h incubation in the drug-free medium and MTT assay (mean ± ES 3/4 independent experiments. *<i>p</i> < 0.05 <i>vs</i> white light).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Overall, these results might indicate that the amount of NO released could be inadequate to induce cell death, thus confirming that the NO release does not play an additive role in the new fluoroquinolone derivatives’ toxic effect.</div><div class="NLM_p">A significant obstacle to the successful chemotherapeutic treatment of tumors is their inadequate response to anticancer drugs due to intrinsic or acquired resistance phenomena. Tumor cells can be insensitive to drug treatment at the therapy onset (intrinsic resistance), or they can initially respond to anticancer agents, becoming refractory on subsequent treatment cycles (acquired resistance). For instance, the development of MDR following an initial drug response severely limits the success of doxorubicin (DOX) treatment of breast cancers.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> DOX is an anthracycline antibiotic targeting topoisomerase II and represents a mainstay in clinical management of early-stage and metastatic breast cancer. MDR to DOX involves few biochemical alterations, such as reduced drug accumulation, increased detoxification, increased DNA repair, topoisomerase II alterations, or in cell cycle regulation. In this scenario, identifying MDR-modulating agents or drugs able to escape MDR phenomena is of utmost importance in anticancer research.</div><div class="NLM_p">As expected, the DOX-resistant MCF7/ADR cell line, obtained by selecting MCF7 cells exposed to increasing DOX concentrations, is significantly less sensitive to anthracycline treatment with respect to the wild-type cell line, with a resistance index (R.I.) of 22 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Interestingly, MCF7/ADR cells showed similar sensitivity to several Cip and Nor derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) as observed for the MCF7 cell line, with the best IC<sub>50</sub> values obtained for carboxylic acids <b>1a</b> and <b>1b</b> (8.72 and 5.63 μM, respectively).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. IC<sub>50</sub> values obtained following 72 h treatment with DOX and the MTT assay (mean ± ES 4/5 independent experiments; ***<i>p</i> < 0.001 <i>vs</i> MCF7).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values Obtained with the MTT Assay following 72 h Treatment with DOX and Ciprofloxacin (Cip)/Norfloxacin (Nor) Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" char="." /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (μM) ± ES<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (μM) ± ES<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center" char="±">MCF7</th><th class="colsep0 rowsep0" align="center" char="±">MCF7/ADR</th><th class="colsep0 rowsep0" align="center" char=".">R.I.</th><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center" char="±">MCF7</th><th class="colsep0 rowsep0" align="center" char="±">MCF7/ADR</th><th class="colsep0 rowsep0" align="center" char=".">R.I.</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char="±">8.80 ± 1.59</td><td class="colsep0 rowsep0" align="char" char="±">8.72 ± 1.25</td><td class="colsep0 rowsep0" align="left" char=".">1.0</td><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char="±">5.24<i><sup>b</sup></i> ± 0.70</td><td class="colsep0 rowsep0" align="char" char="±">5.63<i><sup>b</sup></i> ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char="±">15.45 ± 1.20</td><td class="colsep0 rowsep0" align="char" char="±">19.55 ± 3.20</td><td class="colsep0 rowsep0" align="left" char=".">1.3</td><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="char" char="±">11.68 ± 1.40</td><td class="colsep0 rowsep0" align="char" char="±">15.04 ± 2.10</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char="±">16.84 ± 2.40</td><td class="colsep0 rowsep0" align="char" char="±">15.12 ± 2.30</td><td class="colsep0 rowsep0" align="left" char=".">0.9</td><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="char" char="±">15.04 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">17.15 ± 1.00</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="char" char="±">12.12 ± 1.10</td><td class="colsep0 rowsep0" align="char" char="±">18.76 ± 0.10</td><td class="colsep0 rowsep0" align="left" char=".">1.5</td><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="char" char="±">10.53 ± 1.20</td><td class="colsep0 rowsep0" align="char" char="±">28.04 ± 1.10</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char="±">3.12 ± 0.62</td><td class="colsep0 rowsep0" align="char" char="±">14.69 ± 4.20</td><td class="colsep0 rowsep0" align="left" char=".">4.7</td><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="char" char="±">2.27<i><sup>b</sup></i> ± 0.31</td><td class="colsep0 rowsep0" align="char" char="±">18.31 ± 1.40</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char="±">5.23 ± 0.82</td><td class="colsep0 rowsep0" align="char" char="±">23.55 ± 3.60</td><td class="colsep0 rowsep0" align="left" char=".">4.5</td><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="char" char="±">5.83 ± 0.82</td><td class="colsep0 rowsep0" align="char" char="±">20.02 ± 0.30</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cip</td><td class="colsep0 rowsep0" align="char" char="±">8.85 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">19.12 ± 0.50</td><td class="colsep0 rowsep0" align="left" char=".">2.2</td><td class="colsep0 rowsep0" align="left">Nor</td><td class="colsep0 rowsep0" align="char" char="±">19.37 ± 0.70</td><td class="colsep0 rowsep0" align="char" char="±">20.06 ± 1.40</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DOX</td><td class="colsep0 rowsep0" align="char" char="±">0.031 ± 0.001</td><td class="colsep0 rowsep0" align="char" char="±">66.90 ± 2.56</td><td class="colsep0 rowsep0" align="left" char=".">22</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Mean ± ES 4/5 independent experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last"><i>p</i> < 0.05 <i>vs</i> reference compound.</p></div></div></div><div class="NLM_p">In summary, the <i>in vitro</i> experiments showed that derivatives <b>7a</b> and <b>7b</b> are the most effective Cip analogs against all considered cell lines and with respect to the reference compound, indicating that regardless of the linker length, the carboxylic acid moiety outperforms the ester function (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). In line with these results, Nor derivatives <b>7c</b> and <b>7d</b> displayed a similar trend, and compound <b>7c</b> was the best performing of the series (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Cytotoxicity studies performed on MCF7/ADR resistant cell lines confirmed that the carboxylic moiety is essential for the anticancer activity and that only derivatives <b>1a</b> and <b>1b</b>, where the <i>p</i>-nitro-trifluoromethyl aniline is directly linked to the fluoroquinolone scaffold, can provide IC<sub>50</sub> values in the low micromolar range (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Summary of the most potent compounds synthesized in this work with their IC<sub>50</sub> values on the tested cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vitro</i> Antimicrobial Activity on <i>Pseudomonas aeruginosa</i></h3><div class="NLM_p">Considering that fluoroquinolones, such as Cip and Nor, are among the few antibiotics used to control the growth of <i>P. aeruginosa</i>, an opportunistic pathogen representing one of the most relevant agents of nosocomial infections, we preliminarily determined whether the novel derivatives could also be effective against the model strain PAO1. Our results indicate that, while Cip and Nor had minimal inhibitory concentration (MIC) values of 1.82 ± 1.19 and 4.16 ± 1.80 μg/mL, respectively, none of our newly designed derivatives showed antimicrobial activity comparable or better than reference compounds (MIC ∼25 μg/mL). These results might indicate that the fluoroquinolone scaffold’s structural changes compromise the antimicrobial activity, probably due to an impaired interaction with the microbial cell wall and/or with the bacterial target, <i>e.g.</i>, the DNA gyrase. To rule out the first hypothesis, we investigated the ability of our novel compounds to bind the PAO1 cell wall. Binding experiments showed that upon incubation of <i>P. aeruginosa</i> PAO1 cells with our fluoroquinolones, a decrease in absorbance was observed in the supernatants (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf" class="ext-link">Figures S26 and S27</a>), indicating good binding rates with the outer layer of the cell wall. However, it should be underlined that a good interaction between the molecules and the bacterial cell wall is not predictive of an effective uptake.</div><div class="NLM_p">Since most compounds showed an absorption peak in the 390–395 nm region, we next investigated their activity upon irradiation with blue light. For a preliminary evaluation, we selected compound <b>7c</b>, showing the highest absorption peak in the violet-blue range and some degree of activity against DU145 cancer cells. Upon irradiation with a light-emitting diode at 405 ± 10 nm and a fluence not toxic to cells (20 J/cm<sup>2</sup>), compound <b>7c</b> did not show any antimicrobial activity against <i>P. aeruginosa</i> PAO1 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>a), indicating that despite its interaction with the cell wall, this is not sufficient to induce killing by photo-oxidative stress.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Photodynamic treatment of <i>P. aeruginosa</i> PAO1 (a) and <i>S. aureus</i> ATCC 6538P (b). Bacteria were incubated in the dark with or without <b>7c</b> (10 μM) for 10 min and then irradiated under blue light (20 J/cm<sup>2</sup>). Dark controls were not irradiated. Viable cells are expressed as CFU/mL. Values represent the mean of at least three independent experiments, *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It is well established that one of the major challenges in treating Gram-negative bacteria, with respect to the Gram-positive ones, is the difficulty of antimicrobial agents to strongly bind and cross their cell wall, which significantly differs in composition as compared to the latter. In order to shed light on the specific behavior of our fluoroquinolones, we then evaluated the effectiveness of compound <b>7c</b> in killing Gram-positive <i>Staphylococcus aureus</i>. Interestingly, the photoactivation of <b>7c</b> caused a significant (<i>p</i> < 0.05) 2 log unit decrease in <i>S. aureus</i> with respect to the dark incubated control (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>b). This observation might support the hypothesis that compound <b>7c</b> is able to efficiently bind the cell wall and probably cross the cytoplasmic membrane of <i>S. aureus</i>, ultimately inducing a photo-oxidative stress at the cell-wall level and/or at the cytoplasmic level, thus causing cellular death upon light irradiation. This result indirectly further demonstrates that despite the fact that our fluoroquinolones bind the cell wall of <i>P. aeruginosa</i>, this is not sufficient to induce bacterial killing by photoactivation. The selective activity of derivative <b>7c</b> toward Gram-positive bacteria indicates that our derivatives act as neutral antimicrobial photosensitizers (aPSs). In fact, it has been reported that neutral photosensitizers are usually active toward Gram-positive microorganisms and not in the Gram-negative ones, being able to overcome the murein barrier of the first, but not the outer membrane of the cell wall of the latter.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Based on the observed selectivity of <b>7c</b>, it could be hypothesized that despite the fact that molecular modeling studies (see the following paragraph) account for the effective binding of fluoroquinolones with both topoisomerase II and gyrase, their biological activity against <i>P. aeruginosa</i> is hampered by an ineffective uptake. In the future, this could be overcome by incorporating these molecules within suitably designed carriers.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Computational Studies</h3><div class="NLM_p">Molecular modeling studies were carried out to investigate the interactions with the reference cellular and bacterial targets. The calculated free energies of binding (Δ<i>G</i>) to the catalytic site of the human topoisomerase IIα (Topo IIα), bacterial topoisomerase IIA (Topo IIA), and bacterial gyrase (Gyr) for the novel compounds are reported in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. First, the crystal structure of the Topo IIα isoform (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GWK">5GWK</a>) was used for docking studies.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Calculated Free Energies of Binding (Δ<i>G</i>, in kcal/mol) of the Novel Compounds to the Catalytic Sites of Topo IIα, Topo IIA, and Gyr</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="char" char="." /></col><col align="left" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center" char=".">calcd. Δ<i>G</i> human Topo IIα</th><th class="colsep0 rowsep0" align="center" char=".">calcd. Δ<i>G</i> bacterial Topo IIA</th><th class="colsep0 rowsep0" align="center" char=".">calcd. Δ<i>G</i> bacterial Gyr</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">Cip</td><td class="colsep0 rowsep0" align="char" char=".">–9.1</td><td class="colsep0 rowsep0" align="left" char=".">–11.1</td><td class="colsep0 rowsep0" align="char" char=".">–7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">Nor</td><td class="colsep0 rowsep0" align="char" char=".">–8.5</td><td class="colsep0 rowsep0" align="left" char=".">–10.6</td><td class="colsep0 rowsep0" align="char" char=".">–7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char=".">–11.6</td><td class="colsep0 rowsep0" align="left" char=".">–11.8</td><td class="colsep0 rowsep0" align="char" char=".">–8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.8</td><td class="colsep0 rowsep0" align="left" char=".">–10.8</td><td class="colsep0 rowsep0" align="char" char=".">–8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.8</td><td class="colsep0 rowsep0" align="left" char=".">–9.68</td><td class="colsep0 rowsep0" align="char" char=".">–8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>3b</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.7</td><td class="colsep0 rowsep0" align="left" char=".">–12.1</td><td class="colsep0 rowsep0" align="char" char=".">–9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.7</td><td class="colsep0 rowsep0" align="left" char=".">–13.8</td><td class="colsep0 rowsep0" align="char" char=".">–9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6b</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.1</td><td class="colsep0 rowsep0" align="left" char=".">–10.7</td><td class="colsep0 rowsep0" align="char" char=".">–8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6c</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.5</td><td class="colsep0 rowsep0" align="left" char=".">–11.9</td><td class="colsep0 rowsep0" align="char" char=".">–9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6d</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.0</td><td class="colsep0 rowsep0" align="left" char=".">–13.4</td><td class="colsep0 rowsep0" align="char" char=".">–9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char=".">–11.3</td><td class="colsep0 rowsep0" align="left" char=".">–13.8</td><td class="colsep0 rowsep0" align="char" char=".">–9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char=".">–11.4</td><td class="colsep0 rowsep0" align="left" char=".">–14.1</td><td class="colsep0 rowsep0" align="char" char=".">–8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>7c</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.6</td><td class="colsep0 rowsep0" align="left" char=".">–12.9</td><td class="colsep0 rowsep0" align="char" char=".">–9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>7d</b></td><td class="colsep0 rowsep0" align="char" char=".">–13.2</td><td class="colsep0 rowsep0" align="left" char=".">–15.1</td><td class="colsep0 rowsep0" align="char" char=".">–10.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">DOX</td><td class="colsep0 rowsep0" align="char" char=".">–13.5</td><td class="colsep0 rowsep0" align="left" char=".">–12.5</td><td class="colsep0 rowsep0" align="char" char=".">–12.5</td></tr></tbody></table></div></div><div class="NLM_p">All compounds displayed better <i>in silico</i> affinity toward Topo IIα than Cip and Nor, while DOX showed greater affinity, as demonstrated by experimental data. The Cip derivatives have lower free energies of binding than the Nor derivatives, except for compounds <b>6d</b> and <b>7d</b>. The <b>1a</b> carboxyl group coordinates Mg<sup>2+</sup> via a salt bond of 1.73 Å (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A). Furthermore, the complex is stabilized, within the catalytic site, by the H-bond with the Gly760 and Asp541 backbone, while the nitro group establishes electrostatic interactions with Arg487 (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B).</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. 3D superposition of the best-docked pose for <b>1a</b> bound to the Topo IIα (A) and binding site interactions (B). RMSD superposing on the receptor (C) and starting structure (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The protein aids the anchoring of the ligand within the pocket by a cation-π link formed between Arg487 and the nitro group portion of the ligand. The neighboring DNA bases also contribute to the stabilization of the complex.</div><div class="NLM_p">Once the general interaction model was established, equilibrium molecular dynamics (MD) simulations (100 ns) were performed to analyze the Topo IIα/DNA/<b>1a</b> ternary model system’s evolution and stability. The RMSDs of the tertiary structures (Topo IIα/DNA/<b>1a</b>) compared to the first ones at time 0 were analyzed and plotted during the 100 ns MD simulation (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C). The overall RMSD for the protein system appeared to have reached the equilibrium after 10 ns (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>D), and the stabilization of the protein–ligand complex was reached after 7 ns, keeping the complex’s extensive hydrogen-bonding network constant. The energies of binding, calculated by the Molecular Mechanics Poisson–Boltzmann Surface Area (MM/PBSA) methodology (see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>), including the time average, along MD simulation trajectories were employed to assess the strength of the interactions between the ligand and the binding pocket in the dynamic environment. Compound <b>1a</b> shows a stable fluctuation that settles after the first 10 ns and records an average value of −17.4 kcal/mol in the remaining 90 ns (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf" class="ext-link">Figure S28</a>).</div><div class="NLM_p">The docked laying of <b>1b</b> is very similar to that of <b>1a</b> despite a loss of 0.8 kcal/mol, probably due to the ethyl group’s worse stacking. It is interesting to note that compounds <b>7a</b>, <b>7b</b>, and <b>7d</b> have lower calculated free energies of binding than other compounds against human Topo IIα. Indeed, these compounds have shown excellent results in the tested cancer cell lines.</div><div class="NLM_p">All the novel compounds were anchored in the active sites of Topo IIA (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XCT">2XCT</a>) of <i>S. aureus</i> and DNA gyrase B (PBD ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MS1">6MS1</a>) of <i>P. aeruginosa</i>. Anchored poses with the lowest bond energy, hydrogen bonds, noncovalent interactions, such as the π–π interactions, and the details of the π-cationic interactions were recorded and validated.</div><div class="NLM_p last">All the compounds analyzed showed better <i>in silico</i> affinity on bacterial topoisomerase than Cip and Nor, except compound <b>3a</b>, while all compounds showed lower <i>in silico</i> activity against DNA gyrase. Despite the good <i>in silico</i> results, the compounds have a worse antimicrobial activity <i>in vitro</i> than the reference drugs (Cip and Nor). It seems that the novel compounds bind to the outer membrane of the Gram-negative cell wall, but the crossing of the cytoplasmic membrane to reach the cytoplasmic environment and then the molecular target could represent the issue to overcome. Thus, further investigations are needed to shed light on the observed impairment of novel derivatives’ antimicrobial activity.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this work, we successfully managed to design and synthesize twelve novel Cip and Nor derivatives endowed with a NO photo-donor moiety. The light-triggered release of NO has been demonstrated by spectroscopic and photochemical studies, showing the release of this gasotransmitter in the micromolar range, especially for compound <b>7b</b>. Docking studies confirmed that these novel chemical entities effectively bind to both bacterial and human topoisomerases, with better calculated free binding energies with respect to the parent compounds. <i>P. aeruginosa</i> PAO1 was not sensitive to the novel derivatives, and photoactivation experiments support the hypothesis that this could be ascribable to an inefficient uptake.</div><div class="NLM_p">As far as anticancer activity is concerned, all novel fluoroquinolone derivatives displayed strong anticancer potency on a panel of different cancer cell lines, which was especially remarkable for compounds <b>7a</b>–<b>7d</b>. On the other hand, the light-triggered release of NO from compounds <b>7b</b> and <b>7c</b> did not grant an additional cytotoxic effect on PC3 and DU145 prostate cancer cell lines, although a better response to the compounds was observed following blue light irradiation with respect to white light irradiation. Further studies focused on the precise mechanism of action of these compounds and on the role of NO in these cell lines are in progress.</div><div class="NLM_p last">Importantly, our data showed that some of the tested compounds, including compounds <b>1a</b>, <b>1b</b>, and <b>7a</b>–<b>7d</b>, exhibit cytotoxic effects on MDA-MB231 cells, which are representative of triple-negative breast cancer (TNBC), one of the most aggressive and refractory forms of breast cancer. TBNC does not respond to endocrine therapy or other currently available targeted agents;<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48−50)</a> thus, alternative therapeutic options that can selectively address this tumor subset are urgently needed. In this view, the promising results obtained with our novel derivatives on MDA-MB231 cells represent an encouraging starting point for developing and optimizing more effective treatment. Furthermore, compounds <b>1a</b> and <b>1b</b> also displayed a strong cytotoxic effect on DOX-resistant MCF7/ADR breast cancer cells, making these hybrids promising candidates for MDR breast cancer treatment. As expected, most of our fluoroquinolone derivatives displayed a certain extent of toxicity on healthy cells; this issue could be overcome in the future by encapsulating those molecules within suitably designed delivery systems.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Remarks</h3><div class="NLM_p last">Reagent-grade chemicals were purchased from Sigma-Aldrich or Fluorochem and were used without further purification. All reactions were monitored by thin-layer chromatography (TLC) performed on silica gel Merck 60 F254 plates; the spots were visualized by UV light (λ = 254 and 366 nm) and an iodine chamber. Melting points were determined on a Büchi B-450 apparatus in capillary glass tubes and are uncorrected. Flash chromatography purification was performed on a Merck silica gel 60, 0.040–0.063 mm (230–400 mesh) stationary phase using glass columns with a diameter between 1 and 4 cm. Nuclear magnetic resonance spectra (<sup>1</sup>H NMR and <sup>13</sup>C NMR recorded at 500 and 125 MHz, respectively) were obtained on Varian INOVA spectrometers using CDCl<sub>3</sub>, acetone-<i>d</i><sub>6</sub>, CD<sub>3</sub>OD, and DMSO-<i>d</i><sub>6</sub> with a 0.03% of TMS as an internal standard. Coupling constants (<i>J</i>) are reported in hertz. Signal multiplicities are characterized as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), and app (apparent). Purities of all compounds were ≥95% as determined by microanalysis (C, H, and N) that was performed on a Carlo Erba instrument model E1110; all the results agreed within ±0.4% of the theoretical values.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure for the Synthesis of Carboxylic Acids <b>1a</b> and <b>1b</b></h3><div class="NLM_p">To a suspension of Cip or Nor (0.100 g, 0.3 mmol) in 5 mL of DMSO was added 4-fluoro-1-nitro-2-(trifluoromethyl)benzene (0.063 g, 0.3 mmol) under stirring. The color of the suspension immediately turned yellow. The reaction was carried out in a sealed Pyrex vial at 120 °C for 60 min. After cooling to room temperature, the product was precipitated with deionized water and decanted. The solid yellow residue was repeatedly washed in sequence with deionized water, isopropanol, and diethyl ether. The obtained solid was dried under N<sub>2</sub> and did not require any further purification. According to this procedure, the following products have been obtained.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-Cyclopropyl-6-fluoro-7-(4-(4-nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (<b>1a</b>)</h4><div class="NLM_p last">Yellow solid (89%): mp 296–298 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.67 (s, 1H), 8.13 (d, <i>J</i> = 9.5 Hz, 1H), 7.94 (d, <i>J</i> = 13.5 Hz, 1H), 7.59 (d, <i>J</i> = 7.5 Hz, 1H), 7.37 (d, <i>J</i> = 2.5 Hz, 1H), 7.31 (dd, <i>J</i> = 9.5, 2.5 Hz, 1H), 3.86–3.82 (m, 1H), 3.78 (t, <i>J</i> = 5.0 Hz, 4H), 3.54 (t, <i>J</i> = 4.8 Hz, 4H), 1.32 (q, <i>J</i> = 7.0 Hz, 2H), 1.22–1.19 (m, 2H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 176.35, 165.92, 152.89, 148.10, 144.59 (d, <i>J</i><sub>CF</sub> = 9.9 Hz), 139.19, 135.59, 128.85, 124.33, 121.36, 118.59, 115.29, 111.67 (d, <i>J</i><sub>CF</sub> = 5.1 Hz), 111.08 (d, <i>J</i><sub>CF</sub> = 22.3 Hz), 106.76, 106.18, 48.53, 45.96, 35.87, 7.60. Anal. Calcd. for C<sub>24</sub>H<sub>20</sub>F<sub>4</sub>N<sub>4</sub>O<sub>5</sub>: C, 55.39; H, 3.87; N, 10.77. Found: C, 55.42; H, 3.89; N, 10.74.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-Ethyl-6-fluoro-7-(4-(4-nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (<b>1b</b>)</h4><div class="NLM_p last">Yellow solid (74%): mp 310–312 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.97 (s, 1H), 8.13 (d, <i>J</i> = 9.0 Hz, 1H), 7.97 (d, <i>J</i> = 13.0 Hz, 1H), 7.36 (s, 1H), 7.31 (d, <i>J</i> = 9.0 Hz, 1H), 7.22 (d, <i>J</i> = 7.0 Hz, 1H), 4.61 (q, <i>J</i> = 7.0 Hz, 2H), 3.77 (br s, 4H), 3.53 (br s, 4H), 1.43 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 176.25, 166.06, 153.06, 148.58, 144.86, 137.19, 135.77, 128.80, 124.35, 119.81, 119.32, 117.47, 115.32, 111.68 (d, <i>J</i><sub>CF</sub> = 6.25 Hz), 111.42 (d, <i>J</i><sub>CF</sub> = 28.7 Hz), 105.78, 48.64, 46.06, 41.00, 14.29. Anal. Calcd. for C<sub>23</sub>H<sub>20</sub>F<sub>4</sub>N<sub>4</sub>O<sub>5</sub>: C, 54.33; H, 3.96; N, 11.02. Found: C, 54.50; H, 3.94; N, 10.99.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Synthesis of Ciprofloxacin and Norfloxacin Methyl Esters <b>2a</b> and <b>2b</b></h3><div class="NLM_p">To a warmed suspension of the starting fluoroquinolone (1.00 g, 3.00 mmol) in 100 mL of CH<sub>3</sub>OH was dropped <i>p</i>-toluenesulfonic acid (3.00 g, 15.7 mmol) dissolved in 5 mL of CH<sub>3</sub>OH via a syringe. The resulting solution was refluxed for 22 h. The reaction mixture was then cooled to room temperature, and the reaction solvent was removed under vacuum. To the resulting yellow oil was added a saturated solution of Na<sub>2</sub>CO<sub>3</sub> (50 mL), and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated at reduced pressure. The crude was purified by flash chromatography using a CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH gradient eluting system. According to this procedure, the following products have been obtained.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Methyl 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate (<b>2a</b>)</h4><div class="NLM_p last">White solid (91%): mp 230–233 °C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.54 (s, 1H), 8.02 (d, <i>J</i> = 13.3 Hz, 1H), 7.29–7.27 (m, 1H), 3.91 (s, 3H), 3.46–3.42 (m, 1H), 3.29–3.27 (m, 4H), 3.15–3.13 (m, 4H), 2.40 (s, 2H), 1.33 (t, <i>J</i> = 6.5 Hz, 2H), 1.14 (q, <i>J</i> = 6.5 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 173.24, 166.61, 153.61 (d, <i>J</i><sub>CF</sub> = 247.5 Hz), 148.46, 145.15 (d, <i>J</i><sub>CF</sub> = 10.0 Hz), 138.18, 123.14 (d, <i>J</i><sub>CF</sub> = 7.5 Hz), 113.46 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 110.21, 104.87, 52.20, 51.19, 46.06, 34.65, 8.28. Anal. Calcd for C<sub>18</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>3</sub>: C, 62.60; H, 5.84; N, 12.17. Found: C, 62.78; H, 5.86; N, 12.19.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl 1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate (<b>2b</b>)</h4><div class="NLM_p last">White solid (92%): mp 189–190 °C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.42 (s, 1H), 8.06 (d, <i>J</i> = 13.0 Hz, 1H), 6.73 (d, <i>J</i> = 7.0 Hz, 1H), 4.20 (q, <i>J</i> = 7.5 Hz, 2H), 3.92 (s, 3H), 3.22–3.21 (m, 4H), 3.10–3.08 (m, 4H), 1.92 (s, 2H), 1.54 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 173.15, 166.72, 153.39 (d, <i>J</i><sub>CF</sub> = 238.0 Hz), 148.30, 145.36 (d, <i>J</i><sub>CF</sub> = 10.5 Hz), 136.22, 123.87 (d, <i>J</i><sub>CF</sub> = 6.6 Hz), 113.80 (d, <i>J</i><sub>CF</sub> = 22.9 Hz), 110.26, 103.85, 52.17, 51.36, 49.10, 46.09, 14.50. Anal. Calcd for C<sub>17</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>3</sub>: C, 61.25; H, 6.05; N, 12.61. Found: C, 61.32; H, 6.06; N, 12.58.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for the Synthesis of Methyl Esters <b>3a</b> and <b>3b</b></h3><div class="NLM_p">To a solution of the appropriate fluoroquinolone methyl ester (<b>2a</b> or <b>2b</b>) in anhydrous CH<sub>3</sub>CN (10 mL) at 40 °C was added 4-fluoro-1-nitro-2-(trifluoromethyl)benzene under stirring. The color of the solution immediately turned yellow. The temperature was raised up to 80 °C, and the reaction mixture was left under stirring overnight. The solvent was evaporated, and the crude was diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and washed with deionized water (3 × 25 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and reduced under vacuum. The residue was purified by flash chromatography using a CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH gradient eluting system. According to this procedure, the following products have been obtained.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Methyl 1-Cyclopropyl-6-fluoro-7-(4-(4-nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>3a</b>)</h4><div class="NLM_p last">The title compound was obtained using 0.265 g (0.77 mmol) of <b>2a</b> and 0.172 g (0.82 mmol) of 4-fluoro-1-nitro-2-(trifluoromethyl)benzene. Yellow solid (61%): mp 265–267 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.44 (s, 1H), 8.12 (d, <i>J</i> = 9.5 Hz, 1H), 7.78 (d, <i>J</i> = 13.5 Hz, 1H), 7.47 (d, <i>J</i> = 7.5 Hz, 1H), 7.37 (d, <i>J</i> = 2.5 Hz, 1H), 7.31 (dd, <i>J</i> = 9.5, 2.5 Hz, 1H), 3.77–3.74 (m, 4H), 3.73 (s, 3H), 3.68–3.63 (m, 1H), 3.44–3.42 (m, 4H), 1.27–1.23 (m, 2H), 1.13–1.10 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 173.12, 166.52, 153.44 (d, <i>J</i><sub>CF</sub> = 247.5 Hz), 153.15, 148.65, 143.88 (d, <i>J</i><sub>CF</sub> = 12.5 Hz), 138.15 (d, <i>J</i><sub>CF</sub> = 10.0 Hz), 128.70, 126.46 (d, <i>J</i><sub>CF</sub> = 33.8 Hz), 123.9 (d, <i>J</i><sub>CF</sub> = 7.5 Hz), 123.47, 121.29, 115.41, 113.91 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 112.72 (d, <i>J</i><sub>CF</sub> = 6.3 Hz), 110.56, 105.03, 52.30, 49.54, 47.29, 34.67, 8.36. Anal. Calcd. for C<sub>25</sub>H<sub>22</sub>F<sub>4</sub>N<sub>4</sub>O<sub>5</sub>: C, 56.18; H, 4.15; N, 10.48. Found: C, 56.31; H, 4.13; N, 10.51.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl 1-Ethyl-6-fluoro-7-(4-(4-nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>3b</b>)</h4><div class="NLM_p last">The title compound was obtained using 0.500 g (1.5 mmol) of <b>2b</b> and 0.314 g (1.5 mmol) of 4-fluoro-1-nitro-2-(trifluoromethyl)benzene. Yellow solid (52%): mp 236–238 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.65 (s, 1H), 8.12 (d, <i>J</i> = 9.0 Hz, 1H), 7.83 (d, <i>J</i> = 13.0 Hz, 1H), 7.37 (d, <i>J</i> = 2.5 Hz, 1H), 7.31 (dd, <i>J</i> = 9.5, 3.0 Hz, 1H), 7.08 (d, <i>J</i> = 7.0 Hz, 1H), 4.42 (q, <i>J</i> = 7.0 Hz, 2H), 3.76–3.74 (m, 7H), 3.43–3.41 (m, 4H), 1.38 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.46, 165.10, 153.28, 152.93, 151.31, 148.85, 143.63 (d, <i>J</i><sub>CF</sub> = 10.0 Hz), 136.16, 135.54, 128.83, 124.59, 123.54, 122.74 (d, <i>J</i><sub>CF</sub> = 6.3 Hz), 115.34, 111.92 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 111.72 (d, <i>J</i><sub>CF</sub> = 6.3 Hz), 109.15, 105.88, 51.16, 48.86, 48.05, 46.17, 14.23. Anal. Calcd. for C<sub>24</sub>H<sub>22</sub>F<sub>4</sub>N<sub>4</sub>O<sub>5</sub>: C, 55.17; H, 4.24; N, 10.72. Found: C, 55.28; H, 4.25; N, 10.75.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-((4-Nitro-3-(trifluoromethyl)phenyl)amino)ethanol (<b>4a</b>)</h4><div class="NLM_p last">To a solution of 2-aminoethanol (1.00 g, 16.4 mmol) in anhydrous CH<sub>3</sub>CN (10 mL) was added 4-fluoro-1-nitro-2-(trifluoromethyl)benzene (2.32 g, 11.1 mmol). The reaction was left under stirring at 60 °C overnight. Then, the reaction solvent was removed under reduced pressure and the residue was dissolved in EtOAc and washed with a saturated solution of NaHCO<sub>3</sub> (3 × 25 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The crude was purified by flash chromatography eluting with a 20% of Cy in EtOAc to give the desired product. Yellow solid (72%): <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ 8.01 (d, <i>J</i> = 9.0 Hz, 1H), 7.04 (d, <i>J</i> = 2.5 Hz, 1H), 6.81 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 3.74 (t, <i>J</i> = 5.5 Hz, 2H), 3.35 (t, <i>J</i> = 5.5 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD): δ 154.65, 136.41, 130.34, 127.27 (t, <i>J</i><sub>CF</sub> = 18.4 Hz), 125.08, 122.92, 113.05, 112.26, 61.15, 46.26. Anal. Calcd. for C<sub>9</sub>H<sub>9</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub>: C, 43.21; H, 3.63; N, 11.20. Found: C, 43.12; H, 3.64; N, 11.22.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-((4-Nitro-3-(trifluoromethyl)phenyl)amino)propan-1-ol (<b>4b</b>)</h4><div class="NLM_p last">To a solution of 3-aminopropan-1-ol (0.143 g, 1.90 mmol) in anhydrous CH<sub>3</sub>CN (5 mL) was added 4-fluoro-1-nitro-2-(trifluoromethyl)benzene (0.200 g, 0.95 mmol). The reaction was left under stirring at 60 °C for 12 h in a closed glass Pyrex vial. After the reaction was complete, the reaction solvent was removed under reduced pressure and the residue was repeatedly triturated with <i>n</i>-hexane till the formation of a yellow solid. The solid was decanted, solubilized in EtOAc, and washed with a saturated solution of NaHCO<sub>3</sub> (3 × 25 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and reduced under pressure, affording the pure desired product that did not require any further purification. Yellow solid (quantitative): <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>): δ 8.03 (d, <i>J</i> = 8.5 Hz, 1H), 7.09 (d, <i>J</i> = 3.0 Hz, 1H), 6.88 (dd, <i>J</i> = 6.5, 3.0 Hz, 1H), 6.67 (br s, 1H), 3.82–3.68 (m, 3H), 3.40 (q, <i>J</i> = 6.5 Hz, 2H), 1.90–1.85 (m, 2H); <sup>13</sup>C NMR (125 MHz, acetone-<i>d</i><sub>6</sub>): δ 154.19, 136.02, 130.26, 126.74 (t, <i>J</i><sub>CF</sub> = 38.3 Hz), 123.68 (d, <i>J</i><sub>CF</sub> = 270.8 Hz), 112.00 (d, <i>J</i><sub>CF</sub> = 145.5 Hz), 60.01, 40.97, 29.45. Anal. Calcd. for C<sub>10</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub>: C, 45.46; H, 4.20; N, 10.60. Found: 45.33; H, 4.21; N, 10.63.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for the Synthesis of Methanesulfonates <b>5a</b> and <b>5b</b></h3><div class="NLM_p">To a solution of the appropriate alcohol (<b>4a</b> or <b>4b</b>) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> was added TEA at 0 °C. The reaction mixture was left under stirring for 30 min, and then methanesulfonyl chloride was added dropwise using a dropping funnel. The reaction was left under stirring at room temperature for 60 min. After this time, the solvent was removed under reduced pressure, the resulting residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed in sequence with a saturated solution of NH<sub>4</sub>Cl (25 mL) and a saturated solution of NaHCO<sub>3</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude products were directly used in the next step with no further purification or characterization. According to this procedure, the following products have been synthesized.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-((4-Nitro-3-(trifluoromethyl)phenyl)amino)ethyl Methanesulfonate (<b>5a</b>)</h4><div class="NLM_p last">The title compound was obtained using 0.100 g (0.4 mmol) of <b>4a</b> in 5 mL of anhydrous CH<sub>2</sub>Cl<sub>2</sub>, 166 μL (1.2 mmol) of TEA, and 62 μL (0.8 mmol) of methanesulfonyl chloride. Yellow oil (quantitative).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-((4-Nitro-3-(trifluoromethyl)phenyl)amino)propyl Methanesulfonate (<b>5b</b>)</h4><div class="NLM_p last">The title compound was obtained using 0.300 g (1.13 mmol) of <b>4b</b> in 10 mL of anhydrous CH<sub>2</sub>Cl<sub>2</sub>, 0.345 g (3.40 mmol) of TEA, and 0.328 g (2.26 mmol) of methanesulfonyl chloride. Yellow oil (quantitative).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Synthesis of Methyl Esters <b>6a</b>–<b>6d</b></h3><div class="NLM_p">In a two-neck round-bottom flask, the appropriate fluoroquinolone methyl ester (<b>2a</b> or <b>2b</b>) was added to the appropriate methanesulfonate solution (<b>5a</b> or <b>5b</b>) in anhydrous CH<sub>3</sub>CN under a N<sub>2</sub> atmosphere. The reaction mixture was refluxed under stirring overnight. Then, the solvent was removed under reduced pressure, and a saturated solution of NaHCO<sub>3</sub> was added to the residue. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 25 mL), and then the organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude was purified by flash chromatography using a CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH gradient eluting system. According to this procedure, the following products have been obtained.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Methyl 1-Cyclopropyl-6-fluoro-7-(4-(2-((4-nitro-3-(trifluoromethyl)phenyl)amino)ethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>6a</b>)</h4><div class="NLM_p last">The title compound was synthesized using 0.276 g (0.8 mmol) of <b>2a</b> in 15 mL of anhydrous CH<sub>3</sub>CN and 0.129 g (0.39 mmol) of <b>5a</b>. Yellow solid (69%): mp 231–233 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.44 (s, 1H), 8.08 (d, <i>J</i> = 9.5 Hz, 1H), 7.75 (d, <i>J</i> = 13.0 Hz, 1H), 7.47 (t, <i>J</i> = 5.0 Hz, 1H), 7.43 (d, <i>J</i> = 7.5 Hz, 1H), 7.16 (s, 1H), 6.88 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 3.73 (s, 3H), 3.66–3.62 (m, 1H), 3.37 (app. q, <i>J</i> = 6.0 Hz, 2H), 3.28–3.24 (m, 4H), 2.70–2.65 (m, 4H), 2.63 (t, <i>J</i> = 6.0 Hz, 2H), 1.26–1.24 (m, 2H), 1.11–1.08 (m, 2H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.52, 164.95, 153.57, 152.38 (d, <i>J</i><sub>CF</sub> = 193.0 Hz), 148.22, 143.85 (d, <i>J</i><sub>CF</sub> = 9.6 Hz), 138.05, 133.55, 129.70, 124.82 (d, <i>J</i><sub>CF</sub> = 32.9 Hz), 123.63, 121.79 (d, <i>J</i><sub>CF</sub> = 6.1 Hz), 121.46, 111.50 (d, <i>J</i><sub>CF</sub> = 22.6 Hz), 108.98, 106.18, 55.97, 52.42, 51.23, 49.52, 34.71, 7.51. Anal. Calcd. for C<sub>27</sub>H<sub>27</sub>F<sub>4</sub>N<sub>5</sub>O<sub>5</sub>: C, 56.15; H, 4.71; N, 12.13. Found: C, 55.94; H, 4.70; N, 12.17.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Methyl 1-Cyclopropyl-6-fluoro-7-(4-(3-((4-nitro-3-(trifluoromethyl)phenyl)amino)propyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>6b</b>)</h4><div class="NLM_p last">The title compound was synthesized using 0.350 g (1.01 mmol) of <b>2a</b> in 15 mL of anhydrous CH<sub>3</sub>CN and 0.195 g (0.57 mmol) of <b>5b</b>. Yellow solid (50%): mp 202–204 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.44 (s, 1H), 8.08 (d, <i>J</i> = 9.5 Hz, 1H), 7.75 (d, <i>J</i> = 13.5 Hz, 1H), 7.59 (t, <i>J</i> = 5.5 Hz, 1H), 7.43 (d, <i>J</i> = 7.5 Hz, 1H), 7.07 (s, 1H), 6.85 (dd, <i>J</i> = 9.5, 2.5 Hz, 1H), 3.73 (s, 3H), 3.67–3.62 (m, 1H), 3.29–3.23 (m, 6H), 2.61–2.56 (m, 4H), 2.46 (t, <i>J</i> = 7.0 Hz, 2H), 1.77 (m, 2H), 1.27–1.23 (m, 2H), 1.11–1.08 (m, 2H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.53, 164.96, 152.42 (d, <i>J</i><sub>CF</sub> = 203.8 Hz), 148.22, 143.88 (d, <i>J</i><sub>CF</sub> = 10.0 Hz), 138.06, 133.38, 129.77, 125.02, 123.62, 121.77 (d, <i>J</i><sub>CF</sub> = 6.3 Hz), 121.45, 111.50 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 108.99, 106.16, 54.87, 52.48, 51.24, 49.57, 40.42, 34.70, 25.40, 7.51. Anal. Calcd. for C<sub>28</sub>H<sub>29</sub>F<sub>4</sub>N<sub>5</sub>O<sub>5</sub>: C, 56.85; H, 4.94; N, 11.84. Found: C, 57.01; H, 4.95; N, 11.81.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl 1-Ethyl-6-fluoro-7-(4-(2-((4-nitro-3-(trifluoromethyl)phenyl)amino)ethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>6c</b>)</h4><div class="NLM_p last">The title compound was synthesized using 0.400 g (1.2 mmol) of <b>2b</b> in 15 mL of anhydrous CH<sub>3</sub>CN and 0.197 g (0.6 mmol) of <b>5a</b>. Yellow solid (61%): mp 245–247 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.64 (s, 1H), 8.08 (d, <i>J</i> = 9.5 Hz, 1H), 7.79 (d, <i>J</i> = 13.5 Hz, 1H), 7.47 (t, <i>J</i> = 5.0 Hz, 1H), 7.15 (s, 1H), 7.03 (d, <i>J</i> = 7.0 Hz, 1H), 6.88 (dd, <i>J</i> = 9.5, 2.5 Hz, 1H), 4.40 (q, <i>J</i> = 7.0 Hz, 2H), 3.73 (s, 3H), 3.37 (q, <i>J</i> = 6.0 Hz, 2H), 3.27–3.25 (m, 4H), 2.67–2.65 (m, 4H), 2.62 (t, <i>J</i> = 6.0 Hz, 2H), 1.37 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.46, 165.11, 153.40, 152.29 (d, <i>J</i><sub>CF</sub> = 213.5 Hz), 148.78, 144.16 (d, <i>J</i><sub>CF</sub> = 10.3 Hz), 136.16, 133.53, 129.71, 124.81 (d, <i>J</i><sub>CF</sub> = 31.9 Hz), 123.62, 122.54 (d, <i>J</i><sub>CF</sub> = 6.3 Hz), 121.45, 111.81 (d, <i>J</i><sub>CF</sub> = 22.4 Hz), 109.10, 105.69, 55.96, 52.45, 51.14, 49.54, 48.02, 14.19. Anal. Calcd. for C<sub>26</sub>H<sub>27</sub>F<sub>4</sub>N<sub>5</sub>O<sub>5</sub>: C, 55.22; H, 4.81; N, 12.38. Found: C, 55.40; H, 4.80; N, 12.40.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl 1-Ethyl-6-fluoro-7-(4-(3-((4-nitro-3-(trifluoromethyl)phenyl)amino)propyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>6d</b>)</h4><div class="NLM_p last">The title compound was synthesized using 0.465 g (1.4 mmol) of <b>2b</b> in 15 mL of anhydrous CH<sub>3</sub>CN and 0.240 g (0.7 mmol) of <b>5b</b>. Yellow solid (50%): mp 216–218 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.64 (s, 1H), 8.08 (d, <i>J</i> = 9.5 Hz, 1H), 7.78 (d, <i>J</i> = 13.5 Hz, 1H), 7.59 (t, <i>J</i> = 5.5 Hz, 1H), 7.07 (s, 1H), 7.03 (d, <i>J</i> = 7.0 Hz), 6.84 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 4.40 (q, <i>J</i> = 7.0 Hz, 2H), 3.73 (s, 3H), 3.28–3.20 (m, 6H), 2.60–2.54 (br m, 4H), 2.45 (t, <i>J</i> = 7.0 Hz, 2H), 1.77 (m, 2H), 1.37 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.47, 165.11, 153.40, 152.33 (d, <i>J</i><sub>CF</sub> = 223.4 Hz), 148.78, 144.18 (d, <i>J</i><sub>CF</sub> = 10.3 Hz), 136.16, 133.37, 129.81, 125.00, 123.61, 122.52 (d, <i>J</i><sub>CF</sub> = 6.3 Hz), 121.44, 111.79 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 109.10, 105.66, 54.88, 52.50, 51.14, 49.60, 48.01, 40.43, 25.39, 14.19. Anal. Calcd. for C<sub>27</sub>H<sub>29</sub>F<sub>4</sub>N<sub>5</sub>O<sub>5</sub>: C, 55.96; H, 5.04; N, 12.08. Found: C, 56.08; H, 5.05; N, 12.06.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Procedure for the Synthesis of Carboxylic Acids <b>7a</b>–<b>7d</b></h3><div class="NLM_p">In a round-bottom flask, the appropriate methyl ester (<b>6a</b>–<b>6d</b>) and a solution of 2 M NaOH were refluxed for 24 h under vigorous stirring. After this time, the reaction mixture was cooled, and a solution of 2 M HCl was added up to the isoelectric point. The obtained precipitate was filtered under vacuum and washed in sequence with deionized water, isopropanol, and diethyl ether. The solid was then purified by flash chromatography using a CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH gradient eluting system. According to this procedure, the following products have been obtained.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-Cyclopropyl-6-fluoro-7-(4-(2-((4-nitro-3-(trifluoromethyl)phenyl)amino)ethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (<b>7a</b>)</h4><div class="NLM_p last">The title compound was obtained starting from 0.159 g (0.28 mmol) of <b>6a</b> and 25 mL of 2 M NaOH. Yellow solid (75%): mp 229–231 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.59 (s, 1H), 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 7.83 (d, <i>J</i> = 13.5 Hz, 1H), 7.52–7.47 (m, 2H), 7.16 (s, 1H), 6.89 (d, <i>J</i> = 8.5 Hz, 1H), 3.70 (br s, 1H), 3.29 (m, 6H), 2.70–2.65 (br s, 4H), 2.63 (t, <i>J</i> = 5.5 Hz, 2H), 1.28–1.27 (br m, 2H), 1.09 (br s, 2H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 175.45, 166.42, 153.18, 147.48, 146.44, 138.66, 133.53, 129.73, 124.96, 124.71, 123.65, 119.32, 111.11 (d, <i>J</i><sub>CF</sub> = 21.3 Hz), 105.87, 55.97, 53.84, 52.43, 49.53, 40.11, 7.53. Anal. Calcd. for C<sub>26</sub>H<sub>25</sub>F<sub>4</sub>N<sub>5</sub>O<sub>5</sub>: C, 55.42; H, 4.47; N, 12.43. Found: C, 55.61; H, 4.48; N, 12.40.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-Cyclopropyl-6-fluoro-7-(4-(3-((4-nitro-3-(trifluoromethyl)phenyl)amino)propyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (<b>7b</b>)</h4><div class="NLM_p last">The title compound was obtained starting from 0.112 g (0.19 mmol) of <b>6b</b> and 25 mL of 2 M NaOH. Yellow solid (74%): mp 235–237 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.66 (s, 1H), 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 7.90 (d, <i>J</i> = 13.0 Hz, 1H), 7.63 (s, 1H), 7.57 (d, <i>J</i> = 7.0 Hz, 1H), 7.08 (s, 1H), 6.86 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 3.86–3.80 (br m, 1H), 3.41–3.33 (br s, 4H), 3.29–3.25 (m, 2H), 2.61 (br s, 4H), 2.48–2.42 (br m overlapped with DMSO, 2H), 1.79 (br s, 2H), 1.33–1.30 (m, 2H), 1.20–1.17 (m, 2H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 176.32, 165.88, 153.96, 152.59 (d, <i>J</i><sub>CF</sub> = 152.5 Hz), 147.99, 139.15, 133.40, 129.79, 124.8 (d, <i>J</i><sub>CF</sub> = 32.5 Hz), 123.61, 121.44, 118.57, 110.94 (d, <i>J</i><sub>CF</sub> = 23.8 Hz), 106.73, 106.33, 54.88, 52.25, 50.63, 40.34, 35.84, 28.99, 7.55. Anal. Calcd. for C<sub>27</sub>H<sub>27</sub>F<sub>4</sub>N<sub>5</sub>O<sub>5</sub>: C, 56.15; H, 4.71; N, 12.13. Found: C, 56.02; H, 4.70; N, 12.15.</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-Ethyl-6-fluoro-7-(4-(2-((4-nitro-3-(trifluoromethyl)phenyl)amino)ethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (<b>7c</b>)</h4><div class="NLM_p last">The title compound was obtained starting from 0.177 g (0.31 mmol) of <b>6c</b> and 25 mL of 2 M NaOH. Yellow solid (62%): mp 225–227 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.94 (s, 1H), 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.91 (d, <i>J</i> = 13.5 Hz, 1H), 7.47 (t, <i>J</i> = 5.5 Hz, 1H), 7.21–7.14 (m, 2H), 6.88 (dd, <i>J</i> = 9.5, 2.0 Hz, 1H), 4.58 (q, <i>J</i> = 7.0 Hz, 2H), 3.39–3.33 (m, 6H), 2.69–2.65 (m, 4H), 2.63 (t, <i>J</i> = 6.0 Hz, 2H), 1.41 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 176.12, 166.08, 153.84, 152.50 (d, <i>J</i><sub>CF</sub> = 160.0 Hz), 148.47, 145.42 (d, <i>J</i><sub>CF</sub> = 10.0 Hz), 137.18, 133.54, 129.71, 124.82 (d, <i>J</i><sub>CF</sub> = 32.5 Hz), 123.63, 121.46, 119.19 (d, <i>J</i><sub>CF</sub> = 7.5 Hz), 111.15 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 107.06, 105.76, 55.93, 52.37, 49.45, 49.42, 49.03, 14.29. Anal. Calcd. for C<sub>25</sub>H<sub>25</sub>F<sub>4</sub>N<sub>5</sub>O<sub>5</sub>: C, 54.45; H, 4.57; N, 12.70. Found: C, 54.31; H, 4.56; N, 12.66.</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-Ethyl-6-fluoro-7-(4-(3-((4-nitro-3-(trifluoromethyl)phenyl)amino)propyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (<b>7d</b>)</h4><div class="NLM_p last">The title compound was obtained starting from 0.077 g (0.13 mmol) of <b>6d</b> and 25 mL of 2 M NaOH. Yellow solid (36%): mp 249–251 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.94 (s, 1H), 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.91 (d, <i>J</i> = 13.5 Hz, 1H), 7.59 (s, 1H), 7.17 (s, 1H), 7.06 (s, 1H), 6.84 (br m,1H), 4.59 (app s, 2H), 3.29–3.21 (br m, 6H), 2.62–2.53 (br m, 4H), 2.46 (t, <i>J</i> = 6.0 Hz, 2H), 1.81–1.73 (br m, 2H), 1.42 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 176.14, 166.04, 153.77, 152.44 (d, <i>J</i><sub>CF</sub> = 163.8 Hz), 148.59, 137.16, 133.55, 129.76, 126.58, 125.47, 124.85 (d, <i>J</i><sub>CF</sub> = 31.3 Hz), 123.60, 121.43, 119.26, 111.27 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 107.12, 69.77, 49.07, 33.65, 31.26, 28.98, 22.06, 14.38. Anal. Calcd. for C<sub>26</sub>H<sub>27</sub>F<sub>4</sub>N<sub>5</sub>O<sub>5</sub>: C, 55.22; H, 4.81; N, 12.38. Found: C, 55.07; H, 4.82; N, 12.35.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Griess Test</h3><div class="NLM_p last">The stock solution of the Griess reagent (purchased by Sigma Aldrich Srl) was obtained by dissolving 200 mg of the powder in 5 mL of H<sub>2</sub>O MilliQ. For nitrite quantification, each selected compound was dissolved in anhydrous DMSO to obtain a 1 mM solution (A). Subsequently, 160 μL of each solution A was diluted with 840 μL of H<sub>2</sub>O MilliQ to obtain solution B (160 μM). A total of 500 μL of B was then added to a quartz cuvette containing 500 μL of Griess reagent solution (80 μM). The resulting solutions were then irradiated with a 300 W tungsten lamp at a distance of 40 cm for 15 min, 1 h, and 2 h, recording the absorbance spectrum of each sample at each time point and reading the peak increase at 540 nm. The relationship of absorbance and concentrations of nitrite was constructed by drawing a standard curve using the known concentrations of NaNO<sub>2</sub> (5, 10, 20, 30, 40, and 50 μM).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Cell Lines and <i>In Vitro</i> Culture Conditions</h3><div class="NLM_p last">The cell lines DU145 (HTB-81, human prostate carcinoma), PC3 (CRL-1435, human prostate adenocarcinoma), MCF7 (HTB-22, human breast adenocarcinoma), MDA-MB231 (HTB-26, human breast adenocarcinoma), and HCT116 (CCL-247, human colorectal carcinoma) were obtained from ATCC (American Type Culture Collection, Manassas, VA, USA); WH1 human fibroblasts were kindly provided by Dr. Guven.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> All the cells were maintained under standard culture conditions (37 °C; 5% CO<sub>2</sub>) in the RMPI1640 medium (PC3, MCF7, and MDA-MB231 cells), while DU145 and HCT116 cells were in the DMEM and Iscove’s medium (WH1 cells) supplemented with 10% fetal calf serum, 1% glutamine, and 1% antibiotics mixture; for HCT116 and DU145 cells, 1% sodium pyruvate and 1% non-essential amino acids were also added to the culture medium.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Cell Viability Assay</h3><div class="NLM_p">The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed on all the cell lines tested as previously described<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> with minor modifications. Briefly, according to the growth profiles previously defined for each cell line, adequate numbers of cells were plated in each well of a 96-well plate in 0.1 mL of complete culture medium. Cells were allowed to attach for 24 h before the treatment at 37 °C for 72 h with the compounds at concentrations ranging between 0.1 and 75 μM, bringing the final volume to 0.2 mL/well. Each experiment included eight replications per concentration tested; control samples were run with 0.2% DMSO. At the end of the incubation period, MTT (0.05 mL of a 2 mg/mL stock solution in PBS) was added to each well for 3 h at 37 °C. Cell supernatants were then carefully removed, the blue formazan crystals formed through MTT reduction by metabolically active cells were dissolved in 0.120 mL of DMSO, and the corresponding optical densities were measured at 570 nm using a Universal Microplate Reader EL800 (Bio-Tek, Winooski, VT).</div><div class="NLM_p">To evaluate the contribution of NO release on cell viability, the MTT assay was performed on DU145 and PC3 cells following treatment with <b>7b</b> and <b>7c</b> with 1 h irradiation and 48 h incubation in a drug-free medium.</div><div class="NLM_p last">IC<sub>50</sub> values were estimated from the resulting concentration–response curves by nonlinear regression analysis using GraphPad Prism software, v. 5.0 (GraphPad, San Diego, CA, USA). Differences between IC<sub>50</sub> values were evaluated statistically by analysis of variance with a Bonferroni post-test for multiple comparisons.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Minimum Inhibitory Concentration Determination</h3><div class="NLM_p last"><i>P. aeruginosa</i> PAO1 was chosen as a model microorganism<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and was grown overnight in a Luria Bertani (LB) medium at 37 °C on an orbital shaker at 200 rpm. Minimum inhibitory concentrations (MICs) of quinolone and quinolone derivatives were determined against <i>P. aeruginosa</i> PAO1 by a broth dilution method. Overnight cultures were diluted 100-fold to give a cellular concentration of 10<sup>7</sup> CFU/mL. Decreasing concentrations of compounds, from 200 to 0.1 μg/mL, were added to bacterial samples in a two-fold dilution series. Upon 24 h of incubation at 37 °C, the bacterial samples were observed for microbial growth, and MIC values were determined as minimal concentrations of drugs at which no turbidity was detectable. The assays were performed at least three times.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Bacterial Binding Assay</h3><div class="NLM_p last">The relative efficiency of fluoroquinolone and derivatives in binding <i>P. aeruginosa</i> cells was determined by an indirect method.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a><i>P. aeruginosa</i> PAO1 overnight cultures were centrifuged (5000 rpm for 10 min), and the supernatant was removed. Pellets were suspended and 10-fold diluted in PBS. Fluoroquinolone and fluoroquinolone derivatives were administered at 10 μM and incubated for 1 h at 37 °C in the dark to allow the interaction between the compounds and cells. After dark incubation, samples were centrifuged (10,000 rpm for 10 min), and the visible spectra of the supernatant were recorded (<i>k</i> = 380–700 nm) and compared with the corresponding visible spectrum of each compound.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Antimicrobial Photo-Inactivation Test</h3><div class="NLM_p last">Upon the overnight growth of <i>P. aeruginosa</i> PAO1 and <i>S. aureus</i> ATCC6538P (methicillin susceptible <i>S. aureus</i>, MSSA), cultures were diluted in phosphate buffer (PBS–KH<sub>2</sub>PO<sub>4</sub>/K<sub>2</sub>HPO<sub>4</sub>, 10 mM, pH 7.4) to reach a concentration of ∼10<sup>6</sup> CFU/mL. Compound <b>7c</b> was added to a cell suspension at a final concentration of 10 μM. Cells were incubated in the dark for 10 min and then irradiated under light at 410 ± 10 nm (20 J/cm<sup>2</sup>) or incubated in the dark as a control. Soon after irradiation, the bacterial concentration was evaluated by the viability count technique. Briefly, an aliquot of each sample was 10-fold serially diluted in PBS and a volume of 10 μL of each diluted and undiluted sample was inoculated on LB agar. After overnight incubation at 37 °C, the corresponding cellular concentration was calculated and expressed as CFU/mL.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Molecular Docking</h3><div class="NLM_p last">Flexible ligand docking experiments were performed employing AutoDock 4.2.6 software implemented in YASARA (v. 19.5.5, YASARA Biosciences GmbH, Vienna, Austria)<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> using the crystal structure of the human Topo IIα (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GWK">5GWK</a>), bacterial Topo IIA (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XCT">2XCT</a>), and bacterial DNA gyrase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M1S">6M1S</a>) retrieved from the PDB Data Bank as a fully optimized one and the Lamarckian genetic algorithm (LGA). The maps were generated by the program AutoGrid (4.2.6) with a spacing of 0.375 Å and dimensions that encompass all atoms extending 5 Å from the surface of the structure of the crystallized ligands. All the parameters were inserted at their default settings as previously reported.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In the docking tab, the macromolecule and ligand are selected, and GA parameters are set as ga_runs = 100, ga_pop_size = 150, ga_num_evals = 25,000,000, ga_num_generations = 27,000, ga_elitism = 1, ga_mutation_rate = 0.02, ga_crossover_rate = 0.8, ga_crossover_mode = two points, ga_cauchy_alpha = 0.0, ga_cauchy_beta = 1.0, and number of generations for picking worst individual = 10. Since no water molecules are directly involved in complex stabilization, they were not considered in the docking process (although in the crystallized structure of the bacterial DNA gyrase there are three structural water molecules that form hydrogen bonds between the ligand and some of the amino acids present on the enzymatic site, this network of H-bonds is intrinsic with the structure of the crystallized ligand. Docking calculations performed with the crystallized water molecules led to unsatisfactory results; therefore, the removal of water molecules in the peripheral regions of the binding site does not influence the calculated free binding energies in any way). All protein amino acid residues were kept rigid, whereas all single bonds of ligands were treated as fully flexible. The values of the energies of docking, in kcal/mol, have been calculated employing the “hybrid” force field implemented in AutoDock that contains terms based on molecular mechanics as well as empirical. Although the prediction of absolute binding energies may be less accurate compared to more computationally expensive, purely force field-based methods, this semi-empirical approach is considered as well-suited for the relative rankings.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Molecular Optimization</h3><div class="NLM_p last">The semi-empirical calculations were performed using the parameterized model number 6 Hamiltonian<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> as implemented in the MOPAC package (MOPAC2016 v. 18.151, Stewart Computational Chemistry, Colorado Springs, Colorado, USA). All molecules were fully optimized employing the eigenvector following the algorithm and a gradient minimization of 0.01 together with the precise and ddmin = 0 keywords.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Molecular Dynamics Simulations</h3><div class="NLM_p last">The MD simulations of the human Topo IIα/DNA/<b>1a</b> ternary model system were performed with the YASARA Structure package (19.11.5).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> A periodic simulation cell with boundaries extending 8 Å from the surface of the complex was employed. The box was filled with water, with a maximum sum of all bump water of 1.0 Å and a density of 0.997 g/mL with an explicit solvent. YASARA’s p<i>K</i><sub>a</sub> utility was used to assign p<i>K</i><sub>a</sub> values at pH 7.4,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> and system charges were neutralized with NaCl (0.9% by mass). Water molecules were deleted to readjust the solvent density to 0.997 g/mL. The final system dimensions were approximately 122 × 122 × 122 Å<sup>3</sup>. The ligand force-field parameters were generated with the AutoSMILES utility,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> which employs semi-empirical AM1 geometry optimization. Moreover, the assignment of charges, by the assignment of the AM1BCC atom and bond types with refinement was performed using the RESP charges, and finally the assignments of general AMBER force field atom types. Optimization of the hydrogen bond network of the various enzyme–ligand complexes was obtained using the method established by Hooft <i>et al</i>.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> This model allowed addressing ambiguities arising from multiple side-chain conformations and protonation states that are not well resolved in the electron density. The protein was treated with an AMBER ff14SB force field and<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> the ligand with GAFF2,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and the TIP3P model was used for water. The cutoff was 8 Å for van der Waals forces (the default used by AMBER),<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and no cutoff was applied to electrostatic forces (using the Particle Mesh Ewald algorithm).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> A 100 ps MD simulation was run on the solvent only. The entire system was then energy-minimized using first the steepest descent minimization to remove conformational stress followed by a simulated annealing minimization until convergence (<0.01 kcal/mol Å). The equations of motions were integrated with multiple timesteps of 1.25 fs for bonded interactions and 2.5 fs for nonbonded interactions using the NPT ensemble at a temperature of 298 K and a pressure of 1 atm. The temperature was controlled using the Berendsen thermostat,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and the pressure was controlled using the solvent-probe pressure control mode barostat.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The MD simulation was then initiated with an equilibration period of 10 ns for the assessment of the ligand’s correct pose, and a classical production MD simulation of 100 ns was performed analogously to other experiments reported by us.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a> The MD trajectories were recorded every 100 ps.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> MM/PBSA Calculation of the Energies of Binding during the MD Simulation</h3><div class="NLM_p last">To this purpose, we used the iPBSA script, according to the procedure reported in detail in the original publication,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> with the algorithm for MM/PBSA implemented in the freely available AmberTools21 suite,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> to analyze the ligand/enzyme complex coordinates recorded during the MD simulation.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00917" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00917?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00917</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">NMR spectra, fluorescence and absorption spectra, visible spectrum before and after cell binding, and IC<sub>50</sub> values on DU145, PC3, MCF7, MDA-MB231, and HCT116 cell lines of compounds <b>1a</b>, <b>1b</b>, <b>3a</b>, <b>3b</b>, <b>6a</b>–<b>6d</b>, and <b>7a</b>–<b>7d</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf">jm1c00917_si_001.pdf (2.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_002.csv">jm1c00917_si_002.csv (2.33 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00917" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Greta Varchi</span> - <span class="hlFld-Affiliation affiliation">Institute
for the Organic Synthesis and Photoreactivity − ISOF, Via Piero Gobetti, 101, 40129 Bologna, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8358-3437" title="Orcid link">https://orcid.org/0000-0002-8358-3437</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5a3d283f2e3b742c3b283932331a3329353c7439342874332e"><span class="__cf_email__" data-cfemail="2a4d584f5e4b045c4b584942436a4359454c0449445804435e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agostino Marrazzo</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8728-8857" title="Orcid link">https://orcid.org/0000-0002-8728-8857</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6f020e1d1d0e1515002f1a01060c1b41061b"><span class="__cf_email__" data-cfemail="f09d918282918a8a9fb0859e999384de9984">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonino Nicolò Fallica</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1899-8414" title="Orcid link">https://orcid.org/0000-0003-1899-8414</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carla Barbaraci</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-6155-6702" title="Orcid link">https://orcid.org/0000-0002-6155-6702</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuele Amata</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-4750-3479" title="Orcid link">https://orcid.org/0000-0002-4750-3479</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorella Pasquinucci</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1309-3368" title="Orcid link">https://orcid.org/0000-0003-1309-3368</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rita Turnaturi</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-5895-7820" title="Orcid link">https://orcid.org/0000-0002-5895-7820</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Dichiara</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sebastiano Intagliata</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-0201-1745" title="Orcid link">https://orcid.org/0000-0002-0201-1745</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marzia Bruna Gariboldi</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology and Life Sciences (DBSV), University of Insubria, Via JH Dunant 3, 21100 Varese, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-5683-0885" title="Orcid link">https://orcid.org/0000-0002-5683-0885</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuela Marras</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology and Life Sciences (DBSV), University of Insubria, Via JH Dunant 3, 21100 Varese, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viviana Teresa Orlandi</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology and Life Sciences (DBSV), University of Insubria, Via JH Dunant 3, 21100 Varese, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Ferroni</span> - <span class="hlFld-Affiliation affiliation">Institute
for the Organic Synthesis and Photoreactivity − ISOF, Via Piero Gobetti, 101, 40129 Bologna, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-7386-1624" title="Orcid link">https://orcid.org/0000-0002-7386-1624</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cecilia Martini</span> - <span class="hlFld-Affiliation affiliation">Institute
for the Organic Synthesis and Photoreactivity − ISOF, Via Piero Gobetti, 101, 40129 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Rescifina</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-5039-2151" title="Orcid link">https://orcid.org/0000-0001-5039-2151</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Davide Gentile</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug and Health Sciences (DSFS), University
of Catania, Viale A. Doria, 6, 95125 Catania, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors contributed to the present paper and have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">All the authors gratefully acknowledge the Italian MUR for supporting grant PRIN 2017 (Code 201744BN5T) and PON R&I funds 2014–2020 (CUP: E66C18001320007, AIM1872330, activity 1).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">aPSs</td><td class="NLM_def"><p class="first last">antimicrobial photosensitizers</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony forming unit</p></td></tr><tr><td class="NLM_term">Cip</td><td class="NLM_def"><p class="first last">Ciprofloxacin</p></td></tr><tr><td class="NLM_term">DOX</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">Gyr</td><td class="NLM_def"><p class="first last">gyrase</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimal inhibitory concentration</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">Nor</td><td class="NLM_def"><p class="first last">Norfloxacin</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term"><i>p</i>-TsOH</td><td class="NLM_def"><p class="first last"><i>para</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">R.I.</td><td class="NLM_def"><p class="first last">resistance index</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">Topo</td><td class="NLM_def"><p class="first last">topoisomerase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 71 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmerson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. M.</span></span> <span> </span><span class="NLM_article-title">The quinolones: decades of development and use</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1093/jac/dkg208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1093%2Fjac%2Fdkg208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=12702699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=13-20&author=A.+M.+Emmersonauthor=A.+M.+Jones&title=The+quinolones%3A+decades+of+development+and+use&doi=10.1093%2Fjac%2Fdkg208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The quinolones: Decades of development and use</span></div><div class="casAuthors">Emmerson, A. M.; Jones, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">Suppl. S1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The discovery of nalidixic acid in 1962, and its introduction for clin. use in 1967, marks the beginning of five decades of quinolone development and use.  It was not until the discovery and licensing of the fluoroquinolones in the 1970s and 1980s that these drugs began to establish their place in the armamentarium of clin. useful antimicrobials.  At the beginning of the 21st century, in their fifth decade of discovery and use, our understanding of structure-function relationships has improved, and better compds., in terms of both spectrum of antimicrobial cover and pharmacokinetics, have been developed.  The clin. utility of this expanding class of anti-microbial agents, and the lower propensity for the development of resistance with the "newer" fluoroquinolones will need to be continually monitored in the changing therapeutic environment.  Antibiotic drug choice will remain difficult in the presence of increasing resistance, but the introduction of the new fluoroquinolones has created a new and exciting era in antimicrobial treatment.  The role of these agents has already been acknowledged in a no. of clin. guidelines, and appropriate use of these agents may help to preserve their clin. utility, enabling them to realize their full therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0RRLOgvTYNLVg90H21EOLACvtfcHk0lhAAaABf0p_gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOqu74%253D&md5=04ad837d0f1be12fa7e9944cc9502301</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg208%26sid%3Dliteratum%253Aachs%26aulast%3DEmmerson%26aufirst%3DA.%2BM.%26aulast%3DJones%26aufirst%3DA.%2BM.%26atitle%3DThe%2520quinolones%253A%2520decades%2520of%2520development%2520and%2520use%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26spage%3D13%26epage%3D20%26doi%3D10.1093%2Fjac%2Fdkg208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacGowan, A. P.</span></span> <span> </span><span class="NLM_article-title">Development of the quinolones</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1093/jac/dkg212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1093%2Fjac%2Fdkg212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=12702698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=1-11&author=M.+I.+Anderssonauthor=A.+P.+MacGowan&title=Development+of+the+quinolones&doi=10.1093%2Fjac%2Fdkg212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the quinolones</span></div><div class="casAuthors">Andersson, Monique I.; MacGowan, Alasdair P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">Suppl. S1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Since their discovery in the early 1960s, the quinolone group of antibacterials has generated considerable clin. and scientific interest.  Nalidixic acid, the first quinolone to be developed, was obtained as an impurity during the manuf. of quinine.  Since this time, many derivs. have been synthesized and evaluated for their antibacterial potency.  Two major groups of compds. have been developed from the basic mol.: quinolones and naphthyridones.  Manipulations of the basic mol., including replacing hydrogen with fluorine at position 6, substituting a diamine residue at position 7 and adding new residues at position 1 of the quinolone ring, have led to enhanced antibacterial efficacy.  In general these compds. are well tolerated.  However, some of these structural changes have been found to correlate with specific adverse events: the addn. of fluorine or chlorine at position 8 being assocd. with photoreactivity, e.g. Bay y 3118 and sparfloxacin; and the substitution of an amine or a Me group at position 5 having a potential role in QTc prolongation, e.g. sparfloxacin and grepafloxacin.  Progressive modifications in mol. configuration have resulted in improved breadth and potency of in vitro activity and pharmacokinetics.  One of the most significant developments has been the improved anti-Gram-pos. activity of the newer compds., such as moxifloxacin and garenoxacin.  In the current millennium, these new agents may play an important role in the treatment of respiratory infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXOxpC9VPPpbVg90H21EOLACvtfcHk0lhAAaABf0p_gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOqurc%253D&md5=cd81508f26225254e8a785951636f491</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg212%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DM.%2BI.%26aulast%3DMacGowan%26aufirst%3DA.%2BP.%26atitle%3DDevelopment%2520of%2520the%2520quinolones%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26spage%3D1%26epage%3D11%26doi%3D10.1093%2Fjac%2Fdkg212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosi, E.</span></span> <span> </span><span class="NLM_article-title">Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections</span>. <i>Aust. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1080/1120009X.2017.1380357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1080%2F1120009X.2017.1380357" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2017&pages=10-18&author=A.+Novelliauthor=E.+Rosi&title=Pharmacological+properties+of+oral+antibiotics+for+the+treatment+of+uncomplicated+urinary+tract+infections&doi=10.1080%2F1120009X.2017.1380357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F1120009X.2017.1380357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1120009X.2017.1380357%26sid%3Dliteratum%253Aachs%26aulast%3DNovelli%26aufirst%3DA.%26aulast%3DRosi%26aufirst%3DE.%26atitle%3DPharmacological%2520properties%2520of%2520oral%2520antibiotics%2520for%2520the%2520treatment%2520of%2520uncomplicated%2520urinary%2520tract%2520infections%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2017%26volume%3D29%26spage%3D10%26epage%3D18%26doi%3D10.1080%2F1120009X.2017.1380357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, H. H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuo-Rahma, G. E.-D. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbas, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelhafez, E.-S. M. N.</span></span> <span> </span><span class="NLM_article-title">Current trends and future directions of fluoroquinolones</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3149</span>, <span class="refDoi"> DOI: 10.2174/0929867325666180214122944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.2174%2F0929867325666180214122944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29446718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVWis7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=3132-3149&author=H.+H.+H.+Mohammedauthor=G.+E.-D.+A.+A.+Abuo-Rahmaauthor=S.+H.+Abbasauthor=E.-S.+M.+N.+Abdelhafez&title=Current+trends+and+future+directions+of+fluoroquinolones&doi=10.2174%2F0929867325666180214122944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Current Trends and Future Directions of Fluoroquinolones</span></div><div class="casAuthors">Mohammed, Hamada H. H.; A. A. Abuo-Rahma, Gamal El-Din; Abbas, Samar H.; Abdelhafez, El-Shimaa M. N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3132-3149</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Fluoroquinolones represent an interesting synthetic class of antimicrobial agents with broad spectrum and potent activity.  Since the discovery of nalidixic acid, the prototype of quinolones, several structural modifications to the quinolone nucleus have been carried out for improvement of potency, spectrum of activity, and to understand their structure activity relationship (SAR).  The C-7 substituent was reported to have a major impact on the activity.  Accordingly, Substitution at C-7 or its N-4-piperazinyl moiety was found to affect potency, bioavailability, and physicochem. properties.  Also, it can increase the affinity towards mammalian topoisomerases that may shift quinolones from antibacterial to anticancer candidates.  Moreover, the presence of DNA topoisomerases in both eukaryotic and prokaryotic cells makes them excellent targets for chemotherapeutic intervention in antibacterial and anticancer therapies.  Based on this concept, several fluoroquionolones derivs. have been synthesized and biol. evaluated as antibacterial, antituberculosis, antiproliferative, antiviral and antifungal agents.  This review is an attempt to focus on the therapeutic prospects of fluoroquinolones with an updated account on their atypical applications such as antitubercular and anticancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Fd2-RnBgl7Vg90H21EOLACvtfcHk0lg5Rxm_X0vC7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVWis7jP&md5=dbbc636c493ba3e102c771c282b18274</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867325666180214122944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867325666180214122944%26sid%3Dliteratum%253Aachs%26aulast%3DMohammed%26aufirst%3DH.%2BH.%2BH.%26aulast%3DAbuo-Rahma%26aufirst%3DG.%2BE.-D.%2BA.%2BA.%26aulast%3DAbbas%26aufirst%3DS.%2BH.%26aulast%3DAbdelhafez%26aufirst%3DE.-S.%2BM.%2BN.%26atitle%3DCurrent%2520trends%2520and%2520future%2520directions%2520of%2520fluoroquinolones%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2019%26volume%3D26%26spage%3D3132%26epage%3D3149%26doi%3D10.2174%2F0929867325666180214122944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigel, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steward, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span></span> <span> </span><span class="NLM_article-title">GyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">2661</span>– <span class="NLM_lpage">2667</span>, <span class="refDoi"> DOI: 10.1128/AAC.42.10.2661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1128%2FAAC.42.10.2661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=9756773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Gjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=2661-2667&author=L.+M.+Weigelauthor=C.+D.+Stewardauthor=F.+C.+Tenover&title=GyrA+mutations+associated+with+fluoroquinolone+resistance+in+eight+species+of+Enterobacteriaceae&doi=10.1128%2FAAC.42.10.2661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae</span></div><div class="casAuthors">Weigel, Linda M.; Steward, Christine D.; Tenover, Fred C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2661-2667</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Fluoroquinolone resistance (FQ-R) in clin. isolates of Enterobacteriaceae species has been reported with increasing frequency in recent years.  Two mechanisms of FQ-R have been identified in gram-neg. organisms: mutations in DNA gyrase and reduced intracellular drug accumulation.  A single point mutation in gyrA has been shown to reduce susceptibility to fluoroquinolones.  To det. the extent of gyrA mutations assocd. with FQ-R in enteric bacteria, one set of oligonucleotide primers was selected from conserved sequences in the flanking regions of the quinolone resistance-detg. regions (QRDR) of Escherichia coli and Klebsiella pneumoniae.  This set of primers was used to amplify and sequence the QRDRs from 8 Enterobacteriaceae type strains and 60 fluoroquinolone-resistant clin. isolates of Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, E. coli, K. pneumoniae, Klebsiella oxytoca, Providencia stuartii, and Serratia marcescens.  Although similarity of the nucleotide sequences of seven species ranged from 80.8 to 93.3%, when compared with that of E. coli, the amino acid sequences of the gyrA QRDR were highly conserved.  Conservative amino acid substitutions were detected in the QRDRs of the susceptible type strains of C. freundii, E. aerogenes, K. oxytoca (Ser-83 to Thr), and P. stuartii (Asp-87 to Glu).  Strains with ciprofloxacin MICs of >2 μg/mL expressed amino acid substitutions primarily at the Gly-81, Ser-83, or Asp-87 position.  Fluoroquinolone MICs varied significantly for strains exhibiting identical gyrA mutations, indicating that alterations outside gyrA contribute to resistance.  The type and position of amino acid alterations also differed among these six genera.  High-level FQ-R frequently was assocd. with single gyrA mutations in all species of Enterobacteriaceae in this study except E. coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosESbTyrswrbVg90H21EOLACvtfcHk0lg5Rxm_X0vC7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Gjs78%253D&md5=11793265e79c1a3a2acf5d7c31555f19</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FAAC.42.10.2661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.42.10.2661%26sid%3Dliteratum%253Aachs%26aulast%3DWeigel%26aufirst%3DL.%2BM.%26aulast%3DSteward%26aufirst%3DC.%2BD.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26atitle%3DGyrA%2520mutations%2520associated%2520with%2520fluoroquinolone%2520resistance%2520in%2520eight%2520species%2520of%2520Enterobacteriaceae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1998%26volume%3D42%26spage%3D2661%26epage%3D2667%26doi%3D10.1128%2FAAC.42.10.2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases: structure, function, and mechanism</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.70.1.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1146%2Fannurev.biochem.70.1.369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=11395412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=369-413&author=J.+J.+Champoux&title=DNA+topoisomerases%3A+structure%2C+function%2C+and+mechanism&doi=10.1146%2Fannurev.biochem.70.1.369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">DNA topoisomerases: structure, function, and mechanism</span></div><div class="casAuthors">Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369-413</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 196 refs.  DNA topoisomerases solve the topol. problems assocd. with DNA replication, transcription, recombination, and chromatin remodeling by introducing temporary single- or double-strand breaks in the DNA.  In addn., these enzymes fine-tune the steady-state level of DNA supercoiling both to facilitate protein interactions with the DNA and to prevent excessive supercoiling that is deleterious.  In recent years, the crystal structures of a no. of topoisomerase fragments, representing nearly all of the known classes of enzymes, have been solved.  These structures provide remarkable insights into the mechanisms of these enzymes and complement previous conclusions based on biochem. analyses.  Surprisingly, despite little or no sequence homol., both type IA and type IIA topoisomerases from prokaryotes and the type IIA enzymes from eukaryotes share structural folds that appear to reflect functional motifs within crit. regions of the enzymes.  The type IB enzymes are structurally distinct from all other known topoisomerases but are similar to a class of enzymes referred to as tyrosine recombinases.  The structural themes common to all topoisomerases include hinged clamps that open and close to bind DNA, the presence of DNA binding cavities for temporary storage of DNA segments, and the coupling of protein conformational changes to DNA rotation or DNA movement.  For the type II topoisomerases, the binding and hydrolysis of ATP further modulate conformational changes in the enzymes to effect changes in DNA topol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Y4rDyIYy17Vg90H21EOLACvtfcHk0lg5Rxm_X0vC7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D&md5=67c3e38eb4fcb85527b33d7077309482</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.369%26sid%3Dliteratum%253Aachs%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DDNA%2520topoisomerases%253A%2520structure%252C%2520function%252C%2520and%2520mechanism%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D369%26epage%3D413%26doi%3D10.1146%2Fannurev.biochem.70.1.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gubaev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klostermeier, D.</span></span> <span> </span><span class="NLM_article-title">DNA-induced narrowing of the gyrase N-gate coordinates T-segment capture and strand passage</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">14085</span>– <span class="NLM_lpage">14090</span>, <span class="refDoi"> DOI: 10.1073/pnas.1102100108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1073%2Fpnas.1102100108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=21817063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaqt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=14085-14090&author=A.+Gubaevauthor=D.+Klostermeier&title=DNA-induced+narrowing+of+the+gyrase+N-gate+coordinates+T-segment+capture+and+strand+passage&doi=10.1073%2Fpnas.1102100108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-induced narrowing of the gyrase N-gate coordinates T-segment capture and strand passage</span></div><div class="casAuthors">Gubaev, Airat; Klostermeier, Dagmar</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">14085-14090, S14085/1-S14085/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">DNA gyrase introduces neg. supercoils into DNA in an ATP-dependent reaction.  DNA supercoiling is catalyzed by a strand-passage mechanism, in which a T-segment of DNA is passed through the gap in a transiently cleaved G-segment.  Strand passage requires the coordinated closing and opening of three protein interfaces in gyrase, the N-gate, DNA-gate, and C-gate.  We show here that DNA binding to the DNA-gate of gyrase and wrapping of DNA around the C-terminal domains of GyrA induces a narrowing of the N-gate.  This half-closed state preps. capture of a T-segment in the upper cavity of gyrase.  Subsequent N-gate closure upon binding of ATP then poises the reaction toward strand passage.  The N-gate reopens after ATP hydrolysis, allowing for further catalytic cycles.  DNA binding, cleavage, and wrapping and N-gate narrowing are intimately linked events that coordinate conformational changes at the DNA and the N-gate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKZU3hAJIptLVg90H21EOLACvtfcHk0lg5Rxm_X0vC7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaqt7zE&md5=f3138f3fba25e936b38004570e0ffd4d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1102100108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1102100108%26sid%3Dliteratum%253Aachs%26aulast%3DGubaev%26aufirst%3DA.%26aulast%3DKlostermeier%26aufirst%3DD.%26atitle%3DDNA-induced%2520narrowing%2520of%2520the%2520gyrase%2520N-gate%2520coordinates%2520T-segment%2520capture%2520and%2520strand%2520passage%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D14085%26epage%3D14090%26doi%3D10.1073%2Fpnas.1102100108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blondeau, J. M.</span></span> <span> </span><span class="NLM_article-title">Fluoroquinolones: mechanism of action, classification, and development of resistance</span>. <i>Surv. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">S73</span>– <span class="NLM_lpage">S78</span>, <span class="refDoi"> DOI: 10.1016/j.survophthal.2004.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.survophthal.2004.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=15028482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADC%252BD2c7js1GisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2004&pages=S73-S78&author=J.+M.+Blondeau&title=Fluoroquinolones%3A+mechanism+of+action%2C+classification%2C+and+development+of+resistance&doi=10.1016%2Fj.survophthal.2004.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Fluoroquinolones: mechanism of action, classification, and development of resistance</span></div><div class="casAuthors">Blondeau Joseph M</div><div class="citationInfo"><span class="NLM_cas:title">Survey of ophthalmology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">49 Suppl 2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S73-8</span>
        ISSN:<span class="NLM_cas:issn">0039-6257</span>.
    </div><div class="casAbstract">The fluoroquinolones represent an evolving class of broad-spectrum antimicrobial agents used in the prevention and treatment of a variety of ocular infections; however, resistance to currently available agents in the class has been emerging among ocular pathogens.  This article reviews the mechanism of action of existing and new fluoroquinolones and discusses the structure-activity relationship of the fluoroquinolones as it relates to the classification of these compounds.  This article also highlights the mechanism of resistance among common ocular pathogens and discusses the potential need for newer fluoroquinolones in ophthalmology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3U35K4VKFarmQt-ICR3qNfW6udTcc2eZswwPxAFn7_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7js1GisQ%253D%253D&md5=a6dcc56d7c0864f9f74cdd32913caa72</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.survophthal.2004.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.survophthal.2004.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DBlondeau%26aufirst%3DJ.%2BM.%26atitle%3DFluoroquinolones%253A%2520mechanism%2520of%2520action%252C%2520classification%252C%2520and%2520development%2520of%2520resistance%26jtitle%3DSurv.%2520Ophthalmol.%26date%3D2004%26volume%3D49%26spage%3DS73%26epage%3DS78%26doi%3D10.1016%2Fj.survophthal.2004.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haemers, A.</span></span> <span> </span><span class="NLM_article-title">Quinolone antimicrobial agents: structure-activity relationships</span>. <i>Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1803382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADyaK38XnvF2lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1991&pages=687-700&author=M.+Q.+Zhangauthor=A.+Haemers&title=Quinolone+antimicrobial+agents%3A+structure-activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolone antimicrobial agents:  structure-activity relationships</span></div><div class="casAuthors">Zhang, Ming Qiang; Haemers, A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmazie</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">687-700</span>CODEN:
                <span class="NLM_cas:coden">PHARAT</span>;
        ISSN:<span class="NLM_cas:issn">0031-7144</span>.
    </div><div class="casAbstract">A review with 102 refs.  Topics include: substitution at positions 1 and 2, modification of the 3-carboxylic and 4-oxo groups, substitution at the positions of ring B other than C-7, and substitution at position 7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa8c8ircURpLVg90H21EOLACvtfcHk0lhHnUiYomm7ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XnvF2lsQ%253D%253D&md5=2b7e9fec83abd845f57e80c51c907747</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BQ.%26aulast%3DHaemers%26aufirst%3DA.%26atitle%3DQuinolone%2520antimicrobial%2520agents%253A%2520structure-activity%2520relationships%26jtitle%3DPharmazie%26date%3D1991%26volume%3D46%26spage%3D687%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L. S.</span></span> <span> </span><span class="NLM_article-title">4-Quinolone derivatives and their activities against Gram positive pathogens</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.11.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ejmech.2017.11.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29220792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFejt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=710-723&author=G.+F.+Zhangauthor=S.+Zhangauthor=B.+Panauthor=X.+Liuauthor=L.+S.+Feng&title=4-Quinolone+derivatives+and+their+activities+against+Gram+positive+pathogens&doi=10.1016%2Fj.ejmech.2017.11.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">4-Quinolone derivatives and their activities against Gram positive pathogens</span></div><div class="casAuthors">Zhang, Gui-Fu; Zhang, Shu; Pan, Baofeng; Liu, Xiaofeng; Feng, Lian-Shun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">710-723</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Gram-pos. bacteria are responsible for a broad range of infectious diseases, and the emergency and wide spread of drug-resistant Gram-pos. pathogens including MRSA and MRSE has caused great concern throughout the world. 4-Quinolones which are exemplified by fluoroquinolones are mainstays of chemotherapy against various bacterial infections including Gram-pos. pathogen infections, and their value and role in the treatment of bacterial infections continues to expand.  However, the resistance of Gram-pos. organisms to 4-quinolones develops rapidly and spreads widely, making them more and more ineffective.  To overcome the resistance and reduce the toxicity, numerous of 4-quinolone derivs. were synthesized and screened for their in vitro and in vivo activities against Gram-pos. pathogens, and some of them exhibited excellent potency.  This review aims to outlines the recent advances made towards the discovery of 4-quinolone-based derivs. as anti-Gram-pos. pathogens agents and the crit. aspects of design as well as the structure-activity relation of these derivs.  The enriched SAR paves the way to the further rational development of 4-quinolones with a unique mechanism of action different from that of the currently used drugs to overcome the resistance, well-tolerated and low toxic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_0SCAjPkYbVg90H21EOLACvtfcHk0lhHnUiYomm7ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFejt7nO&md5=2e034ddd0049c24c91b9f4237091de99</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.11.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.11.082%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%2BF.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DL.%2BS.%26atitle%3D4-Quinolone%2520derivatives%2520and%2520their%2520activities%2520against%2520Gram%2520positive%2520pathogens%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D710%26epage%3D723%26doi%3D10.1016%2Fj.ejmech.2017.11.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varshney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, N.</span></span> <span> </span><span class="NLM_article-title">Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation</span>. <i>BMC cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">581</span>, <span class="refDoi"> DOI: 10.1186/s12885-015-1560-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1186%2Fs12885-015-1560-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=26260159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADC%252BC287hvVSnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=581&author=V.+Yadavauthor=P.+Varshneyauthor=S.+Sultanaauthor=J.+Yadavauthor=N.+Saini&title=Moxifloxacin+and+ciprofloxacin+induces+S-phase+arrest+and+augments+apoptotic+effects+of+cisplatin+in+human+pancreatic+cancer+cells+via+ERK+activation&doi=10.1186%2Fs12885-015-1560-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation</span></div><div class="casAuthors">Yadav Vikas; Varshney Pallavi; Yadav Jyoti; Saini Neeru; Yadav Vikas; Sultana Sarwat</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">581</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Pancreatic cancer, one of the most dreadful gastrointestinal tract malignancies, with the current chemotherapeutic drugs has posed a major impediment owing to poor prognosis and chemo-resistance thereby suggesting critical need for additional drugs as therapeutics in combating the situation.  Fluoroquinolones have shown promising and significant anti-tumor effects on several carcinoma cell lines.  METHODS:  Previously, we reported growth inhibitory effects of fourth generation fluoroquinolone Gatifloxacin, while in the current study we have investigated the anti-proliferative and apoptosis-inducing mechanism of older generation fluoroquinolones Moxifloxacin and Ciprofloxacin on the pancreatic cancer cell-lines MIA PaCa-2 and Panc-1.  Cytotoxicity was measured by MTT assay.  Apoptosis induction was evaluated using annexin assay, cell cycle assay and activation of caspase-3, 8, 9 were measured by western blotting and enzyme activity assay.  RESULTS:  Herein, we found that both the fluoroquinolones suppressed the proliferation of pancreatic cancer cells by causing S-phase arrest and apoptosis.  Blockade in S-phase of cell cycle was associated with decrease in the levels of p27, p21, CDK2, cyclin-A and cyclin-E.  Herein we also observed triggering of extrinsic as well as intrinsic mitochondrial apoptotic pathway as suggested by the activation of caspase-8, 9, 3, and Bid respectively.  All this was accompanied by downregulation of antiapoptotic protein Bcl-xL and upregulation of proapoptotic protein Bak.  Our results strongly suggest the role of extracellular-signal-regulated kinases (ERK1/2), but not p53, p38 and c-JUN N-terminal kinase (JNK) in fluoroquinolone induced growth inhibitory effects in both the cell lines.  Additionally, we also found both the fluoroquinolones to augment the apoptotic effects of broad spectrum anticancer drug Cisplatin via ERK.  CONCLUSION:  The fact that these fluoroquinolones synergize the effect of cisplatin opens new insight into therapeutic index in treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR24ymZPiYCy1m8bhe6roZYfW6udTcc2ea_MIX8ybBI3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287hvVSnug%253D%253D&md5=4cd8a5188e5924c3e78a909080a90454</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1560-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1560-y%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DV.%26aulast%3DVarshney%26aufirst%3DP.%26aulast%3DSultana%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DJ.%26aulast%3DSaini%26aufirst%3DN.%26atitle%3DMoxifloxacin%2520and%2520ciprofloxacin%2520induces%2520S-phase%2520arrest%2520and%2520augments%2520apoptotic%2520effects%2520of%2520cisplatin%2520in%2520human%2520pancreatic%2520cancer%2520cells%2520via%2520ERK%2520activation%26jtitle%3DBMC%2520cancer%26date%3D2015%26volume%3D15%26spage%3D581%26doi%3D10.1186%2Fs12885-015-1560-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herold, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganslmayer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerauer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuppan, D.</span></span> <span> </span><span class="NLM_article-title">Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6600079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1038%2Fsj.bjc.6600079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=11875713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD38XisFOls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=443-448&author=C.+Heroldauthor=M.+Ockerauthor=M.+Ganslmayerauthor=H.+Gerauerauthor=E.+G.+Hahnauthor=D.+Schuppan&title=Ciprofloxacin+induces+apoptosis+and+inhibits+proliferation+of+human+colorectal+carcinoma+cells&doi=10.1038%2Fsj.bjc.6600079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells</span></div><div class="casAuthors">Herold, C.; Ocker, M.; Ganslmayer, M.; Gerauer, H.; Hahn, E. G.; Schuppan, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-448</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Efficacy of chemotherapy in advanced stages of colorectal tumors is limited.  The quinolone antibiotic ciprofloxacin was recently shown to inhibit growth and to induce apoptosis in human bladder carcinomas cells.  The authors investigated the effect of ciprofloxacin on colon carcinoma lines in vitro.  CC-531, SW-403 and HT-29 colon carcinoma and HepG2 hepatoma cells (control cells) were exposed to ciprofloxacin.  Proliferation was assessed by bromodeoxyuridine-incorporation into DNA and apoptosis was measured by flow cytometry after propidium iodide or JC-1 staining.  Expression of anti-apoptotic Bcl-2 and pro-apoptotic Bax was analyzed by semiquant. Western blot anal. and activity of caspases 3, 8 and 9 by substrate-cleavage assays.  Ciprofloxacin suppressed DNA synthesis of all colon carcinoma cells time- and dose-dependently, whereas the hepatoma cells remained unaffected.  Apoptosis reached its max. between 200 and 500 μg ml-1.  This was accompanied by an upregulation of Bax and of the activity of caspases 3, 8 and 9, and paralleled by a decrease of the mitochondrial membrane potential.  Ciprofloxacin decreases proliferation and induces apoptosis of colon carcinoma cells, possibly in part by blocking mitochondrial DNA synthesis.  Therefore, qualification of ciprofloxacin as adjunctive agent for colorectal cancer should be evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89M8dpMfTsbVg90H21EOLACvtfcHk0liUjeU2VgPeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisFOls7g%253D&md5=efedae539d59a9ab6ff8ccd811a3e643</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6600079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6600079%26sid%3Dliteratum%253Aachs%26aulast%3DHerold%26aufirst%3DC.%26aulast%3DOcker%26aufirst%3DM.%26aulast%3DGanslmayer%26aufirst%3DM.%26aulast%3DGerauer%26aufirst%3DH.%26aulast%3DHahn%26aufirst%3DE.%2BG.%26aulast%3DSchuppan%26aufirst%3DD.%26atitle%3DCiprofloxacin%2520induces%2520apoptosis%2520and%2520inhibits%2520proliferation%2520of%2520human%2520colorectal%2520carcinoma%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2002%26volume%3D86%26spage%3D443%26epage%3D448%26doi%3D10.1038%2Fsj.bjc.6600079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bisacchi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, M. R.</span></span> <span> </span><span class="NLM_article-title">A ″Double-edged″ scaffold: antitumor power within the antibacterial quinolone</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.2174/0929867323666151223095839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.2174%2F0929867323666151223095839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=26695512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=520-577&author=G.+S.+Bisacchiauthor=M.+R.+Hale&title=A+%E2%80%B3Double-edged%E2%80%B3+scaffold%3A+antitumor+power+within+the+antibacterial+quinolone&doi=10.2174%2F0929867323666151223095839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone</span></div><div class="casAuthors">Bisacchi, Gregory S.; Hale, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">520-577</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In the late 1980s, reports emerged describing exptl. antibacterial quinolones having significant potency against eukaryotic Type II topoisomerases (topo II) and showing cytotoxic activity against tumor cell lines.  As a result, several pharmaceutical companies initiated quinolone anticancer programs to explore the potential of this class in comparison to conventional human topo II inhibiting antitumor drugs such as doxorubicin and etoposide.  In this review, we present a modern re-evaluation of the anticancer potential of the quinolone class in the context of today's predominantly pathway-based (rather than cytotoxicity-based) oncol. drug R&D environment.  The quinolone eukaryotic SAR is comprehensively discussed, contrasted with the corresponding prokaryotic data, and merged with recent structural biol. information which is now beginning to help explain the basis for that SAR.  Quinolone topo II inhibitors appear to be much less susceptible to efflux-mediated resistance, a current limitation of therapy with conventional agents.  Recent advances in the biol. understanding of human topo II isoforms suggest that significant progress might now be made in overcoming two other treatment-limiting disadvantages of conventional topo II inhibitors, namely cardiotoxicity and drug-induced secondary leukemias.  We propose that quinolone class topo II inhibitors could have a useful future therapeutic role due to the continued need for effective topo II drugs in many cancer treatment settings, and due to the recent biol. and structural advances which can now provide, for the first time, specific guidance for the design of a new class of inhibitors potentially superior to existing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoudxhdr0QJNbVg90H21EOLACvtfcHk0liUjeU2VgPeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCktr0%253D&md5=d1b12021b59ac40ede71c7fdae0ad625</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F0929867323666151223095839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666151223095839%26sid%3Dliteratum%253Aachs%26aulast%3DBisacchi%26aufirst%3DG.%2BS.%26aulast%3DHale%26aufirst%3DM.%2BR.%26atitle%3DA%2520%25E2%2580%25B3Double-edged%25E2%2580%25B3%2520scaffold%253A%2520antitumor%2520power%2520within%2520the%2520antibacterial%2520quinolone%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D520%26epage%3D577%26doi%3D10.2174%2F0929867323666151223095839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aal, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aziz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaykoon, M. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuo-Rahma, G. E.-D. A.</span></span> <span> </span><span class="NLM_article-title">Towards anticancer fluoroquinolones: A review article</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1800376</span>, <span class="refDoi"> DOI: 10.1002/ardp.201800376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fardp.201800376" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2019&pages=1800376&author=M.+A.+A.+Abdel-Aalauthor=S.+A.+Abdel-Azizauthor=M.+S.+A.+Shaykoonauthor=G.+E.-D.+A.+Abuo-Rahma&title=Towards+anticancer+fluoroquinolones%3A+A+review+article&doi=10.1002%2Fardp.201800376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fardp.201800376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201800376%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Aal%26aufirst%3DM.%2BA.%2BA.%26aulast%3DAbdel-Aziz%26aufirst%3DS.%2BA.%26aulast%3DShaykoon%26aufirst%3DM.%2BS.%2BA.%26aulast%3DAbuo-Rahma%26aufirst%3DG.%2BE.-D.%2BA.%26atitle%3DTowards%2520anticancer%2520fluoroquinolones%253A%2520A%2520review%2520article%26jtitle%3DArch.%2520Pharm.%26date%3D2019%26volume%3D352%26spage%3D1800376%26doi%3D10.1002%2Fardp.201800376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sissi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, M.</span></span> <span> </span><span class="NLM_article-title">The quinolone family: from antibacterial to anticancer agents</span>. <i>Curr. Med. Chem.: Anti-Cancer Agents</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.2174/1568011033482279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.2174%2F1568011033482279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=14529452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFOns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=439-450&author=C.+Sissiauthor=M.+Palumbo&title=The+quinolone+family%3A+from+antibacterial+to+anticancer+agents&doi=10.2174%2F1568011033482279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The quinolone family: From antibacterial to anticancer agents</span></div><div class="casAuthors">Sissi, Claudia; Palumbo, Manlio</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">439-450</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review focuses on the structural modifications responsible for the transformation of an antibacterial into an anticancer agent.  Indeed, a distinctive feature of drugs based on the quinolone structure is their remarkable ability to target different type II topoisomerase enzymes.  In particular, some congeners of this drug family display high activity not only against bacterial topoisomerases, but also against eukaryotic topoisomerases and are toxic to cultured mammalian cells and in vivo tumor models.  Hence, these cytotoxic quinolones represent an exploitable source of new anticancer agents, which might also help addressing side-toxicity and resistance phenomena.  Their ability to bind metal ion co-factors represents an addnl. means of modulating their pharmacol. response(s).  Moreover, quinolones link antibacterial and anticancer chemotherapy together and provide an opportunity to clarify drug mechanism across divergent species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp52bib_wURurVg90H21EOLACvtfcHk0ljIjF7V-NeXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFOns7k%253D&md5=f032383de40223659143e2519371c5c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1568011033482279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011033482279%26sid%3Dliteratum%253Aachs%26aulast%3DSissi%26aufirst%3DC.%26aulast%3DPalumbo%26aufirst%3DM.%26atitle%3DThe%2520quinolone%2520family%253A%2520from%2520antibacterial%2520to%2520anticancer%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2003%26volume%3D3%26spage%3D439%26epage%3D450%26doi%3D10.2174%2F1568011033482279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawtin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockett, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byl, J. A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. A.</span></span> <span> </span><span class="NLM_article-title">Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e10186</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0010186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1371%2Fjournal.pone.0010186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=20419121" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=R.+E.+Hawtinauthor=D.+E.+Stockettauthor=J.+A.+W.+Bylauthor=R.+S.+McDowellauthor=N.+Tanauthor=M.+R.+Arkinauthor=A.+Conroyauthor=W.+Yangauthor=N.+Osheroffauthor=J.+A.+Fox&title=Voreloxin+is+an+anticancer+quinolone+derivative+that+intercalates+DNA+and+poisons+topoisomerase+II&doi=10.1371%2Fjournal.pone.0010186"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0010186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0010186%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DR.%2BE.%26aulast%3DStockett%26aufirst%3DD.%2BE.%26aulast%3DByl%26aufirst%3DJ.%2BA.%2BW.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DTan%26aufirst%3DN.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DConroy%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DOsheroff%26aufirst%3DN.%26aulast%3DFox%26aufirst%3DJ.%2BA.%26atitle%3DVoreloxin%2520is%2520an%2520anticancer%2520quinolone%2520derivative%2520that%2520intercalates%2520DNA%2520and%2520poisons%2520topoisomerase%2520II%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0010186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancet, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbour, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigneux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horst, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Récher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimek, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carella, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egyed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantarjian, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, R. K.</span></span> <span> </span><span class="NLM_article-title">Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">e514</span>– <span class="NLM_lpage">e518</span>, <span class="refDoi"> DOI: 10.3324/haematol.2018.191361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3324%2Fhaematol.2018.191361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29794146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFyrtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2018&pages=e514-e518&author=F.+Ravandiauthor=E.+K.+Ritchieauthor=H.+Sayarauthor=J.+E.+Lancetauthor=M.+D.+Craigauthor=N.+Veyauthor=S.+A.+Stricklandauthor=G.+J.+Schillerauthor=E.+Jabbourauthor=A.+Pigneuxauthor=H.+A.+Horstauthor=C.+R%C3%A9cherauthor=V.+M.+Klimekauthor=J.+E.+Cortesauthor=A.+M.+Carellaauthor=M.+Egyedauthor=U.+Krugauthor=J.+A.+Foxauthor=A.+R.+Craigauthor=R.+Wardauthor=J.+A.+Smithauthor=G.+Actonauthor=H.+M.+Kantarjianauthor=R.+K.+Stuart&title=Phase+3+results+for+vosaroxin%2Fcytarabine+in+the+subset+of+patients+%E2%89%A560+years+old+with+refractory%2Fearly+relapsed+acute+myeloid+leukemia&doi=10.3324%2Fhaematol.2018.191361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia</span></div><div class="casAuthors">Ravandi, Farhad; Ritchie, Ellen K.; Sayar, Hamid; Lancet, Jeffrey E.; Craig, Michael D.; Vey, Norbert; Strickland, Stephen A.; Schiller, Gary J.; Jabbour, Elias; Pigneux, Arnaud; Horst, Heinz-August; Recher, Christian; Klimek, Virginia M.; Cortes, Jorge E.; Carella, Angelo-Michele; Egyed, Miklos; Krug, Utz; Fox, Judith A.; Craig, Adam R.; Ward, Renee; Smith, Jennifer A.; Acton, Gary; Kantarjian, Hagop M.; Stuart, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e514</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">1592-8721</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">A review discussing vosaroxin/cytarabine in the subset of old patients with refractory/early relapsed acute myeloid leukemia.  Hese results prompted further analyses in patient sub- groups as defined by age and disease status.  60 Years old with Ref/eRel AML that merits confirmation with a randomized clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa2UwKiADlLrVg90H21EOLACvtfcHk0ljIjF7V-NeXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFyrtL%252FK&md5=338c819c54512ed4a0fd3edccabfacbd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2018.191361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2018.191361%26sid%3Dliteratum%253Aachs%26aulast%3DRavandi%26aufirst%3DF.%26aulast%3DRitchie%26aufirst%3DE.%2BK.%26aulast%3DSayar%26aufirst%3DH.%26aulast%3DLancet%26aufirst%3DJ.%2BE.%26aulast%3DCraig%26aufirst%3DM.%2BD.%26aulast%3DVey%26aufirst%3DN.%26aulast%3DStrickland%26aufirst%3DS.%2BA.%26aulast%3DSchiller%26aufirst%3DG.%2BJ.%26aulast%3DJabbour%26aufirst%3DE.%26aulast%3DPigneux%26aufirst%3DA.%26aulast%3DHorst%26aufirst%3DH.%2BA.%26aulast%3DR%25C3%25A9cher%26aufirst%3DC.%26aulast%3DKlimek%26aufirst%3DV.%2BM.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26aulast%3DCarella%26aufirst%3DA.%2BM.%26aulast%3DEgyed%26aufirst%3DM.%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DFox%26aufirst%3DJ.%2BA.%26aulast%3DCraig%26aufirst%3DA.%2BR.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DActon%26aufirst%3DG.%26aulast%3DKantarjian%26aufirst%3DH.%2BM.%26aulast%3DStuart%26aufirst%3DR.%2BK.%26atitle%3DPhase%25203%2520results%2520for%2520vosaroxin%252Fcytarabine%2520in%2520the%2520subset%2520of%2520patients%2520%25E2%2589%25A560%2520years%2520old%2520with%2520refractory%252Fearly%2520relapsed%2520acute%2520myeloid%2520leukemia%26jtitle%3DHaematologica%26date%3D2018%26volume%3D103%26spage%3De514%26epage%3De518%26doi%3D10.3324%2Fhaematol.2018.191361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittalà, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistarà, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardile, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziano, A. C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraix, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sortino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span> <span> </span><span class="NLM_article-title">Novel sigma receptor ligand-nitric oxide photodonors: molecular hybrids for double-targeted antiproliferative effect</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9531</span>– <span class="NLM_lpage">9544</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00791</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00791" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOitrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9531-9544&author=E.+Amataauthor=M.+Dichiaraauthor=E.+Arenaauthor=V.+Pittal%C3%A0author=V.+Pistar%C3%A0author=V.+Cardileauthor=A.+C.+E.+Grazianoauthor=A.+Fraixauthor=A.+Marrazzoauthor=S.+Sortinoauthor=O.+Prezzavento&title=Novel+sigma+receptor+ligand-nitric+oxide+photodonors%3A+molecular+hybrids+for+double-targeted+antiproliferative+effect&doi=10.1021%2Facs.jmedchem.7b00791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect</span></div><div class="casAuthors">Amata, Emanuele; Dichiara, Maria; Arena, Emanuela; Pittala, Valeria; Pistara, Venerando; Cardile, Venera; Graziano, Adriana Carol Eleonora; Fraix, Aurore; Marrazzo, Agostino; Sortino, Salvatore; Prezzavento, Orazio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9531-9544</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This contribution reports the synthesis and evaluation of novel hybrid compds. that conjugate a sigma (σ) receptor pharmacophore and a nitric oxide (NO) photodonor.  All compds. preserve their capability to generate NO under visible light and possess overall σ receptor nanomolar affinity, with one of them (8b) exhibiting remarkable σ2 receptor selectivity.  Compds. 8b, 11a, and 11b were tested on tumorigenic MCF-7 and A2058 cells expressing high levels of σ2 and σ1 receptor, resp.  Considerable loss of cell viability was detected under light excitation, while negligible effects in the dark were detected.  Moreover, they did not show any significant cytotoxicity in the dark or under irradn. on nontumorigenic NCTC-2544 keratinocytes.  NO-induced redn. of cellular viability was demonstrated by in-cell NO detection and total nitrite estn.  For the first time, a combination of σ receptor moieties and a NO photodonor is reported, providing distinctive ligands potentially useful for cancer management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2xXCAIFqTR7Vg90H21EOLACvtfcHk0lhRlNGkGg2HVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOitrvL&md5=a2fae378332770556c38d230d2952295</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00791%26sid%3Dliteratum%253Aachs%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DArena%26aufirst%3DE.%26aulast%3DPittal%25C3%25A0%26aufirst%3DV.%26aulast%3DPistar%25C3%25A0%26aufirst%3DV.%26aulast%3DCardile%26aufirst%3DV.%26aulast%3DGraziano%26aufirst%3DA.%2BC.%2BE.%26aulast%3DFraix%26aufirst%3DA.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DSortino%26aufirst%3DS.%26aulast%3DPrezzavento%26aufirst%3DO.%26atitle%3DNovel%2520sigma%2520receptor%2520ligand-nitric%2520oxide%2520photodonors%253A%2520molecular%2520hybrids%2520for%2520double-targeted%2520antiproliferative%2520effect%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9531%26epage%3D9544%26doi%3D10.1021%2Facs.jmedchem.7b00791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnaturi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Mantia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasello, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acquaviva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Giacomo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span> <span> </span><span class="NLM_article-title">Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: synthesis, in silico, and biological evaluation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">889</span>– <span class="NLM_lpage">894</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00661</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00661" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmvV2qt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=889-894&author=E.+Amataauthor=M.+Dichiaraauthor=D.+Gentileauthor=A.+Marrazzoauthor=R.+Turnaturiauthor=E.+Arenaauthor=A.+La+Mantiaauthor=B.+R.+Tomaselloauthor=R.+Acquavivaauthor=C.+Di+Giacomoauthor=A.+Rescifinaauthor=O.+Prezzavento&title=Sigma+receptor+ligands+carrying+a+nitric+oxide+donor+nitrate+moiety%3A+synthesis%2C+in+silico%2C+and+biological+evaluation&doi=10.1021%2Facsmedchemlett.9b00661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation</span></div><div class="casAuthors">Amata, Emanuele; Dichiara, Maria; Gentile, Davide; Marrazzo, Agostino; Turnaturi, Rita; Arena, Emanuela; La Mantia, Alfonsina; Tomasello, Barbara Rita; Acquaviva, Rosaria; Di Giacomo, Claudia; Rescifina, Antonio; Prezzavento, Orazio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">889-894</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the development of mol. hybrids in which a nitrate group serving as nitric oxide (NO) donor is covalently joined to σ receptor ligands to give candidates for double-targeted cancer therapy.  The compds. have been evaluated in radioligand binding assay at both σ receptors and selected compds. tested for NO release.  Compds. 9, 15, 18, 19, and 21 were subjected to MTT test.  Compd. 15 produced a significant redn. of MCF-7 and Caco-2 cellular viability with comparable IC50 as doxorubicin, being also not toxic for fibroblast HFF-1 cells.  Compd. 15 has shown a σ1 receptor antagonist/σ2 receptor agonist profile.  Two derivs. of compd. 15 lacking the nitrate group did not induce a redn. of MCF-7 cellular viability, suggesting a potential synergistic effect between the σ receptors and the NO-mediated events.  Overall, the combination of NO donor and σ receptors ligands provided compds. with beneficial effects for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxBfdn3ngPoLVg90H21EOLACvtfcHk0lhRlNGkGg2HVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmvV2qt70%253D&md5=2288c983e4641fadd126ef96f7a446da</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00661%26sid%3Dliteratum%253Aachs%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DTurnaturi%26aufirst%3DR.%26aulast%3DArena%26aufirst%3DE.%26aulast%3DLa%2BMantia%26aufirst%3DA.%26aulast%3DTomasello%26aufirst%3DB.%2BR.%26aulast%3DAcquaviva%26aufirst%3DR.%26aulast%3DDi%2BGiacomo%26aufirst%3DC.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DPrezzavento%26aufirst%3DO.%26atitle%3DSigma%2520receptor%2520ligands%2520carrying%2520a%2520nitric%2520oxide%2520donor%2520nitrate%2520moiety%253A%2520synthesis%252C%2520in%2520silico%252C%2520and%2520biological%2520evaluation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D889%26epage%3D894%26doi%3D10.1021%2Facsmedchemlett.9b00661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Giacomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Valerio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciatore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cataldi, A.</span></span> <span> </span><span class="NLM_article-title">MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells</span>. <i>Cell. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=26068914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADC%252BC2MbjtV2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=17-23&author=V.+Di%0AGiacomoauthor=V.+Di+Valerioauthor=M.+Rapinoauthor=D.+Boscoauthor=I.+Cacciatoreauthor=M.+Ciullaauthor=A.+Marrazzoauthor=J.+Fioritoauthor=A.+Di+Stefanoauthor=A.+Cataldi&title=MRJF4%2C+a+novel+histone+deacetylase+inhibitor%2C+induces+p21+mediated+autophagy+in+PC3+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells</span></div><div class="casAuthors">Di Giacomo V; Ciulla M; Di Stefano A; Cataldi A; Di Valerio V; Rapino M; Bosco D; Cacciatore I; Marrazzo A; Fiorito J</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and molecular biology (Noisy-le-Grand, France)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">17-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autophagy is a cellular defense mechanism which occurs through degradation and recycling of cytoplasmic constituents and represents a caspase&mdash;independent alternative to cell death by apoptosis.  It is generally accepted that the suppression of autophagy in many cancer cells is directly correlated to malignancy; hence, the control of autophagy genes could represent a target for cancer therapy.  The inhibition of cell proliferation through autophagy activation could be an important mechanism for many anti&mdash;tumor drugs.  Here we report the effects of a novel histone deacetylase inhibitor MRJF4 (racemic mixture) and of its two enantiomers [(+)&mdash;MRJF4 and (&mdash;)&mdash;MRJF4] on the morphological and molecular mechanisms causing death and migration of PC3 prostatic cancer cells.  In particular, we investigated the occurrence of the autophagic process, both at morphological and molecular levels (LC3 expression), and its relationship with p21, a key molecule which regulates cell cycle and autophagy cell death.  Moreover, pERK/Nf&mdash;kB driven intracellular signaling, the expression of MMP9 protein &mdash; a key component of cell migration &mdash; invasion, and metastasis were assayed.  Our results showed that the anti&mdash;proliferative effects of MRJF4 due to autophagy occurrence, documented by LC3 increase and ultrastructural modifications, and the reduction of invasiveness seem to be mediated by the down&mdash;regulation of pERK/NF&mdash;kB signaling pathway, along with p21 up&mdash;regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoYKhEO3wZnHwOGIfWJ7-GfW6udTcc2eZ2BjjGtX5SsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbjtV2mtw%253D%253D&md5=b9e0e06dd53194b5159436a53f863a29</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiacomo%26aufirst%3DV.%26aulast%3DDi%2BValerio%26aufirst%3DV.%26aulast%3DRapino%26aufirst%3DM.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DCacciatore%26aufirst%3DI.%26aulast%3DCiulla%26aufirst%3DM.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DDi%2BStefano%26aufirst%3DA.%26aulast%3DCataldi%26aufirst%3DA.%26atitle%3DMRJF4%252C%2520a%2520novel%2520histone%2520deacetylase%2520inhibitor%252C%2520induces%2520p21%2520mediated%2520autophagy%2520in%2520PC3%2520prostate%2520cancer%2520cells%26jtitle%3DCell.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D61%26spage%3D17%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olivieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinciguerra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giurdanella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporarello, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anfuso, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span> <span> </span><span class="NLM_article-title">Antiangiogenic effect of (±)-haloperidol metabolite II valproate ester [(±)-MRJF22] in human microvascular retinal endothelial cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9960</span>– <span class="NLM_lpage">9966</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yks77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9960-9966&author=M.+Olivieriauthor=E.+Amataauthor=S.+Vinciguerraauthor=J.+Fioritoauthor=G.+Giurdanellaauthor=F.+Dragoauthor=N.+Caporarelloauthor=O.+Prezzaventoauthor=E.+Arenaauthor=L.+Salernoauthor=A.+Rescifinaauthor=G.+Lupoauthor=C.+D.+Anfusoauthor=A.+Marrazzo&title=Antiangiogenic+effect+of+%28%C2%B1%29-haloperidol+metabolite+II+valproate+ester+%5B%28%C2%B1%29-MRJF22%5D+in+human+microvascular+retinal+endothelial+cells&doi=10.1021%2Facs.jmedchem.6b01039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells</span></div><div class="casAuthors">Olivieri, Melania; Amata, Emanuele; Vinciguerra, Shila; Fiorito, Jole; Giurdanella, Giovanni; Drago, Filippo; Caporarello, Nunzia; Prezzavento, Orazio; Arena, Emanuela; Salerno, Loredana; Rescifina, Antonio; Lupo, Gabriella; Anfuso, Carmelina Daniela; Marrazzo, Agostino</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9960-9966</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(±)-MRJF22 [(±)-2], a novel prodrug of haloperidol metabolite II (sigma-1 receptor antagonist/sigma-2 receptor agonist ligand) obtained by conjugation to valproic acid (histone deacetylase inhibitor) via an ester bond, exhibits antiangiogenic activity, being able to reduce human retinal endothelial cell (HREC) viability in a comparable manner to bevacizumab.  Moreover, (±)-2 was able to significantly reduce viable cells count, endothelial cell migration, and tube formation in vascular endothelial growth factor A (VEGF-A) stimulated HREC cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJedDLZWd8jbVg90H21EOLACvtfcHk0li083D-plalyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yks77P&md5=f0a092eedd76c583f4dabaa7151774c4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01039%26sid%3Dliteratum%253Aachs%26aulast%3DOlivieri%26aufirst%3DM.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DVinciguerra%26aufirst%3DS.%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DGiurdanella%26aufirst%3DG.%26aulast%3DDrago%26aufirst%3DF.%26aulast%3DCaporarello%26aufirst%3DN.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DArena%26aufirst%3DE.%26aulast%3DSalerno%26aufirst%3DL.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DLupo%26aufirst%3DG.%26aulast%3DAnfuso%26aufirst%3DC.%2BD.%26aulast%3DMarrazzo%26aufirst%3DA.%26atitle%3DAntiangiogenic%2520effect%2520of%2520%2528%25C2%25B1%2529-haloperidol%2520metabolite%2520II%2520valproate%2520ester%2520%255B%2528%25C2%25B1%2529-MRJF22%255D%2520in%2520human%2520microvascular%2520retinal%2520endothelial%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9960%26epage%3D9966%26doi%3D10.1021%2Facs.jmedchem.6b01039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sozio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Giacomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciatore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cataldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turkez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parenti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span> <span> </span><span class="NLM_article-title">Haloperidol metabolite II prodrug: asymmetric synthesis and biological evaluation on rat C6 glioma cells</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ejmech.2014.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=25461306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyksbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2015&pages=1-9&author=P.+Sozioauthor=J.+Fioritoauthor=V.+Di+Giacomoauthor=A.+Di+Stefanoauthor=L.+Marinelliauthor=I.+Cacciatoreauthor=A.+Cataldiauthor=S.+Pacellaauthor=H.+Turkezauthor=C.+Parentiauthor=A.+Rescifinaauthor=A.+Marrazzo&title=Haloperidol+metabolite+II+prodrug%3A+asymmetric+synthesis+and+biological+evaluation+on+rat+C6+glioma+cells&doi=10.1016%2Fj.ejmech.2014.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Haloperidol metabolite II prodrug: Asymmetric synthesis and biological evaluation on rat C6 glioma cells</span></div><div class="casAuthors">Sozio, Piera; Fiorito, Jole; Di Giacomo, Viviana; Di Stefano, Antonio; Marinelli, Lisa; Cacciatore, Ivana; Cataldi, Amelia; Pacella, Stephanie; Turkez, Hasan; Parenti, Carmela; Rescifina, Antonio; Marrazzo, Agostino</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In a previous work the authors reported the antiproliferative effects of (±)-MRJF4, a novel haloperidol metabolite II (HP-mII) (a sigma-1 antagonist and sigma-2 agonist) prodrug, obtained through conjugation to 4-phenylbutyric acid (PhBA) [a histone deacetylase inhibitor (HDACi)] by an ester bond.  As a continuation of this work, here the authors report the asym. synthesis of compds. Benzenebutanoic acid 4-[(1R)-4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)butyl ester [(R)-(+)-MRJF4] and 4-[(1R)-4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)butyl ester [(S)-(-)-MRJF4] and the evaluation of their biol. activity on rat C6 glioma cells, derived from glioblastoma multiforme (GBM), which is the most common and deadliest central nervous system (CNS) invasive malignancy.  Favorable physicochem. properties, high permeability in the parallel artificial membrane permeability assay (PAMPA), good enzymic and chem. stability, in vivo anticancer activity, assocd. with the capacity to reduce cell viability and to increase cell death by apoptosis, render compd. (R)-(+)-MRJF4 a promising candidate for the development of a useful therapeutic for glioma therapy.  The synthesis of the target compds. was achieved by a reaction of (αS)-4-(4-chlorophenyl)-α-(4-fluorophenyl)-4-hydroxy-1-piperidienbutanol or (αR)-4-(4-chlorophenyl)-α-(4-fluorophenyl)-4-hydroxy-1-piperidienbutanol with benzenebutanoyl chloride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa48fSw9hC67Vg90H21EOLACvtfcHk0li083D-plalyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyksbvP&md5=cd126d3df0c611a02cf58320c7dd3fa0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DSozio%26aufirst%3DP.%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DDi%2BGiacomo%26aufirst%3DV.%26aulast%3DDi%2BStefano%26aufirst%3DA.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DCacciatore%26aufirst%3DI.%26aulast%3DCataldi%26aufirst%3DA.%26aulast%3DPacella%26aufirst%3DS.%26aulast%3DTurkez%26aufirst%3DH.%26aulast%3DParenti%26aufirst%3DC.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DMarrazzo%26aufirst%3DA.%26atitle%3DHaloperidol%2520metabolite%2520II%2520prodrug%253A%2520asymmetric%2520synthesis%2520and%2520biological%2520evaluation%2520on%2520rat%2520C6%2520glioma%2520cells%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D90%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.ejmech.2014.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonavida, B.</span></span> <span> </span><span class="NLM_article-title">Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">113913</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2020.113913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.bcp.2020.113913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=32173364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXls1Cmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2020&pages=113913&author=B.+Bonavida&title=Sensitizing+activities+of+nitric+oxide+donors+for+cancer+resistance+to+anticancer+therapeutic+drugs&doi=10.1016%2Fj.bcp.2020.113913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs</span></div><div class="casAuthors">Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113913</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cancer is not a single disease but it constitutes a large variety of different types that are also different from each other phenotypically and molecularly.  Although the std. treatments have resulted in clin. responses in a subset of patients, though, many patients relapse and no longer respond to further treatments.  Hence, both the innate and adaptive resistance to treatments are the main challenges in today's treatment strategies.  Noteworthy, several novel treatment strategies, particularly immunotherapies, used alone or in combination, have been developed and that have significantly improved the therapeutic response of many unresponsive cancer patients.  Nevertheless, even with the latest new developments of therapeutics that were effective in a larger subset of patients, there is still an urgent need to treat the remaining unresponsive subset of patients.  This requires the development of new targeting agents of superior antitumor activities that will lead to overcoming the unaffected resistance by current treatments.  There has been accumulating evidence suggesting nitric oxide donors as such targeting agents and considering their pleiotropic antitumor activities, including both the reversal of chemo and immuno-resistance of various unresponsive resistant cancers.  The in vitro and in vivo preclin. findings corroborate the sensitizing antitumor activities of nitric oxide donors.  In addn., a few clin. findings with NO donors that have been applied in patients have corroborated their antitumor and sensitizing activities in combination with std. therapies.  In this review, the role and underlying mechanisms by which nitric oxide donors sensitize cancer resistant cells to both chemotherapy and immunotherapy are briefly described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtTJZtSO_AU7Vg90H21EOLACvtfcHk0lhXhlN36Ee2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXls1Cmsbw%253D&md5=26ad629e0366dd9c659c069bc58d956e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2020.113913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2020.113913%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DSensitizing%2520activities%2520of%2520nitric%2520oxide%2520donors%2520for%2520cancer%2520resistance%2520to%2520anticancer%2520therapeutic%2520drugs%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2020%26volume%3D176%26spage%3D113913%26doi%3D10.1016%2Fj.bcp.2020.113913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hays, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonavida, B.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide-mediated enhancement and reversal of resistance of anticancer therapies</span>. <i>Antioxidants</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">407</span>, <span class="refDoi"> DOI: 10.3390/antiox8090407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fantiox8090407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVyqt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=407&author=E.+Haysauthor=B.+Bonavida&title=Nitric+oxide-mediated+enhancement+and+reversal+of+resistance+of+anticancer+therapies&doi=10.3390%2Fantiox8090407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide-mediated enhancement and reversal of resistance of anticancer therapies</span></div><div class="casAuthors">Hays, Emily; Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">407pp.</span>CODEN:
                <span class="NLM_cas:coden">ANTIGE</span>;
        ISSN:<span class="NLM_cas:issn">2076-3921</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Hence, there is a need to develop novel approaches to treat those anticancer therapy unresponsive patients.  Several investigations have been reported to explain the underlying mechanisms of immune resistance, including the anti-proliferative and anti-apoptotic pathways and, in addn., the increased expression of the transcription factor Yin-Yang 1 (YY1) and the programmed death ligand 1 (PD-L1).  Treatment with nitric oxide (NO) donors has been shown to sensitize many types of tumors to chemotherapy, immunotherapy, and radiotherapy.  Treatment of cancer cell lines with NO donors has resulted in the inhibition of cancer cell activities via, in part, the inhibition of YY1 and PD-L1.  The NO-mediated inhibition of YY1 was the result of both the inhibition of the upstream NF-κB pathway as well as the S-nitrosylation of YY1, leading to both the downregulation of YY1 expression as well as the inhibition of YY1-DNA binding activity, resp.  Also, treatment with NO donors induced the inhibition of YY1 and resulted in the inhibition of PD-L1 expression.  Based on the above findings, we propose that treatment of tumor cells with the combination of NO donors, at optimal noncytotoxic doses, and anti-tumor cytotoxic effector cells or other conventional therapies will result in a synergistic anticancer activity and tumor regression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod7Riu2bmBCrVg90H21EOLACvtfcHk0lhXhlN36Ee2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVyqt73E&md5=bc0ec2913cb52e7eda0d09ba1f6f109f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fantiox8090407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fantiox8090407%26sid%3Dliteratum%253Aachs%26aulast%3DHays%26aufirst%3DE.%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DNitric%2520oxide-mediated%2520enhancement%2520and%2520reversal%2520of%2520resistance%2520of%2520anticancer%2520therapies%26jtitle%3DAntioxidants%26date%3D2019%26volume%3D8%26spage%3D407%26doi%3D10.3390%2Fantiox8090407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, R. M. J.</span></span> <span> </span><span class="NLM_article-title">The l-arginine: nitric oxide pathway</span>. <i>Curr Opin Nephrol Hypertens.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1097/00041552-199301000-00018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1097%2F00041552-199301000-00018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=7522910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fgs1CmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1993&pages=122-128&author=R.+M.+J.+Palmer&title=The+l-arginine%3A+nitric+oxide+pathway&doi=10.1097%2F00041552-199301000-00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The L-arginine: nitric oxide pathway</span></div><div class="casAuthors">Palmer R M</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in nephrology and hypertension</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-8</span>
        ISSN:<span class="NLM_cas:issn">1062-4821</span>.
    </div><div class="casAbstract">The L-arginine: nitric oxide pathway is widely recognized as an important regulator of cell function and communication in a variety of physiological and pathophysiological situations.  Recent advances in the biochemistry and molecular biology of nitric oxide synthases have contributed significantly to our understanding of the regulation of nitric oxide synthesis in health and disease.  This pathway has been implicated in the pathogenesis of septic shock, hypertension, and atherosclerosis as well as in the antihypertensive action of converting enzyme inhibitors.  Progress in this field, which spans the cardiovascular, immune, and nervous systems, has been rapid, and its full potential is yet to be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHpybKVxyobyXXDYhVZBdlfW6udTcc2eaefLq4aQ-DKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fgs1CmtQ%253D%253D&md5=ddf4e056f9722ea3dc21d148db28e957</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1097%2F00041552-199301000-00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00041552-199301000-00018%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DThe%2520l-arginine%253A%2520nitric%2520oxide%2520pathway%26jtitle%3DCurr%2520Opin%2520Nephrol%2520Hypertens.%26date%3D1993%26volume%3D2%26spage%3D122%26epage%3D128%26doi%3D10.1097%2F00041552-199301000-00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moncada, S.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide</span>. <i>J. Hypertens. Suppl.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">S35</span>– <span class="NLM_lpage">S39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=7539493" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=S35-S39&author=S.+Moncada&title=Nitric+oxide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DNitric%2520oxide%26jtitle%3DJ.%2520Hypertens.%2520Suppl.%26date%3D1994%26volume%3D12%26spage%3DS35%26epage%3DS39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Star, R. A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide</span>. <i>Am. J. Med. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1097/00000441-199311000-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1097%2F00000441-199311000-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=7694458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADyaK2c%252Fls1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1993&pages=348-358&author=R.+A.+Star&title=Nitric+oxide&doi=10.1097%2F00000441-199311000-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide</span></div><div class="casAuthors">Star R A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of the medical sciences</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-58</span>
        ISSN:<span class="NLM_cas:issn">0002-9629</span>.
    </div><div class="casAbstract">Nitric oxide is a newly discovered gas that mediates communication between adjacent cells and signals inside cells.  Defects in the nitric oxide signalling cascade have been found in patients with systemic hypertension, pulmonary hypertension, and coronary artery disease.  High concentrations of nitric oxide are cytotoxic.  Over-production of nitric oxide contributes to the pathogenesis of septic shock and uremic bleeding.  This review focuses on the cardiovascular and platelet actions of nitric oxide, with emphasis on clinical studies of agents that modulate the nitric oxide signalling cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1Euevg9zSTZVVjGoY74BafW6udTcc2eaefLq4aQ-DKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252Fls1Crtg%253D%253D&md5=e0402d48d03e32d7d209240cbf494d9d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1097%2F00000441-199311000-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000441-199311000-00015%26sid%3Dliteratum%253Aachs%26aulast%3DStar%26aufirst%3DR.%2BA.%26atitle%3DNitric%2520oxide%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D1993%26volume%3D306%26spage%3D348%26epage%3D358%26doi%3D10.1097%2F00000441-199311000-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orlandi, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolando, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzarato, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span> <span> </span><span class="NLM_article-title">Anti-Pseudomonas activity of 3-nitro-4-phenylfuroxan</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">1557</span>– <span class="NLM_lpage">1566</span>, <span class="refDoi"> DOI: 10.1099/mic.0.000730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1099%2Fmic.0.000730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=30300122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXislyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2018&pages=1557-1566&author=V.+T.+Orlandiauthor=F.+Bologneseauthor=B.+Rolandoauthor=S.+Guglielmoauthor=L.+Lazzaratoauthor=R.+Fruttero&title=Anti-Pseudomonas+activity+of+3-nitro-4-phenylfuroxan&doi=10.1099%2Fmic.0.000730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Pseudomonas activity of 3-nitro-4-phenylfuroxan</span></div><div class="casAuthors">Orlandi, Viviana Teresa; Bolognese, Fabrizio; Rolando, Barbara; Guglielmo, Stefano; Lazzarato, Loretta; Fruttero, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1557-1566</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1465-2080</span>.
    
            (<span class="NLM_cas:orgname">Microbiology Society</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa is a microorganism that is well adapted to both clin. and industrial settings, where it can form adherent communities that are difficult to eradicate.  New anti-Pseudomonas compds. and strategies are necessary, as the current antimicrobial approaches for the inhibition of biofilm formation and, above all, the eradication of formed biofilms are ineffective.  Compds. that belong to the furoxan family, which are well-known NO donors, have recently been shown to display anti-Pseudomonas activity.  The present study investigates three furoxan compds. that are substituted at the hetero-ring with electron-withdrawing groups (NO2, CN, CONH2) for their effects on P. aeruginosa PAO1 growth and biofilm formation/dispersal.  Of the furoxans tested, only 3-nitro-4-phenylfuroxan (KN455) inhibited the growth of suspended P. aeruginosa PAO1 cultures.  Furthermore, KN455 inhibited the formation of both younger and older biofilms with very high yields and thus proved itself to be toxic to planktonic subpopulations.  It also displayed moderate eradicating power.  The activity of KN455 does not appear to be related to its capacity to release small amts. of NO.  Interestingly, the isomer 4-nitro-3-phenylfuroxan (KN454), included for comparison, displayed a comparable antibiofilm rate, but did not show the same antimicrobial activity against suspended cells and planktonic subpopulations.  While hypotheses as to the mechanism of action have been formulated, further investigations are necessary to shed light onto the antimicrobial activity of this furoxan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCrsFGf-IOHLVg90H21EOLACvtfcHk0lgABc9vhD9XnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXislyhtLo%253D&md5=0143969d8229a4437bb2dc0c353eff50</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.000730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.000730%26sid%3Dliteratum%253Aachs%26aulast%3DOrlandi%26aufirst%3DV.%2BT.%26aulast%3DBolognese%26aufirst%3DF.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DFruttero%26aufirst%3DR.%26atitle%3DAnti-Pseudomonas%2520activity%2520of%25203-nitro-4-phenylfuroxan%26jtitle%3DMicrobiology%26date%3D2018%26volume%3D164%26spage%3D1557%26epage%3D1566%26doi%3D10.1099%2Fmic.0.000730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridnour, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isenberg, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Santana, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Switzer, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donzelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolocci, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, D. A.</span></span> <span> </span><span class="NLM_article-title">The chemical biology of nitric oxide: implications in cellular signaling</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2008.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.freeradbiomed.2008.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=18439435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2008&pages=18-31&author=D.+D.+Thomasauthor=L.+A.+Ridnourauthor=J.+S.+Isenbergauthor=W.+Flores-Santanaauthor=C.+H.+Switzerauthor=S.+Donzelliauthor=P.+Hussainauthor=C.+Vecoliauthor=N.+Paolocciauthor=S.+Ambsauthor=C.+A.+Coltonauthor=C.+C.+Harrisauthor=D.+D.+Robertsauthor=D.+A.+Wink&title=The+chemical+biology+of+nitric+oxide%3A+implications+in+cellular+signaling&doi=10.1016%2Fj.freeradbiomed.2008.03.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The chemical biology of nitric oxide: Implications in cellular signaling</span></div><div class="casAuthors">Thomas, Douglas D.; Ridnour, Lisa A.; Isenberg, Jeffrey S.; Flores-Santana, Wilmarie; Switzer, Christopher H.; Donzelli, Sonia; Hussain, Perwez; Vecoli, Cecilia; Paolocci, Nazareno; Ambs, Stefan; Colton, Carol A.; Harris, Curtis C.; Roberts, David D.; Wink, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-31</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  NO has earned the reputation of being a signaling mediator with many diverse and often opposing biol. activities.  The diversity in response to this simple diat. mol. comes from the enormous variety of chem. reactions and biol. properties assocd. with it.  In the past few years, the importance of steady-state NO concns. has emerged as a key determinant of its biol. function.  Precise cellular responses are differentially regulated by specific NO concn.  The authors propose 5 basic distinct concn. levels of NO activity: cGMP-mediated processes ([NO] < 1-30 nM), Akt phosphorylation ([NO] = 30-100 nM), stabilization of HIF-1α ([NO] = 100-300 nM), phosphorylation of p53 ([NO] > 400 nM), and nitrosative stress (1 μM).  In general, lower NO concns. promote cell survival and proliferation, whereas higher levels favor cell cycle arrest, apoptosis, and senescence.  Free radical interactions will also influence NO signaling.  One of the consequences of reactive O species generation is to reduce NO concns.  This antagonizes the signaling of NO and in some cases results in converting a cell-cycle arrest profile to a cell survival profile.  The resulting reactive N species that are generated from these reactions can also have biol. effects and increase oxidative and nitrosative stress responses.  A no. of factors det. the formation of NO and its concn., such as diffusion, consumption, and substrate availability, which are referred to as kinetic determinants for mol. target interactions.  These are the chem. and biochem. parameters that shape cellular responses to NO.  Here, the authors discuss signal transduction and the biochem. of NO in terms of the direct and indirect reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBy1CNbcvHq7Vg90H21EOLACvtfcHk0lgABc9vhD9XnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFaqt7w%253D&md5=927163ba426538f3e1733797f69621f6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2008.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2008.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DD.%2BD.%26aulast%3DRidnour%26aufirst%3DL.%2BA.%26aulast%3DIsenberg%26aufirst%3DJ.%2BS.%26aulast%3DFlores-Santana%26aufirst%3DW.%26aulast%3DSwitzer%26aufirst%3DC.%2BH.%26aulast%3DDonzelli%26aufirst%3DS.%26aulast%3DHussain%26aufirst%3DP.%26aulast%3DVecoli%26aufirst%3DC.%26aulast%3DPaolocci%26aufirst%3DN.%26aulast%3DAmbs%26aufirst%3DS.%26aulast%3DColton%26aufirst%3DC.%2BA.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DRoberts%26aufirst%3DD.%2BD.%26aulast%3DWink%26aufirst%3DD.%2BA.%26atitle%3DThe%2520chemical%2520biology%2520of%2520nitric%2520oxide%253A%2520implications%2520in%2520cellular%2520signaling%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2008%26volume%3D45%26spage%3D18%26epage%3D31%26doi%3D10.1016%2Fj.freeradbiomed.2008.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, C.</span></span> <span> </span><span class="NLM_article-title">Gasotransmitters in cancer: from pathophysiology to experimental therapy</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1038/nrd.2015.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1038%2Fnrd.2015.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=26678620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCrurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=185-203&author=C.+Szabo&title=Gasotransmitters+in+cancer%3A+from+pathophysiology+to+experimental+therapy&doi=10.1038%2Fnrd.2015.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Gasotransmitters in cancer: from pathophysiology to experimental therapy</span></div><div class="casAuthors">Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">185-203</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The three endogenous gaseous transmitters - nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) - regulate a no. of key biol. functions.  Emerging data have revealed several new mechanisms for each of these three gasotransmitters in tumor biol.  It is now appreciated that they show bimodal pharmacol. character in cancer, in that not only the inhibition of their biosynthesis but also elevation of their concn. beyond a certain threshold can exert anticancer effects.  This Review discusses the role of each gasotransmitter in cancer and the effects of pharmacol. agents - some of which are in early-stage clin. studies - that modulate the levels of each gasotransmitter.  A clearer understanding of the pharmacol. character of these three gases and the mechanisms underlying their biol. effects is expected to guide further clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwYul_JkB2s7Vg90H21EOLACvtfcHk0lgABc9vhD9XnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCrurnF&md5=e58b917180ac87d4d65e3f80f6a04233</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2015.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2015.1%26sid%3Dliteratum%253Aachs%26aulast%3DSzabo%26aufirst%3DC.%26atitle%3DGasotransmitters%2520in%2520cancer%253A%2520from%2520pathophysiology%2520to%2520experimental%2520therapy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2016%26volume%3D15%26spage%3D185%26epage%3D203%26doi%3D10.1038%2Fnrd.2015.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viarisio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costamagna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescarmona, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosia, A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=15695394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=516-525&author=C.+Rigantiauthor=E.+Miragliaauthor=D.+Viarisioauthor=C.+Costamagnaauthor=G.+Pescarmonaauthor=D.+Ghigoauthor=A.+Bosia&title=Nitric+oxide+reverts+the+resistance+to+doxorubicin+in+human+colon+cancer+cells+by+inhibiting+the+drug+efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span></div><div class="casAuthors">Riganti, Chiara; Miraglia, Erica; Viarisio, Daniele; Costamagna, Costanzo; Pescarmona, Gianpiero; Ghigo, Dario; Bosia, Amalia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">516-525</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is a phenomenon by which cancer cells evade the cytotoxic effects of chemotherapeutic agents.  It may occur through different mechanisms, but it often correlates with the overexpression of integral membrane transporters, such as P-glycoprotein (Pgp) and MDR-assocd. proteins (MRPs), with resulting decrease of drug accumulation and cellular death.  Doxorubicin is a substrate of Pgp; it has been suggested that its ability to induce synthesis of nitric oxide (NO) could explain, at least in part, its cytotoxic effects.  Culturing the human epithelial colon cell line HT29 in the presence of doxorubicin, we obtained a doxorubicin-resistant (HT29-dx) cell population: these cells accumulated less intracellular doxorubicin, were less sensitive to the cytotoxic effects of doxorubicin and cisplatin, overexpressed Pgp and MRP3, and exhibited a lower NO prodn. (both under basal conditions and after doxorubicin stimulation).  The resistance to doxorubicin could be reversed when HT29-dx cells were incubated with inducers of NO synthesis (cytokines mix, atorvastatin).  Some NO donors increased the drug accumulation in HT29-dx cells in a guanosine-3':5'-cyclic monophosphate-independent way; this effect was assocd. with a marked redn. of doxorubicin efflux rate in HT29 and HT29-dx cells, and tyrosine nitration in the MRP3 protein.  Our results suggest that onset of MDR and impairment of NO synthesis are related; this finding could point to a new strategy to reverse doxorubicin resistance in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTu2bqm5O1DbVg90H21EOLACvtfcHk0lj2-A3gsfY6Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D&md5=e0e7757d954680c9b9eb3470a1758da6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DMiraglia%26aufirst%3DE.%26aulast%3DViarisio%26aufirst%3DD.%26aulast%3DCostamagna%26aufirst%3DC.%26aulast%3DPescarmona%26aufirst%3DG.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DBosia%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520reverts%2520the%2520resistance%2520to%2520doxorubicin%2520in%2520human%2520colon%2520cancer%2520cells%2520by%2520inhibiting%2520the%2520drug%2520efflux%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D516%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide donor-based cancer therapy: advances and prospects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7617</span>– <span class="NLM_lpage">7635</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01672</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01672" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslKjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7617-7635&author=Z.+Huangauthor=J.+Fuauthor=Y.+Zhang&title=Nitric+oxide+donor-based+cancer+therapy%3A+advances+and+prospects&doi=10.1021%2Facs.jmedchem.6b01672"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects</span></div><div class="casAuthors">Huang, Zhangjian; Fu, Junjie; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7617-7635</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The increasing understanding of the role of nitric oxide (NO) in cancer biol. has generated significant progress in the use of NO donor-based therapy to fight cancer.  These advances strongly suggest the potential adoption of NO donor-based therapy in clin. practice, and this has been supported by several clin. studies in the past decade.  In this review, the authors first highlight several types of important NO donors, including recently developed NO donors bearing a dinitroazetidine skeleton, represented by RRx-001, with potential utility in cancer therapy.  Special emphasis is then given to the combination of NO donor(s) with other therapies to achieve synergy and to the hybridization of NO donor(s) with an anticancer drug/agent/fragment to enhance the activity or specificity or to reduce toxicity.  In addn., the authors briefly describe inducible NO synthase gene therapy and nanotechnol., which have recently entered the field of NO donor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPi-02-7rrIrVg90H21EOLACvtfcHk0lj2-A3gsfY6Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslKjtLg%253D&md5=37c58426b9b4a543b3112b4a4239f8c4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01672%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DNitric%2520oxide%2520donor-based%2520cancer%2520therapy%253A%2520advances%2520and%2520prospects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7617%26epage%3D7635%26doi%3D10.1021%2Facs.jmedchem.6b01672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelegrino, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nascimento, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortella, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubilar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabra, A. B.</span></span> <span> </span><span class="NLM_article-title">Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">113740</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2019.113740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.bcp.2019.113740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31786262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVKrt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2020&pages=113740&author=J.+C.+Pierettiauthor=M.+T.+Pelegrinoauthor=M.+H.+M.+Nascimentoauthor=G.+R.+Tortellaauthor=O.+Rubilarauthor=A.+B.+Seabra&title=Small+molecules+for+great+solutions%3A+Can+nitric+oxide-releasing+nanomaterials+overcome+drug+resistance+in+chemotherapy%3F&doi=10.1016%2Fj.bcp.2019.113740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?</span></div><div class="casAuthors">Pieretti, Joana C.; Pelegrino, Milena T.; Nascimento, Monica H. M.; Tortella, Gonzalo R.; Rubilar, Olga; Seabra, Amedea B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113740</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is an endogenous free radical that controls important physiol. and pathophysiol. processes, including a role in cancer biol.  NO can have a direct toxic effect on tumors, or it can sensitize cancer cells and contribute to the reversal of multidrug resistance (MDR).  As NO is a gas and free radical, NO donors have been investigated for their anticancer effects.  In recent years, the combination of NO donors with nanomaterials has been emerging as a promising strategy to promote spatial-temporal NO release/generation directly at the target site of application (tumor tissue).  Smart nanocarriers that are able to release NO under controlled stimuli have been extensively developed.  Moreover, important publications have demonstrated the promising applications of NO-releasing nanomaterials in combination with traditional chemotherapies in which NO can sensitize cancer cells.  In this direction, this review presents and discusses the recent progress in the design of versatile nanocarriers that are able to release/generate therapeutic amts. of NO and which can be combined with conventional anticancer therapies.  These nanocarriers have the ability to release NO on-demand by external stimuli such as pH, wave, or light exposure.  In addn., the possible mechanisms of NO in sensitizing tumor tissue and the impact and challenges of nanomaterials in cancer treatment are also presented and discussed.  The biol. and pharmacol. aspects of NO donors in cancer are discussed.  Finally, challenges and perspectives in the development of versatile nanoplatforms to efficiently deliver NO in clin. cancer treatment are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotnO90pIqIlrVg90H21EOLACvtfcHk0lj2-A3gsfY6Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVKrt7nI&md5=2e40b472d2db04100c93f94d979228e2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2019.113740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2019.113740%26sid%3Dliteratum%253Aachs%26aulast%3DPieretti%26aufirst%3DJ.%2BC.%26aulast%3DPelegrino%26aufirst%3DM.%2BT.%26aulast%3DNascimento%26aufirst%3DM.%2BH.%2BM.%26aulast%3DTortella%26aufirst%3DG.%2BR.%26aulast%3DRubilar%26aufirst%3DO.%26aulast%3DSeabra%26aufirst%3DA.%2BB.%26atitle%3DSmall%2520molecules%2520for%2520great%2520solutions%253A%2520Can%2520nitric%2520oxide-releasing%2520nanomaterials%2520overcome%2520drug%2520resistance%2520in%2520chemotherapy%253F%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2020%26volume%3D176%26spage%3D113740%26doi%3D10.1016%2Fj.bcp.2019.113740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alimoradi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, G. I.</span></span> <span> </span><span class="NLM_article-title">Controlled delivery of nitric oxide for cancer therapy</span>. <i>Pharm. Nanotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">303</span>, <span class="refDoi"> DOI: 10.2174/2211738507666190429111306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.2174%2F2211738507666190429111306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31595847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2isbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&pages=279-303&author=H.+Alimoradiauthor=K.+Greishauthor=A.+B.+Gambleauthor=G.+I.+Giles&title=Controlled+delivery+of+nitric+oxide+for+cancer+therapy&doi=10.2174%2F2211738507666190429111306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Controlled Delivery of Nitric Oxide for Cancer Therapy</span></div><div class="casAuthors">Alimoradi, Houman; Greish, Khaled; Gamble, Allan B.; Giles, Gregory I.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Nanotechnology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-303</span>CODEN:
                <span class="NLM_cas:coden">PNHABM</span>;
        ISSN:<span class="NLM_cas:issn">2211-7385</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is a short-lived, endogenously produced, signaling mol. which plays multiple roles in mammalian physiol.  Underprodn. of NO is assocd. with several pathol. processes; hence a broad range of NO donors have emerged as potential therapeutics for cardiovascular and respiratory disorders, wound healing, the immune response to infection, and cancer.  However, short half-lives, chem. reactivity, rapid systemic clearance, and cytotoxicity have hindered the clin. development of most low mol. wt. NO donors.  Hence, for controlled NO delivery, there has been extensive effort to design novel NO-releasing biomaterials for tumor targeting.  This review covers the effects of NO in cancer biol., NO releasing moieties which can be used for NO delivery, and current advances in the design of NO releasing biomaterials focusing on their applications for tumor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo4uth5KZiQrVg90H21EOLACvtfcHk0lj2-A3gsfY6Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2isbzK&md5=a6c655bd9359176d8b9714f767f04da1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F2211738507666190429111306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F2211738507666190429111306%26sid%3Dliteratum%253Aachs%26aulast%3DAlimoradi%26aufirst%3DH.%26aulast%3DGreish%26aufirst%3DK.%26aulast%3DGamble%26aufirst%3DA.%2BB.%26aulast%3DGiles%26aufirst%3DG.%2BI.%26atitle%3DControlled%2520delivery%2520of%2520nitric%2520oxide%2520for%2520cancer%2520therapy%26jtitle%3DPharm.%2520Nanotechnol.%26date%3D2019%26volume%3D7%26spage%3D279%26epage%3D303%26doi%3D10.2174%2F2211738507666190429111306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span> <span> </span><span class="NLM_article-title">Light-induced therapies for prostate cancer treatment</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">719</span>, <span class="refDoi"> DOI: 10.3389/fchem.2019.00719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3389%2Ffchem.2019.00719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31737599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpvV2jtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&pages=719&author=C.+Ferroniauthor=A.+Del+Rioauthor=C.+Martiniauthor=E.+Manoniauthor=G.+Varchi&title=Light-induced+therapies+for+prostate+cancer+treatment&doi=10.3389%2Ffchem.2019.00719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Light-induced therapies for prostate cancer treatment</span></div><div class="casAuthors">Ferroni, Claudia; Del Rio, Alberto; Martini, Cecilia; Manoni, Elisabetta; Varchi, Greta</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">719</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Prostate cancer (PC) is one of the most widespread tumors affecting the urinary system and the fifth-leading cause from cancer death in men worldwide.  Despite PC mortality rates have been decreasing during the last years, most likely due to an intensification of early diagnosis, still more than 300,000 men die each year because of this disease.  In this view, researchers in all countries are engaged in finding new ways to tackle PC, including the design and synthesis of novel mol. and macromol. entities able to challenge different PC biol. targets, while limiting the extent of unwanted side effects that significantly limitmen's life quality.  Among this field of research, photo-induced therapies, such as photodynamic and photothermal therapies (PDT and PTT), might represent an important advancement in PC treatment due to their extremely localized and controlled cytotoxic effect, as well as their low incidence of side effects and tumor resistance occurrence.  Based on these considerations, this review aims to gather and discuss the last 5-years literature reports dealing with the synthesis and biol. activity of mol. conjugates and nano-platforms for photo-induced therapies as co-adjuvant or combined therapeutic modalities for the treatment of localized PC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYu7sgmw7WBbVg90H21EOLACvtfcHk0lhL5bCEnIGvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpvV2jtbo%253D&md5=a2d0c4e102aae625946a66cabc1830bd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2019.00719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2019.00719%26sid%3Dliteratum%253Aachs%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DDel%2BRio%26aufirst%3DA.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DManoni%26aufirst%3DE.%26aulast%3DVarchi%26aufirst%3DG.%26atitle%3DLight-induced%2520therapies%2520for%2520prostate%2520cancer%2520treatment%26jtitle%3DFront.%2520Chem.%26date%3D2019%26volume%3D7%26spage%3D719%26doi%3D10.3389%2Ffchem.2019.00719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rapozzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietra, E. d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cesselli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castoria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Donato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saracino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benfenati, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span> <span> </span><span class="NLM_article-title">Androgen receptor targeted conjugate for bimodal photodynamic therapy of prostate cancer in vitro</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.5b00261</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.5b00261" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKitLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=1662-1671&author=V.+Rapozziauthor=D.+Ragnoauthor=A.+Guerriniauthor=C.+Ferroniauthor=E.+d.+Pietraauthor=D.+Cesselliauthor=G.+Castoriaauthor=M.+Di+Donatoauthor=E.+Saracinoauthor=V.+Benfenatiauthor=G.+Varchi&title=Androgen+receptor+targeted+conjugate+for+bimodal+photodynamic+therapy+of+prostate+cancer+in+vitro&doi=10.1021%2Facs.bioconjchem.5b00261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Androgen Receptor Targeted Conjugate for Bimodal Photodynamic Therapy of Prostate Cancer in Vitro</span></div><div class="casAuthors">Rapozzi, Valentina; Ragno, Daniele; Guerrini, Andrea; Ferroni, Claudia; Pietra, Emilia della; Cesselli, Daniela; Castoria, Gabriella; Di Donato, Marzia; Saracino, Emanuela; Benfenati, Valentina; Varchi, Greta</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1662-1671</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate cancer (PC) represents the most common type of cancer among males and is the second leading cause of cancer death in men in Western society.  Current options for PC therapy remain unsatisfactory, since they often produce uncomfortable long-term side effects, such as impotence (70%) and incontinence (5-20%) even in the first stages of the disease.  Light-triggered therapies, such as photodynamic therapy, have the potential to provide important advances in the treatment of localized and partially metastasized prostate cancer.  We have designed a novel mol. conjugate (DR2) constituted of a photosensitizer (pheophorbide a, Pba), connected to a nonsteroidal anti-androgen mol. through a small pegylated linker.  This study aims at investigating whether DR2 represents a valuable approach for PC treatment based on light-induced prodn. of single oxygen and nitric oxide (NO) in vitro.  Besides being able to efficiently bind the androgen receptor (AR), the 2-trifluoromethylnitrobenzene ring on the DR2 backbone is able to release cytotoxic NO under the exclusive control of light, thus augmenting the general photodynamic effect.  Although DR2 is similarly internalized in cells expressing different levels of androgen receptor, the AR ligand prevents its efflux through the ABCG2-pump.  In vitro phototoxicity expts. demonstrated the ability of DR2 to kill cancer cells more efficiently than Pba, while no dark toxicity was obsd.  Overall, the presented approach is very promising for further development of AR-photosensitizer conjugates in the multimodal photodynamic treatment of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3_qTqjMfaFLVg90H21EOLACvtfcHk0lhL5bCEnIGvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKitLfO&md5=484a723a12bb5c050181c0f5c0e66794</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.5b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.5b00261%26sid%3Dliteratum%253Aachs%26aulast%3DRapozzi%26aufirst%3DV.%26aulast%3DRagno%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DA.%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DPietra%26aufirst%3DE.%2Bd.%26aulast%3DCesselli%26aufirst%3DD.%26aulast%3DCastoria%26aufirst%3DG.%26aulast%3DDi%2BDonato%26aufirst%3DM.%26aulast%3DSaracino%26aufirst%3DE.%26aulast%3DBenfenati%26aufirst%3DV.%26aulast%3DVarchi%26aufirst%3DG.%26atitle%3DAndrogen%2520receptor%2520targeted%2520conjugate%2520for%2520bimodal%2520photodynamic%2520therapy%2520of%2520prostate%2520cancer%2520in%2520vitro%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26spage%3D1662%26epage%3D1671%26doi%3D10.1021%2Facs.bioconjchem.5b00261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rapozzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Pietra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xodo, L. E.</span></span> <span> </span><span class="NLM_article-title">A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1007/s10637-016-0396-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1007%2Fs10637-016-0396-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=27726093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Ojtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=115-123&author=V.+Rapozziauthor=G.+Varchiauthor=E.+Della+Pietraauthor=C.+Ferroniauthor=L.+E.+Xodo&title=A+photodynamic+bifunctional+conjugate+for+prostate+cancer%3A+an+in+vitro+mechanistic+study&doi=10.1007%2Fs10637-016-0396-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study</span></div><div class="casAuthors">Rapozzi, Valentina; Varchi, Greta; Della Pietra, Emilia; Ferroni, Claudia; Xodo, Luigi E.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-123</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) has drawn considerable attention for its efficacy against certain types of cancers.  It shows however limits in the case of deep cancers, favoring tumor recurrence under suboptimal conditions.  More insight into the mol. mechanisms of PDT-induced cytotoxicity and cytoprotection is essential to extend and strengthen this therapeutic modality.  As PDT induces iNOS/NO in both tumor and microenvironment, we examd. the role of nitric oxide (NO) in cytotoxicity and cytoprotection.  Our findings show that NO mediates its cellular effects by acting on the NF-κB/YY1/RKIP loop, which controls cell growth and apoptosis.  The cytoprotective effect of PDT-induced NO is obsd. at low NO levels, which activate the pro-survival/anti-apoptotic NF-κB and YY1, while inhibiting the anti-survival/pro-apoptotic and metastasis suppressor RKIP.  In contrast, high PDT-induced NO levels inhibit NF-κB and YY1 and induce RKIP, resulting in significant anti-tumor activity.  These findings reveal a crit. role played by NO in PDT and suggest that the use of bifunctional PDT agents composed of a photosensitizer and a NO-donor could enhance the photo-treatment effect.  To address this issue we propose as PDT agent, a bimol. conjugate called DR2, composed of a photosensitizer (Pheophorbide a) and a non-steroidal anti-androgen mol. capable of releasing NO under the exclusive control of light.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf65fk9S-2HrVg90H21EOLACvtfcHk0lhL5bCEnIGvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Ojtb3E&md5=0bbc6de258596c171e4e5b6f15b39120</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs10637-016-0396-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-016-0396-x%26sid%3Dliteratum%253Aachs%26aulast%3DRapozzi%26aufirst%3DV.%26aulast%3DVarchi%26aufirst%3DG.%26aulast%3DDella%2BPietra%26aufirst%3DE.%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DXodo%26aufirst%3DL.%2BE.%26atitle%3DA%2520photodynamic%2520bifunctional%2520conjugate%2520for%2520prostate%2520cancer%253A%2520an%2520in%2520vitro%2520mechanistic%2520study%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2017%26volume%3D35%26spage%3D115%26epage%3D123%26doi%3D10.1007%2Fs10637-016-0396-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballestri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgiu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span> <span> </span><span class="NLM_article-title">Core-shell poly-methyl methacrylate nanoparticles covalently functionalized with a non-symmetric porphyrin for anticancer photodynamic therapy</span>. <i>J. Photochem. Photobiol. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2018.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.jphotobiol.2018.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=30064063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVSqtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2018&pages=169-177&author=M.+Ballestriauthor=E.+Carusoauthor=A.+Guerriniauthor=C.+Ferroniauthor=S.+Banfiauthor=M.+Gariboldiauthor=E.+Montiauthor=G.+Sotgiuauthor=G.+Varchi&title=Core-shell+poly-methyl+methacrylate+nanoparticles+covalently+functionalized+with+a+non-symmetric+porphyrin+for+anticancer+photodynamic+therapy&doi=10.1016%2Fj.jphotobiol.2018.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Core-shell poly-methyl methacrylate nanoparticles covalently functionalized with a non-symmetric porphyrin for anticancer photodynamic therapy</span></div><div class="casAuthors">Ballestri, Marco; Caruso, Enrico; Guerrini, Andrea; Ferroni, Claudia; Banfi, Stefano; Gariboldi, Marzia; Monti, Elena; Sotgiu, Giovanna; Varchi, Greta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">169-177</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is an anticancer modality that exploits singlet oxygen and other reactive oxygen species, that are formed by selective irradn. of photosensitive mols., to kill cancer cells.  Most photosensitizers (PS) are hydrophobic and poorly sol. in water and several nanoplatforms have been established to achieve a more efficient delivery.  Moreover, the covalent binding of the PS to nanoparticles could in principle reduce unwanted bleaching of the PS, while preserving its photodynamic activity.  In this study we report the synthesis of a novel non-sym. diaryl-porphyrin suitably modified with a polymerizable pendant, that was used for the prepn. of core-shell poly-Me methacrylate nanoparticles covalently loaded with the diaryl-porphyrin (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="afffe2e2eeefffc0ddf9ce">[email protected]</a>).  Particles, which were prepd. with two different porphyrin loadings, are spherical in shape and with a narrow hydrodynamic diam. around 70 nm and a pos. zeta potential.  Their photo-toxicity was tested against the human colon carcinoma cell line HCT116 and the human ovarian adenocarcinoma cell line SKOV3.  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="c4948989858494abb692a5">[email protected]</a> were able to inhibit tumor cells proliferation similarly to the free porphyrin, thus confirming that the covalent attachment of the PS to PMMA nanoparticles allows to preserve PS photodynamic activity and in vitro efficacy.  Flow cytometric anal. of apoptotic cells demonstrates that, esp. in SKOV3 cells, the free diaryl-porphyrin is more effective in inducing apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw9GKXkLEcoLVg90H21EOLACvtfcHk0ljClAjE8vdHZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVSqtbjM&md5=9f033c10208c08597ae3981bf2531001</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2018.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2018.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DBallestri%26aufirst%3DM.%26aulast%3DCaruso%26aufirst%3DE.%26aulast%3DGuerrini%26aufirst%3DA.%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DBanfi%26aufirst%3DS.%26aulast%3DGariboldi%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DSotgiu%26aufirst%3DG.%26aulast%3DVarchi%26aufirst%3DG.%26atitle%3DCore-shell%2520poly-methyl%2520methacrylate%2520nanoparticles%2520covalently%2520functionalized%2520with%2520a%2520non-symmetric%2520porphyrin%2520for%2520anticancer%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%2520B%26date%3D2018%26volume%3D186%26spage%3D169%26epage%3D177%26doi%3D10.1016%2Fj.jphotobiol.2018.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerbara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malacarne, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marras, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and photodynamic activity of novel non-symmetrical diaryl porphyrins against cancer cell lines</span>. <i>J. Photochem. Photobiol. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2019.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.jphotobiol.2019.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31075653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFWnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2019&pages=39-50&author=E.+Carusoauthor=M.+Cerbaraauthor=M.+C.+Malacarneauthor=E.+Marrasauthor=E.+Montiauthor=M.+B.+Gariboldi&title=Synthesis+and+photodynamic+activity+of+novel+non-symmetrical+diaryl+porphyrins+against+cancer+cell+lines&doi=10.1016%2Fj.jphotobiol.2019.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and photodynamic activity of novel non-symmetrical diaryl porphyrins against cancer cell lines</span></div><div class="casAuthors">Caruso, Enrico; Cerbara, Monica; Malacarne, Miryam Chiara; Marras, Emanuela; Monti, Elena; Gariboldi, Marzia Bruna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-50</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) of cancer uses photosensitizers (PS), a light source and oxygen to generate high levels of reactive oxygen species (ROS), that exert a cytotoxic action on tumor cells.  In the present study, we investigate the in vitro photodynamic effects of four novel non-sym. diaryl porphyrins, two of which bear one pentafluoro-Ph and one bromo-alkyl (apolar) pendant, whereas the two others bear one pentafluoro-Ph and one cationic pyridine pendant.  The four compds. were tested in a small panel of human cancer cell lines, and their photodynamic activities were compared with that of m-THPC (Foscan), currently the most successful PS approved for clin. use in cancer PDT.  The results of the cytotoxicity studies indicate that the two mols. bearing the cationic pendant are more potent in vitro than those with the apolar pendant, and that they are as potent as Foscan.  To gain further insights into the mechanism of PS-induced phototoxicity, induction of apoptotic, autophagic and necrotic cell death, and generation of reactive oxygen species (ROS) were evaluated in cancer cells following exposure to the PSs and irradn.  The data obtained from this work support a greater potency of diaryl porphyrins with a pos. charge in inducing cell death, as compared to those with the bromo-alkyl pendant; most importantly, some of these novel compds. exhibit features that might make them superior to the clin. approved PS Foscan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmaoC6tV5py7Vg90H21EOLACvtfcHk0ljClAjE8vdHZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFWnsrk%253D&md5=7e9f79f09b1b76d3be404e94a5d5f02c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2019.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2019.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DE.%26aulast%3DCerbara%26aufirst%3DM.%26aulast%3DMalacarne%26aufirst%3DM.%2BC.%26aulast%3DMarras%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DGariboldi%26aufirst%3DM.%2BB.%26atitle%3DSynthesis%2520and%2520photodynamic%2520activity%2520of%2520novel%2520non-symmetrical%2520diaryl%2520porphyrins%2520against%2520cancer%2520cell%2520lines%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%2520B%26date%3D2019%26volume%3D195%26spage%3D39%26epage%3D50%26doi%3D10.1016%2Fj.jphotobiol.2019.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgiu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagnella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandi, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marras, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluigi, A.</span></span> <span> </span><span class="NLM_article-title">Wool Keratin 3D scaffolds with light-triggered antimicrobial activity</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2882</span>– <span class="NLM_lpage">2890</span>, <span class="refDoi"> DOI: 10.1021/acs.biomac.6b00697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biomac.6b00697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1CltrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=2882-2890&author=C.+Ferroniauthor=G.+Sotgiuauthor=A.+Sagnellaauthor=G.+Varchiauthor=A.+Guerriniauthor=D.+Giuriauthor=E.+Poloauthor=V.+T.+Orlandiauthor=E.+Marrasauthor=M.+Gariboldiauthor=E.+Montiauthor=A.+Aluigi&title=Wool+Keratin+3D+scaffolds+with+light-triggered+antimicrobial+activity&doi=10.1021%2Facs.biomac.6b00697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Wool Keratin 3D Scaffolds with Light-Triggered Antimicrobial Activity</span></div><div class="casAuthors">Ferroni, Claudia; Sotgiu, Giovanna; Sagnella, Anna; Varchi, Greta; Guerrini, Andrea; Giuri, Demetra; Polo, Eleonora; Orlandi, Viviana Teresa; Marras, Emanuela; Gariboldi, Marzia; Monti, Elena; Aluigi, Annalisa</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2882-2890</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photoactivatable keratin sponges were prepd. from protein aq. solns. by the freeze-drying method, followed by photofunctionalization with two different photosensitizers (PS): Azure A (AzA) and 5,10,15,20-tetrakis [4-(2-N,N,N-trimethylethylthio)-2,3,5,6-tetrafluorophenyl]porphyrin tetraiodide salt (TTFAP).  The prepd. sponges have a porosity between 49% and 80% and a mean pore size in the 37-80 μm range.  As compared to AzA, TTFAP interacts more strongly with the sponges as demonstrated by a lower PS release (6% vs 20%), a decreased swelling ratio (1.6 vs 7.4), and a slower biodegrdn. rate.  Nevertheless, AzA-loaded sponges showed the highest photoactivity, as also demonstrated by their higher antibactericidal activity toward both Gram-pos. and Gram-neg. bacteria.  The obtained results suggest that the antimicrobial photodynamic effect can be finely triggered through a proper selection of the amt. and type of photosensitizer, as well as through the irradn. time.  Finally, all the prepd. sponges support human fibroblast cells growth, while no significant cell viability impairment is obsd. upon light irradn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKPr1ElmerNLVg90H21EOLACvtfcHk0ljClAjE8vdHZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1CltrnL&md5=926487cb3a127666eca4517c582a8931</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.biomac.6b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biomac.6b00697%26sid%3Dliteratum%253Aachs%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DSotgiu%26aufirst%3DG.%26aulast%3DSagnella%26aufirst%3DA.%26aulast%3DVarchi%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DA.%26aulast%3DGiuri%26aufirst%3DD.%26aulast%3DPolo%26aufirst%3DE.%26aulast%3DOrlandi%26aufirst%3DV.%2BT.%26aulast%3DMarras%26aufirst%3DE.%26aulast%3DGariboldi%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DAluigi%26aufirst%3DA.%26atitle%3DWool%2520Keratin%25203D%2520scaffolds%2520with%2520light-triggered%2520antimicrobial%2520activity%26jtitle%3DBiomacromolecules%26date%3D2016%26volume%3D17%26spage%3D2882%26epage%3D2890%26doi%3D10.1021%2Facs.biomac.6b00697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malacarne, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandi, V. T.</span></span> <span> </span><span class="NLM_article-title">Cationic diarylporphyrins: In vitro versatile anticancer and antibacterial photosensitizers</span>. <i>J. Photochem. Photobiol. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">111548</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2019.111548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.jphotobiol.2019.111548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31288120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlejurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2019&pages=111548&author=E.+Carusoauthor=M.+C.+Malacarneauthor=S.+Banfiauthor=M.+B.+Gariboldiauthor=V.+T.+Orlandi&title=Cationic+diarylporphyrins%3A+In+vitro+versatile+anticancer+and+antibacterial+photosensitizers&doi=10.1016%2Fj.jphotobiol.2019.111548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic diarylporphyrins: In vitro versatile anticancer and antibacterial photosensitizers</span></div><div class="casAuthors">Caruso, Enrico; Malacarne, Miryam Chiara; Banfi, Stefano; Gariboldi, Marzia Bruna; Orlandi, Viviana Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111548</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The visible light combined with photosensitizers (PSs) is exploited in both antitumoral and antimicrobial fields inducing a photo-oxidative stress within the target cells.  Among the different PSs, porphyrins belong to the family of the most promising compds. to be used in clin. photodynamic applications.  Although in the last years many porphyrins have been synthesized and tested, only a few reports concern the in vitro elects of the 5,15-diarylporphyrins.  In this work, the activity of four 5,15-diarylporphyrins (compds. 7-10), bearing alkoxy-linked pyridinium appendixes, have been tested on cancer cell lines and against bacterial cultures.  Among the synthesized PSs, compds. 7 and 9 are not sym. substituted porphyrins showing one cationic charge tethered at the end of one 4C or 8C carbon chains, resp.  On the other hand, compds. 8 and 10 are sym. substituted and show two chains of C4 and C8 carbons featuring a cationic charge at the end of both chains.  The dicationic 8 and 10 were more hydrophilic than monocationic 7 and 9, outlining that the presence of two pyridinium salts have a higher impact on the soly. in the aq. phase than the lipophilic elect exerted by the length of the alkyl chains.  Furthermore, these four PSs showed a similar rate of photobleaching, irresp. of the length and no. of chains and the no. of pos. charges.  Among the eukaryotic cell lines, the SKOV3 cells were particularly sensitive to the photodynamic activity of all the tested diarylporphyrins, while the HCT116 cells were found more sensitive to PSs bearing C4 chain (7 and 8), regardless the no. of cationic charges.  The photo-induced killing elect of these porphyrins was also tested against two different bacterial cultures.  As expected, the Gram pos. Bacillus subtilis was more sensitive than the Gram neg. Escherichia coli, and the dicationic porphyrin 8, bearing two C4 chains, was the most efficient on both microorganisms.  In conclusion, the new compd. 8 seems to be an optimal candidate to deepen as versatile anticancer and antibacterial photosensitizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyFChk-pIex7Vg90H21EOLACvtfcHk0lhT0mNk-La02Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlejurbK&md5=f58257bd9f5d851613a48f4443588ff1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2019.111548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2019.111548%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DE.%26aulast%3DMalacarne%26aufirst%3DM.%2BC.%26aulast%3DBanfi%26aufirst%3DS.%26aulast%3DGariboldi%26aufirst%3DM.%2BB.%26aulast%3DOrlandi%26aufirst%3DV.%2BT.%26atitle%3DCationic%2520diarylporphyrins%253A%2520In%2520vitro%2520versatile%2520anticancer%2520and%2520antibacterial%2520photosensitizers%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%2520B%26date%3D2019%26volume%3D197%26spage%3D111548%26doi%3D10.1016%2Fj.jphotobiol.2019.111548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorrenti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittalà, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnaturi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbagallo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanella, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Raimondo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intagliata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, L.</span></span> <span> </span><span class="NLM_article-title">Targeting heme oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ejmech.2018.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=30261468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSrtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2018&pages=937-950&author=V.+Sorrentiauthor=V.+Pittal%C3%A0author=G.+Romeoauthor=E.+Amataauthor=M.+Dichiaraauthor=A.+Marrazzoauthor=R.+Turnaturiauthor=O.+Prezzaventoauthor=I.+Barbagalloauthor=L.+Vanellaauthor=A.+Rescifinaauthor=G.+Florestaauthor=D.+Tibulloauthor=F.+Di+Raimondoauthor=S.+Intagliataauthor=L.+Salerno&title=Targeting+heme+oxygenase-1+with+hybrid+compounds+to+overcome+Imatinib+resistance+in+chronic+myeloid+leukemia+cell+lines&doi=10.1016%2Fj.ejmech.2018.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines</span></div><div class="casAuthors">Sorrenti, Valeria; Pittala, Valeria; Romeo, Giuseppe; Amata, Emanuele; Dichiara, Maria; Marrazzo, Agostino; Turnaturi, Rita; Prezzavento, Orazio; Barbagallo, Ignazio; Vanella, Luca; Rescifina, Antonio; Floresta, Giuseppe; Tibullo, Daniele; Di Raimondo, Francesco; Intagliata, Sebastiano; Salerno, Loredana</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">937-950</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Heme oxygenase-1 (HO-1) is a cytoprotective enzyme and a survival-enhancing factor in a no. of cancers.  Chronic myeloid leukemia (CML) is a blood cancer caused by pathol. kinase activity of the BCR-ABL protein, currently treated with tyrosine kinase inhibitors (TKIs) such as Imatinib (IM).  However, resistance to TKIs persists in a no. of patients and HO-1 overexpression has been linked with the induction of chemoresistance in CML.  With this in mind, in this study, we designed and synthesized the first series of hybrid compds. obtained by combining the structures of IM, as BCR-ABL inhibitor, with imidazole-based HO-1 inhibitors.  We found that many hybrids were able to inhibit the enzymic activity of both targets and to reduce the viability of CML-IM resistant cells, showing that a single mol. entity may reduce the resistance phenomenon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofaDl0TAXJ2bVg90H21EOLACvtfcHk0lhT0mNk-La02Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSrtL3L&md5=841b4fa9268a786b36afacd3bfa8b02b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DSorrenti%26aufirst%3DV.%26aulast%3DPittal%25C3%25A0%26aufirst%3DV.%26aulast%3DRomeo%26aufirst%3DG.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DTurnaturi%26aufirst%3DR.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DBarbagallo%26aufirst%3DI.%26aulast%3DVanella%26aufirst%3DL.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DTibullo%26aufirst%3DD.%26aulast%3DDi%2BRaimondo%26aufirst%3DF.%26aulast%3DIntagliata%26aufirst%3DS.%26aulast%3DSalerno%26aufirst%3DL.%26atitle%3DTargeting%2520heme%2520oxygenase-1%2520with%2520hybrid%2520compounds%2520to%2520overcome%2520Imatinib%2520resistance%2520in%2520chronic%2520myeloid%2520leukemia%2520cell%2520lines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D158%26spage%3D937%26epage%3D950%26doi%3D10.1016%2Fj.ejmech.2018.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moorcroft, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, R. G.</span></span> <span> </span><span class="NLM_article-title">Detection and determination of nitrate and nitrite: a review</span>. <i>Talanta</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1016/S0039-9140(01)00323-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2FS0039-9140%2801%2900323-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=18968301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=785-803&author=M.+J.+Moorcroftauthor=J.+Davisauthor=R.+G.+Compton&title=Detection+and+determination+of+nitrate+and+nitrite%3A+a+review&doi=10.1016%2FS0039-9140%2801%2900323-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and determination of nitrate and nitrite: a review</span></div><div class="casAuthors">Moorcroft, M. J.; Davis, J.; Compton, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Talanta</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">785-803</span>CODEN:
                <span class="NLM_cas:coden">TLNTA2</span>;
        ISSN:<span class="NLM_cas:issn">0039-9140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with 179 refs., of the strategies employed to facilitate the detection, detn. and monitoring of nitrate and/or nitrite is presented.  A concise survey of the literature covering 180 reports submitted over the past decade was compiled and the relevant anal. parameters (methodol., matrix, detection limits, range, etc.) tabulated.  The various advantages/disadvantages and limitations of the various techniques were exposed such that the applicability of a technique developed for one type of matrix can be meaningfully assessed before attempting to transfer the technol. to another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIp_m_44IeErVg90H21EOLACvtfcHk0lhT0mNk-La02Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFGqs70%253D&md5=d5758292848a86d5723236704d0ec082</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0039-9140%2801%2900323-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0039-9140%252801%252900323-X%26sid%3Dliteratum%253Aachs%26aulast%3DMoorcroft%26aufirst%3DM.%2BJ.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DCompton%26aufirst%3DR.%2BG.%26atitle%3DDetection%2520and%2520determination%2520of%2520nitrate%2520and%2520nitrite%253A%2520a%2520review%26jtitle%3DTalanta%26date%3D2001%26volume%3D54%26spage%3D785%26epage%3D803%26doi%3D10.1016%2FS0039-9140%2801%2900323-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seebacher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.</span></span> <span> </span><span class="NLM_article-title">Novel strategies to prevent the development of multidrug resistance (MDR) in cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">84559</span>– <span class="NLM_lpage">84571</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.19187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.18632%2Foncotarget.19187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29137448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADC%252BC1M3htFyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=84559-84571&author=J.+Wangauthor=N.+Seebacherauthor=H.+Shiauthor=Q.+Kanauthor=Z.+Duan&title=Novel+strategies+to+prevent+the+development+of+multidrug+resistance+%28MDR%29+in+cancer&doi=10.18632%2Foncotarget.19187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel strategies to prevent the development of multidrug resistance (MDR) in cancer</span></div><div class="casAuthors">Wang Jinglu; Shi Huirong; Kan Quancheng; Duan Zhenfeng; Wang Jinglu; Seebacher Nicole; Duan Zhenfeng</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">84559-84571</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of multidrug resistance (MDR) is one of the major challenges to the success of traditional chemotherapy treatment in cancer patients.  Most studies to date have focused on strategies to reverse MDR following its development.  However, agents utilizing this approach have proven to be of limited clinical use, failing to demonstrate an improvement in therapeutic efficacy with almost no significant survival benefits observed in cancer clinical trials.  An alternative approach that has been applied is to prevent or delay MDR prior or early in its development.  Recent investigations have shown that preventing the emergence of MDR at the onset of chemotherapy treatment, rather than reversing MDR once it has developed, may assist in overcoming drug resistance.  In this review, we focus on a number of novel strategies used by small-molecule inhibitors to prevent the development of MDR.  These agents hold great promise for prolonging the efficacy of chemotherapy treatment and improving the clinical outcomes of patients with cancers that are susceptible to MDR development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvBIUBaePxjUkUaC_kzhvyfW6udTcc2ebScwEv744yQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3htFyksg%253D%253D&md5=ef038f59e40e65b3ed161f011ee0d53e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.19187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.19187%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSeebacher%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DKan%26aufirst%3DQ.%26aulast%3DDuan%26aufirst%3DZ.%26atitle%3DNovel%2520strategies%2520to%2520prevent%2520the%2520development%2520of%2520multidrug%2520resistance%2520%2528MDR%2529%2520in%2520cancer%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D84559%26epage%3D84571%26doi%3D10.18632%2Foncotarget.19187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">111108</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2020.111108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.biopha.2020.111108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=33341670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3MXktV2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2021&pages=111108&author=J.+Maoauthor=L.+Qiuauthor=L.+Geauthor=J.+Zhouauthor=Q.+Jiauthor=Y.+Yangauthor=M.+Longauthor=D.+Wangauthor=L.+Tengauthor=J.+Chen&title=Overcoming+multidrug+resistance+by+intracellular+drug+release+and+inhibiting+p-glycoprotein+efflux+in+breast+cancer&doi=10.1016%2Fj.biopha.2020.111108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer</span></div><div class="casAuthors">Mao, Jing; Qiu, Lipeng; Ge, Lu; Zhou, Juan; Ji, Qian; Yang, Yang; Long, Miaomiao; Wang, Danhui; Teng, Liping; Chen, Jinghua</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111108</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Doxorubicin (DOX) is limited to use in clin. practice because of poor targeting, serious side effects and multidrug resistance (MDR).  Vitamin E and its derivs. are currently considered as hydrophobic material that can reverse tumor MDR by suppressing the action of p-glycoprotein (p-gp).  Therefore, redn.-sensitive amphiphilic heparosan polysaccharide-cystamine-vitamin E succinate (KSV) copolymers were designed to reverse breast cancer MDR cells.  The spherical micelles (DOX/KSV) micelles which had suitable particle size presented redox-sensitive release character.  Simultaneously, DOX-loaded redn. insensitive heparosan-adipic dihydrazide-vitamin E succinate (KV) micellar system was designed as a control.  DOX/KSV and DOX/KV micelles had the higher capability to overcome tumor MDR than that free DOX.  However, DOX/KSV had the highest amt. of cellular uptake which might be caused by the synergistic intracellular drug release and inhibition of p-gp expression.  The mechanism expts. revealed that DOX/KSV could be fast disassembled to release DOX after internalization into tumor cells.  Moreover, DOX/KSV produced more ROS than free DOX and DOX/KV resulting in enhanced anticancer effect.  In vivo tumor-bearing mice study suggested that DOX/KSV micelles could efficiently enhance antitumor effect by overcoming tumor MDR and reduce toxicity of DOX.  The DOX/KSV micelles could synergistically increase the therapeutic effect of chemotherapeutic drug on tumor MDR cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOUzPeJAOOnbVg90H21EOLACvtfcHk0lg1SDCgZAevew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXktV2isg%253D%253D&md5=d18bb30d146e12b01eca01ca9cfb971d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2020.111108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2020.111108%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DTeng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DOvercoming%2520multidrug%2520resistance%2520by%2520intracellular%2520drug%2520release%2520and%2520inhibiting%2520p-glycoprotein%2520efflux%2520in%2520breast%2520cancer%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2021%26volume%3D134%26spage%3D111108%26doi%3D10.1016%2Fj.biopha.2020.111108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">George, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishen, A.</span></span> <span> </span><span class="NLM_article-title">Uptake pathways of anionic and cationic photosensitizers into bacteria</span>. <i>Photochem. Photobiol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1039/b809624d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1039%2Fb809624d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=19492106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1yitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=788-795&author=S.+Georgeauthor=M.+R.+Hamblinauthor=A.+Kishen&title=Uptake+pathways+of+anionic+and+cationic+photosensitizers+into+bacteria&doi=10.1039%2Fb809624d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Uptake pathways of anionic and cationic photosensitizers into bacteria</span></div><div class="casAuthors">George, Saji; Hamblin, Michael R.; Kishen, Anil</div><div class="citationInfo"><span class="NLM_cas:title">Photochemical & Photobiological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-795</span>CODEN:
                <span class="NLM_cas:coden">PPSHCB</span>;
        ISSN:<span class="NLM_cas:issn">1474-905X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The effect of divalent cations (calcium and magnesium) and a permeabilizing agent (EDTA) on the uptake of a cationic photosensitizer (PS), methylene blue (MB), and two anionic PSs, rose bengal (RB) and indocyanine green (ICG), by Gram-pos. Enterococcus faecalis and Gram-neg. Actinobacillus actinomycetemcomitans was examd.  The possible roles of multidrug efflux pumps and protein transporters in photosensitizer uptake were assessed in E. faecalis cells by studies using an efflux pump inhibitor (verapamil) and trypsin treatment resp.  Divalent cations enhanced the uptake and photodynamic inactivation potential of both RB and ICG in E. faecalis and A. actinomycetemcomitans, while they decreased the uptake and bacterial killing by MB.  Verapamil increased the uptake of RB (possibly due to efflux pump inhibition), whereas trypsin treatment resulted in significant decrease in RB and ICG uptake.  The results suggested that the uptake of anionic PSs by bacterial cells may be mediated through a combination of electrostatic charge interaction and by protein transporters, while the uptake of cationic PSs, as previously reported, is mediated by electrostatic interactions and self promoted uptake pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoew3RNtfYKV7Vg90H21EOLACvtfcHk0lg1SDCgZAevew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1yitrs%253D&md5=0fd1a4d454e7d86f92a306c8fe9c1c18</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1039%2Fb809624d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb809624d%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26aulast%3DKishen%26aufirst%3DA.%26atitle%3DUptake%2520pathways%2520of%2520anionic%2520and%2520cationic%2520photosensitizers%2520into%2520bacteria%26jtitle%3DPhotochem.%2520Photobiol.%2520Sci.%26date%3D2009%26volume%3D8%26spage%3D788%26epage%3D795%26doi%3D10.1039%2Fb809624d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, N. L.</span></span> <span> </span><span class="NLM_article-title">Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1126/science.1204117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1126%2Fscience.1204117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=21778401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovF2mur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2011&pages=459-462&author=C.+C.+Wuauthor=T.+K.+Liauthor=L.+Farhauthor=L.+Y.+Linauthor=T.+S.+Linauthor=Y.+J.+Yuauthor=T.+J.+Yenauthor=C.+W.+Chiangauthor=N.+L.+Chan&title=Structural+basis+of+type+II+topoisomerase+inhibition+by+the+anticancer+drug+etoposide&doi=10.1126%2Fscience.1204117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide</span></div><div class="casAuthors">Wu, Chyuan-Chuan; Li, Tsai-Kun; Farh, Lynn; Lin, Li-Ying; Lin, Te-Sheng; Yu, Yu-Jen; Yen, Tien-Jui; Chiang, Chia-Wang; Chan, Nei-Li</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">6041</span>),
    <span class="NLM_cas:pages">459-462</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Type II topoisomerases (TOP2s) resolve the topol. problems of DNA by transiently cleaving both strands of a DNA duplex to form a cleavage complex through which another DNA segment can be transported.  Several widely prescribed anticancer drugs increase the population of TOP2 cleavage complex, which leads to TOP2-mediated chromosome DNA breakage and death of cancer cells.  We present the crystal structure of a large fragment of human TOP2β complexed to DNA and to the anticancer drug etoposide to reveal structural details of drug-induced stabilization of a cleavage complex.  The interplay between the protein, the DNA, and the drug explains the structure-activity relations of etoposide derivs. and the mol. basis of drug-resistant mutations.  The anal. of protein-drug interactions provides information applicable for developing an isoform-specific TOP2-targeting strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBC6vqPeyB-bVg90H21EOLACvtfcHk0lh6lRCQQsiULg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovF2mur0%253D&md5=c2eab1b2e9b8a75322b88e76c62c4b74</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1126%2Fscience.1204117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1204117%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DFarh%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DL.%2BY.%26aulast%3DLin%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DY.%2BJ.%26aulast%3DYen%26aufirst%3DT.%2BJ.%26aulast%3DChiang%26aufirst%3DC.%2BW.%26aulast%3DChan%26aufirst%3DN.%2BL.%26atitle%3DStructural%2520basis%2520of%2520type%2520II%2520topoisomerase%2520inhibition%2520by%2520the%2520anticancer%2520drug%2520etoposide%26jtitle%3DScience%26date%3D2011%26volume%3D333%26spage%3D459%26epage%3D462%26doi%3D10.1126%2Fscience.1204117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djamgoz, M. B. A.</span></span> <span> </span><span class="NLM_article-title">Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ctrv.2017.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29202431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=110-122&author=A.+Leeauthor=M.+B.+A.+Djamgoz&title=Triple+negative+breast+cancer%3A+Emerging+therapeutic+modalities+and+novel+combination+therapies&doi=10.1016%2Fj.ctrv.2017.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies</span></div><div class="casAuthors">Lee, Alice; Djamgoz, Mustafa B. A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-122</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Triple neg. breast cancer (TNBC) is a complex and aggressive subtype of breast cancer which lacks estrogen receptors, progesterone receptors and HER2 amplification, thereby making it difficult to target therapeutically.  In addn., TNBC has the highest rates of metastatic disease and the poorest overall survival of all breast cancer subtypes.  Resultantly, development of targeted therapies for TNBC is urgently needed.  Recent efforts aimed at mol. characterization of TNBCs have revealed various emerging therapeutic targets including PARP1, receptor and non-receptor tyrosine kinases, immune-checkpoints, androgen receptor and epigenetic proteins.  Key successes include that of the PARP inhibitor, olaparib, which prolonged progression-free survival in a trial of BRCA-mutated breast cancer and for which clin. approval (in this setting) appears imminent.  Nevertheless, the heterogeneity of TNBC has limited the clin. benefits of many trialled therapies in 'unselected' patients.  Further, drug resistance develops following use of many targeted monotherapies due to upregulation of compensatory signalling pathways.  In this review, we evaluate the current status of investigational targeted treatments and present evidence for the role of novel biomarkers and combination therapies in increasing response rates and circumventing drug-induced resistance.  Addnl., we discuss promising novel targets in metastatic TNBC identified through preclin. and/or epidemiol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraUe6qPPRyzbVg90H21EOLACvtfcHk0lh6lRCQQsiULg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnK&md5=738b63405e3d6c1a3541982a6987a2dd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%26aulast%3DDjamgoz%26aufirst%3DM.%2BB.%2BA.%26atitle%3DTriple%2520negative%2520breast%2520cancer%253A%2520Emerging%2520therapeutic%2520modalities%2520and%2520novel%2520combination%2520therapies%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D62%26spage%3D110%26epage%3D122%26doi%3D10.1016%2Fj.ctrv.2017.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eroles, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaragoza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vin̈a, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lluch, A.</span></span> <span> </span><span class="NLM_article-title">Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2009.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ctrv.2009.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=20060649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFChsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=206-215&author=A.+Boschauthor=P.+Erolesauthor=R.+Zaragozaauthor=J.+R.+Vin%CC%88aauthor=A.+Lluch&title=Triple-negative+breast+cancer%3A+molecular+features%2C+pathogenesis%2C+treatment+and+current+lines+of+research&doi=10.1016%2Fj.ctrv.2009.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research</span></div><div class="casAuthors">Bosch, Ana; Eroles, Pilar; Zaragoza, Rosa; Vina, Juan R.; Lluch, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-215</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Breast cancer is a heterogeneous disease with different morphologies, mol. profiles, clin. behavior and response to therapy.  The triple neg. is a particular type of breast cancer defined by absence of estrogen and progesterone receptor expression as well as absence of ERBB2 amplification.  It is characterized by its biol. aggressiveness, worse prognosis and lack of a therapeutic target in contrast with hormonal receptor pos. and ERBB2+ breast cancers.  Given these characteristics, triple-neg. breast cancer is a challenge in today's clin. practice.  A new breast cancer classification emerged recently in the scientific scene based in gene expression profiles.  The new subgroups (luminal, ERBB2, normal breast and basal-like) have distinct gene expression patterns and phenotypical characteristics.  Triple-neg. breast cancer shares phenotypical features with basal-like breast cancer, which is in turn the most aggressive and with worse outcome.  Since microarray gene-expression assays are only used in the research setting, clinicians use the triple-neg. definition as a surrogate of basal-like breast cancer.  The aim of this review, that focuses on triple-neg. breast cancer, is to summarize the most relevant knowledge on this particular type of cancer in terms of mol. features, pathogenesis, clin. characteristics, current treatments and the new therapeutic options that include the use of platinum compds., EGFR antagonists, antiangiogenics and PARP inhibitors.  Advances in research are promising and new types of active drugs will become a reality in the near future, making possible a better outcome for this subgroup of breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiAeBmEDMIRbVg90H21EOLACvtfcHk0lh6lRCQQsiULg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFChsbo%253D&md5=2414fb4f19f90c67e891672b3a65b8bf</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2009.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2009.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DBosch%26aufirst%3DA.%26aulast%3DEroles%26aufirst%3DP.%26aulast%3DZaragoza%26aufirst%3DR.%26aulast%3DVin%25CC%2588a%26aufirst%3DJ.%2BR.%26aulast%3DLluch%26aufirst%3DA.%26atitle%3DTriple-negative%2520breast%2520cancer%253A%2520molecular%2520features%252C%2520pathogenesis%252C%2520treatment%2520and%2520current%2520lines%2520of%2520research%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2010%26volume%3D36%26spage%3D206%26epage%3D215%26doi%3D10.1016%2Fj.ctrv.2009.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietenpol, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symmans, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C.</span></span> <span> </span><span class="NLM_article-title">Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2723</span>– <span class="NLM_lpage">2733</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1158%2F1078-0432.CCR-12-2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=23549873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2ktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2723-2733&author=K.+D.+Yuauthor=R.+Zhuauthor=M.+Zhanauthor=A.+A.+Rodriguezauthor=W.+Yangauthor=S.+Wongauthor=A.+Makrisauthor=B.+D.+Lehmannauthor=X.+Chenauthor=I.+Mayerauthor=J.+A.+Pietenpolauthor=Z.+M.+Shaoauthor=W.+F.+Symmansauthor=J.+C.+Chang&title=Identification+of+prognosis-relevant+subgroups+in+patients+with+chemoresistant+triple-negative+breast+cancer&doi=10.1158%2F1078-0432.CCR-12-2986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer</span></div><div class="casAuthors">Yu, Ke-Da; Zhu, Rui; Zhan, Ming; Rodriguez, Angel A.; Yang, Wei; Wong, Stephen; Makris, Andreas; Lehmann, Brian D.; Chen, Xi; Mayer, Ingrid; Pietenpol, Jennifer A.; Shao, Zhi-Ming; Symmans, W. Fraser; Chang, Jenny C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2723-2733</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Patients with triple-neg. breast cancer (TNBC) and residual disease after neoadjuvant chemotherapy generally have worse outcome; however, some patients with residual tumor after neoadjuvant chemotherapy do not relapse.  We hypothesize that there are subgroups of patients with chemoresistant TNBC with different prognosis.  Exptl. Design: Forty-nine chemoresistant cases from 111 patients with TNBC treated with neoadjuvant chemotherapy (M.D. Anderson Cancer Center, Houston, TX) constituted the discovery cohort, and 25 chemoresistant samples from 47 neoadjuvant chemotherapy-treated TNBC (The Methodist Hospital, Houston, TX) were chosen for validation.  Extended validation was carried out in 269 operable TNBC predicted to be chemoresistant by expression pattern from published datasets.  Results: We established a seven-gene prognostic signature using dChip and gene set enrichment analyses.  In the independent validation cohort, the classifier predicted correctly with pos. predictive value of 75.0% and neg. predictive value (i.e., relapse-free survival; RFS) of 76.9% at 3 years.  Those predicted to relapse had a HR of 4.67 [95% confidence interval (CI): 1.27-17.15] for relapse in 3 years.  In extended validation, patients predicted not to relapse exhibited 3-yr RFS of 78.9%, whereas the 3-yr RFS was 48.5% for patients predicted to relapse, with HR of 2.61 (95% CI: 1.52-4.49).  The TNBC subgroup that predicted to have relatively favorable prognosis was characterized by high expression of "luminal-like" genes [androgen-receptor (AR) and GATA3], whereas the subgroup with worse prognosis was characterized by expression of cancer stem-cell markers.  Conclusion: We developed a clin. relevant signature for patients with chemoresistant TNBC.  For these women, new therapeutic strategies like targeting AR activation or cancer stem cells may need to be developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr97SbiyNt-OLVg90H21EOLACvtfcHk0ljUFVAmUNJfjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2ktbc%253D&md5=75646315c3e391a9ba7c43125d47bff2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-2986%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%2BD.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DZhan%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DA.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DMakris%26aufirst%3DA.%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMayer%26aufirst%3DI.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26aulast%3DShao%26aufirst%3DZ.%2BM.%26aulast%3DSymmans%26aufirst%3DW.%2BF.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26atitle%3DIdentification%2520of%2520prognosis-relevant%2520subgroups%2520in%2520patients%2520with%2520chemoresistant%2520triple-negative%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D2723%26epage%3D2733%26doi%3D10.1158%2F1078-0432.CCR-12-2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stover, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erwin, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizoguchi, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrener, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkman, F. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufnagle, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagrou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garber, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goltry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolentino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrock-Wadman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brody, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulter, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folger, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larbig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, G. K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reizer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saier, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lory, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, M. V.</span></span> <span> </span><span class="NLM_article-title">Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.1038/35023079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1038%2F35023079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10984043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlKqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=959-964&author=C.+K.+Stoverauthor=X.+Q.+Phamauthor=A.+L.+Erwinauthor=S.+D.+Mizoguchiauthor=P.+Warrenerauthor=M.+J.+Hickeyauthor=F.+S.+L.+Brinkmanauthor=W.+O.+Hufnagleauthor=D.+J.+Kowalikauthor=M.+Lagrouauthor=R.+L.+Garberauthor=L.+Goltryauthor=E.+Tolentinoauthor=S.+Westbrock-Wadmanauthor=Y.+Yuanauthor=L.+L.+Brodyauthor=S.+N.+Coulterauthor=K.+R.+Folgerauthor=A.+Kasauthor=K.+Larbigauthor=R.+Limauthor=K.+Smithauthor=D.+Spencerauthor=G.+K.-S.+Wongauthor=Z.+Wuauthor=I.+T.+Paulsenauthor=J.+Reizerauthor=M.+H.+Saierauthor=R.+E.+W.+Hancockauthor=S.+Loryauthor=M.+V.+Olson&title=Complete+genome+sequence+of+Pseudomonas+aeruginosa+PAO1%2C+an+opportunistic+pathogen&doi=10.1038%2F35023079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Complete genome sequence of Pseudomonas aeruginosa PA01</span></div><div class="casAuthors">Stover, C. K.; Pham, X. Q.; Erwin, A. L.; Mizoguchi, S. D.; Warrener, P.; Hickey, M. J.; Brinkman, F. S. L.; Hufnagle, W. O.; Kowalik, J.; Lagrou, M.; Garber, R. L.; Goltry, L.; Tolentino, E.; Westbrock-Wadman, S.; Yuan, Y.; Brody, L. L.; Coulter, S. N.; Folger, K. R.; Kas, A.; Larbig, K.; Lim, R.; Smith, K.; Spencer, D.; Wong, G. K.-S.; Wu, Z.; Paulsen, I. T.; Reizer, J.; Saier, M. H.; Hancock, R. E. W.; Lory, S.; Olson, M. V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6799</span>),
    <span class="NLM_cas:pages">959-964</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa is a ubiquitous environmental bacterium that is one of the top three causes of opportunistic human infections.  A major factor in its prominence as a pathogen is its intrinsic resistance to antibiotics and disinfectants.  The authors now report the complete sequence of P. aeruginosa strain PA01.  At 6.3 million base pairs, this is the largest bacterial genome sequenced, and the sequence provides insights into the basis of the versatility and intrinsic drug resistance of P. aeruginosa.  Consistent with its larger genome size and environmental adaptability, P. aeruginosa contains the highest proportion of regulatory genes obsd. for a bacterial genome and a large no. of genes involved in the catabolism, transport and efflux of org. compds. as well as four potential chemotaxis systems.  The size and complexity of the P. aeruginosa genome is proposed to reflect an evolutionary adaptation permitting it to thrive in diverse environments and resist the effects of a variety of antimicrobial substances.  The genome and protein sequences are deposited in the GenBank database with Accession No. AE004091, as well at the web site http://www.pseudomonas.com.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFWCFBwqX4gLVg90H21EOLACvtfcHk0ljUFVAmUNJfjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlKqsrY%253D&md5=aaf166751567ffd3a8ea0631e9bd7b9e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2F35023079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35023079%26sid%3Dliteratum%253Aachs%26aulast%3DStover%26aufirst%3DC.%2BK.%26aulast%3DPham%26aufirst%3DX.%2BQ.%26aulast%3DErwin%26aufirst%3DA.%2BL.%26aulast%3DMizoguchi%26aufirst%3DS.%2BD.%26aulast%3DWarrener%26aufirst%3DP.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DBrinkman%26aufirst%3DF.%2BS.%2BL.%26aulast%3DHufnagle%26aufirst%3DW.%2BO.%26aulast%3DKowalik%26aufirst%3DD.%2BJ.%26aulast%3DLagrou%26aufirst%3DM.%26aulast%3DGarber%26aufirst%3DR.%2BL.%26aulast%3DGoltry%26aufirst%3DL.%26aulast%3DTolentino%26aufirst%3DE.%26aulast%3DWestbrock-Wadman%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DBrody%26aufirst%3DL.%2BL.%26aulast%3DCoulter%26aufirst%3DS.%2BN.%26aulast%3DFolger%26aufirst%3DK.%2BR.%26aulast%3DKas%26aufirst%3DA.%26aulast%3DLarbig%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSpencer%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DG.%2BK.-S.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DPaulsen%26aufirst%3DI.%2BT.%26aulast%3DReizer%26aufirst%3DJ.%26aulast%3DSaier%26aufirst%3DM.%2BH.%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26aulast%3DLory%26aufirst%3DS.%26aulast%3DOlson%26aufirst%3DM.%2BV.%26atitle%3DComplete%2520genome%2520sequence%2520of%2520Pseudomonas%2520aeruginosa%2520PAO1%252C%2520an%2520opportunistic%2520pathogen%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D959%26epage%3D964%26doi%3D10.1038%2F35023079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orlandi, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martegani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mat’átková, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paldrychová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, E.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy by diaryl-porphyrins to control the growth of Candida albicans</span>. <i>Cosmetics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">31</span>, <span class="refDoi"> DOI: 10.3390/cosmetics7020031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fcosmetics7020031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFyjtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=31&author=V.+T.+Orlandiauthor=E.+Marteganiauthor=F.+Bologneseauthor=N.+Trivellinauthor=O.+Mat%E2%80%99%C3%A1tkov%C3%A1author=M.+Paldrychov%C3%A1author=A.+Bajauthor=E.+Caruso&title=Photodynamic+therapy+by+diaryl-porphyrins+to+control+the+growth+of+Candida+albicans&doi=10.3390%2Fcosmetics7020031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy by diaryl-porphyrins to control the growth of Candida albicans</span></div><div class="casAuthors">Orlandi, Viviana Teresa; Martegani, Eleonora; Bolognese, Fabrizio; Trivellin, Nicola; Mat'Atkov, Olga; Paldrychova, Martina; Baj, Andreina; Caruso, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Cosmetics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">31</span>CODEN:
                <span class="NLM_cas:coden">COSMCC</span>;
        ISSN:<span class="NLM_cas:issn">2079-9284</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Candida albicans is an opportunistic pathogen that often causes skin infections such as oral thrush, nail fungus, athlete's foot, and diaper rash.  Under particular conditions, C. albicans alters the natural balance of the host microbiota, and as a result, the skin or its accessory structures lose their function and appearance.  Conventional antimycotic drugs are highly toxic to host tissues, and long-lasting drug administration induces the arising of resistant strains that make the antimycotic therapy ineffective.  Among new antimicrobial approaches to combine with traditional drugs, light-based techniques are very promising.  In this study, a panel of dyes was considered for photodynamic therapy (PDT) applications to control the growth of the model strain C. albicans ATCC 14053.  The chosen photosensitizers (PSs) belong to the family of synthetic porphyrins, and in particular, they are diaryl-porphyrins.  Among these, two monocationic PSs were shown to be particularly efficient In killing C. albicans upon irradn. with light at 410 nm, In a light-dose-dependent manner.  The elicited photo-oxidative stress induced the loss of the internal cellular architecture and death.  The photodynamic treatment was also successful In inhibiting the biofilm formation of clin. C. albicans strains.  In conclusion, this study supports the great potential of diaryl-porphyrins In antimicrobial PDT to control the growth of yeasts on body tissues easily reachable by light sources, such as skin and oral cavity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAQSeE1nD4uLVg90H21EOLACvtfcHk0ljUFVAmUNJfjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFyjtLjL&md5=0848ad8f3bdcb7273e86c8ecde992b16</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3390%2Fcosmetics7020031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcosmetics7020031%26sid%3Dliteratum%253Aachs%26aulast%3DOrlandi%26aufirst%3DV.%2BT.%26aulast%3DMartegani%26aufirst%3DE.%26aulast%3DBolognese%26aufirst%3DF.%26aulast%3DTrivellin%26aufirst%3DN.%26aulast%3DMat%25E2%2580%2599%25C3%25A1tkov%25C3%25A1%26aufirst%3DO.%26aulast%3DPaldrychov%25C3%25A1%26aufirst%3DM.%26aulast%3DBaj%26aufirst%3DA.%26aulast%3DCaruso%26aufirst%3DE.%26atitle%3DPhotodynamic%2520therapy%2520by%2520diaryl-porphyrins%2520to%2520control%2520the%2520growth%2520of%2520Candida%2520albicans%26jtitle%3DCosmetics%26date%3D2020%26volume%3D7%26spage%3D31%26doi%3D10.3390%2Fcosmetics7020031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flaberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guven, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashuba, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekely, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, G.</span></span> <span> </span><span class="NLM_article-title">The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">2274</span>– <span class="NLM_lpage">2283</span>, <span class="refDoi"> DOI: 10.1002/ijc.27521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fijc.27521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=22396138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks12gsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=2274-2283&author=E.+Flabergauthor=H.+Guvenauthor=A.+Savchenkoauthor=T.+Pavlovaauthor=V.+Kashubaauthor=L.+Szekelyauthor=G.+Klein&title=The+architecture+of+fibroblast+monolayers+of+different+origin+differentially+influences+tumor+cell+growth&doi=10.1002%2Fijc.27521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth</span></div><div class="casAuthors">Flaberg, Emilie; Guven, Hayrettin; Savchenko, Andrii; Pavlova, Tatiana; Kashuba, Vladimir; Szekely, Laszlo; Klein, George</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2274-2283</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Normal human and murine fibroblasts can inhibit proliferation of tumor cells when co-cultured in vitro.  The inhibitory capacity varies depending on the donor and the site of origin of the fibroblast.  It requires direct cell-to-cell contact and is not transferable with supernatant.  Here, we show that effective inhibition also requires the formation of a morphol. intact fibroblast monolayer before the seeding of the tumor cells.  Interference with the formation of the monolayer impairs the inhibition.  Subclones of TERT-immortalized fibroblasts were selected on the basis of differences in the growth pattern and related inhibitory activity.  Whereas the well-organized "whirly" (WH) growth pattern was assocd. with strong inhibition, the disorganized "crossy" (CR) growth pattern was linked to reduced inhibition.  Time lapse imaging of tumor-fibroblast co-cultures using extended field live cell microscopy revealed that fibroblast monolayers with growth inhibitory capacity also reduced the motility of the tumor cells whereas noninhibitory monolayers had no effect on tumor cell motility.  Gene expression pattern of two isogenic pairs of fibroblasts, WH and CR subclones of the TERT immortalized line (inhibitory, and less inhibitory subsequently) and freshly explanted skin (inhibitory) and hernia (noninhibitory) fibroblasts derived from the same patient, identified a set of genes that co-segregated with the inhibitory phenotype.  This suggests that our model system may reveal mol. mechanisms involved in contact-mediated microenvironmental surveillance that may protect the organism from the outgrowth of disseminated tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67jZ1iKlmx7Vg90H21EOLACvtfcHk0liFeaz4wWg0sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks12gsrs%253D&md5=f3836fbf47a8ee2d8baeae4a6acd3c3f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fijc.27521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27521%26sid%3Dliteratum%253Aachs%26aulast%3DFlaberg%26aufirst%3DE.%26aulast%3DGuven%26aufirst%3DH.%26aulast%3DSavchenko%26aufirst%3DA.%26aulast%3DPavlova%26aufirst%3DT.%26aulast%3DKashuba%26aufirst%3DV.%26aulast%3DSzekely%26aufirst%3DL.%26aulast%3DKlein%26aufirst%3DG.%26atitle%3DThe%2520architecture%2520of%2520fibroblast%2520monolayers%2520of%2520different%2520origin%2520differentially%2520influences%2520tumor%2520cell%2520growth%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D131%26spage%3D2274%26epage%3D2283%26doi%3D10.1002%2Fijc.27521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonzi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craparotta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span> <span> </span><span class="NLM_article-title">The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.canlet.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=25979228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1egs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2015&pages=156-164&author=M.+B.+Gariboldiauthor=E.+Taianaauthor=M.+C.+Bonziauthor=I.+Craparottaauthor=S.+Giovannardiauthor=M.+Manciniauthor=E.+Monti&title=The+BH3-mimetic+obatoclax+reduces+HIF-1%CE%B1+levels+and+HIF-1+transcriptional+activity+and+sensitizes+hypoxic+colon+adenocarcinoma+cells+to+5-fluorouracil&doi=10.1016%2Fj.canlet.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil</span></div><div class="casAuthors">Gariboldi, Marzia B.; Taiana, Elisa; Bonzi, Maria Chiara; Craparotta, Ilaria; Giovannardi, Stefano; Mancini, Monica; Monti, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-164</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activation of hypoxia-inducible factor (HIF)-1 is a feature of hypoxic solid tumors that has been assocd. with drug resistance, mainly due to disruption of Bcl-2 family dynamics.  Resetting the balance in favor of proapoptotic family members is an attractive therapeutic goal that has been pursued by developing BH3-mimetic compds.  In the present study we evaluated the response of human colon adenocarcinoma cells to the BH3-mimetic obatoclax (OBX), in terms of growth arrest, apoptosis and autophagy, in the presence or absence of HIF-1α-stabilizing conditions; its possible effect on HIF-1α expression and HIF-1 activity; and the possibility to improve the response of colon cancer cells to cytotoxic chemotherapeutics by combining them with OBX.  Colon cancer cell response to the BH3-mimetic was unmodified by HIF-1 activation and OBX induced a decrease in HIF-1α protein levels and HIF-1 transcriptional activity, probably by decreasing HIF-1α synthesis and facilitating a VHL-independent proteasomal degrdn. pathway.  Finally, a chemosensitizing effect of OBX with respect to 5-fluorouracil or oxaliplatin treatment was obsd., highlighting the possibility that patients with hypoxic colon tumors might benefit from combined regimens including OBX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrblJExRQW-IbVg90H21EOLACvtfcHk0liFeaz4wWg0sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1egs78%253D&md5=18738781bc23f4aeedc73a6a857ba9dc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DGariboldi%26aufirst%3DM.%2BB.%26aulast%3DTaiana%26aufirst%3DE.%26aulast%3DBonzi%26aufirst%3DM.%2BC.%26aulast%3DCraparotta%26aufirst%3DI.%26aulast%3DGiovannardi%26aufirst%3DS.%26aulast%3DMancini%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DE.%26atitle%3DThe%2520BH3-mimetic%2520obatoclax%2520reduces%2520HIF-1%25CE%25B1%2520levels%2520and%2520HIF-1%2520transcriptional%2520activity%2520and%2520sensitizes%2520hypoxic%2520colon%2520adenocarcinoma%2520cells%2520to%25205-fluorouracil%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D364%26spage%3D156%26epage%3D164%26doi%3D10.1016%2Fj.canlet.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koraimann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span> <span> </span><span class="NLM_article-title">Increasing the precision of comparative models with YASARA NOVA—a self-parameterizing force field</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1002/prot.10104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fprot.10104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=11948792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFantbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2002&pages=393-402&author=E.+Kriegerauthor=G.+Koraimannauthor=G.+Vriend&title=Increasing+the+precision+of+comparative+models+with+YASARA+NOVA%E2%80%94a+self-parameterizing+force+field&doi=10.1002%2Fprot.10104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing the precision of comparative models with yasara NOVA-a self-parameterizing force field</span></div><div class="casAuthors">Krieger, Elmar; Koraimann, Gunther; Vriend, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-402</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">One of the conclusions drawn at the CASP4 meeting in Asilomar was that applying various force fields during refinement of template-based models tends to move predictions in the wrong direction, away from the exptl. detd. coordinates.  We have derived an all-atom force field aimed at protein and nucleotide optimization in vacuo (NOVA), which has been specifically designed to avoid this problem.  NOVA resembles common mol. dynamics force fields but has been automatically parameterized with two major goals: (i) not to make high resoln. x-ray structures worse and (ii) to improve homol. models built by WHAT IF.  Force-field parameters were not required to be phys. correct; instead, they were optimized with random Monte Carlo moves in force-field parameter space, each one evaluated by simulated annealing runs of a 50-protein optimization set.  Errors inherent to the approx. force-field equation could thus be canceled by errors in force-field parameters.  Compared with the optimization set, the force field did equally well on an independent validation set and is shown to move in silico models closer to reality.  It can be applied to modeling applications as well as x-ray and NMR structure refinement.  A new method to assign force-field parameters based on mol. trees is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6LW7Vk3vpG7Vg90H21EOLACvtfcHk0liFeaz4wWg0sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFantbg%253D&md5=0f187e3ef132542e716eaae61df13b2d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fprot.10104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10104%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26aulast%3DKoraimann%26aufirst%3DG.%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DIncreasing%2520the%2520precision%2520of%2520comparative%2520models%2520with%2520YASARA%2520NOVA%25E2%2580%2594a%2520self-parameterizing%2520force%2520field%26jtitle%3DProteins%26date%3D2002%26volume%3D47%26spage%3D393%26epage%3D402%26doi%3D10.1002%2Fprot.10104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patamia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span> <span> </span><span class="NLM_article-title">Computational tools in the discovery of FABP4 Ligands: A statistical and molecular modeling approach</span>. <i>Mar. drugs.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">624</span>, <span class="refDoi"> DOI: 10.3390/md17110624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fmd17110624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpvVCntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=624&author=G.+Florestaauthor=D.+Gentileauthor=G.+Perriniauthor=V.+Patamiaauthor=A.+Rescifina&title=Computational+tools+in+the+discovery+of+FABP4+Ligands%3A+A+statistical+and+molecular+modeling+approach&doi=10.3390%2Fmd17110624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Computational tools in the discovery of FABP4 ligands: a statistical and molecular modeling approach</span></div><div class="casAuthors">Floresta, Giuseppe; Gentile, Dave; Perrini, Giancarlo; Patamia, Vincenzo; Rescifina, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">624</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Small mol. inhibitors of adipocyte fatty-acid binding protein 4 (FABP4) have received interest following the recent publication of their pharmacol. beneficial effects.  Recently, it was revealed that FABP4 is an attractive mol. target for the treatment of type 2 diabetes, other metabolic diseases, and some type of cancers.  In past years, hundreds of effective FABP4 inhibitors have been synthesized and discovered, but, unfortunately, none have reached the clin. research phase.  The field of computer-aided drug design seems to be promising and useful for the identification of FABP4 inhibitors; hence, different structure- and ligand-based computational approaches have been used for their identification.  In this paper, we searched for new potentially active FABP4 ligands in the Marine Natural Products (MNP) database.  We retrieved 14,492 compds. from this database and filtered through them with a statistical and computational filter.  Seven compds. were suggested by our methodol. to possess a potential inhibitory activity upon FABP4 in the range of 97-331 nM.  ADMET property prediction was performed to validate the hypothesis of the interaction with the intended target and to assess the drug-likeness of these derivs.  From these analyses, three mols. that are excellent candidates for becoming new drugs were found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNr8x3uZQgWbVg90H21EOLACvtfcHk0liJvjpLP4_sRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpvVCntrg%253D&md5=ad4d21185344cc9a9873a48ef53fd80f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3390%2Fmd17110624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd17110624%26sid%3Dliteratum%253Aachs%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DPerrini%26aufirst%3DG.%26aulast%3DPatamia%26aufirst%3DV.%26aulast%3DRescifina%26aufirst%3DA.%26atitle%3DComputational%2520tools%2520in%2520the%2520discovery%2520of%2520FABP4%2520Ligands%253A%2520A%2520statistical%2520and%2520molecular%2520modeling%2520approach%26jtitle%3DMar.%2520drugs.%26date%3D2019%26volume%3D17%26spage%3D624%26doi%3D10.3390%2Fmd17110624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuochi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furneri, P. M.</span></span> <span> </span><span class="NLM_article-title">New anti SARS-Cov-2 targets for quinoline derivatives chloroquine and hydroxychloroquine</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5856</span>, <span class="refDoi"> DOI: 10.3390/ijms21165856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fijms21165856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVChsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=5856&author=D.+Gentileauthor=V.+Fuochiauthor=A.+Rescifinaauthor=P.+M.+Furneri&title=New+anti+SARS-Cov-2+targets+for+quinoline+derivatives+chloroquine+and+hydroxychloroquine&doi=10.3390%2Fijms21165856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">New anti SARS-Cov-2 targets for quinoline derivatives chloroquine and hydroxychloroquine</span></div><div class="casAuthors">Gentile, Davide; Fuochi, Virginia; Rescifina, Antonio; Furneri, Pio Maria</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5856</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a severe global health crisis.  In this paper, we used docking and simulation methods to identify potential targets and the mechanism of action of chloroquine (CQ) and hydroxychloroquine (HCQ) against SARS-CoV-2.  Our results showed that both CQ and HCQ influenced the functionality of the envelope (E) protein, necessary in the maturation processes of the virus, due to interactions that modify the flexibility of the protein structure.  Furthermore, CQ and HCQ also influenced the proofreading and capping of viral RNA in SARS-CoV-2, performed by nsp10/nsp14 and nsp10/nsp16.  In particular, HCQ demonstrated a better energy binding with the examd. targets compared to CQ, probably due to the hydrogen bonding of the hydroxyl group of HCQ with polar amino acid residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzcz7VVeNGWLVg90H21EOLACvtfcHk0liJvjpLP4_sRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVChsbnP&md5=7bf89ed990cb0373d53448c773613f78</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3390%2Fijms21165856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21165856%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DFuochi%26aufirst%3DV.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DFurneri%26aufirst%3DP.%2BM.%26atitle%3DNew%2520anti%2520SARS-Cov-2%2520targets%2520for%2520quinoline%2520derivatives%2520chloroquine%2520and%2520hydroxychloroquine%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D5856%26doi%3D10.3390%2Fijms21165856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span> <span> </span><span class="NLM_article-title">A semiempirical free energy force field with charge-based desolvation</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1145</span>– <span class="NLM_lpage">1152</span>, <span class="refDoi"> DOI: 10.1002/jcc.20634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fjcc.20634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=17274016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVSms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=1145-1152&author=R.+Hueyauthor=G.+M.+Morrisauthor=A.+J.+Olsonauthor=D.+S.+Goodsell&title=A+semiempirical+free+energy+force+field+with+charge-based+desolvation&doi=10.1002%2Fjcc.20634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A semiempirical free energy force field with charge-based desolvation</span></div><div class="casAuthors">Huey, Ruth; Morris, Garrett M.; Olson, Arthur J.; Goodsell, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1145-1152</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors describe the development and testing of a semiempirical free energy force field for use in AutoDock4 and similar grid-based docking methods.  The force field is based on a comprehensive thermodn. model that allows incorporation of intramol. energies into the predicted free energy of binding.  It also incorporates a charge-based method for evaluation of desolvation designed to use a typical set of atom types.  The method has been calibrated on a set of 188 diverse protein-ligand complexes of known structure and binding energy, and tested on a set of 100 complexes of ligands with retroviral proteases.  The force field shows improvement in redocking simulations over the previous AutoDock3 force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonvP0et7yst7Vg90H21EOLACvtfcHk0liJvjpLP4_sRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVSms78%253D&md5=6fe6ef9bc0bd8149203a2b7351a2f15c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20634%26sid%3Dliteratum%253Aachs%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26atitle%3DA%2520semiempirical%2520free%2520energy%2520force%2520field%2520with%2520charge-based%2520desolvation%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2007%26volume%3D28%26spage%3D1145%26epage%3D1152%26doi%3D10.1002%2Fjcc.20634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J. J. P.</span></span> <span> </span><span class="NLM_article-title">Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements</span>. <i>J. Mol. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1007/s00894-007-0233-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1007%2Fs00894-007-0233-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=17828561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlequr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1173-1213&author=J.+J.+P.+Stewart&title=Optimization+of+parameters+for+semiempirical+methods+V%3A+modification+of+NDDO+approximations+and+application+to+70+elements&doi=10.1007%2Fs00894-007-0233-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements</span></div><div class="casAuthors">Stewart, James J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1173-1213</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Several modifications that have been made to the NDDO core-core interaction term and to the method of parameter optimization are described.  These changes have resulted in a more complete parameter optimization, called PM6, which has, in turn, allowed 70 elements to be parameterized.  The av. unsigned error (AUE) between calcd. and ref. heats of formation for 4,492 species was 8.0 kcal mol-1.  For the subset of 1,373 compds. involving only the elements H, C, N, O, F, P, S, Cl, and Br, the PM6 AUE was 4.4 kcal mol-1.  The equivalent AUE for other methods were: RM1: 5.0, B3LYP 6-31G*: 5.2, PM5: 5.7, PM3: 6.3, HF 6-31G*: 7.4, and AM1: 10.0 kcal mol-1.  Several long-standing faults in AM1 and PM3 have been cor. and significant improvements have been made in the prediction of geometries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl-g7DsFjK8LVg90H21EOLACvtfcHk0lij_vhDhGqnEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlequr7N&md5=7d22928c8e3423f3ca8f2e7c77e6e6c9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs00894-007-0233-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-007-0233-4%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DJ.%2BJ.%2BP.%26atitle%3DOptimization%2520of%2520parameters%2520for%2520semiempirical%2520methods%2520V%253A%2520modification%2520of%2520NDDO%2520approximations%2520and%2520application%2520to%252070%2520elements%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2007%26volume%3D13%26spage%3D1173%26epage%3D1213%26doi%3D10.1007%2Fs00894-007-0233-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span>; <span class="NLM_string-name">Nielsen, J. E.</span>; <span class="NLM_string-name">Spronk, C. A. E. M.</span>; <span class="NLM_string-name">Vriend, G.</span></span> <span> </span><span class="NLM_article-title">Fast empirical pKa prediction by Ewald summation</span>.  <i>Computational Drug Discovery and Design</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2006</span>,  <span class="NLM_volume">25</span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1016/j.jmgm.2006.02.009</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.jmgm.2006.02.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=481-486&author=E.+Krieger&author=J.+E.+Nielsen&author=C.+A.+E.+M.+Spronk&author=G.+Vriend&title=Computational+Drug+Discovery+and+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2006.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fj.jmgm.2006.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26atitle%3DFast%2520empirical%2520pKa%2520prediction%2520by%2520Ewald%2520summation%26btitle%3DComputational%2520Drug%2520Discovery%2520and%2520Design%26pub%3DSpringer%26date%3D2006%26volume%3D25%26spage%3D481%26epage%3D486%26doi%3D10.1016%2Fj.jmgm.2006.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbrack, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, B.</span></span> <span> </span><span class="NLM_article-title">Assignment of protonation states in proteins and ligands: combining pK<sub>a</sub> prediction with hydrogen bonding network optimization</span>. <i>Methods Mol. Bio.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>819</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1007/978-1-61779-465-0_25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1007%2F978-1-61779-465-0_25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=22183550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSjur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=819&publication_year=2012&pages=405-421&author=E.+Kriegerauthor=R.+Dunbrackauthor=R.+Hooftauthor=B.+Krieger&title=Assignment+of+protonation+states+in+proteins+and+ligands%3A+combining+pKa+prediction+with+hydrogen+bonding+network+optimization&doi=10.1007%2F978-1-61779-465-0_25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Assignment of protonation states in proteins and ligands: combining pKa prediction with hydrogen bonding network optimization</span></div><div class="casAuthors">Krieger, Elmar; Dunbrack, Roland; Hooft, Rob; Krieger, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">819</span>
        (<span class="NLM_cas:issue">Computational Drug Discovery and Design</span>),
    <span class="NLM_cas:pages">405-421</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Among the many applications of mol. modeling, drug design is probably the one with the highest demands on the accuracy of the underlying structures.  During lead optimization, the position of every atom in the binding site should ideally be known with high precision to identify those chem. modifications that are most likely to increase drug affinity.  Unfortunately, X-ray crystallog. at common resoln. yields an electron d. map that is too coarse, since the chem. elements and their protonation states cannot be fully resolved.  This chapter describes the steps required to fill in the missing knowledge, by devising an algorithm that can detect and resolve the ambiguities.  First, the pKa values of acidic and basic groups are predicted.  Second, their potential protonation states are detd., including all permutations (considering for example protons that can jump between the oxygens of a phosphate group).  Third, those groups of atoms are identified that can adopt alternative but indistinguishable conformations with essentially the same electron d.  Fourth, potential hydrogen bond donors and acceptors are located.  Finally, all these data are combined in a single "configuration energy function," whose global min. is found with the SCWRL algorithm, which employs dead-end elimination and graph theory.  As a result, one obtains a complete model of the protein and its bound ligand, with ambiguous groups rotated to the best orientation and with protonation states assigned considering the current pH and the H-bonding network.  An implementation of the algorithm has been available since 2008 as part of the YASARA modeling & simulation program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFpCHVYXJkBrVg90H21EOLACvtfcHk0lij_vhDhGqnEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSjur%252FE&md5=8525f958edc1f737aaf3c305aef34bb1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-465-0_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-465-0_25%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26aulast%3DDunbrack%26aufirst%3DR.%26aulast%3DHooft%26aufirst%3DR.%26aulast%3DKrieger%26aufirst%3DB.%26atitle%3DAssignment%2520of%2520protonation%2520states%2520in%2520proteins%2520and%2520ligands%253A%2520combining%2520pKa%2520prediction%2520with%2520hydrogen%2520bonding%2520network%2520optimization%26jtitle%3DMethods%2520Mol.%2520Bio.%26date%3D2012%26volume%3D819%26spage%3D405%26epage%3D421%26doi%3D10.1007%2F978-1-61779-465-0_25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maier, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasavajhala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span> <span> </span><span class="NLM_article-title">ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3696</span>– <span class="NLM_lpage">3713</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00255</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00255" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3696-3713&author=J.+A.+Maierauthor=C.+Martinezauthor=K.+Kasavajhalaauthor=L.+Wickstromauthor=K.+E.+Hauserauthor=C.+Simmerling&title=ff14SB%3A+Improving+the+accuracy+of+protein+side+chain+and+backbone+parameters+from+ff99SB&doi=10.1021%2Facs.jctc.5b00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</span></div><div class="casAuthors">Maier, James A.; Martinez, Carmenza; Kasavajhala, Koushik; Wickstrom, Lauren; Hauser, Kevin E.; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3696-3713</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. mechanics is powerful for its speed in atomistic simulations, but an accurate force field is required.  The Amber ff99SB force field improved protein secondary structure balance and dynamics from earlier force fields like ff99, but weaknesses in side chain rotamer and backbone secondary structure preferences have been identified.  Here, we performed a complete refit of all amino acid side chain dihedral parameters, which had been carried over from ff94.  The training set of conformations included multidimensional dihedral scans designed to improve transferability of the parameters.  Improvement in all amino acids was obtained as compared to ff99SB.  Parameters were also generated for alternate protonation states of ionizable side chains.  Av. errors in relative energies of pairs of conformations were under 1.0 kcal/mol as compared to QM, reduced 35% from ff99SB.  We also took the opportunity to make empirical adjustments to the protein backbone dihedral parameters as compared to ff99SB.  Multiple small adjustments of φ and ψ parameters were tested against NMR scalar coupling data and secondary structure content for short peptides.  The best results were obtained from a phys. motivated adjustment to the φ rotational profile that compensates for lack of ff99SB QM training data in the β-ppII transition region.  Together, these backbone and side chain modifications (hereafter called ff14SB) not only better reproduced their benchmarks, but also improved secondary structure content in small peptides and reprodn. of NMR χ1 scalar coupling measurements for proteins in soln.  We also discuss the Amber ff12SB parameter set, a preliminary version of ff14SB that includes most of its improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgntnN9ES97rVg90H21EOLACvtfcHk0lij_vhDhGqnEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN&md5=7b803577b3b6912cc6750cfbd356596e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00255%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DC.%26aulast%3DKasavajhala%26aufirst%3DK.%26aulast%3DWickstrom%26aufirst%3DL.%26aulast%3DHauser%26aufirst%3DK.%2BE.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3Dff14SB%253A%2520Improving%2520the%2520accuracy%2520of%2520protein%2520side%2520chain%2520and%2520backbone%2520parameters%2520from%2520ff99SB%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2015%26volume%3D11%26spage%3D3696%26epage%3D3713%26doi%3D10.1021%2Facs.jctc.5b00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Development and testing of a general amber force field</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1002/jcc.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+amber+force+field&doi=10.1002%2Fjcc.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0lj8VClteHI0rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1157%26epage%3D1174%26doi%3D10.1002%2Fjcc.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strockbine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roitberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span> <span> </span><span class="NLM_article-title">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1002/prot.21123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fprot.21123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=16981200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=712-725&author=V.+Hornakauthor=R.+Abelauthor=A.+Okurauthor=B.+Strockbineauthor=A.+Roitbergauthor=C.+Simmerling&title=Comparison+of+multiple+Amber+force+fields+and+development+of+improved+protein+backbone+parameters&doi=10.1002%2Fprot.21123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span></div><div class="casAuthors">Hornak, Viktor; Abel, Robert; Okur, Asim; Strockbine, Bentley; Roitberg, Adrian; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-725</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The ff94 force field that is commonly assocd. with the Amber simulation package is one of the most widely used parameter sets for biomol. simulation.  After a decade of extensive use and testing, limitations in this force field, such as over-stabilization of α-helixes, were reported by the authors and other researchers.  This led to a no. of attempts to improve these parameters, resulting in a variety of "Amber" force fields and significant difficulty in detg. which should be used for a particular application.  The authors show that several of these continue to suffer from inadequate balance between different secondary structure elements.  In addn., the approach used in most of these studies neglected to account for the existence in Amber of two sets of backbone .vphi./ψ dihedral terms.  This led to parameter sets that provide unreasonable conformational preferences for glycine.  The authors report here an effort to improve the .vphi./ψ dihedral terms in the ff99 energy function.  Dihedral term parameters are based on fitting the energies of multiple conformations of glycine and alanine tetrapeptides from high level ab initio quantum mech. calcns.  The new parameters for backbone dihedrals replace those in the existing ff99 force field.  This parameter set, which the authors denote ff99SB, achieves a better balance of secondary structure elements as judged by improved distribution of backbone dihedrals for glycine and alanine with respect to PDB survey data.  It also accomplishes improved agreement with published exptl. data for conformational preferences of short alanine peptides and better accord with exptl. NMR relaxation data of test protein systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoASzza-Gd7Vg90H21EOLACvtfcHk0lj8VClteHI0rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM&md5=de683a26eca9e83ae524726e97ac22fa</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fprot.21123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21123%26sid%3Dliteratum%253Aachs%26aulast%3DHornak%26aufirst%3DV.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DOkur%26aufirst%3DA.%26aulast%3DStrockbine%26aufirst%3DB.%26aulast%3DRoitberg%26aufirst%3DA.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3DComparison%2520of%2520multiple%2520Amber%2520force%2520fields%2520and%2520development%2520of%2520improved%2520protein%2520backbone%2520parameters%26jtitle%3DProteins%26date%3D2006%26volume%3D65%26spage%3D712%26epage%3D725%26doi%3D10.1002%2Fprot.21123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Essmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkowitz, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L. G.</span></span> <span> </span><span class="NLM_article-title">A Smooth particle mesh Ewald method</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8577</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1063/1.470117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1063%2F1.470117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8593&author=U.+Essmannauthor=L.+Pereraauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+Smooth+particle+mesh+Ewald+method&doi=10.1063%2F1.470117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A smooth particle mesh Ewald method</span></div><div class="casAuthors">Essmann, Ulrich; Perera, Lalith; Berkowitz, Max L.; Darden, Tom; Lee, Hsing; Pedersen, Lee G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8577-93</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The previously developed particle mesh Ewald method is reformulated in terms of efficient B-spline interpolation of the structure factors.  This reformulation allows a natural extension of the method to potentials of the form 1/rp with p ≥ 1.  Furthermore, efficient calcn. of the virial tensor follows.  Use of B-splines in the place of Lagrange interpolation leads to analytic gradients as well as a significant improvement in the accuracy.  The authors demonstrate that arbitrary accuracy can be achieved, independent of system size N, at a cost that scales as N log(N).  For biomol. systems with many thousands of atoms and this method permits the use of Ewald summation at a computational cost comparable to that of a simple truncation method of 10 Å or less.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Bp1XlSY32LVg90H21EOLACvtfcHk0lj8VClteHI0rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D&md5=092a679dd3bee08da28df41e302383a7</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssmann%26aufirst%3DU.%26aulast%3DPerera%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520Smooth%2520particle%2520mesh%2520Ewald%2520method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8593%26doi%3D10.1063%2F1.470117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postma, J. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gunsteren, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haak, J. R.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics with coupling to an external bath</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">3684</span>– <span class="NLM_lpage">3690</span>, <span class="refDoi"> DOI: 10.1063/1.448118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1063%2F1.448118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=3684-3690&author=H.+J.+C.+Berendsenauthor=J.+P.+M.+Postmaauthor=W.+F.+van+Gunsterenauthor=A.+DiNolaauthor=J.+R.+Haak&title=Molecular+dynamics+with+coupling+to+an+external+bath&doi=10.1063%2F1.448118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics with coupling to an external bath</span></div><div class="casAuthors">Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; DiNola, A.; Haak, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3684-90</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">In mol. dynamics (MD) simulations, the need often arises to maintain such parameters as temp. or pressure rather than energy and vol., or to impose gradients for studying transport properties in nonequil. MD.  A method is described to realize coupling to an external bath with const. temp. or pressure with adjustable time consts. for the coupling.  The method is easily extendable to other variables and to gradients, and can be applied also to polyat. mols. involving internal constraints.  The influence of coupling time consts. on dynamical variables is evaluated.  A leap-frog algorithm is presented for the general case involving constraints with coupling to both a const. temp. and a const. pressure bath.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecrpUZWkh37Vg90H21EOLACvtfcHk0lj8VClteHI0rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D&md5=5510dc00297d63b91ee3a7a4ae5aacb1</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1063%2F1.448118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.448118%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DPostma%26aufirst%3DJ.%2BP.%2BM.%26aulast%3Dvan%2BGunsteren%26aufirst%3DW.%2BF.%26aulast%3DDiNola%26aufirst%3DA.%26aulast%3DHaak%26aufirst%3DJ.%2BR.%26atitle%3DMolecular%2520dynamics%2520with%2520coupling%2520to%2520an%2520external%2520bath%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1984%26volume%3D81%26spage%3D3684%26epage%3D3690%26doi%3D10.1063%2F1.448118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span> <span> </span><span class="NLM_article-title">New ways to boost molecular dynamics simulations</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">996</span>– <span class="NLM_lpage">1007</span>, <span class="refDoi"> DOI: 10.1002/jcc.23899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fjcc.23899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=25824339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVOgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=996-1007&author=E.+Kriegerauthor=G.+Vriend&title=New+ways+to+boost+molecular+dynamics+simulations&doi=10.1002%2Fjcc.23899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">New ways to boost molecular dynamics simulations</span></div><div class="casAuthors">Krieger, Elmar; Vriend, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">996-1007</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe a set of algorithms that allow to simulate dihydrofolate reductase (DHFR, a common benchmark) with the AMBER all-atom force field at 160 ns/day on a single Intel Core i7 5960X CPU (no graphics processing unit (GPU), 23,786 atoms, particle mesh Ewald (PME), 8.0 Å cutoff, correct atom masses, reproducible trajectory, CPU with 3.6 GHz, no turbo boost, 8 AVX registers).  The new features include a mixed multiple time-step algorithm (reaching 5 fs), a tuned version of LINCS to constrain bond angles, the fusion of pair list creation and force calcn., pressure coupling with a "densostat," and exploitation of new CPU instruction sets like AVX2.  The impact of Intel's new transactional memory, at. instructions, and sloppy pair lists is also analyzed.  The algorithms map well to GPUs and can automatically handle most Protein Data Bank (PDB) files including ligands.  An implementation is available as part of the YASARA mol. modeling and simulation program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoniH36hOPj37Vg90H21EOLACvtfcHk0lg6EWiMdNqIvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVOgsbo%253D&md5=5b3cd97c67fa308b9333d016cf31e0b7</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fjcc.23899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.23899%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DNew%2520ways%2520to%2520boost%2520molecular%2520dynamics%2520simulations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2015%26volume%3D36%26spage%3D996%26epage%3D1007%26doi%3D10.1002%2Fjcc.23899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span> <span> </span><span class="NLM_article-title">Morphing of Ibogaine: A successful attempt into the search for sigma-2 receptor ligands</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">488</span>, <span class="refDoi"> DOI: 10.3390/ijms20030488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fijms20030488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlSrs7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=488&author=G.+Florestaauthor=M.+Dichiaraauthor=D.+Gentileauthor=O.+Prezzaventoauthor=A.+Marrazzoauthor=A.+Rescifinaauthor=E.+Amata&title=Morphing+of+Ibogaine%3A+A+successful+attempt+into+the+search+for+sigma-2+receptor+ligands&doi=10.3390%2Fijms20030488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Morphing of Ibogaine: a successful attempt into the search for sigma-2 receptor ligands</span></div><div class="casAuthors">Floresta, Giuseppe; Dichiara, Maria; Gentile, Davide; Prezzavento, Orazio; Marrazzo, Agostino; Rescifina, Antonio; Amata, Emanuele</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">488</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Ibogaine is a psychoactive indole alkaloid with high affinity for several targets including the σ2 receptor.  Indeed, extensive data support the involvement of the σ2 receptor in neurol. disorders, including Alzheimer's disease, schizophrenia, alc. abuse and pain.  Due to its serious side effects which prevent ibogaine from potential clin. applications, novel ibogaine derivs. endowed with improved σ2 receptor affinity may be particularly beneficial.  With the purpose to facilitate the investigation of iboga alkaloid derivs. which may serve as templates for the design of selective σ2 receptor ligands, here we report a deconstruction study on the ibogaine tricyclic moiety and a successive scaffold-hopping of the indole counterpart.  A 3D-QSAR model has been applied to predict the σ2 pKi values of the new compds., whereas a mol. docking study conducted upon the σ2 receptor built by homol. modeling was used to further validate the best-scored mols.  We eventually evaluated pinoline, a carboline deriv., for σ2 receptor affinity through radioligand binding assay and the results confirmed the predicted high μM range of affinity and good selectivity.  The obtained results could be helpful in the drug design process of new ibogaine simplified analogs with improved σ2 receptor binding capabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxMtynO_4qvbVg90H21EOLACvtfcHk0lg6EWiMdNqIvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlSrs7bM&md5=1cc78e31aebed4cbe1a43aa6f77cc478</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.3390%2Fijms20030488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20030488%26sid%3Dliteratum%253Aachs%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DAmata%26aufirst%3DE.%26atitle%3DMorphing%2520of%2520Ibogaine%253A%2520A%2520successful%2520attempt%2520into%2520the%2520search%2520for%2520sigma-2%2520receptor%2520ligands%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D488%26doi%3D10.3390%2Fijms20030488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patamia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchio, M.</span></span> <span> </span><span class="NLM_article-title">Repurposing of FDA-approved drugs for treating iatrogenic botulism: A paired 3D-QSAR/docking approach<sup>†</sup></span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fcmdc.201900594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31774239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlais7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=256-262&author=G.+Florestaauthor=V.+Patamiaauthor=D.+Gentileauthor=F.+Molteniauthor=A.+Santamatoauthor=A.+Rescifinaauthor=M.+Vecchio&title=Repurposing+of+FDA-approved+drugs+for+treating+iatrogenic+botulism%3A+A+paired+3D-QSAR%2Fdocking+approach%E2%80%A0&doi=10.1002%2Fcmdc.201900594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach†</span></div><div class="casAuthors">Floresta, Giuseppe; Patamia, Vincenzo; Gentile, Davide; Molteni, Franco; Santamato, Andrea; Rescifina, Antonio; Vecchio, Michele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-262</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Botulinum neurotoxin (BoNT) is widely used for the treatment of spasticity, focal dystonia, chronic migraine, facial hemispasm, and facial aesthetic treatments.  Generally, treatment with botulinum toxin is a safe procedure when conducted by clinicians with expertise, and local side effects are rare and transient.  However, occasionally adverse effects can occur due to the spread of the drug to nontargeted muscles and organs, producing dry mouth, fatigue, and flu-like symptoms, up to signs of systemic botulism, which appears to be more frequent in children treated for spasticity than in adults.  In silico 3D-QSAR and mol. docking studies were performed to build a structure-based model on selected potent known botulinum neurotoxin type A inhibitors; this was used to screen the US Food and Drug Administration (FDA) database.  Thirty mols. were identified as possible light-chain BoNT/A inhibitors.  In this study, we applied a well-established ligand- and structure-based methodol. for the identification of hit compds. among a database of FDA-approved drugs.  The identification of budesonide, protirelin, and ciclesonide followed by other compds. can be considered a starting point for investigations of selected compds. that could bypass much of the time and costs involved in the drug approval process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofgLgIX3ZJW7Vg90H21EOLACvtfcHk0lg6EWiMdNqIvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlais7%252FI&md5=1acf0d5493435aca8e9438dc79f71bf5</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900594%26sid%3Dliteratum%253Aachs%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DPatamia%26aufirst%3DV.%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DMolteni%26aufirst%3DF.%26aulast%3DSantamato%26aufirst%3DA.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DVecchio%26aufirst%3DM.%26atitle%3DRepurposing%2520of%2520FDA-approved%2520drugs%2520for%2520treating%2520iatrogenic%2520botulism%253A%2520A%2520paired%25203D-QSAR%252Fdocking%2520approach%25E2%2580%25A0%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D256%26epage%3D262%26doi%3D10.1002%2Fcmdc.201900594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahakyan, H.</span></span> <span> </span><span class="NLM_article-title">Improving virtual screening results with MM/GBSA and MM/PBSA rescoring</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1007/s10822-021-00389-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1007%2Fs10822-021-00389-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=33983518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3MXhtV2gsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2021&pages=731-736&author=H.+Sahakyan&title=Improving+virtual+screening+results+with+MM%2FGBSA+and+MM%2FPBSA+rescoring&doi=10.1007%2Fs10822-021-00389-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Improving virtual screening results with MM/GBSA and MM/PBSA rescoring</span></div><div class="casAuthors">Sahakyan, Harutyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">731-736</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Virtual screening (VS) based on mol. docking is one of the most useful methods in computer-aided drug design.  By allowing to identify computationally putative ligands binding to the proteins of interest, VS dramatically reduces the time and expense of the development of novel therapeutics.  Among the limitations of the VS approaches is the low accuracy of scoring functions implemented in docking methods for assessing binding affinity.  Many such scoring functions are developed for rapid, high-throughput evaluation of binding energy of multiple conformations generated by a searching algorithm.  The methods for more rigorous calcn. of binding affinity calcn. are generally time-consuming.  Even so, in many studies more accurate methods were used for rescoring of the final poses and false-pos. hits evaluation.  We performed VS for three benchmark sets and used energy minimization with MM/PB(GB)SA methods (mol. mechanics energies combined with the Poisson-Boltzmann or generalized Born and surface area) to rescore binding affinities.  The comparison of the area under the curve (AUC), enrichment factor (EF), and Boltzmann-enhanced discrimination of receiver operating characteristics (BEDROC) showed essential improvements in the binding energy prediction after the rescoring.  Finally, we provide a program for minimization and rescoring VS results based on freely available AmberTools.  The code requires just the final binding poses of the ligand as the input and can be used with any docking program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF1xaf4SHLnrVg90H21EOLACvtfcHk0lhbAjqbA6xSxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXhtV2gsbjF&md5=ea3d72c7ad2434ee3d2cfa370ecf97e5</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1007%2Fs10822-021-00389-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-021-00389-3%26sid%3Dliteratum%253Aachs%26aulast%3DSahakyan%26aufirst%3DH.%26atitle%3DImproving%2520virtual%2520screening%2520results%2520with%2520MM%252FGBSA%2520and%2520MM%252FPBSA%2520rescoring%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2021%26volume%3D35%26spage%3D731%26epage%3D736%26doi%3D10.1007%2Fs10822-021-00389-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Aktulga, H. M.</span>; <span class="NLM_string-name">Belfon, K.</span>; <span class="NLM_string-name">Ben-Shalom, I. Y.</span>; <span class="NLM_string-name">Brozell, S. R.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham, T. E.,  III</span>; <span class="NLM_string-name">Cruzeiro, V. W. D.</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Giambasu, G.</span>; <span class="NLM_string-name">Gilson, M. K.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A.W.</span>; <span class="NLM_string-name">Harris, R.</span>; <span class="NLM_string-name">Izadi, S.</span>; <span class="NLM_string-name">Izmailov, S. A.</span>; <span class="NLM_string-name">Jin, C.</span>; <span class="NLM_string-name">Kasavajhala, K.</span>; <span class="NLM_string-name">Kaymak, M. C.</span>; <span class="NLM_string-name">King, E.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Kurtzman, T.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Lin, C.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Machado, M.</span>; <span class="NLM_string-name">Man, V.</span>; <span class="NLM_string-name">Manathunga, M.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Miao, Y.</span>; <span class="NLM_string-name">Mikhailovskii, O.</span>; <span class="NLM_string-name">Monard, G.</span>; <span class="NLM_string-name">Nguyen, H.</span>; <span class="NLM_string-name">O’Hearn, K. A.</span>; <span class="NLM_string-name">Onufriev, A.</span>; <span class="NLM_string-name">Pan, F.</span>; <span class="NLM_string-name">Pantano, S.</span>; <span class="NLM_string-name">Qi, R.</span>; <span class="NLM_string-name">Rahnamoun, A.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Sagui, C.</span>; <span class="NLM_string-name">Schott-Verdugo, S.</span>; <span class="NLM_string-name">Shen, J.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Skrynnikov, N. R.</span>; <span class="NLM_string-name">Smith, J.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wei, H.</span>; <span class="NLM_string-name">Wolf, R. M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Xue, Y.</span>; <span class="NLM_string-name">York, D. M.</span>; <span class="NLM_string-name">Zhao, S.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> (<span class="NLM_year">2021</span>),  <i>Amber 2021</i>; <span class="NLM_publisher-name">University of California</span>, <span class="NLM_publisher-loc">San Francisco</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=D.+A.+Case&author=H.+M.+Aktulga&author=K.+Belfon&author=I.+Y.+Ben-Shalom&author=S.+R.+Brozell&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=V.+W.+D.+Cruzeiro&author=T.+A.+Darden&author=R.+E.+Duke&author=G.+Giambasu&author=M.+K.+Gilson&author=H.+Gohlke&author=A.W.+Goetz&author=R.+Harris&author=S.+Izadi&author=S.+A.+Izmailov&author=C.+Jin&author=K.+Kasavajhala&author=M.+C.+Kaymak&author=E.+King&author=A.+Kovalenko&author=T.+Kurtzman&author=T.+S.+Lee&author=S.+LeGrand&author=P.+Li&author=C.+Lin&author=J.+Liu&author=T.+Luchko&author=R.+Luo&author=M.+Machado&author=V.+Man&author=M.+Manathunga&author=K.+M.+Merz&author=Y.+Miao&author=O.+Mikhailovskii&author=G.+Monard&author=H.+Nguyen&author=K.+A.+O%E2%80%99Hearn&author=A.+Onufriev&author=F.+Pan&author=S.+Pantano&author=R.+Qi&author=A.+Rahnamoun&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=S.+Schott-Verdugo&author=J.+Shen&author=C.+L.+Simmerling&author=N.+R.+Skrynnikov&author=J.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=H.+Wei&author=R.+M.+Wolf&author=X.+Wu&author=Y.+Xue&author=D.+M.+York&author=S.+Zhao&author=P.+A.+Kollman&title=Amber+2021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26date%3D2021%26btitle%3DAmber%25202021%26pub%3DUniversity%2520of%2520California" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of Ciprofloxacin, Norfloxacin, and Vosaroxin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Antimicrobial (A) and antitumoral (B) structure–activity relationships of 4-quinolones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Strategy for the Synthesis of Compounds <b>1</b>–<b>3a,b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 4-fluoro-1-nitro-2-(trifluoromethyl)benzene, DMSO, 120 °C, 1 h; (ii) CH<sub>3</sub>OH, <i>p</i>-TsOH, 70 °C, 22 h; (iii) 4-fluoro-1-nitro-2-(trifluoromethyl)benzene, CH<sub>3</sub>CN, 80 °C, overnight.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Strategy for the Synthesis of Final Compounds <b>6a–6d</b> and <b>7a–7d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 1-aminoethanol or 1-aminopropan-3-ol, CH<sub>3</sub>CN, 60 °C, overnight; (ii) CH<sub>3</sub>SO<sub>2</sub>Cl, TEA, dry CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, then room temperature, 1 h; (iii) <b>2a</b> and <b>2b</b>, CH<sub>3</sub>CN, reflux, overnight; (iv) aqueous NaOH 2 M, reflux, 24 h.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. NO detection by a Griess test. Effects of 80 μM solution of <b>1a</b>, <b>1b</b>, and <b>7a</b>–<b>7d</b> on NO production after 1 h of white light irradiation (mean ± SD of three independent experiments). Nitrite concentration was determined by comparing the test samples’ absorbance values to a standard curve generated by serial dilution of 50 μM NaNO<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IC<sub>50</sub> values obtained following 72 h treatment with Ciprofloxacin (C) and its derivatives in the MTT assay (mean ± ES 4/5 independent experiments; *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 <i>vs</i> Cip).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. IC<sub>50</sub> values obtained following 72 h treatment with Norfloxacin (N) and its derivatives in the MTT assay (mean ± ES 4/5 independent experiments; °<i>p</i> < 0.05, °°<i>p</i> < 0.01, °°°<i>p</i> < 0.001 <i>vs</i> Nor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. IC<sub>50</sub> values obtained following 24 h treatment with compound <b>7b</b> or <b>7c</b> with 1 h irradiation and 48 h incubation in the drug-free medium and MTT assay (mean ± ES 3/4 independent experiments. *<i>p</i> < 0.05 <i>vs</i> white light).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. IC<sub>50</sub> values obtained following 72 h treatment with DOX and the MTT assay (mean ± ES 4/5 independent experiments; ***<i>p</i> < 0.001 <i>vs</i> MCF7).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Summary of the most potent compounds synthesized in this work with their IC<sub>50</sub> values on the tested cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Photodynamic treatment of <i>P. aeruginosa</i> PAO1 (a) and <i>S. aureus</i> ATCC 6538P (b). Bacteria were incubated in the dark with or without <b>7c</b> (10 μM) for 10 min and then irradiated under blue light (20 J/cm<sup>2</sup>). Dark controls were not irradiated. Viable cells are expressed as CFU/mL. Values represent the mean of at least three independent experiments, *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/medium/jm1c00917_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. 3D superposition of the best-docked pose for <b>1a</b> bound to the Topo IIα (A) and binding site interactions (B). RMSD superposing on the receptor (C) and starting structure (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00917/20210728/images/large/jm1c00917_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00917&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 71 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmerson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. M.</span></span> <span> </span><span class="NLM_article-title">The quinolones: decades of development and use</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1093/jac/dkg208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1093%2Fjac%2Fdkg208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=12702699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=13-20&author=A.+M.+Emmersonauthor=A.+M.+Jones&title=The+quinolones%3A+decades+of+development+and+use&doi=10.1093%2Fjac%2Fdkg208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The quinolones: Decades of development and use</span></div><div class="casAuthors">Emmerson, A. M.; Jones, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">Suppl. S1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The discovery of nalidixic acid in 1962, and its introduction for clin. use in 1967, marks the beginning of five decades of quinolone development and use.  It was not until the discovery and licensing of the fluoroquinolones in the 1970s and 1980s that these drugs began to establish their place in the armamentarium of clin. useful antimicrobials.  At the beginning of the 21st century, in their fifth decade of discovery and use, our understanding of structure-function relationships has improved, and better compds., in terms of both spectrum of antimicrobial cover and pharmacokinetics, have been developed.  The clin. utility of this expanding class of anti-microbial agents, and the lower propensity for the development of resistance with the "newer" fluoroquinolones will need to be continually monitored in the changing therapeutic environment.  Antibiotic drug choice will remain difficult in the presence of increasing resistance, but the introduction of the new fluoroquinolones has created a new and exciting era in antimicrobial treatment.  The role of these agents has already been acknowledged in a no. of clin. guidelines, and appropriate use of these agents may help to preserve their clin. utility, enabling them to realize their full therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0RRLOgvTYNLVg90H21EOLACvtfcHk0lhx3V4O4CtPxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOqu74%253D&md5=04ad837d0f1be12fa7e9944cc9502301</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg208%26sid%3Dliteratum%253Aachs%26aulast%3DEmmerson%26aufirst%3DA.%2BM.%26aulast%3DJones%26aufirst%3DA.%2BM.%26atitle%3DThe%2520quinolones%253A%2520decades%2520of%2520development%2520and%2520use%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26spage%3D13%26epage%3D20%26doi%3D10.1093%2Fjac%2Fdkg208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacGowan, A. P.</span></span> <span> </span><span class="NLM_article-title">Development of the quinolones</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1093/jac/dkg212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1093%2Fjac%2Fdkg212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=12702698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=1-11&author=M.+I.+Anderssonauthor=A.+P.+MacGowan&title=Development+of+the+quinolones&doi=10.1093%2Fjac%2Fdkg212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the quinolones</span></div><div class="casAuthors">Andersson, Monique I.; MacGowan, Alasdair P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">Suppl. S1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Since their discovery in the early 1960s, the quinolone group of antibacterials has generated considerable clin. and scientific interest.  Nalidixic acid, the first quinolone to be developed, was obtained as an impurity during the manuf. of quinine.  Since this time, many derivs. have been synthesized and evaluated for their antibacterial potency.  Two major groups of compds. have been developed from the basic mol.: quinolones and naphthyridones.  Manipulations of the basic mol., including replacing hydrogen with fluorine at position 6, substituting a diamine residue at position 7 and adding new residues at position 1 of the quinolone ring, have led to enhanced antibacterial efficacy.  In general these compds. are well tolerated.  However, some of these structural changes have been found to correlate with specific adverse events: the addn. of fluorine or chlorine at position 8 being assocd. with photoreactivity, e.g. Bay y 3118 and sparfloxacin; and the substitution of an amine or a Me group at position 5 having a potential role in QTc prolongation, e.g. sparfloxacin and grepafloxacin.  Progressive modifications in mol. configuration have resulted in improved breadth and potency of in vitro activity and pharmacokinetics.  One of the most significant developments has been the improved anti-Gram-pos. activity of the newer compds., such as moxifloxacin and garenoxacin.  In the current millennium, these new agents may play an important role in the treatment of respiratory infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXOxpC9VPPpbVg90H21EOLACvtfcHk0lhx3V4O4CtPxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOqurc%253D&md5=cd81508f26225254e8a785951636f491</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg212%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DM.%2BI.%26aulast%3DMacGowan%26aufirst%3DA.%2BP.%26atitle%3DDevelopment%2520of%2520the%2520quinolones%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26spage%3D1%26epage%3D11%26doi%3D10.1093%2Fjac%2Fdkg212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosi, E.</span></span> <span> </span><span class="NLM_article-title">Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections</span>. <i>Aust. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1080/1120009X.2017.1380357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1080%2F1120009X.2017.1380357" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2017&pages=10-18&author=A.+Novelliauthor=E.+Rosi&title=Pharmacological+properties+of+oral+antibiotics+for+the+treatment+of+uncomplicated+urinary+tract+infections&doi=10.1080%2F1120009X.2017.1380357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F1120009X.2017.1380357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1120009X.2017.1380357%26sid%3Dliteratum%253Aachs%26aulast%3DNovelli%26aufirst%3DA.%26aulast%3DRosi%26aufirst%3DE.%26atitle%3DPharmacological%2520properties%2520of%2520oral%2520antibiotics%2520for%2520the%2520treatment%2520of%2520uncomplicated%2520urinary%2520tract%2520infections%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2017%26volume%3D29%26spage%3D10%26epage%3D18%26doi%3D10.1080%2F1120009X.2017.1380357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, H. H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuo-Rahma, G. E.-D. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbas, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelhafez, E.-S. M. N.</span></span> <span> </span><span class="NLM_article-title">Current trends and future directions of fluoroquinolones</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3149</span>, <span class="refDoi"> DOI: 10.2174/0929867325666180214122944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.2174%2F0929867325666180214122944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29446718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVWis7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=3132-3149&author=H.+H.+H.+Mohammedauthor=G.+E.-D.+A.+A.+Abuo-Rahmaauthor=S.+H.+Abbasauthor=E.-S.+M.+N.+Abdelhafez&title=Current+trends+and+future+directions+of+fluoroquinolones&doi=10.2174%2F0929867325666180214122944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Current Trends and Future Directions of Fluoroquinolones</span></div><div class="casAuthors">Mohammed, Hamada H. H.; A. A. Abuo-Rahma, Gamal El-Din; Abbas, Samar H.; Abdelhafez, El-Shimaa M. N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3132-3149</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Fluoroquinolones represent an interesting synthetic class of antimicrobial agents with broad spectrum and potent activity.  Since the discovery of nalidixic acid, the prototype of quinolones, several structural modifications to the quinolone nucleus have been carried out for improvement of potency, spectrum of activity, and to understand their structure activity relationship (SAR).  The C-7 substituent was reported to have a major impact on the activity.  Accordingly, Substitution at C-7 or its N-4-piperazinyl moiety was found to affect potency, bioavailability, and physicochem. properties.  Also, it can increase the affinity towards mammalian topoisomerases that may shift quinolones from antibacterial to anticancer candidates.  Moreover, the presence of DNA topoisomerases in both eukaryotic and prokaryotic cells makes them excellent targets for chemotherapeutic intervention in antibacterial and anticancer therapies.  Based on this concept, several fluoroquionolones derivs. have been synthesized and biol. evaluated as antibacterial, antituberculosis, antiproliferative, antiviral and antifungal agents.  This review is an attempt to focus on the therapeutic prospects of fluoroquinolones with an updated account on their atypical applications such as antitubercular and anticancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Fd2-RnBgl7Vg90H21EOLACvtfcHk0ljcPt7SswxE0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVWis7jP&md5=dbbc636c493ba3e102c771c282b18274</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867325666180214122944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867325666180214122944%26sid%3Dliteratum%253Aachs%26aulast%3DMohammed%26aufirst%3DH.%2BH.%2BH.%26aulast%3DAbuo-Rahma%26aufirst%3DG.%2BE.-D.%2BA.%2BA.%26aulast%3DAbbas%26aufirst%3DS.%2BH.%26aulast%3DAbdelhafez%26aufirst%3DE.-S.%2BM.%2BN.%26atitle%3DCurrent%2520trends%2520and%2520future%2520directions%2520of%2520fluoroquinolones%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2019%26volume%3D26%26spage%3D3132%26epage%3D3149%26doi%3D10.2174%2F0929867325666180214122944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigel, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steward, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span></span> <span> </span><span class="NLM_article-title">GyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">2661</span>– <span class="NLM_lpage">2667</span>, <span class="refDoi"> DOI: 10.1128/AAC.42.10.2661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1128%2FAAC.42.10.2661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=9756773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Gjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=2661-2667&author=L.+M.+Weigelauthor=C.+D.+Stewardauthor=F.+C.+Tenover&title=GyrA+mutations+associated+with+fluoroquinolone+resistance+in+eight+species+of+Enterobacteriaceae&doi=10.1128%2FAAC.42.10.2661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae</span></div><div class="casAuthors">Weigel, Linda M.; Steward, Christine D.; Tenover, Fred C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2661-2667</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Fluoroquinolone resistance (FQ-R) in clin. isolates of Enterobacteriaceae species has been reported with increasing frequency in recent years.  Two mechanisms of FQ-R have been identified in gram-neg. organisms: mutations in DNA gyrase and reduced intracellular drug accumulation.  A single point mutation in gyrA has been shown to reduce susceptibility to fluoroquinolones.  To det. the extent of gyrA mutations assocd. with FQ-R in enteric bacteria, one set of oligonucleotide primers was selected from conserved sequences in the flanking regions of the quinolone resistance-detg. regions (QRDR) of Escherichia coli and Klebsiella pneumoniae.  This set of primers was used to amplify and sequence the QRDRs from 8 Enterobacteriaceae type strains and 60 fluoroquinolone-resistant clin. isolates of Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, E. coli, K. pneumoniae, Klebsiella oxytoca, Providencia stuartii, and Serratia marcescens.  Although similarity of the nucleotide sequences of seven species ranged from 80.8 to 93.3%, when compared with that of E. coli, the amino acid sequences of the gyrA QRDR were highly conserved.  Conservative amino acid substitutions were detected in the QRDRs of the susceptible type strains of C. freundii, E. aerogenes, K. oxytoca (Ser-83 to Thr), and P. stuartii (Asp-87 to Glu).  Strains with ciprofloxacin MICs of >2 μg/mL expressed amino acid substitutions primarily at the Gly-81, Ser-83, or Asp-87 position.  Fluoroquinolone MICs varied significantly for strains exhibiting identical gyrA mutations, indicating that alterations outside gyrA contribute to resistance.  The type and position of amino acid alterations also differed among these six genera.  High-level FQ-R frequently was assocd. with single gyrA mutations in all species of Enterobacteriaceae in this study except E. coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosESbTyrswrbVg90H21EOLACvtfcHk0ljcPt7SswxE0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Gjs78%253D&md5=11793265e79c1a3a2acf5d7c31555f19</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FAAC.42.10.2661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.42.10.2661%26sid%3Dliteratum%253Aachs%26aulast%3DWeigel%26aufirst%3DL.%2BM.%26aulast%3DSteward%26aufirst%3DC.%2BD.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26atitle%3DGyrA%2520mutations%2520associated%2520with%2520fluoroquinolone%2520resistance%2520in%2520eight%2520species%2520of%2520Enterobacteriaceae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1998%26volume%3D42%26spage%3D2661%26epage%3D2667%26doi%3D10.1128%2FAAC.42.10.2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Champoux, J. J.</span></span> <span> </span><span class="NLM_article-title">DNA topoisomerases: structure, function, and mechanism</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.70.1.369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1146%2Fannurev.biochem.70.1.369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=11395412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=369-413&author=J.+J.+Champoux&title=DNA+topoisomerases%3A+structure%2C+function%2C+and+mechanism&doi=10.1146%2Fannurev.biochem.70.1.369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">DNA topoisomerases: structure, function, and mechanism</span></div><div class="casAuthors">Champoux, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369-413</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 196 refs.  DNA topoisomerases solve the topol. problems assocd. with DNA replication, transcription, recombination, and chromatin remodeling by introducing temporary single- or double-strand breaks in the DNA.  In addn., these enzymes fine-tune the steady-state level of DNA supercoiling both to facilitate protein interactions with the DNA and to prevent excessive supercoiling that is deleterious.  In recent years, the crystal structures of a no. of topoisomerase fragments, representing nearly all of the known classes of enzymes, have been solved.  These structures provide remarkable insights into the mechanisms of these enzymes and complement previous conclusions based on biochem. analyses.  Surprisingly, despite little or no sequence homol., both type IA and type IIA topoisomerases from prokaryotes and the type IIA enzymes from eukaryotes share structural folds that appear to reflect functional motifs within crit. regions of the enzymes.  The type IB enzymes are structurally distinct from all other known topoisomerases but are similar to a class of enzymes referred to as tyrosine recombinases.  The structural themes common to all topoisomerases include hinged clamps that open and close to bind DNA, the presence of DNA binding cavities for temporary storage of DNA segments, and the coupling of protein conformational changes to DNA rotation or DNA movement.  For the type II topoisomerases, the binding and hydrolysis of ATP further modulate conformational changes in the enzymes to effect changes in DNA topol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Y4rDyIYy17Vg90H21EOLACvtfcHk0ljmTa5eVytnWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7Y%253D&md5=67c3e38eb4fcb85527b33d7077309482</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.369%26sid%3Dliteratum%253Aachs%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26atitle%3DDNA%2520topoisomerases%253A%2520structure%252C%2520function%252C%2520and%2520mechanism%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D369%26epage%3D413%26doi%3D10.1146%2Fannurev.biochem.70.1.369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gubaev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klostermeier, D.</span></span> <span> </span><span class="NLM_article-title">DNA-induced narrowing of the gyrase N-gate coordinates T-segment capture and strand passage</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">14085</span>– <span class="NLM_lpage">14090</span>, <span class="refDoi"> DOI: 10.1073/pnas.1102100108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1073%2Fpnas.1102100108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=21817063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaqt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=14085-14090&author=A.+Gubaevauthor=D.+Klostermeier&title=DNA-induced+narrowing+of+the+gyrase+N-gate+coordinates+T-segment+capture+and+strand+passage&doi=10.1073%2Fpnas.1102100108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-induced narrowing of the gyrase N-gate coordinates T-segment capture and strand passage</span></div><div class="casAuthors">Gubaev, Airat; Klostermeier, Dagmar</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">14085-14090, S14085/1-S14085/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">DNA gyrase introduces neg. supercoils into DNA in an ATP-dependent reaction.  DNA supercoiling is catalyzed by a strand-passage mechanism, in which a T-segment of DNA is passed through the gap in a transiently cleaved G-segment.  Strand passage requires the coordinated closing and opening of three protein interfaces in gyrase, the N-gate, DNA-gate, and C-gate.  We show here that DNA binding to the DNA-gate of gyrase and wrapping of DNA around the C-terminal domains of GyrA induces a narrowing of the N-gate.  This half-closed state preps. capture of a T-segment in the upper cavity of gyrase.  Subsequent N-gate closure upon binding of ATP then poises the reaction toward strand passage.  The N-gate reopens after ATP hydrolysis, allowing for further catalytic cycles.  DNA binding, cleavage, and wrapping and N-gate narrowing are intimately linked events that coordinate conformational changes at the DNA and the N-gate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKZU3hAJIptLVg90H21EOLACvtfcHk0ljmTa5eVytnWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaqt7zE&md5=f3138f3fba25e936b38004570e0ffd4d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1102100108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1102100108%26sid%3Dliteratum%253Aachs%26aulast%3DGubaev%26aufirst%3DA.%26aulast%3DKlostermeier%26aufirst%3DD.%26atitle%3DDNA-induced%2520narrowing%2520of%2520the%2520gyrase%2520N-gate%2520coordinates%2520T-segment%2520capture%2520and%2520strand%2520passage%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D14085%26epage%3D14090%26doi%3D10.1073%2Fpnas.1102100108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blondeau, J. M.</span></span> <span> </span><span class="NLM_article-title">Fluoroquinolones: mechanism of action, classification, and development of resistance</span>. <i>Surv. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">S73</span>– <span class="NLM_lpage">S78</span>, <span class="refDoi"> DOI: 10.1016/j.survophthal.2004.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.survophthal.2004.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=15028482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADC%252BD2c7js1GisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2004&pages=S73-S78&author=J.+M.+Blondeau&title=Fluoroquinolones%3A+mechanism+of+action%2C+classification%2C+and+development+of+resistance&doi=10.1016%2Fj.survophthal.2004.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Fluoroquinolones: mechanism of action, classification, and development of resistance</span></div><div class="casAuthors">Blondeau Joseph M</div><div class="citationInfo"><span class="NLM_cas:title">Survey of ophthalmology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">49 Suppl 2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S73-8</span>
        ISSN:<span class="NLM_cas:issn">0039-6257</span>.
    </div><div class="casAbstract">The fluoroquinolones represent an evolving class of broad-spectrum antimicrobial agents used in the prevention and treatment of a variety of ocular infections; however, resistance to currently available agents in the class has been emerging among ocular pathogens.  This article reviews the mechanism of action of existing and new fluoroquinolones and discusses the structure-activity relationship of the fluoroquinolones as it relates to the classification of these compounds.  This article also highlights the mechanism of resistance among common ocular pathogens and discusses the potential need for newer fluoroquinolones in ophthalmology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3U35K4VKFarmQt-ICR3qNfW6udTcc2eaKcQBW_X1-fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7js1GisQ%253D%253D&md5=a6dcc56d7c0864f9f74cdd32913caa72</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.survophthal.2004.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.survophthal.2004.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DBlondeau%26aufirst%3DJ.%2BM.%26atitle%3DFluoroquinolones%253A%2520mechanism%2520of%2520action%252C%2520classification%252C%2520and%2520development%2520of%2520resistance%26jtitle%3DSurv.%2520Ophthalmol.%26date%3D2004%26volume%3D49%26spage%3DS73%26epage%3DS78%26doi%3D10.1016%2Fj.survophthal.2004.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haemers, A.</span></span> <span> </span><span class="NLM_article-title">Quinolone antimicrobial agents: structure-activity relationships</span>. <i>Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1803382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADyaK38XnvF2lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1991&pages=687-700&author=M.+Q.+Zhangauthor=A.+Haemers&title=Quinolone+antimicrobial+agents%3A+structure-activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolone antimicrobial agents:  structure-activity relationships</span></div><div class="casAuthors">Zhang, Ming Qiang; Haemers, A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmazie</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">687-700</span>CODEN:
                <span class="NLM_cas:coden">PHARAT</span>;
        ISSN:<span class="NLM_cas:issn">0031-7144</span>.
    </div><div class="casAbstract">A review with 102 refs.  Topics include: substitution at positions 1 and 2, modification of the 3-carboxylic and 4-oxo groups, substitution at the positions of ring B other than C-7, and substitution at position 7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa8c8ircURpLVg90H21EOLACvtfcHk0ljmo_fVrVeRbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XnvF2lsQ%253D%253D&md5=2b7e9fec83abd845f57e80c51c907747</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BQ.%26aulast%3DHaemers%26aufirst%3DA.%26atitle%3DQuinolone%2520antimicrobial%2520agents%253A%2520structure-activity%2520relationships%26jtitle%3DPharmazie%26date%3D1991%26volume%3D46%26spage%3D687%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L. S.</span></span> <span> </span><span class="NLM_article-title">4-Quinolone derivatives and their activities against Gram positive pathogens</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.11.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ejmech.2017.11.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29220792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFejt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=710-723&author=G.+F.+Zhangauthor=S.+Zhangauthor=B.+Panauthor=X.+Liuauthor=L.+S.+Feng&title=4-Quinolone+derivatives+and+their+activities+against+Gram+positive+pathogens&doi=10.1016%2Fj.ejmech.2017.11.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">4-Quinolone derivatives and their activities against Gram positive pathogens</span></div><div class="casAuthors">Zhang, Gui-Fu; Zhang, Shu; Pan, Baofeng; Liu, Xiaofeng; Feng, Lian-Shun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">710-723</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Gram-pos. bacteria are responsible for a broad range of infectious diseases, and the emergency and wide spread of drug-resistant Gram-pos. pathogens including MRSA and MRSE has caused great concern throughout the world. 4-Quinolones which are exemplified by fluoroquinolones are mainstays of chemotherapy against various bacterial infections including Gram-pos. pathogen infections, and their value and role in the treatment of bacterial infections continues to expand.  However, the resistance of Gram-pos. organisms to 4-quinolones develops rapidly and spreads widely, making them more and more ineffective.  To overcome the resistance and reduce the toxicity, numerous of 4-quinolone derivs. were synthesized and screened for their in vitro and in vivo activities against Gram-pos. pathogens, and some of them exhibited excellent potency.  This review aims to outlines the recent advances made towards the discovery of 4-quinolone-based derivs. as anti-Gram-pos. pathogens agents and the crit. aspects of design as well as the structure-activity relation of these derivs.  The enriched SAR paves the way to the further rational development of 4-quinolones with a unique mechanism of action different from that of the currently used drugs to overcome the resistance, well-tolerated and low toxic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_0SCAjPkYbVg90H21EOLACvtfcHk0ljmo_fVrVeRbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFejt7nO&md5=2e034ddd0049c24c91b9f4237091de99</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.11.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.11.082%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%2BF.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DL.%2BS.%26atitle%3D4-Quinolone%2520derivatives%2520and%2520their%2520activities%2520against%2520Gram%2520positive%2520pathogens%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D710%26epage%3D723%26doi%3D10.1016%2Fj.ejmech.2017.11.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varshney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, N.</span></span> <span> </span><span class="NLM_article-title">Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation</span>. <i>BMC cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">581</span>, <span class="refDoi"> DOI: 10.1186/s12885-015-1560-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1186%2Fs12885-015-1560-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=26260159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADC%252BC287hvVSnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=581&author=V.+Yadavauthor=P.+Varshneyauthor=S.+Sultanaauthor=J.+Yadavauthor=N.+Saini&title=Moxifloxacin+and+ciprofloxacin+induces+S-phase+arrest+and+augments+apoptotic+effects+of+cisplatin+in+human+pancreatic+cancer+cells+via+ERK+activation&doi=10.1186%2Fs12885-015-1560-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation</span></div><div class="casAuthors">Yadav Vikas; Varshney Pallavi; Yadav Jyoti; Saini Neeru; Yadav Vikas; Sultana Sarwat</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">581</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Pancreatic cancer, one of the most dreadful gastrointestinal tract malignancies, with the current chemotherapeutic drugs has posed a major impediment owing to poor prognosis and chemo-resistance thereby suggesting critical need for additional drugs as therapeutics in combating the situation.  Fluoroquinolones have shown promising and significant anti-tumor effects on several carcinoma cell lines.  METHODS:  Previously, we reported growth inhibitory effects of fourth generation fluoroquinolone Gatifloxacin, while in the current study we have investigated the anti-proliferative and apoptosis-inducing mechanism of older generation fluoroquinolones Moxifloxacin and Ciprofloxacin on the pancreatic cancer cell-lines MIA PaCa-2 and Panc-1.  Cytotoxicity was measured by MTT assay.  Apoptosis induction was evaluated using annexin assay, cell cycle assay and activation of caspase-3, 8, 9 were measured by western blotting and enzyme activity assay.  RESULTS:  Herein, we found that both the fluoroquinolones suppressed the proliferation of pancreatic cancer cells by causing S-phase arrest and apoptosis.  Blockade in S-phase of cell cycle was associated with decrease in the levels of p27, p21, CDK2, cyclin-A and cyclin-E.  Herein we also observed triggering of extrinsic as well as intrinsic mitochondrial apoptotic pathway as suggested by the activation of caspase-8, 9, 3, and Bid respectively.  All this was accompanied by downregulation of antiapoptotic protein Bcl-xL and upregulation of proapoptotic protein Bak.  Our results strongly suggest the role of extracellular-signal-regulated kinases (ERK1/2), but not p53, p38 and c-JUN N-terminal kinase (JNK) in fluoroquinolone induced growth inhibitory effects in both the cell lines.  Additionally, we also found both the fluoroquinolones to augment the apoptotic effects of broad spectrum anticancer drug Cisplatin via ERK.  CONCLUSION:  The fact that these fluoroquinolones synergize the effect of cisplatin opens new insight into therapeutic index in treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR24ymZPiYCy1m8bhe6roZYfW6udTcc2eZp1q78H70dNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287hvVSnug%253D%253D&md5=4cd8a5188e5924c3e78a909080a90454</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1560-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1560-y%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DV.%26aulast%3DVarshney%26aufirst%3DP.%26aulast%3DSultana%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DJ.%26aulast%3DSaini%26aufirst%3DN.%26atitle%3DMoxifloxacin%2520and%2520ciprofloxacin%2520induces%2520S-phase%2520arrest%2520and%2520augments%2520apoptotic%2520effects%2520of%2520cisplatin%2520in%2520human%2520pancreatic%2520cancer%2520cells%2520via%2520ERK%2520activation%26jtitle%3DBMC%2520cancer%26date%3D2015%26volume%3D15%26spage%3D581%26doi%3D10.1186%2Fs12885-015-1560-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herold, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganslmayer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerauer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuppan, D.</span></span> <span> </span><span class="NLM_article-title">Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6600079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1038%2Fsj.bjc.6600079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=11875713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD38XisFOls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=443-448&author=C.+Heroldauthor=M.+Ockerauthor=M.+Ganslmayerauthor=H.+Gerauerauthor=E.+G.+Hahnauthor=D.+Schuppan&title=Ciprofloxacin+induces+apoptosis+and+inhibits+proliferation+of+human+colorectal+carcinoma+cells&doi=10.1038%2Fsj.bjc.6600079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells</span></div><div class="casAuthors">Herold, C.; Ocker, M.; Ganslmayer, M.; Gerauer, H.; Hahn, E. G.; Schuppan, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-448</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Efficacy of chemotherapy in advanced stages of colorectal tumors is limited.  The quinolone antibiotic ciprofloxacin was recently shown to inhibit growth and to induce apoptosis in human bladder carcinomas cells.  The authors investigated the effect of ciprofloxacin on colon carcinoma lines in vitro.  CC-531, SW-403 and HT-29 colon carcinoma and HepG2 hepatoma cells (control cells) were exposed to ciprofloxacin.  Proliferation was assessed by bromodeoxyuridine-incorporation into DNA and apoptosis was measured by flow cytometry after propidium iodide or JC-1 staining.  Expression of anti-apoptotic Bcl-2 and pro-apoptotic Bax was analyzed by semiquant. Western blot anal. and activity of caspases 3, 8 and 9 by substrate-cleavage assays.  Ciprofloxacin suppressed DNA synthesis of all colon carcinoma cells time- and dose-dependently, whereas the hepatoma cells remained unaffected.  Apoptosis reached its max. between 200 and 500 μg ml-1.  This was accompanied by an upregulation of Bax and of the activity of caspases 3, 8 and 9, and paralleled by a decrease of the mitochondrial membrane potential.  Ciprofloxacin decreases proliferation and induces apoptosis of colon carcinoma cells, possibly in part by blocking mitochondrial DNA synthesis.  Therefore, qualification of ciprofloxacin as adjunctive agent for colorectal cancer should be evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89M8dpMfTsbVg90H21EOLACvtfcHk0lhFkdWEkib22Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisFOls7g%253D&md5=efedae539d59a9ab6ff8ccd811a3e643</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6600079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6600079%26sid%3Dliteratum%253Aachs%26aulast%3DHerold%26aufirst%3DC.%26aulast%3DOcker%26aufirst%3DM.%26aulast%3DGanslmayer%26aufirst%3DM.%26aulast%3DGerauer%26aufirst%3DH.%26aulast%3DHahn%26aufirst%3DE.%2BG.%26aulast%3DSchuppan%26aufirst%3DD.%26atitle%3DCiprofloxacin%2520induces%2520apoptosis%2520and%2520inhibits%2520proliferation%2520of%2520human%2520colorectal%2520carcinoma%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2002%26volume%3D86%26spage%3D443%26epage%3D448%26doi%3D10.1038%2Fsj.bjc.6600079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bisacchi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, M. R.</span></span> <span> </span><span class="NLM_article-title">A ″Double-edged″ scaffold: antitumor power within the antibacterial quinolone</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.2174/0929867323666151223095839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.2174%2F0929867323666151223095839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=26695512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=520-577&author=G.+S.+Bisacchiauthor=M.+R.+Hale&title=A+%E2%80%B3Double-edged%E2%80%B3+scaffold%3A+antitumor+power+within+the+antibacterial+quinolone&doi=10.2174%2F0929867323666151223095839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone</span></div><div class="casAuthors">Bisacchi, Gregory S.; Hale, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">520-577</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In the late 1980s, reports emerged describing exptl. antibacterial quinolones having significant potency against eukaryotic Type II topoisomerases (topo II) and showing cytotoxic activity against tumor cell lines.  As a result, several pharmaceutical companies initiated quinolone anticancer programs to explore the potential of this class in comparison to conventional human topo II inhibiting antitumor drugs such as doxorubicin and etoposide.  In this review, we present a modern re-evaluation of the anticancer potential of the quinolone class in the context of today's predominantly pathway-based (rather than cytotoxicity-based) oncol. drug R&D environment.  The quinolone eukaryotic SAR is comprehensively discussed, contrasted with the corresponding prokaryotic data, and merged with recent structural biol. information which is now beginning to help explain the basis for that SAR.  Quinolone topo II inhibitors appear to be much less susceptible to efflux-mediated resistance, a current limitation of therapy with conventional agents.  Recent advances in the biol. understanding of human topo II isoforms suggest that significant progress might now be made in overcoming two other treatment-limiting disadvantages of conventional topo II inhibitors, namely cardiotoxicity and drug-induced secondary leukemias.  We propose that quinolone class topo II inhibitors could have a useful future therapeutic role due to the continued need for effective topo II drugs in many cancer treatment settings, and due to the recent biol. and structural advances which can now provide, for the first time, specific guidance for the design of a new class of inhibitors potentially superior to existing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoudxhdr0QJNbVg90H21EOLACvtfcHk0lh98iOQKYKm1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCktr0%253D&md5=d1b12021b59ac40ede71c7fdae0ad625</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F0929867323666151223095839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666151223095839%26sid%3Dliteratum%253Aachs%26aulast%3DBisacchi%26aufirst%3DG.%2BS.%26aulast%3DHale%26aufirst%3DM.%2BR.%26atitle%3DA%2520%25E2%2580%25B3Double-edged%25E2%2580%25B3%2520scaffold%253A%2520antitumor%2520power%2520within%2520the%2520antibacterial%2520quinolone%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D520%26epage%3D577%26doi%3D10.2174%2F0929867323666151223095839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aal, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aziz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaykoon, M. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuo-Rahma, G. E.-D. A.</span></span> <span> </span><span class="NLM_article-title">Towards anticancer fluoroquinolones: A review article</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1800376</span>, <span class="refDoi"> DOI: 10.1002/ardp.201800376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fardp.201800376" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2019&pages=1800376&author=M.+A.+A.+Abdel-Aalauthor=S.+A.+Abdel-Azizauthor=M.+S.+A.+Shaykoonauthor=G.+E.-D.+A.+Abuo-Rahma&title=Towards+anticancer+fluoroquinolones%3A+A+review+article&doi=10.1002%2Fardp.201800376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fardp.201800376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201800376%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Aal%26aufirst%3DM.%2BA.%2BA.%26aulast%3DAbdel-Aziz%26aufirst%3DS.%2BA.%26aulast%3DShaykoon%26aufirst%3DM.%2BS.%2BA.%26aulast%3DAbuo-Rahma%26aufirst%3DG.%2BE.-D.%2BA.%26atitle%3DTowards%2520anticancer%2520fluoroquinolones%253A%2520A%2520review%2520article%26jtitle%3DArch.%2520Pharm.%26date%3D2019%26volume%3D352%26spage%3D1800376%26doi%3D10.1002%2Fardp.201800376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sissi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, M.</span></span> <span> </span><span class="NLM_article-title">The quinolone family: from antibacterial to anticancer agents</span>. <i>Curr. Med. Chem.: Anti-Cancer Agents</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.2174/1568011033482279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.2174%2F1568011033482279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=14529452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFOns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=439-450&author=C.+Sissiauthor=M.+Palumbo&title=The+quinolone+family%3A+from+antibacterial+to+anticancer+agents&doi=10.2174%2F1568011033482279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The quinolone family: From antibacterial to anticancer agents</span></div><div class="casAuthors">Sissi, Claudia; Palumbo, Manlio</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">439-450</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review focuses on the structural modifications responsible for the transformation of an antibacterial into an anticancer agent.  Indeed, a distinctive feature of drugs based on the quinolone structure is their remarkable ability to target different type II topoisomerase enzymes.  In particular, some congeners of this drug family display high activity not only against bacterial topoisomerases, but also against eukaryotic topoisomerases and are toxic to cultured mammalian cells and in vivo tumor models.  Hence, these cytotoxic quinolones represent an exploitable source of new anticancer agents, which might also help addressing side-toxicity and resistance phenomena.  Their ability to bind metal ion co-factors represents an addnl. means of modulating their pharmacol. response(s).  Moreover, quinolones link antibacterial and anticancer chemotherapy together and provide an opportunity to clarify drug mechanism across divergent species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp52bib_wURurVg90H21EOLACvtfcHk0lh98iOQKYKm1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFOns7k%253D&md5=f032383de40223659143e2519371c5c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1568011033482279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011033482279%26sid%3Dliteratum%253Aachs%26aulast%3DSissi%26aufirst%3DC.%26aulast%3DPalumbo%26aufirst%3DM.%26atitle%3DThe%2520quinolone%2520family%253A%2520from%2520antibacterial%2520to%2520anticancer%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2003%26volume%3D3%26spage%3D439%26epage%3D450%26doi%3D10.2174%2F1568011033482279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawtin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockett, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byl, J. A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. A.</span></span> <span> </span><span class="NLM_article-title">Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e10186</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0010186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1371%2Fjournal.pone.0010186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=20419121" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=R.+E.+Hawtinauthor=D.+E.+Stockettauthor=J.+A.+W.+Bylauthor=R.+S.+McDowellauthor=N.+Tanauthor=M.+R.+Arkinauthor=A.+Conroyauthor=W.+Yangauthor=N.+Osheroffauthor=J.+A.+Fox&title=Voreloxin+is+an+anticancer+quinolone+derivative+that+intercalates+DNA+and+poisons+topoisomerase+II&doi=10.1371%2Fjournal.pone.0010186"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0010186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0010186%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DR.%2BE.%26aulast%3DStockett%26aufirst%3DD.%2BE.%26aulast%3DByl%26aufirst%3DJ.%2BA.%2BW.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DTan%26aufirst%3DN.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DConroy%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DOsheroff%26aufirst%3DN.%26aulast%3DFox%26aufirst%3DJ.%2BA.%26atitle%3DVoreloxin%2520is%2520an%2520anticancer%2520quinolone%2520derivative%2520that%2520intercalates%2520DNA%2520and%2520poisons%2520topoisomerase%2520II%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0010186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancet, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbour, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigneux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horst, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Récher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimek, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carella, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egyed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantarjian, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, R. K.</span></span> <span> </span><span class="NLM_article-title">Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">e514</span>– <span class="NLM_lpage">e518</span>, <span class="refDoi"> DOI: 10.3324/haematol.2018.191361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3324%2Fhaematol.2018.191361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29794146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFyrtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2018&pages=e514-e518&author=F.+Ravandiauthor=E.+K.+Ritchieauthor=H.+Sayarauthor=J.+E.+Lancetauthor=M.+D.+Craigauthor=N.+Veyauthor=S.+A.+Stricklandauthor=G.+J.+Schillerauthor=E.+Jabbourauthor=A.+Pigneuxauthor=H.+A.+Horstauthor=C.+R%C3%A9cherauthor=V.+M.+Klimekauthor=J.+E.+Cortesauthor=A.+M.+Carellaauthor=M.+Egyedauthor=U.+Krugauthor=J.+A.+Foxauthor=A.+R.+Craigauthor=R.+Wardauthor=J.+A.+Smithauthor=G.+Actonauthor=H.+M.+Kantarjianauthor=R.+K.+Stuart&title=Phase+3+results+for+vosaroxin%2Fcytarabine+in+the+subset+of+patients+%E2%89%A560+years+old+with+refractory%2Fearly+relapsed+acute+myeloid+leukemia&doi=10.3324%2Fhaematol.2018.191361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia</span></div><div class="casAuthors">Ravandi, Farhad; Ritchie, Ellen K.; Sayar, Hamid; Lancet, Jeffrey E.; Craig, Michael D.; Vey, Norbert; Strickland, Stephen A.; Schiller, Gary J.; Jabbour, Elias; Pigneux, Arnaud; Horst, Heinz-August; Recher, Christian; Klimek, Virginia M.; Cortes, Jorge E.; Carella, Angelo-Michele; Egyed, Miklos; Krug, Utz; Fox, Judith A.; Craig, Adam R.; Ward, Renee; Smith, Jennifer A.; Acton, Gary; Kantarjian, Hagop M.; Stuart, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e514</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">1592-8721</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">A review discussing vosaroxin/cytarabine in the subset of old patients with refractory/early relapsed acute myeloid leukemia.  Hese results prompted further analyses in patient sub- groups as defined by age and disease status.  60 Years old with Ref/eRel AML that merits confirmation with a randomized clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa2UwKiADlLrVg90H21EOLACvtfcHk0lhH6lBP3dbLLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFyrtL%252FK&md5=338c819c54512ed4a0fd3edccabfacbd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2018.191361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2018.191361%26sid%3Dliteratum%253Aachs%26aulast%3DRavandi%26aufirst%3DF.%26aulast%3DRitchie%26aufirst%3DE.%2BK.%26aulast%3DSayar%26aufirst%3DH.%26aulast%3DLancet%26aufirst%3DJ.%2BE.%26aulast%3DCraig%26aufirst%3DM.%2BD.%26aulast%3DVey%26aufirst%3DN.%26aulast%3DStrickland%26aufirst%3DS.%2BA.%26aulast%3DSchiller%26aufirst%3DG.%2BJ.%26aulast%3DJabbour%26aufirst%3DE.%26aulast%3DPigneux%26aufirst%3DA.%26aulast%3DHorst%26aufirst%3DH.%2BA.%26aulast%3DR%25C3%25A9cher%26aufirst%3DC.%26aulast%3DKlimek%26aufirst%3DV.%2BM.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26aulast%3DCarella%26aufirst%3DA.%2BM.%26aulast%3DEgyed%26aufirst%3DM.%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DFox%26aufirst%3DJ.%2BA.%26aulast%3DCraig%26aufirst%3DA.%2BR.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DActon%26aufirst%3DG.%26aulast%3DKantarjian%26aufirst%3DH.%2BM.%26aulast%3DStuart%26aufirst%3DR.%2BK.%26atitle%3DPhase%25203%2520results%2520for%2520vosaroxin%252Fcytarabine%2520in%2520the%2520subset%2520of%2520patients%2520%25E2%2589%25A560%2520years%2520old%2520with%2520refractory%252Fearly%2520relapsed%2520acute%2520myeloid%2520leukemia%26jtitle%3DHaematologica%26date%3D2018%26volume%3D103%26spage%3De514%26epage%3De518%26doi%3D10.3324%2Fhaematol.2018.191361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittalà, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistarà, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardile, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziano, A. C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraix, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sortino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span> <span> </span><span class="NLM_article-title">Novel sigma receptor ligand-nitric oxide photodonors: molecular hybrids for double-targeted antiproliferative effect</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9531</span>– <span class="NLM_lpage">9544</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00791</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00791" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOitrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9531-9544&author=E.+Amataauthor=M.+Dichiaraauthor=E.+Arenaauthor=V.+Pittal%C3%A0author=V.+Pistar%C3%A0author=V.+Cardileauthor=A.+C.+E.+Grazianoauthor=A.+Fraixauthor=A.+Marrazzoauthor=S.+Sortinoauthor=O.+Prezzavento&title=Novel+sigma+receptor+ligand-nitric+oxide+photodonors%3A+molecular+hybrids+for+double-targeted+antiproliferative+effect&doi=10.1021%2Facs.jmedchem.7b00791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect</span></div><div class="casAuthors">Amata, Emanuele; Dichiara, Maria; Arena, Emanuela; Pittala, Valeria; Pistara, Venerando; Cardile, Venera; Graziano, Adriana Carol Eleonora; Fraix, Aurore; Marrazzo, Agostino; Sortino, Salvatore; Prezzavento, Orazio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9531-9544</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This contribution reports the synthesis and evaluation of novel hybrid compds. that conjugate a sigma (σ) receptor pharmacophore and a nitric oxide (NO) photodonor.  All compds. preserve their capability to generate NO under visible light and possess overall σ receptor nanomolar affinity, with one of them (8b) exhibiting remarkable σ2 receptor selectivity.  Compds. 8b, 11a, and 11b were tested on tumorigenic MCF-7 and A2058 cells expressing high levels of σ2 and σ1 receptor, resp.  Considerable loss of cell viability was detected under light excitation, while negligible effects in the dark were detected.  Moreover, they did not show any significant cytotoxicity in the dark or under irradn. on nontumorigenic NCTC-2544 keratinocytes.  NO-induced redn. of cellular viability was demonstrated by in-cell NO detection and total nitrite estn.  For the first time, a combination of σ receptor moieties and a NO photodonor is reported, providing distinctive ligands potentially useful for cancer management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2xXCAIFqTR7Vg90H21EOLACvtfcHk0lgwRnNa5onnIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOitrvL&md5=a2fae378332770556c38d230d2952295</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00791%26sid%3Dliteratum%253Aachs%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DArena%26aufirst%3DE.%26aulast%3DPittal%25C3%25A0%26aufirst%3DV.%26aulast%3DPistar%25C3%25A0%26aufirst%3DV.%26aulast%3DCardile%26aufirst%3DV.%26aulast%3DGraziano%26aufirst%3DA.%2BC.%2BE.%26aulast%3DFraix%26aufirst%3DA.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DSortino%26aufirst%3DS.%26aulast%3DPrezzavento%26aufirst%3DO.%26atitle%3DNovel%2520sigma%2520receptor%2520ligand-nitric%2520oxide%2520photodonors%253A%2520molecular%2520hybrids%2520for%2520double-targeted%2520antiproliferative%2520effect%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9531%26epage%3D9544%26doi%3D10.1021%2Facs.jmedchem.7b00791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnaturi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Mantia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasello, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acquaviva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Giacomo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span> <span> </span><span class="NLM_article-title">Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: synthesis, in silico, and biological evaluation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">889</span>– <span class="NLM_lpage">894</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00661</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00661" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmvV2qt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=889-894&author=E.+Amataauthor=M.+Dichiaraauthor=D.+Gentileauthor=A.+Marrazzoauthor=R.+Turnaturiauthor=E.+Arenaauthor=A.+La+Mantiaauthor=B.+R.+Tomaselloauthor=R.+Acquavivaauthor=C.+Di+Giacomoauthor=A.+Rescifinaauthor=O.+Prezzavento&title=Sigma+receptor+ligands+carrying+a+nitric+oxide+donor+nitrate+moiety%3A+synthesis%2C+in+silico%2C+and+biological+evaluation&doi=10.1021%2Facsmedchemlett.9b00661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation</span></div><div class="casAuthors">Amata, Emanuele; Dichiara, Maria; Gentile, Davide; Marrazzo, Agostino; Turnaturi, Rita; Arena, Emanuela; La Mantia, Alfonsina; Tomasello, Barbara Rita; Acquaviva, Rosaria; Di Giacomo, Claudia; Rescifina, Antonio; Prezzavento, Orazio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">889-894</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the development of mol. hybrids in which a nitrate group serving as nitric oxide (NO) donor is covalently joined to σ receptor ligands to give candidates for double-targeted cancer therapy.  The compds. have been evaluated in radioligand binding assay at both σ receptors and selected compds. tested for NO release.  Compds. 9, 15, 18, 19, and 21 were subjected to MTT test.  Compd. 15 produced a significant redn. of MCF-7 and Caco-2 cellular viability with comparable IC50 as doxorubicin, being also not toxic for fibroblast HFF-1 cells.  Compd. 15 has shown a σ1 receptor antagonist/σ2 receptor agonist profile.  Two derivs. of compd. 15 lacking the nitrate group did not induce a redn. of MCF-7 cellular viability, suggesting a potential synergistic effect between the σ receptors and the NO-mediated events.  Overall, the combination of NO donor and σ receptors ligands provided compds. with beneficial effects for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxBfdn3ngPoLVg90H21EOLACvtfcHk0lgwRnNa5onnIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmvV2qt70%253D&md5=2288c983e4641fadd126ef96f7a446da</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00661%26sid%3Dliteratum%253Aachs%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DTurnaturi%26aufirst%3DR.%26aulast%3DArena%26aufirst%3DE.%26aulast%3DLa%2BMantia%26aufirst%3DA.%26aulast%3DTomasello%26aufirst%3DB.%2BR.%26aulast%3DAcquaviva%26aufirst%3DR.%26aulast%3DDi%2BGiacomo%26aufirst%3DC.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DPrezzavento%26aufirst%3DO.%26atitle%3DSigma%2520receptor%2520ligands%2520carrying%2520a%2520nitric%2520oxide%2520donor%2520nitrate%2520moiety%253A%2520synthesis%252C%2520in%2520silico%252C%2520and%2520biological%2520evaluation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D889%26epage%3D894%26doi%3D10.1021%2Facsmedchemlett.9b00661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Giacomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Valerio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciatore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cataldi, A.</span></span> <span> </span><span class="NLM_article-title">MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells</span>. <i>Cell. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=26068914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADC%252BC2MbjtV2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=17-23&author=V.+Di%0AGiacomoauthor=V.+Di+Valerioauthor=M.+Rapinoauthor=D.+Boscoauthor=I.+Cacciatoreauthor=M.+Ciullaauthor=A.+Marrazzoauthor=J.+Fioritoauthor=A.+Di+Stefanoauthor=A.+Cataldi&title=MRJF4%2C+a+novel+histone+deacetylase+inhibitor%2C+induces+p21+mediated+autophagy+in+PC3+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells</span></div><div class="casAuthors">Di Giacomo V; Ciulla M; Di Stefano A; Cataldi A; Di Valerio V; Rapino M; Bosco D; Cacciatore I; Marrazzo A; Fiorito J</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and molecular biology (Noisy-le-Grand, France)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">17-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autophagy is a cellular defense mechanism which occurs through degradation and recycling of cytoplasmic constituents and represents a caspase&mdash;independent alternative to cell death by apoptosis.  It is generally accepted that the suppression of autophagy in many cancer cells is directly correlated to malignancy; hence, the control of autophagy genes could represent a target for cancer therapy.  The inhibition of cell proliferation through autophagy activation could be an important mechanism for many anti&mdash;tumor drugs.  Here we report the effects of a novel histone deacetylase inhibitor MRJF4 (racemic mixture) and of its two enantiomers [(+)&mdash;MRJF4 and (&mdash;)&mdash;MRJF4] on the morphological and molecular mechanisms causing death and migration of PC3 prostatic cancer cells.  In particular, we investigated the occurrence of the autophagic process, both at morphological and molecular levels (LC3 expression), and its relationship with p21, a key molecule which regulates cell cycle and autophagy cell death.  Moreover, pERK/Nf&mdash;kB driven intracellular signaling, the expression of MMP9 protein &mdash; a key component of cell migration &mdash; invasion, and metastasis were assayed.  Our results showed that the anti&mdash;proliferative effects of MRJF4 due to autophagy occurrence, documented by LC3 increase and ultrastructural modifications, and the reduction of invasiveness seem to be mediated by the down&mdash;regulation of pERK/NF&mdash;kB signaling pathway, along with p21 up&mdash;regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoYKhEO3wZnHwOGIfWJ7-GfW6udTcc2ebfkEUBgnqaoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbjtV2mtw%253D%253D&md5=b9e0e06dd53194b5159436a53f863a29</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiacomo%26aufirst%3DV.%26aulast%3DDi%2BValerio%26aufirst%3DV.%26aulast%3DRapino%26aufirst%3DM.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DCacciatore%26aufirst%3DI.%26aulast%3DCiulla%26aufirst%3DM.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DDi%2BStefano%26aufirst%3DA.%26aulast%3DCataldi%26aufirst%3DA.%26atitle%3DMRJF4%252C%2520a%2520novel%2520histone%2520deacetylase%2520inhibitor%252C%2520induces%2520p21%2520mediated%2520autophagy%2520in%2520PC3%2520prostate%2520cancer%2520cells%26jtitle%3DCell.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D61%26spage%3D17%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olivieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinciguerra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giurdanella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporarello, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anfuso, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span> <span> </span><span class="NLM_article-title">Antiangiogenic effect of (±)-haloperidol metabolite II valproate ester [(±)-MRJF22] in human microvascular retinal endothelial cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9960</span>– <span class="NLM_lpage">9966</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yks77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9960-9966&author=M.+Olivieriauthor=E.+Amataauthor=S.+Vinciguerraauthor=J.+Fioritoauthor=G.+Giurdanellaauthor=F.+Dragoauthor=N.+Caporarelloauthor=O.+Prezzaventoauthor=E.+Arenaauthor=L.+Salernoauthor=A.+Rescifinaauthor=G.+Lupoauthor=C.+D.+Anfusoauthor=A.+Marrazzo&title=Antiangiogenic+effect+of+%28%C2%B1%29-haloperidol+metabolite+II+valproate+ester+%5B%28%C2%B1%29-MRJF22%5D+in+human+microvascular+retinal+endothelial+cells&doi=10.1021%2Facs.jmedchem.6b01039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells</span></div><div class="casAuthors">Olivieri, Melania; Amata, Emanuele; Vinciguerra, Shila; Fiorito, Jole; Giurdanella, Giovanni; Drago, Filippo; Caporarello, Nunzia; Prezzavento, Orazio; Arena, Emanuela; Salerno, Loredana; Rescifina, Antonio; Lupo, Gabriella; Anfuso, Carmelina Daniela; Marrazzo, Agostino</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9960-9966</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(±)-MRJF22 [(±)-2], a novel prodrug of haloperidol metabolite II (sigma-1 receptor antagonist/sigma-2 receptor agonist ligand) obtained by conjugation to valproic acid (histone deacetylase inhibitor) via an ester bond, exhibits antiangiogenic activity, being able to reduce human retinal endothelial cell (HREC) viability in a comparable manner to bevacizumab.  Moreover, (±)-2 was able to significantly reduce viable cells count, endothelial cell migration, and tube formation in vascular endothelial growth factor A (VEGF-A) stimulated HREC cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJedDLZWd8jbVg90H21EOLACvtfcHk0ljdha2xk-Miaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yks77P&md5=f0a092eedd76c583f4dabaa7151774c4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01039%26sid%3Dliteratum%253Aachs%26aulast%3DOlivieri%26aufirst%3DM.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DVinciguerra%26aufirst%3DS.%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DGiurdanella%26aufirst%3DG.%26aulast%3DDrago%26aufirst%3DF.%26aulast%3DCaporarello%26aufirst%3DN.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DArena%26aufirst%3DE.%26aulast%3DSalerno%26aufirst%3DL.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DLupo%26aufirst%3DG.%26aulast%3DAnfuso%26aufirst%3DC.%2BD.%26aulast%3DMarrazzo%26aufirst%3DA.%26atitle%3DAntiangiogenic%2520effect%2520of%2520%2528%25C2%25B1%2529-haloperidol%2520metabolite%2520II%2520valproate%2520ester%2520%255B%2528%25C2%25B1%2529-MRJF22%255D%2520in%2520human%2520microvascular%2520retinal%2520endothelial%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9960%26epage%3D9966%26doi%3D10.1021%2Facs.jmedchem.6b01039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sozio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Giacomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciatore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cataldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turkez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parenti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span> <span> </span><span class="NLM_article-title">Haloperidol metabolite II prodrug: asymmetric synthesis and biological evaluation on rat C6 glioma cells</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ejmech.2014.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=25461306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyksbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2015&pages=1-9&author=P.+Sozioauthor=J.+Fioritoauthor=V.+Di+Giacomoauthor=A.+Di+Stefanoauthor=L.+Marinelliauthor=I.+Cacciatoreauthor=A.+Cataldiauthor=S.+Pacellaauthor=H.+Turkezauthor=C.+Parentiauthor=A.+Rescifinaauthor=A.+Marrazzo&title=Haloperidol+metabolite+II+prodrug%3A+asymmetric+synthesis+and+biological+evaluation+on+rat+C6+glioma+cells&doi=10.1016%2Fj.ejmech.2014.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Haloperidol metabolite II prodrug: Asymmetric synthesis and biological evaluation on rat C6 glioma cells</span></div><div class="casAuthors">Sozio, Piera; Fiorito, Jole; Di Giacomo, Viviana; Di Stefano, Antonio; Marinelli, Lisa; Cacciatore, Ivana; Cataldi, Amelia; Pacella, Stephanie; Turkez, Hasan; Parenti, Carmela; Rescifina, Antonio; Marrazzo, Agostino</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In a previous work the authors reported the antiproliferative effects of (±)-MRJF4, a novel haloperidol metabolite II (HP-mII) (a sigma-1 antagonist and sigma-2 agonist) prodrug, obtained through conjugation to 4-phenylbutyric acid (PhBA) [a histone deacetylase inhibitor (HDACi)] by an ester bond.  As a continuation of this work, here the authors report the asym. synthesis of compds. Benzenebutanoic acid 4-[(1R)-4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)butyl ester [(R)-(+)-MRJF4] and 4-[(1R)-4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)butyl ester [(S)-(-)-MRJF4] and the evaluation of their biol. activity on rat C6 glioma cells, derived from glioblastoma multiforme (GBM), which is the most common and deadliest central nervous system (CNS) invasive malignancy.  Favorable physicochem. properties, high permeability in the parallel artificial membrane permeability assay (PAMPA), good enzymic and chem. stability, in vivo anticancer activity, assocd. with the capacity to reduce cell viability and to increase cell death by apoptosis, render compd. (R)-(+)-MRJF4 a promising candidate for the development of a useful therapeutic for glioma therapy.  The synthesis of the target compds. was achieved by a reaction of (αS)-4-(4-chlorophenyl)-α-(4-fluorophenyl)-4-hydroxy-1-piperidienbutanol or (αR)-4-(4-chlorophenyl)-α-(4-fluorophenyl)-4-hydroxy-1-piperidienbutanol with benzenebutanoyl chloride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa48fSw9hC67Vg90H21EOLACvtfcHk0ljdha2xk-Miaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyksbvP&md5=cd126d3df0c611a02cf58320c7dd3fa0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DSozio%26aufirst%3DP.%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DDi%2BGiacomo%26aufirst%3DV.%26aulast%3DDi%2BStefano%26aufirst%3DA.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DCacciatore%26aufirst%3DI.%26aulast%3DCataldi%26aufirst%3DA.%26aulast%3DPacella%26aufirst%3DS.%26aulast%3DTurkez%26aufirst%3DH.%26aulast%3DParenti%26aufirst%3DC.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DMarrazzo%26aufirst%3DA.%26atitle%3DHaloperidol%2520metabolite%2520II%2520prodrug%253A%2520asymmetric%2520synthesis%2520and%2520biological%2520evaluation%2520on%2520rat%2520C6%2520glioma%2520cells%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D90%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.ejmech.2014.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonavida, B.</span></span> <span> </span><span class="NLM_article-title">Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">113913</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2020.113913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.bcp.2020.113913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=32173364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXls1Cmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2020&pages=113913&author=B.+Bonavida&title=Sensitizing+activities+of+nitric+oxide+donors+for+cancer+resistance+to+anticancer+therapeutic+drugs&doi=10.1016%2Fj.bcp.2020.113913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs</span></div><div class="casAuthors">Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113913</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cancer is not a single disease but it constitutes a large variety of different types that are also different from each other phenotypically and molecularly.  Although the std. treatments have resulted in clin. responses in a subset of patients, though, many patients relapse and no longer respond to further treatments.  Hence, both the innate and adaptive resistance to treatments are the main challenges in today's treatment strategies.  Noteworthy, several novel treatment strategies, particularly immunotherapies, used alone or in combination, have been developed and that have significantly improved the therapeutic response of many unresponsive cancer patients.  Nevertheless, even with the latest new developments of therapeutics that were effective in a larger subset of patients, there is still an urgent need to treat the remaining unresponsive subset of patients.  This requires the development of new targeting agents of superior antitumor activities that will lead to overcoming the unaffected resistance by current treatments.  There has been accumulating evidence suggesting nitric oxide donors as such targeting agents and considering their pleiotropic antitumor activities, including both the reversal of chemo and immuno-resistance of various unresponsive resistant cancers.  The in vitro and in vivo preclin. findings corroborate the sensitizing antitumor activities of nitric oxide donors.  In addn., a few clin. findings with NO donors that have been applied in patients have corroborated their antitumor and sensitizing activities in combination with std. therapies.  In this review, the role and underlying mechanisms by which nitric oxide donors sensitize cancer resistant cells to both chemotherapy and immunotherapy are briefly described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtTJZtSO_AU7Vg90H21EOLACvtfcHk0ljdha2xk-Miaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXls1Cmsbw%253D&md5=26ad629e0366dd9c659c069bc58d956e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2020.113913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2020.113913%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DSensitizing%2520activities%2520of%2520nitric%2520oxide%2520donors%2520for%2520cancer%2520resistance%2520to%2520anticancer%2520therapeutic%2520drugs%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2020%26volume%3D176%26spage%3D113913%26doi%3D10.1016%2Fj.bcp.2020.113913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hays, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonavida, B.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide-mediated enhancement and reversal of resistance of anticancer therapies</span>. <i>Antioxidants</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">407</span>, <span class="refDoi"> DOI: 10.3390/antiox8090407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fantiox8090407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVyqt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=407&author=E.+Haysauthor=B.+Bonavida&title=Nitric+oxide-mediated+enhancement+and+reversal+of+resistance+of+anticancer+therapies&doi=10.3390%2Fantiox8090407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide-mediated enhancement and reversal of resistance of anticancer therapies</span></div><div class="casAuthors">Hays, Emily; Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">407pp.</span>CODEN:
                <span class="NLM_cas:coden">ANTIGE</span>;
        ISSN:<span class="NLM_cas:issn">2076-3921</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Hence, there is a need to develop novel approaches to treat those anticancer therapy unresponsive patients.  Several investigations have been reported to explain the underlying mechanisms of immune resistance, including the anti-proliferative and anti-apoptotic pathways and, in addn., the increased expression of the transcription factor Yin-Yang 1 (YY1) and the programmed death ligand 1 (PD-L1).  Treatment with nitric oxide (NO) donors has been shown to sensitize many types of tumors to chemotherapy, immunotherapy, and radiotherapy.  Treatment of cancer cell lines with NO donors has resulted in the inhibition of cancer cell activities via, in part, the inhibition of YY1 and PD-L1.  The NO-mediated inhibition of YY1 was the result of both the inhibition of the upstream NF-κB pathway as well as the S-nitrosylation of YY1, leading to both the downregulation of YY1 expression as well as the inhibition of YY1-DNA binding activity, resp.  Also, treatment with NO donors induced the inhibition of YY1 and resulted in the inhibition of PD-L1 expression.  Based on the above findings, we propose that treatment of tumor cells with the combination of NO donors, at optimal noncytotoxic doses, and anti-tumor cytotoxic effector cells or other conventional therapies will result in a synergistic anticancer activity and tumor regression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod7Riu2bmBCrVg90H21EOLACvtfcHk0lgil8DMnSKfjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVyqt73E&md5=bc0ec2913cb52e7eda0d09ba1f6f109f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fantiox8090407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fantiox8090407%26sid%3Dliteratum%253Aachs%26aulast%3DHays%26aufirst%3DE.%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DNitric%2520oxide-mediated%2520enhancement%2520and%2520reversal%2520of%2520resistance%2520of%2520anticancer%2520therapies%26jtitle%3DAntioxidants%26date%3D2019%26volume%3D8%26spage%3D407%26doi%3D10.3390%2Fantiox8090407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, R. M. J.</span></span> <span> </span><span class="NLM_article-title">The l-arginine: nitric oxide pathway</span>. <i>Curr Opin Nephrol Hypertens.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1097/00041552-199301000-00018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1097%2F00041552-199301000-00018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=7522910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fgs1CmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1993&pages=122-128&author=R.+M.+J.+Palmer&title=The+l-arginine%3A+nitric+oxide+pathway&doi=10.1097%2F00041552-199301000-00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The L-arginine: nitric oxide pathway</span></div><div class="casAuthors">Palmer R M</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in nephrology and hypertension</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-8</span>
        ISSN:<span class="NLM_cas:issn">1062-4821</span>.
    </div><div class="casAbstract">The L-arginine: nitric oxide pathway is widely recognized as an important regulator of cell function and communication in a variety of physiological and pathophysiological situations.  Recent advances in the biochemistry and molecular biology of nitric oxide synthases have contributed significantly to our understanding of the regulation of nitric oxide synthesis in health and disease.  This pathway has been implicated in the pathogenesis of septic shock, hypertension, and atherosclerosis as well as in the antihypertensive action of converting enzyme inhibitors.  Progress in this field, which spans the cardiovascular, immune, and nervous systems, has been rapid, and its full potential is yet to be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHpybKVxyobyXXDYhVZBdlfW6udTcc2eabCGfKVSv2iLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fgs1CmtQ%253D%253D&md5=ddf4e056f9722ea3dc21d148db28e957</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1097%2F00041552-199301000-00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00041552-199301000-00018%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DThe%2520l-arginine%253A%2520nitric%2520oxide%2520pathway%26jtitle%3DCurr%2520Opin%2520Nephrol%2520Hypertens.%26date%3D1993%26volume%3D2%26spage%3D122%26epage%3D128%26doi%3D10.1097%2F00041552-199301000-00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moncada, S.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide</span>. <i>J. Hypertens. Suppl.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">S35</span>– <span class="NLM_lpage">S39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=7539493" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=S35-S39&author=S.+Moncada&title=Nitric+oxide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DNitric%2520oxide%26jtitle%3DJ.%2520Hypertens.%2520Suppl.%26date%3D1994%26volume%3D12%26spage%3DS35%26epage%3DS39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Star, R. A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide</span>. <i>Am. J. Med. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1097/00000441-199311000-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1097%2F00000441-199311000-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=7694458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADyaK2c%252Fls1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1993&pages=348-358&author=R.+A.+Star&title=Nitric+oxide&doi=10.1097%2F00000441-199311000-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide</span></div><div class="casAuthors">Star R A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of the medical sciences</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-58</span>
        ISSN:<span class="NLM_cas:issn">0002-9629</span>.
    </div><div class="casAbstract">Nitric oxide is a newly discovered gas that mediates communication between adjacent cells and signals inside cells.  Defects in the nitric oxide signalling cascade have been found in patients with systemic hypertension, pulmonary hypertension, and coronary artery disease.  High concentrations of nitric oxide are cytotoxic.  Over-production of nitric oxide contributes to the pathogenesis of septic shock and uremic bleeding.  This review focuses on the cardiovascular and platelet actions of nitric oxide, with emphasis on clinical studies of agents that modulate the nitric oxide signalling cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1Euevg9zSTZVVjGoY74BafW6udTcc2eb0ojgZZYp0Kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252Fls1Crtg%253D%253D&md5=e0402d48d03e32d7d209240cbf494d9d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1097%2F00000441-199311000-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000441-199311000-00015%26sid%3Dliteratum%253Aachs%26aulast%3DStar%26aufirst%3DR.%2BA.%26atitle%3DNitric%2520oxide%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D1993%26volume%3D306%26spage%3D348%26epage%3D358%26doi%3D10.1097%2F00000441-199311000-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orlandi, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolando, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzarato, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span> <span> </span><span class="NLM_article-title">Anti-Pseudomonas activity of 3-nitro-4-phenylfuroxan</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">1557</span>– <span class="NLM_lpage">1566</span>, <span class="refDoi"> DOI: 10.1099/mic.0.000730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1099%2Fmic.0.000730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=30300122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXislyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2018&pages=1557-1566&author=V.+T.+Orlandiauthor=F.+Bologneseauthor=B.+Rolandoauthor=S.+Guglielmoauthor=L.+Lazzaratoauthor=R.+Fruttero&title=Anti-Pseudomonas+activity+of+3-nitro-4-phenylfuroxan&doi=10.1099%2Fmic.0.000730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Pseudomonas activity of 3-nitro-4-phenylfuroxan</span></div><div class="casAuthors">Orlandi, Viviana Teresa; Bolognese, Fabrizio; Rolando, Barbara; Guglielmo, Stefano; Lazzarato, Loretta; Fruttero, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1557-1566</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1465-2080</span>.
    
            (<span class="NLM_cas:orgname">Microbiology Society</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa is a microorganism that is well adapted to both clin. and industrial settings, where it can form adherent communities that are difficult to eradicate.  New anti-Pseudomonas compds. and strategies are necessary, as the current antimicrobial approaches for the inhibition of biofilm formation and, above all, the eradication of formed biofilms are ineffective.  Compds. that belong to the furoxan family, which are well-known NO donors, have recently been shown to display anti-Pseudomonas activity.  The present study investigates three furoxan compds. that are substituted at the hetero-ring with electron-withdrawing groups (NO2, CN, CONH2) for their effects on P. aeruginosa PAO1 growth and biofilm formation/dispersal.  Of the furoxans tested, only 3-nitro-4-phenylfuroxan (KN455) inhibited the growth of suspended P. aeruginosa PAO1 cultures.  Furthermore, KN455 inhibited the formation of both younger and older biofilms with very high yields and thus proved itself to be toxic to planktonic subpopulations.  It also displayed moderate eradicating power.  The activity of KN455 does not appear to be related to its capacity to release small amts. of NO.  Interestingly, the isomer 4-nitro-3-phenylfuroxan (KN454), included for comparison, displayed a comparable antibiofilm rate, but did not show the same antimicrobial activity against suspended cells and planktonic subpopulations.  While hypotheses as to the mechanism of action have been formulated, further investigations are necessary to shed light onto the antimicrobial activity of this furoxan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCrsFGf-IOHLVg90H21EOLACvtfcHk0lhUL3oSdjnb-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXislyhtLo%253D&md5=0143969d8229a4437bb2dc0c353eff50</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.000730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.000730%26sid%3Dliteratum%253Aachs%26aulast%3DOrlandi%26aufirst%3DV.%2BT.%26aulast%3DBolognese%26aufirst%3DF.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DFruttero%26aufirst%3DR.%26atitle%3DAnti-Pseudomonas%2520activity%2520of%25203-nitro-4-phenylfuroxan%26jtitle%3DMicrobiology%26date%3D2018%26volume%3D164%26spage%3D1557%26epage%3D1566%26doi%3D10.1099%2Fmic.0.000730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridnour, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isenberg, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Santana, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Switzer, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donzelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolocci, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, D. A.</span></span> <span> </span><span class="NLM_article-title">The chemical biology of nitric oxide: implications in cellular signaling</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2008.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.freeradbiomed.2008.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=18439435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2008&pages=18-31&author=D.+D.+Thomasauthor=L.+A.+Ridnourauthor=J.+S.+Isenbergauthor=W.+Flores-Santanaauthor=C.+H.+Switzerauthor=S.+Donzelliauthor=P.+Hussainauthor=C.+Vecoliauthor=N.+Paolocciauthor=S.+Ambsauthor=C.+A.+Coltonauthor=C.+C.+Harrisauthor=D.+D.+Robertsauthor=D.+A.+Wink&title=The+chemical+biology+of+nitric+oxide%3A+implications+in+cellular+signaling&doi=10.1016%2Fj.freeradbiomed.2008.03.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The chemical biology of nitric oxide: Implications in cellular signaling</span></div><div class="casAuthors">Thomas, Douglas D.; Ridnour, Lisa A.; Isenberg, Jeffrey S.; Flores-Santana, Wilmarie; Switzer, Christopher H.; Donzelli, Sonia; Hussain, Perwez; Vecoli, Cecilia; Paolocci, Nazareno; Ambs, Stefan; Colton, Carol A.; Harris, Curtis C.; Roberts, David D.; Wink, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-31</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  NO has earned the reputation of being a signaling mediator with many diverse and often opposing biol. activities.  The diversity in response to this simple diat. mol. comes from the enormous variety of chem. reactions and biol. properties assocd. with it.  In the past few years, the importance of steady-state NO concns. has emerged as a key determinant of its biol. function.  Precise cellular responses are differentially regulated by specific NO concn.  The authors propose 5 basic distinct concn. levels of NO activity: cGMP-mediated processes ([NO] < 1-30 nM), Akt phosphorylation ([NO] = 30-100 nM), stabilization of HIF-1α ([NO] = 100-300 nM), phosphorylation of p53 ([NO] > 400 nM), and nitrosative stress (1 μM).  In general, lower NO concns. promote cell survival and proliferation, whereas higher levels favor cell cycle arrest, apoptosis, and senescence.  Free radical interactions will also influence NO signaling.  One of the consequences of reactive O species generation is to reduce NO concns.  This antagonizes the signaling of NO and in some cases results in converting a cell-cycle arrest profile to a cell survival profile.  The resulting reactive N species that are generated from these reactions can also have biol. effects and increase oxidative and nitrosative stress responses.  A no. of factors det. the formation of NO and its concn., such as diffusion, consumption, and substrate availability, which are referred to as kinetic determinants for mol. target interactions.  These are the chem. and biochem. parameters that shape cellular responses to NO.  Here, the authors discuss signal transduction and the biochem. of NO in terms of the direct and indirect reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBy1CNbcvHq7Vg90H21EOLACvtfcHk0ljDEfzdaja1Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFaqt7w%253D&md5=927163ba426538f3e1733797f69621f6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2008.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2008.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DD.%2BD.%26aulast%3DRidnour%26aufirst%3DL.%2BA.%26aulast%3DIsenberg%26aufirst%3DJ.%2BS.%26aulast%3DFlores-Santana%26aufirst%3DW.%26aulast%3DSwitzer%26aufirst%3DC.%2BH.%26aulast%3DDonzelli%26aufirst%3DS.%26aulast%3DHussain%26aufirst%3DP.%26aulast%3DVecoli%26aufirst%3DC.%26aulast%3DPaolocci%26aufirst%3DN.%26aulast%3DAmbs%26aufirst%3DS.%26aulast%3DColton%26aufirst%3DC.%2BA.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DRoberts%26aufirst%3DD.%2BD.%26aulast%3DWink%26aufirst%3DD.%2BA.%26atitle%3DThe%2520chemical%2520biology%2520of%2520nitric%2520oxide%253A%2520implications%2520in%2520cellular%2520signaling%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2008%26volume%3D45%26spage%3D18%26epage%3D31%26doi%3D10.1016%2Fj.freeradbiomed.2008.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, C.</span></span> <span> </span><span class="NLM_article-title">Gasotransmitters in cancer: from pathophysiology to experimental therapy</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1038/nrd.2015.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1038%2Fnrd.2015.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=26678620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCrurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=185-203&author=C.+Szabo&title=Gasotransmitters+in+cancer%3A+from+pathophysiology+to+experimental+therapy&doi=10.1038%2Fnrd.2015.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Gasotransmitters in cancer: from pathophysiology to experimental therapy</span></div><div class="casAuthors">Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">185-203</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The three endogenous gaseous transmitters - nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) - regulate a no. of key biol. functions.  Emerging data have revealed several new mechanisms for each of these three gasotransmitters in tumor biol.  It is now appreciated that they show bimodal pharmacol. character in cancer, in that not only the inhibition of their biosynthesis but also elevation of their concn. beyond a certain threshold can exert anticancer effects.  This Review discusses the role of each gasotransmitter in cancer and the effects of pharmacol. agents - some of which are in early-stage clin. studies - that modulate the levels of each gasotransmitter.  A clearer understanding of the pharmacol. character of these three gases and the mechanisms underlying their biol. effects is expected to guide further clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwYul_JkB2s7Vg90H21EOLACvtfcHk0ljDEfzdaja1Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCrurnF&md5=e58b917180ac87d4d65e3f80f6a04233</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2015.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2015.1%26sid%3Dliteratum%253Aachs%26aulast%3DSzabo%26aufirst%3DC.%26atitle%3DGasotransmitters%2520in%2520cancer%253A%2520from%2520pathophysiology%2520to%2520experimental%2520therapy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2016%26volume%3D15%26spage%3D185%26epage%3D203%26doi%3D10.1038%2Fnrd.2015.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viarisio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costamagna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescarmona, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosia, A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=15695394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=516-525&author=C.+Rigantiauthor=E.+Miragliaauthor=D.+Viarisioauthor=C.+Costamagnaauthor=G.+Pescarmonaauthor=D.+Ghigoauthor=A.+Bosia&title=Nitric+oxide+reverts+the+resistance+to+doxorubicin+in+human+colon+cancer+cells+by+inhibiting+the+drug+efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span></div><div class="casAuthors">Riganti, Chiara; Miraglia, Erica; Viarisio, Daniele; Costamagna, Costanzo; Pescarmona, Gianpiero; Ghigo, Dario; Bosia, Amalia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">516-525</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is a phenomenon by which cancer cells evade the cytotoxic effects of chemotherapeutic agents.  It may occur through different mechanisms, but it often correlates with the overexpression of integral membrane transporters, such as P-glycoprotein (Pgp) and MDR-assocd. proteins (MRPs), with resulting decrease of drug accumulation and cellular death.  Doxorubicin is a substrate of Pgp; it has been suggested that its ability to induce synthesis of nitric oxide (NO) could explain, at least in part, its cytotoxic effects.  Culturing the human epithelial colon cell line HT29 in the presence of doxorubicin, we obtained a doxorubicin-resistant (HT29-dx) cell population: these cells accumulated less intracellular doxorubicin, were less sensitive to the cytotoxic effects of doxorubicin and cisplatin, overexpressed Pgp and MRP3, and exhibited a lower NO prodn. (both under basal conditions and after doxorubicin stimulation).  The resistance to doxorubicin could be reversed when HT29-dx cells were incubated with inducers of NO synthesis (cytokines mix, atorvastatin).  Some NO donors increased the drug accumulation in HT29-dx cells in a guanosine-3':5'-cyclic monophosphate-independent way; this effect was assocd. with a marked redn. of doxorubicin efflux rate in HT29 and HT29-dx cells, and tyrosine nitration in the MRP3 protein.  Our results suggest that onset of MDR and impairment of NO synthesis are related; this finding could point to a new strategy to reverse doxorubicin resistance in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTu2bqm5O1DbVg90H21EOLACvtfcHk0ljDEfzdaja1Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D&md5=e0e7757d954680c9b9eb3470a1758da6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DMiraglia%26aufirst%3DE.%26aulast%3DViarisio%26aufirst%3DD.%26aulast%3DCostamagna%26aufirst%3DC.%26aulast%3DPescarmona%26aufirst%3DG.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DBosia%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520reverts%2520the%2520resistance%2520to%2520doxorubicin%2520in%2520human%2520colon%2520cancer%2520cells%2520by%2520inhibiting%2520the%2520drug%2520efflux%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D516%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide donor-based cancer therapy: advances and prospects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7617</span>– <span class="NLM_lpage">7635</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01672</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01672" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslKjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7617-7635&author=Z.+Huangauthor=J.+Fuauthor=Y.+Zhang&title=Nitric+oxide+donor-based+cancer+therapy%3A+advances+and+prospects&doi=10.1021%2Facs.jmedchem.6b01672"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects</span></div><div class="casAuthors">Huang, Zhangjian; Fu, Junjie; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7617-7635</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The increasing understanding of the role of nitric oxide (NO) in cancer biol. has generated significant progress in the use of NO donor-based therapy to fight cancer.  These advances strongly suggest the potential adoption of NO donor-based therapy in clin. practice, and this has been supported by several clin. studies in the past decade.  In this review, the authors first highlight several types of important NO donors, including recently developed NO donors bearing a dinitroazetidine skeleton, represented by RRx-001, with potential utility in cancer therapy.  Special emphasis is then given to the combination of NO donor(s) with other therapies to achieve synergy and to the hybridization of NO donor(s) with an anticancer drug/agent/fragment to enhance the activity or specificity or to reduce toxicity.  In addn., the authors briefly describe inducible NO synthase gene therapy and nanotechnol., which have recently entered the field of NO donor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPi-02-7rrIrVg90H21EOLACvtfcHk0liSaNcjP7Bb-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslKjtLg%253D&md5=37c58426b9b4a543b3112b4a4239f8c4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01672%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DNitric%2520oxide%2520donor-based%2520cancer%2520therapy%253A%2520advances%2520and%2520prospects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7617%26epage%3D7635%26doi%3D10.1021%2Facs.jmedchem.6b01672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelegrino, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nascimento, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortella, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubilar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabra, A. B.</span></span> <span> </span><span class="NLM_article-title">Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">113740</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2019.113740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.bcp.2019.113740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31786262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVKrt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2020&pages=113740&author=J.+C.+Pierettiauthor=M.+T.+Pelegrinoauthor=M.+H.+M.+Nascimentoauthor=G.+R.+Tortellaauthor=O.+Rubilarauthor=A.+B.+Seabra&title=Small+molecules+for+great+solutions%3A+Can+nitric+oxide-releasing+nanomaterials+overcome+drug+resistance+in+chemotherapy%3F&doi=10.1016%2Fj.bcp.2019.113740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?</span></div><div class="casAuthors">Pieretti, Joana C.; Pelegrino, Milena T.; Nascimento, Monica H. M.; Tortella, Gonzalo R.; Rubilar, Olga; Seabra, Amedea B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113740</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is an endogenous free radical that controls important physiol. and pathophysiol. processes, including a role in cancer biol.  NO can have a direct toxic effect on tumors, or it can sensitize cancer cells and contribute to the reversal of multidrug resistance (MDR).  As NO is a gas and free radical, NO donors have been investigated for their anticancer effects.  In recent years, the combination of NO donors with nanomaterials has been emerging as a promising strategy to promote spatial-temporal NO release/generation directly at the target site of application (tumor tissue).  Smart nanocarriers that are able to release NO under controlled stimuli have been extensively developed.  Moreover, important publications have demonstrated the promising applications of NO-releasing nanomaterials in combination with traditional chemotherapies in which NO can sensitize cancer cells.  In this direction, this review presents and discusses the recent progress in the design of versatile nanocarriers that are able to release/generate therapeutic amts. of NO and which can be combined with conventional anticancer therapies.  These nanocarriers have the ability to release NO on-demand by external stimuli such as pH, wave, or light exposure.  In addn., the possible mechanisms of NO in sensitizing tumor tissue and the impact and challenges of nanomaterials in cancer treatment are also presented and discussed.  The biol. and pharmacol. aspects of NO donors in cancer are discussed.  Finally, challenges and perspectives in the development of versatile nanoplatforms to efficiently deliver NO in clin. cancer treatment are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotnO90pIqIlrVg90H21EOLACvtfcHk0liSaNcjP7Bb-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVKrt7nI&md5=2e40b472d2db04100c93f94d979228e2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2019.113740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2019.113740%26sid%3Dliteratum%253Aachs%26aulast%3DPieretti%26aufirst%3DJ.%2BC.%26aulast%3DPelegrino%26aufirst%3DM.%2BT.%26aulast%3DNascimento%26aufirst%3DM.%2BH.%2BM.%26aulast%3DTortella%26aufirst%3DG.%2BR.%26aulast%3DRubilar%26aufirst%3DO.%26aulast%3DSeabra%26aufirst%3DA.%2BB.%26atitle%3DSmall%2520molecules%2520for%2520great%2520solutions%253A%2520Can%2520nitric%2520oxide-releasing%2520nanomaterials%2520overcome%2520drug%2520resistance%2520in%2520chemotherapy%253F%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2020%26volume%3D176%26spage%3D113740%26doi%3D10.1016%2Fj.bcp.2019.113740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alimoradi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, G. I.</span></span> <span> </span><span class="NLM_article-title">Controlled delivery of nitric oxide for cancer therapy</span>. <i>Pharm. Nanotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">303</span>, <span class="refDoi"> DOI: 10.2174/2211738507666190429111306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.2174%2F2211738507666190429111306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31595847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2isbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&pages=279-303&author=H.+Alimoradiauthor=K.+Greishauthor=A.+B.+Gambleauthor=G.+I.+Giles&title=Controlled+delivery+of+nitric+oxide+for+cancer+therapy&doi=10.2174%2F2211738507666190429111306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Controlled Delivery of Nitric Oxide for Cancer Therapy</span></div><div class="casAuthors">Alimoradi, Houman; Greish, Khaled; Gamble, Allan B.; Giles, Gregory I.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Nanotechnology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-303</span>CODEN:
                <span class="NLM_cas:coden">PNHABM</span>;
        ISSN:<span class="NLM_cas:issn">2211-7385</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is a short-lived, endogenously produced, signaling mol. which plays multiple roles in mammalian physiol.  Underprodn. of NO is assocd. with several pathol. processes; hence a broad range of NO donors have emerged as potential therapeutics for cardiovascular and respiratory disorders, wound healing, the immune response to infection, and cancer.  However, short half-lives, chem. reactivity, rapid systemic clearance, and cytotoxicity have hindered the clin. development of most low mol. wt. NO donors.  Hence, for controlled NO delivery, there has been extensive effort to design novel NO-releasing biomaterials for tumor targeting.  This review covers the effects of NO in cancer biol., NO releasing moieties which can be used for NO delivery, and current advances in the design of NO releasing biomaterials focusing on their applications for tumor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo4uth5KZiQrVg90H21EOLACvtfcHk0lhNoMUMTKEiVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2isbzK&md5=a6c655bd9359176d8b9714f767f04da1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F2211738507666190429111306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F2211738507666190429111306%26sid%3Dliteratum%253Aachs%26aulast%3DAlimoradi%26aufirst%3DH.%26aulast%3DGreish%26aufirst%3DK.%26aulast%3DGamble%26aufirst%3DA.%2BB.%26aulast%3DGiles%26aufirst%3DG.%2BI.%26atitle%3DControlled%2520delivery%2520of%2520nitric%2520oxide%2520for%2520cancer%2520therapy%26jtitle%3DPharm.%2520Nanotechnol.%26date%3D2019%26volume%3D7%26spage%3D279%26epage%3D303%26doi%3D10.2174%2F2211738507666190429111306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span> <span> </span><span class="NLM_article-title">Light-induced therapies for prostate cancer treatment</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">719</span>, <span class="refDoi"> DOI: 10.3389/fchem.2019.00719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3389%2Ffchem.2019.00719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31737599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpvV2jtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&pages=719&author=C.+Ferroniauthor=A.+Del+Rioauthor=C.+Martiniauthor=E.+Manoniauthor=G.+Varchi&title=Light-induced+therapies+for+prostate+cancer+treatment&doi=10.3389%2Ffchem.2019.00719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Light-induced therapies for prostate cancer treatment</span></div><div class="casAuthors">Ferroni, Claudia; Del Rio, Alberto; Martini, Cecilia; Manoni, Elisabetta; Varchi, Greta</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">719</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Prostate cancer (PC) is one of the most widespread tumors affecting the urinary system and the fifth-leading cause from cancer death in men worldwide.  Despite PC mortality rates have been decreasing during the last years, most likely due to an intensification of early diagnosis, still more than 300,000 men die each year because of this disease.  In this view, researchers in all countries are engaged in finding new ways to tackle PC, including the design and synthesis of novel mol. and macromol. entities able to challenge different PC biol. targets, while limiting the extent of unwanted side effects that significantly limitmen's life quality.  Among this field of research, photo-induced therapies, such as photodynamic and photothermal therapies (PDT and PTT), might represent an important advancement in PC treatment due to their extremely localized and controlled cytotoxic effect, as well as their low incidence of side effects and tumor resistance occurrence.  Based on these considerations, this review aims to gather and discuss the last 5-years literature reports dealing with the synthesis and biol. activity of mol. conjugates and nano-platforms for photo-induced therapies as co-adjuvant or combined therapeutic modalities for the treatment of localized PC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYu7sgmw7WBbVg90H21EOLACvtfcHk0lhNoMUMTKEiVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpvV2jtbo%253D&md5=a2d0c4e102aae625946a66cabc1830bd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2019.00719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2019.00719%26sid%3Dliteratum%253Aachs%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DDel%2BRio%26aufirst%3DA.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DManoni%26aufirst%3DE.%26aulast%3DVarchi%26aufirst%3DG.%26atitle%3DLight-induced%2520therapies%2520for%2520prostate%2520cancer%2520treatment%26jtitle%3DFront.%2520Chem.%26date%3D2019%26volume%3D7%26spage%3D719%26doi%3D10.3389%2Ffchem.2019.00719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rapozzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietra, E. d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cesselli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castoria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Donato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saracino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benfenati, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span> <span> </span><span class="NLM_article-title">Androgen receptor targeted conjugate for bimodal photodynamic therapy of prostate cancer in vitro</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.5b00261</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.5b00261" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKitLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=1662-1671&author=V.+Rapozziauthor=D.+Ragnoauthor=A.+Guerriniauthor=C.+Ferroniauthor=E.+d.+Pietraauthor=D.+Cesselliauthor=G.+Castoriaauthor=M.+Di+Donatoauthor=E.+Saracinoauthor=V.+Benfenatiauthor=G.+Varchi&title=Androgen+receptor+targeted+conjugate+for+bimodal+photodynamic+therapy+of+prostate+cancer+in+vitro&doi=10.1021%2Facs.bioconjchem.5b00261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Androgen Receptor Targeted Conjugate for Bimodal Photodynamic Therapy of Prostate Cancer in Vitro</span></div><div class="casAuthors">Rapozzi, Valentina; Ragno, Daniele; Guerrini, Andrea; Ferroni, Claudia; Pietra, Emilia della; Cesselli, Daniela; Castoria, Gabriella; Di Donato, Marzia; Saracino, Emanuela; Benfenati, Valentina; Varchi, Greta</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1662-1671</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate cancer (PC) represents the most common type of cancer among males and is the second leading cause of cancer death in men in Western society.  Current options for PC therapy remain unsatisfactory, since they often produce uncomfortable long-term side effects, such as impotence (70%) and incontinence (5-20%) even in the first stages of the disease.  Light-triggered therapies, such as photodynamic therapy, have the potential to provide important advances in the treatment of localized and partially metastasized prostate cancer.  We have designed a novel mol. conjugate (DR2) constituted of a photosensitizer (pheophorbide a, Pba), connected to a nonsteroidal anti-androgen mol. through a small pegylated linker.  This study aims at investigating whether DR2 represents a valuable approach for PC treatment based on light-induced prodn. of single oxygen and nitric oxide (NO) in vitro.  Besides being able to efficiently bind the androgen receptor (AR), the 2-trifluoromethylnitrobenzene ring on the DR2 backbone is able to release cytotoxic NO under the exclusive control of light, thus augmenting the general photodynamic effect.  Although DR2 is similarly internalized in cells expressing different levels of androgen receptor, the AR ligand prevents its efflux through the ABCG2-pump.  In vitro phototoxicity expts. demonstrated the ability of DR2 to kill cancer cells more efficiently than Pba, while no dark toxicity was obsd.  Overall, the presented approach is very promising for further development of AR-photosensitizer conjugates in the multimodal photodynamic treatment of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3_qTqjMfaFLVg90H21EOLACvtfcHk0lg67y4hY_sE4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKitLfO&md5=484a723a12bb5c050181c0f5c0e66794</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.5b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.5b00261%26sid%3Dliteratum%253Aachs%26aulast%3DRapozzi%26aufirst%3DV.%26aulast%3DRagno%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DA.%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DPietra%26aufirst%3DE.%2Bd.%26aulast%3DCesselli%26aufirst%3DD.%26aulast%3DCastoria%26aufirst%3DG.%26aulast%3DDi%2BDonato%26aufirst%3DM.%26aulast%3DSaracino%26aufirst%3DE.%26aulast%3DBenfenati%26aufirst%3DV.%26aulast%3DVarchi%26aufirst%3DG.%26atitle%3DAndrogen%2520receptor%2520targeted%2520conjugate%2520for%2520bimodal%2520photodynamic%2520therapy%2520of%2520prostate%2520cancer%2520in%2520vitro%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26spage%3D1662%26epage%3D1671%26doi%3D10.1021%2Facs.bioconjchem.5b00261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rapozzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Pietra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xodo, L. E.</span></span> <span> </span><span class="NLM_article-title">A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1007/s10637-016-0396-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1007%2Fs10637-016-0396-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=27726093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Ojtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=115-123&author=V.+Rapozziauthor=G.+Varchiauthor=E.+Della+Pietraauthor=C.+Ferroniauthor=L.+E.+Xodo&title=A+photodynamic+bifunctional+conjugate+for+prostate+cancer%3A+an+in+vitro+mechanistic+study&doi=10.1007%2Fs10637-016-0396-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study</span></div><div class="casAuthors">Rapozzi, Valentina; Varchi, Greta; Della Pietra, Emilia; Ferroni, Claudia; Xodo, Luigi E.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-123</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) has drawn considerable attention for its efficacy against certain types of cancers.  It shows however limits in the case of deep cancers, favoring tumor recurrence under suboptimal conditions.  More insight into the mol. mechanisms of PDT-induced cytotoxicity and cytoprotection is essential to extend and strengthen this therapeutic modality.  As PDT induces iNOS/NO in both tumor and microenvironment, we examd. the role of nitric oxide (NO) in cytotoxicity and cytoprotection.  Our findings show that NO mediates its cellular effects by acting on the NF-κB/YY1/RKIP loop, which controls cell growth and apoptosis.  The cytoprotective effect of PDT-induced NO is obsd. at low NO levels, which activate the pro-survival/anti-apoptotic NF-κB and YY1, while inhibiting the anti-survival/pro-apoptotic and metastasis suppressor RKIP.  In contrast, high PDT-induced NO levels inhibit NF-κB and YY1 and induce RKIP, resulting in significant anti-tumor activity.  These findings reveal a crit. role played by NO in PDT and suggest that the use of bifunctional PDT agents composed of a photosensitizer and a NO-donor could enhance the photo-treatment effect.  To address this issue we propose as PDT agent, a bimol. conjugate called DR2, composed of a photosensitizer (Pheophorbide a) and a non-steroidal anti-androgen mol. capable of releasing NO under the exclusive control of light.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf65fk9S-2HrVg90H21EOLACvtfcHk0lg67y4hY_sE4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Ojtb3E&md5=0bbc6de258596c171e4e5b6f15b39120</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs10637-016-0396-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-016-0396-x%26sid%3Dliteratum%253Aachs%26aulast%3DRapozzi%26aufirst%3DV.%26aulast%3DVarchi%26aufirst%3DG.%26aulast%3DDella%2BPietra%26aufirst%3DE.%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DXodo%26aufirst%3DL.%2BE.%26atitle%3DA%2520photodynamic%2520bifunctional%2520conjugate%2520for%2520prostate%2520cancer%253A%2520an%2520in%2520vitro%2520mechanistic%2520study%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2017%26volume%3D35%26spage%3D115%26epage%3D123%26doi%3D10.1007%2Fs10637-016-0396-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballestri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgiu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span> <span> </span><span class="NLM_article-title">Core-shell poly-methyl methacrylate nanoparticles covalently functionalized with a non-symmetric porphyrin for anticancer photodynamic therapy</span>. <i>J. Photochem. Photobiol. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2018.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.jphotobiol.2018.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=30064063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVSqtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2018&pages=169-177&author=M.+Ballestriauthor=E.+Carusoauthor=A.+Guerriniauthor=C.+Ferroniauthor=S.+Banfiauthor=M.+Gariboldiauthor=E.+Montiauthor=G.+Sotgiuauthor=G.+Varchi&title=Core-shell+poly-methyl+methacrylate+nanoparticles+covalently+functionalized+with+a+non-symmetric+porphyrin+for+anticancer+photodynamic+therapy&doi=10.1016%2Fj.jphotobiol.2018.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Core-shell poly-methyl methacrylate nanoparticles covalently functionalized with a non-symmetric porphyrin for anticancer photodynamic therapy</span></div><div class="casAuthors">Ballestri, Marco; Caruso, Enrico; Guerrini, Andrea; Ferroni, Claudia; Banfi, Stefano; Gariboldi, Marzia; Monti, Elena; Sotgiu, Giovanna; Varchi, Greta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">169-177</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is an anticancer modality that exploits singlet oxygen and other reactive oxygen species, that are formed by selective irradn. of photosensitive mols., to kill cancer cells.  Most photosensitizers (PS) are hydrophobic and poorly sol. in water and several nanoplatforms have been established to achieve a more efficient delivery.  Moreover, the covalent binding of the PS to nanoparticles could in principle reduce unwanted bleaching of the PS, while preserving its photodynamic activity.  In this study we report the synthesis of a novel non-sym. diaryl-porphyrin suitably modified with a polymerizable pendant, that was used for the prepn. of core-shell poly-Me methacrylate nanoparticles covalently loaded with the diaryl-porphyrin (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="6b3b26262a2b3b04193d0a">[email protected]</a>).  Particles, which were prepd. with two different porphyrin loadings, are spherical in shape and with a narrow hydrodynamic diam. around 70 nm and a pos. zeta potential.  Their photo-toxicity was tested against the human colon carcinoma cell line HCT116 and the human ovarian adenocarcinoma cell line SKOV3.  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="b7e7fafaf6f7e7d8c5e1d6">[email protected]</a> were able to inhibit tumor cells proliferation similarly to the free porphyrin, thus confirming that the covalent attachment of the PS to PMMA nanoparticles allows to preserve PS photodynamic activity and in vitro efficacy.  Flow cytometric anal. of apoptotic cells demonstrates that, esp. in SKOV3 cells, the free diaryl-porphyrin is more effective in inducing apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw9GKXkLEcoLVg90H21EOLACvtfcHk0ljBxq79kjqhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVSqtbjM&md5=9f033c10208c08597ae3981bf2531001</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2018.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2018.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DBallestri%26aufirst%3DM.%26aulast%3DCaruso%26aufirst%3DE.%26aulast%3DGuerrini%26aufirst%3DA.%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DBanfi%26aufirst%3DS.%26aulast%3DGariboldi%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DSotgiu%26aufirst%3DG.%26aulast%3DVarchi%26aufirst%3DG.%26atitle%3DCore-shell%2520poly-methyl%2520methacrylate%2520nanoparticles%2520covalently%2520functionalized%2520with%2520a%2520non-symmetric%2520porphyrin%2520for%2520anticancer%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%2520B%26date%3D2018%26volume%3D186%26spage%3D169%26epage%3D177%26doi%3D10.1016%2Fj.jphotobiol.2018.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerbara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malacarne, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marras, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and photodynamic activity of novel non-symmetrical diaryl porphyrins against cancer cell lines</span>. <i>J. Photochem. Photobiol. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2019.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.jphotobiol.2019.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31075653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFWnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2019&pages=39-50&author=E.+Carusoauthor=M.+Cerbaraauthor=M.+C.+Malacarneauthor=E.+Marrasauthor=E.+Montiauthor=M.+B.+Gariboldi&title=Synthesis+and+photodynamic+activity+of+novel+non-symmetrical+diaryl+porphyrins+against+cancer+cell+lines&doi=10.1016%2Fj.jphotobiol.2019.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and photodynamic activity of novel non-symmetrical diaryl porphyrins against cancer cell lines</span></div><div class="casAuthors">Caruso, Enrico; Cerbara, Monica; Malacarne, Miryam Chiara; Marras, Emanuela; Monti, Elena; Gariboldi, Marzia Bruna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-50</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) of cancer uses photosensitizers (PS), a light source and oxygen to generate high levels of reactive oxygen species (ROS), that exert a cytotoxic action on tumor cells.  In the present study, we investigate the in vitro photodynamic effects of four novel non-sym. diaryl porphyrins, two of which bear one pentafluoro-Ph and one bromo-alkyl (apolar) pendant, whereas the two others bear one pentafluoro-Ph and one cationic pyridine pendant.  The four compds. were tested in a small panel of human cancer cell lines, and their photodynamic activities were compared with that of m-THPC (Foscan), currently the most successful PS approved for clin. use in cancer PDT.  The results of the cytotoxicity studies indicate that the two mols. bearing the cationic pendant are more potent in vitro than those with the apolar pendant, and that they are as potent as Foscan.  To gain further insights into the mechanism of PS-induced phototoxicity, induction of apoptotic, autophagic and necrotic cell death, and generation of reactive oxygen species (ROS) were evaluated in cancer cells following exposure to the PSs and irradn.  The data obtained from this work support a greater potency of diaryl porphyrins with a pos. charge in inducing cell death, as compared to those with the bromo-alkyl pendant; most importantly, some of these novel compds. exhibit features that might make them superior to the clin. approved PS Foscan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmaoC6tV5py7Vg90H21EOLACvtfcHk0ljBxq79kjqhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFWnsrk%253D&md5=7e9f79f09b1b76d3be404e94a5d5f02c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2019.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2019.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DE.%26aulast%3DCerbara%26aufirst%3DM.%26aulast%3DMalacarne%26aufirst%3DM.%2BC.%26aulast%3DMarras%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DGariboldi%26aufirst%3DM.%2BB.%26atitle%3DSynthesis%2520and%2520photodynamic%2520activity%2520of%2520novel%2520non-symmetrical%2520diaryl%2520porphyrins%2520against%2520cancer%2520cell%2520lines%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%2520B%26date%3D2019%26volume%3D195%26spage%3D39%26epage%3D50%26doi%3D10.1016%2Fj.jphotobiol.2019.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferroni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgiu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagnella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandi, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marras, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluigi, A.</span></span> <span> </span><span class="NLM_article-title">Wool Keratin 3D scaffolds with light-triggered antimicrobial activity</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2882</span>– <span class="NLM_lpage">2890</span>, <span class="refDoi"> DOI: 10.1021/acs.biomac.6b00697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biomac.6b00697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1CltrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=2882-2890&author=C.+Ferroniauthor=G.+Sotgiuauthor=A.+Sagnellaauthor=G.+Varchiauthor=A.+Guerriniauthor=D.+Giuriauthor=E.+Poloauthor=V.+T.+Orlandiauthor=E.+Marrasauthor=M.+Gariboldiauthor=E.+Montiauthor=A.+Aluigi&title=Wool+Keratin+3D+scaffolds+with+light-triggered+antimicrobial+activity&doi=10.1021%2Facs.biomac.6b00697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Wool Keratin 3D Scaffolds with Light-Triggered Antimicrobial Activity</span></div><div class="casAuthors">Ferroni, Claudia; Sotgiu, Giovanna; Sagnella, Anna; Varchi, Greta; Guerrini, Andrea; Giuri, Demetra; Polo, Eleonora; Orlandi, Viviana Teresa; Marras, Emanuela; Gariboldi, Marzia; Monti, Elena; Aluigi, Annalisa</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2882-2890</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photoactivatable keratin sponges were prepd. from protein aq. solns. by the freeze-drying method, followed by photofunctionalization with two different photosensitizers (PS): Azure A (AzA) and 5,10,15,20-tetrakis [4-(2-N,N,N-trimethylethylthio)-2,3,5,6-tetrafluorophenyl]porphyrin tetraiodide salt (TTFAP).  The prepd. sponges have a porosity between 49% and 80% and a mean pore size in the 37-80 μm range.  As compared to AzA, TTFAP interacts more strongly with the sponges as demonstrated by a lower PS release (6% vs 20%), a decreased swelling ratio (1.6 vs 7.4), and a slower biodegrdn. rate.  Nevertheless, AzA-loaded sponges showed the highest photoactivity, as also demonstrated by their higher antibactericidal activity toward both Gram-pos. and Gram-neg. bacteria.  The obtained results suggest that the antimicrobial photodynamic effect can be finely triggered through a proper selection of the amt. and type of photosensitizer, as well as through the irradn. time.  Finally, all the prepd. sponges support human fibroblast cells growth, while no significant cell viability impairment is obsd. upon light irradn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKPr1ElmerNLVg90H21EOLACvtfcHk0li7dG3wwrCwHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1CltrnL&md5=926487cb3a127666eca4517c582a8931</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.biomac.6b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biomac.6b00697%26sid%3Dliteratum%253Aachs%26aulast%3DFerroni%26aufirst%3DC.%26aulast%3DSotgiu%26aufirst%3DG.%26aulast%3DSagnella%26aufirst%3DA.%26aulast%3DVarchi%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DA.%26aulast%3DGiuri%26aufirst%3DD.%26aulast%3DPolo%26aufirst%3DE.%26aulast%3DOrlandi%26aufirst%3DV.%2BT.%26aulast%3DMarras%26aufirst%3DE.%26aulast%3DGariboldi%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DAluigi%26aufirst%3DA.%26atitle%3DWool%2520Keratin%25203D%2520scaffolds%2520with%2520light-triggered%2520antimicrobial%2520activity%26jtitle%3DBiomacromolecules%26date%3D2016%26volume%3D17%26spage%3D2882%26epage%3D2890%26doi%3D10.1021%2Facs.biomac.6b00697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malacarne, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandi, V. T.</span></span> <span> </span><span class="NLM_article-title">Cationic diarylporphyrins: In vitro versatile anticancer and antibacterial photosensitizers</span>. <i>J. Photochem. Photobiol. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">111548</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2019.111548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.jphotobiol.2019.111548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31288120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlejurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2019&pages=111548&author=E.+Carusoauthor=M.+C.+Malacarneauthor=S.+Banfiauthor=M.+B.+Gariboldiauthor=V.+T.+Orlandi&title=Cationic+diarylporphyrins%3A+In+vitro+versatile+anticancer+and+antibacterial+photosensitizers&doi=10.1016%2Fj.jphotobiol.2019.111548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic diarylporphyrins: In vitro versatile anticancer and antibacterial photosensitizers</span></div><div class="casAuthors">Caruso, Enrico; Malacarne, Miryam Chiara; Banfi, Stefano; Gariboldi, Marzia Bruna; Orlandi, Viviana Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111548</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The visible light combined with photosensitizers (PSs) is exploited in both antitumoral and antimicrobial fields inducing a photo-oxidative stress within the target cells.  Among the different PSs, porphyrins belong to the family of the most promising compds. to be used in clin. photodynamic applications.  Although in the last years many porphyrins have been synthesized and tested, only a few reports concern the in vitro elects of the 5,15-diarylporphyrins.  In this work, the activity of four 5,15-diarylporphyrins (compds. 7-10), bearing alkoxy-linked pyridinium appendixes, have been tested on cancer cell lines and against bacterial cultures.  Among the synthesized PSs, compds. 7 and 9 are not sym. substituted porphyrins showing one cationic charge tethered at the end of one 4C or 8C carbon chains, resp.  On the other hand, compds. 8 and 10 are sym. substituted and show two chains of C4 and C8 carbons featuring a cationic charge at the end of both chains.  The dicationic 8 and 10 were more hydrophilic than monocationic 7 and 9, outlining that the presence of two pyridinium salts have a higher impact on the soly. in the aq. phase than the lipophilic elect exerted by the length of the alkyl chains.  Furthermore, these four PSs showed a similar rate of photobleaching, irresp. of the length and no. of chains and the no. of pos. charges.  Among the eukaryotic cell lines, the SKOV3 cells were particularly sensitive to the photodynamic activity of all the tested diarylporphyrins, while the HCT116 cells were found more sensitive to PSs bearing C4 chain (7 and 8), regardless the no. of cationic charges.  The photo-induced killing elect of these porphyrins was also tested against two different bacterial cultures.  As expected, the Gram pos. Bacillus subtilis was more sensitive than the Gram neg. Escherichia coli, and the dicationic porphyrin 8, bearing two C4 chains, was the most efficient on both microorganisms.  In conclusion, the new compd. 8 seems to be an optimal candidate to deepen as versatile anticancer and antibacterial photosensitizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyFChk-pIex7Vg90H21EOLACvtfcHk0li7dG3wwrCwHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlejurbK&md5=f58257bd9f5d851613a48f4443588ff1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2019.111548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2019.111548%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DE.%26aulast%3DMalacarne%26aufirst%3DM.%2BC.%26aulast%3DBanfi%26aufirst%3DS.%26aulast%3DGariboldi%26aufirst%3DM.%2BB.%26aulast%3DOrlandi%26aufirst%3DV.%2BT.%26atitle%3DCationic%2520diarylporphyrins%253A%2520In%2520vitro%2520versatile%2520anticancer%2520and%2520antibacterial%2520photosensitizers%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%2520B%26date%3D2019%26volume%3D197%26spage%3D111548%26doi%3D10.1016%2Fj.jphotobiol.2019.111548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorrenti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittalà, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnaturi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbagallo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanella, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Raimondo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intagliata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, L.</span></span> <span> </span><span class="NLM_article-title">Targeting heme oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ejmech.2018.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=30261468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSrtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2018&pages=937-950&author=V.+Sorrentiauthor=V.+Pittal%C3%A0author=G.+Romeoauthor=E.+Amataauthor=M.+Dichiaraauthor=A.+Marrazzoauthor=R.+Turnaturiauthor=O.+Prezzaventoauthor=I.+Barbagalloauthor=L.+Vanellaauthor=A.+Rescifinaauthor=G.+Florestaauthor=D.+Tibulloauthor=F.+Di+Raimondoauthor=S.+Intagliataauthor=L.+Salerno&title=Targeting+heme+oxygenase-1+with+hybrid+compounds+to+overcome+Imatinib+resistance+in+chronic+myeloid+leukemia+cell+lines&doi=10.1016%2Fj.ejmech.2018.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines</span></div><div class="casAuthors">Sorrenti, Valeria; Pittala, Valeria; Romeo, Giuseppe; Amata, Emanuele; Dichiara, Maria; Marrazzo, Agostino; Turnaturi, Rita; Prezzavento, Orazio; Barbagallo, Ignazio; Vanella, Luca; Rescifina, Antonio; Floresta, Giuseppe; Tibullo, Daniele; Di Raimondo, Francesco; Intagliata, Sebastiano; Salerno, Loredana</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">937-950</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Heme oxygenase-1 (HO-1) is a cytoprotective enzyme and a survival-enhancing factor in a no. of cancers.  Chronic myeloid leukemia (CML) is a blood cancer caused by pathol. kinase activity of the BCR-ABL protein, currently treated with tyrosine kinase inhibitors (TKIs) such as Imatinib (IM).  However, resistance to TKIs persists in a no. of patients and HO-1 overexpression has been linked with the induction of chemoresistance in CML.  With this in mind, in this study, we designed and synthesized the first series of hybrid compds. obtained by combining the structures of IM, as BCR-ABL inhibitor, with imidazole-based HO-1 inhibitors.  We found that many hybrids were able to inhibit the enzymic activity of both targets and to reduce the viability of CML-IM resistant cells, showing that a single mol. entity may reduce the resistance phenomenon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofaDl0TAXJ2bVg90H21EOLACvtfcHk0ljaswMFNUsqGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSrtL3L&md5=841b4fa9268a786b36afacd3bfa8b02b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DSorrenti%26aufirst%3DV.%26aulast%3DPittal%25C3%25A0%26aufirst%3DV.%26aulast%3DRomeo%26aufirst%3DG.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DTurnaturi%26aufirst%3DR.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DBarbagallo%26aufirst%3DI.%26aulast%3DVanella%26aufirst%3DL.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DTibullo%26aufirst%3DD.%26aulast%3DDi%2BRaimondo%26aufirst%3DF.%26aulast%3DIntagliata%26aufirst%3DS.%26aulast%3DSalerno%26aufirst%3DL.%26atitle%3DTargeting%2520heme%2520oxygenase-1%2520with%2520hybrid%2520compounds%2520to%2520overcome%2520Imatinib%2520resistance%2520in%2520chronic%2520myeloid%2520leukemia%2520cell%2520lines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D158%26spage%3D937%26epage%3D950%26doi%3D10.1016%2Fj.ejmech.2018.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moorcroft, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, R. G.</span></span> <span> </span><span class="NLM_article-title">Detection and determination of nitrate and nitrite: a review</span>. <i>Talanta</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1016/S0039-9140(01)00323-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2FS0039-9140%2801%2900323-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=18968301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=785-803&author=M.+J.+Moorcroftauthor=J.+Davisauthor=R.+G.+Compton&title=Detection+and+determination+of+nitrate+and+nitrite%3A+a+review&doi=10.1016%2FS0039-9140%2801%2900323-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and determination of nitrate and nitrite: a review</span></div><div class="casAuthors">Moorcroft, M. J.; Davis, J.; Compton, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Talanta</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">785-803</span>CODEN:
                <span class="NLM_cas:coden">TLNTA2</span>;
        ISSN:<span class="NLM_cas:issn">0039-9140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with 179 refs., of the strategies employed to facilitate the detection, detn. and monitoring of nitrate and/or nitrite is presented.  A concise survey of the literature covering 180 reports submitted over the past decade was compiled and the relevant anal. parameters (methodol., matrix, detection limits, range, etc.) tabulated.  The various advantages/disadvantages and limitations of the various techniques were exposed such that the applicability of a technique developed for one type of matrix can be meaningfully assessed before attempting to transfer the technol. to another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIp_m_44IeErVg90H21EOLACvtfcHk0ljaswMFNUsqGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFGqs70%253D&md5=d5758292848a86d5723236704d0ec082</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0039-9140%2801%2900323-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0039-9140%252801%252900323-X%26sid%3Dliteratum%253Aachs%26aulast%3DMoorcroft%26aufirst%3DM.%2BJ.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DCompton%26aufirst%3DR.%2BG.%26atitle%3DDetection%2520and%2520determination%2520of%2520nitrate%2520and%2520nitrite%253A%2520a%2520review%26jtitle%3DTalanta%26date%3D2001%26volume%3D54%26spage%3D785%26epage%3D803%26doi%3D10.1016%2FS0039-9140%2801%2900323-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seebacher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.</span></span> <span> </span><span class="NLM_article-title">Novel strategies to prevent the development of multidrug resistance (MDR) in cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">84559</span>– <span class="NLM_lpage">84571</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.19187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.18632%2Foncotarget.19187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29137448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A280%3ADC%252BC1M3htFyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=84559-84571&author=J.+Wangauthor=N.+Seebacherauthor=H.+Shiauthor=Q.+Kanauthor=Z.+Duan&title=Novel+strategies+to+prevent+the+development+of+multidrug+resistance+%28MDR%29+in+cancer&doi=10.18632%2Foncotarget.19187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel strategies to prevent the development of multidrug resistance (MDR) in cancer</span></div><div class="casAuthors">Wang Jinglu; Shi Huirong; Kan Quancheng; Duan Zhenfeng; Wang Jinglu; Seebacher Nicole; Duan Zhenfeng</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">84559-84571</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of multidrug resistance (MDR) is one of the major challenges to the success of traditional chemotherapy treatment in cancer patients.  Most studies to date have focused on strategies to reverse MDR following its development.  However, agents utilizing this approach have proven to be of limited clinical use, failing to demonstrate an improvement in therapeutic efficacy with almost no significant survival benefits observed in cancer clinical trials.  An alternative approach that has been applied is to prevent or delay MDR prior or early in its development.  Recent investigations have shown that preventing the emergence of MDR at the onset of chemotherapy treatment, rather than reversing MDR once it has developed, may assist in overcoming drug resistance.  In this review, we focus on a number of novel strategies used by small-molecule inhibitors to prevent the development of MDR.  These agents hold great promise for prolonging the efficacy of chemotherapy treatment and improving the clinical outcomes of patients with cancers that are susceptible to MDR development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvBIUBaePxjUkUaC_kzhvyfW6udTcc2eZ8r2JXtUAa6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3htFyksg%253D%253D&md5=ef038f59e40e65b3ed161f011ee0d53e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.19187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.19187%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSeebacher%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DKan%26aufirst%3DQ.%26aulast%3DDuan%26aufirst%3DZ.%26atitle%3DNovel%2520strategies%2520to%2520prevent%2520the%2520development%2520of%2520multidrug%2520resistance%2520%2528MDR%2529%2520in%2520cancer%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D84559%26epage%3D84571%26doi%3D10.18632%2Foncotarget.19187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">111108</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2020.111108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.biopha.2020.111108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=33341670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3MXktV2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2021&pages=111108&author=J.+Maoauthor=L.+Qiuauthor=L.+Geauthor=J.+Zhouauthor=Q.+Jiauthor=Y.+Yangauthor=M.+Longauthor=D.+Wangauthor=L.+Tengauthor=J.+Chen&title=Overcoming+multidrug+resistance+by+intracellular+drug+release+and+inhibiting+p-glycoprotein+efflux+in+breast+cancer&doi=10.1016%2Fj.biopha.2020.111108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer</span></div><div class="casAuthors">Mao, Jing; Qiu, Lipeng; Ge, Lu; Zhou, Juan; Ji, Qian; Yang, Yang; Long, Miaomiao; Wang, Danhui; Teng, Liping; Chen, Jinghua</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111108</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Doxorubicin (DOX) is limited to use in clin. practice because of poor targeting, serious side effects and multidrug resistance (MDR).  Vitamin E and its derivs. are currently considered as hydrophobic material that can reverse tumor MDR by suppressing the action of p-glycoprotein (p-gp).  Therefore, redn.-sensitive amphiphilic heparosan polysaccharide-cystamine-vitamin E succinate (KSV) copolymers were designed to reverse breast cancer MDR cells.  The spherical micelles (DOX/KSV) micelles which had suitable particle size presented redox-sensitive release character.  Simultaneously, DOX-loaded redn. insensitive heparosan-adipic dihydrazide-vitamin E succinate (KV) micellar system was designed as a control.  DOX/KSV and DOX/KV micelles had the higher capability to overcome tumor MDR than that free DOX.  However, DOX/KSV had the highest amt. of cellular uptake which might be caused by the synergistic intracellular drug release and inhibition of p-gp expression.  The mechanism expts. revealed that DOX/KSV could be fast disassembled to release DOX after internalization into tumor cells.  Moreover, DOX/KSV produced more ROS than free DOX and DOX/KV resulting in enhanced anticancer effect.  In vivo tumor-bearing mice study suggested that DOX/KSV micelles could efficiently enhance antitumor effect by overcoming tumor MDR and reduce toxicity of DOX.  The DOX/KSV micelles could synergistically increase the therapeutic effect of chemotherapeutic drug on tumor MDR cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOUzPeJAOOnbVg90H21EOLACvtfcHk0lgU0rvXcMYVFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXktV2isg%253D%253D&md5=d18bb30d146e12b01eca01ca9cfb971d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2020.111108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2020.111108%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DTeng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DOvercoming%2520multidrug%2520resistance%2520by%2520intracellular%2520drug%2520release%2520and%2520inhibiting%2520p-glycoprotein%2520efflux%2520in%2520breast%2520cancer%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2021%26volume%3D134%26spage%3D111108%26doi%3D10.1016%2Fj.biopha.2020.111108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">George, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishen, A.</span></span> <span> </span><span class="NLM_article-title">Uptake pathways of anionic and cationic photosensitizers into bacteria</span>. <i>Photochem. Photobiol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1039/b809624d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1039%2Fb809624d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=19492106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1yitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=788-795&author=S.+Georgeauthor=M.+R.+Hamblinauthor=A.+Kishen&title=Uptake+pathways+of+anionic+and+cationic+photosensitizers+into+bacteria&doi=10.1039%2Fb809624d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Uptake pathways of anionic and cationic photosensitizers into bacteria</span></div><div class="casAuthors">George, Saji; Hamblin, Michael R.; Kishen, Anil</div><div class="citationInfo"><span class="NLM_cas:title">Photochemical & Photobiological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-795</span>CODEN:
                <span class="NLM_cas:coden">PPSHCB</span>;
        ISSN:<span class="NLM_cas:issn">1474-905X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The effect of divalent cations (calcium and magnesium) and a permeabilizing agent (EDTA) on the uptake of a cationic photosensitizer (PS), methylene blue (MB), and two anionic PSs, rose bengal (RB) and indocyanine green (ICG), by Gram-pos. Enterococcus faecalis and Gram-neg. Actinobacillus actinomycetemcomitans was examd.  The possible roles of multidrug efflux pumps and protein transporters in photosensitizer uptake were assessed in E. faecalis cells by studies using an efflux pump inhibitor (verapamil) and trypsin treatment resp.  Divalent cations enhanced the uptake and photodynamic inactivation potential of both RB and ICG in E. faecalis and A. actinomycetemcomitans, while they decreased the uptake and bacterial killing by MB.  Verapamil increased the uptake of RB (possibly due to efflux pump inhibition), whereas trypsin treatment resulted in significant decrease in RB and ICG uptake.  The results suggested that the uptake of anionic PSs by bacterial cells may be mediated through a combination of electrostatic charge interaction and by protein transporters, while the uptake of cationic PSs, as previously reported, is mediated by electrostatic interactions and self promoted uptake pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoew3RNtfYKV7Vg90H21EOLACvtfcHk0lgU0rvXcMYVFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1yitrs%253D&md5=0fd1a4d454e7d86f92a306c8fe9c1c18</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1039%2Fb809624d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb809624d%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26aulast%3DKishen%26aufirst%3DA.%26atitle%3DUptake%2520pathways%2520of%2520anionic%2520and%2520cationic%2520photosensitizers%2520into%2520bacteria%26jtitle%3DPhotochem.%2520Photobiol.%2520Sci.%26date%3D2009%26volume%3D8%26spage%3D788%26epage%3D795%26doi%3D10.1039%2Fb809624d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, N. L.</span></span> <span> </span><span class="NLM_article-title">Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1126/science.1204117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1126%2Fscience.1204117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=21778401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovF2mur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2011&pages=459-462&author=C.+C.+Wuauthor=T.+K.+Liauthor=L.+Farhauthor=L.+Y.+Linauthor=T.+S.+Linauthor=Y.+J.+Yuauthor=T.+J.+Yenauthor=C.+W.+Chiangauthor=N.+L.+Chan&title=Structural+basis+of+type+II+topoisomerase+inhibition+by+the+anticancer+drug+etoposide&doi=10.1126%2Fscience.1204117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide</span></div><div class="casAuthors">Wu, Chyuan-Chuan; Li, Tsai-Kun; Farh, Lynn; Lin, Li-Ying; Lin, Te-Sheng; Yu, Yu-Jen; Yen, Tien-Jui; Chiang, Chia-Wang; Chan, Nei-Li</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">6041</span>),
    <span class="NLM_cas:pages">459-462</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Type II topoisomerases (TOP2s) resolve the topol. problems of DNA by transiently cleaving both strands of a DNA duplex to form a cleavage complex through which another DNA segment can be transported.  Several widely prescribed anticancer drugs increase the population of TOP2 cleavage complex, which leads to TOP2-mediated chromosome DNA breakage and death of cancer cells.  We present the crystal structure of a large fragment of human TOP2β complexed to DNA and to the anticancer drug etoposide to reveal structural details of drug-induced stabilization of a cleavage complex.  The interplay between the protein, the DNA, and the drug explains the structure-activity relations of etoposide derivs. and the mol. basis of drug-resistant mutations.  The anal. of protein-drug interactions provides information applicable for developing an isoform-specific TOP2-targeting strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBC6vqPeyB-bVg90H21EOLACvtfcHk0liNXX85q-rODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovF2mur0%253D&md5=c2eab1b2e9b8a75322b88e76c62c4b74</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1126%2Fscience.1204117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1204117%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DFarh%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DL.%2BY.%26aulast%3DLin%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DY.%2BJ.%26aulast%3DYen%26aufirst%3DT.%2BJ.%26aulast%3DChiang%26aufirst%3DC.%2BW.%26aulast%3DChan%26aufirst%3DN.%2BL.%26atitle%3DStructural%2520basis%2520of%2520type%2520II%2520topoisomerase%2520inhibition%2520by%2520the%2520anticancer%2520drug%2520etoposide%26jtitle%3DScience%26date%3D2011%26volume%3D333%26spage%3D459%26epage%3D462%26doi%3D10.1126%2Fscience.1204117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djamgoz, M. B. A.</span></span> <span> </span><span class="NLM_article-title">Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ctrv.2017.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=29202431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=110-122&author=A.+Leeauthor=M.+B.+A.+Djamgoz&title=Triple+negative+breast+cancer%3A+Emerging+therapeutic+modalities+and+novel+combination+therapies&doi=10.1016%2Fj.ctrv.2017.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies</span></div><div class="casAuthors">Lee, Alice; Djamgoz, Mustafa B. A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-122</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Triple neg. breast cancer (TNBC) is a complex and aggressive subtype of breast cancer which lacks estrogen receptors, progesterone receptors and HER2 amplification, thereby making it difficult to target therapeutically.  In addn., TNBC has the highest rates of metastatic disease and the poorest overall survival of all breast cancer subtypes.  Resultantly, development of targeted therapies for TNBC is urgently needed.  Recent efforts aimed at mol. characterization of TNBCs have revealed various emerging therapeutic targets including PARP1, receptor and non-receptor tyrosine kinases, immune-checkpoints, androgen receptor and epigenetic proteins.  Key successes include that of the PARP inhibitor, olaparib, which prolonged progression-free survival in a trial of BRCA-mutated breast cancer and for which clin. approval (in this setting) appears imminent.  Nevertheless, the heterogeneity of TNBC has limited the clin. benefits of many trialled therapies in 'unselected' patients.  Further, drug resistance develops following use of many targeted monotherapies due to upregulation of compensatory signalling pathways.  In this review, we evaluate the current status of investigational targeted treatments and present evidence for the role of novel biomarkers and combination therapies in increasing response rates and circumventing drug-induced resistance.  Addnl., we discuss promising novel targets in metastatic TNBC identified through preclin. and/or epidemiol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraUe6qPPRyzbVg90H21EOLACvtfcHk0liNXX85q-rODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnK&md5=738b63405e3d6c1a3541982a6987a2dd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%26aulast%3DDjamgoz%26aufirst%3DM.%2BB.%2BA.%26atitle%3DTriple%2520negative%2520breast%2520cancer%253A%2520Emerging%2520therapeutic%2520modalities%2520and%2520novel%2520combination%2520therapies%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D62%26spage%3D110%26epage%3D122%26doi%3D10.1016%2Fj.ctrv.2017.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eroles, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaragoza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vin̈a, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lluch, A.</span></span> <span> </span><span class="NLM_article-title">Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2009.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.ctrv.2009.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=20060649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFChsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=206-215&author=A.+Boschauthor=P.+Erolesauthor=R.+Zaragozaauthor=J.+R.+Vin%CC%88aauthor=A.+Lluch&title=Triple-negative+breast+cancer%3A+molecular+features%2C+pathogenesis%2C+treatment+and+current+lines+of+research&doi=10.1016%2Fj.ctrv.2009.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research</span></div><div class="casAuthors">Bosch, Ana; Eroles, Pilar; Zaragoza, Rosa; Vina, Juan R.; Lluch, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-215</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Breast cancer is a heterogeneous disease with different morphologies, mol. profiles, clin. behavior and response to therapy.  The triple neg. is a particular type of breast cancer defined by absence of estrogen and progesterone receptor expression as well as absence of ERBB2 amplification.  It is characterized by its biol. aggressiveness, worse prognosis and lack of a therapeutic target in contrast with hormonal receptor pos. and ERBB2+ breast cancers.  Given these characteristics, triple-neg. breast cancer is a challenge in today's clin. practice.  A new breast cancer classification emerged recently in the scientific scene based in gene expression profiles.  The new subgroups (luminal, ERBB2, normal breast and basal-like) have distinct gene expression patterns and phenotypical characteristics.  Triple-neg. breast cancer shares phenotypical features with basal-like breast cancer, which is in turn the most aggressive and with worse outcome.  Since microarray gene-expression assays are only used in the research setting, clinicians use the triple-neg. definition as a surrogate of basal-like breast cancer.  The aim of this review, that focuses on triple-neg. breast cancer, is to summarize the most relevant knowledge on this particular type of cancer in terms of mol. features, pathogenesis, clin. characteristics, current treatments and the new therapeutic options that include the use of platinum compds., EGFR antagonists, antiangiogenics and PARP inhibitors.  Advances in research are promising and new types of active drugs will become a reality in the near future, making possible a better outcome for this subgroup of breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiAeBmEDMIRbVg90H21EOLACvtfcHk0ljvFyoPrAavnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFChsbo%253D&md5=2414fb4f19f90c67e891672b3a65b8bf</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2009.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2009.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DBosch%26aufirst%3DA.%26aulast%3DEroles%26aufirst%3DP.%26aulast%3DZaragoza%26aufirst%3DR.%26aulast%3DVin%25CC%2588a%26aufirst%3DJ.%2BR.%26aulast%3DLluch%26aufirst%3DA.%26atitle%3DTriple-negative%2520breast%2520cancer%253A%2520molecular%2520features%252C%2520pathogenesis%252C%2520treatment%2520and%2520current%2520lines%2520of%2520research%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2010%26volume%3D36%26spage%3D206%26epage%3D215%26doi%3D10.1016%2Fj.ctrv.2009.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietenpol, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symmans, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C.</span></span> <span> </span><span class="NLM_article-title">Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2723</span>– <span class="NLM_lpage">2733</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1158%2F1078-0432.CCR-12-2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=23549873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2ktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2723-2733&author=K.+D.+Yuauthor=R.+Zhuauthor=M.+Zhanauthor=A.+A.+Rodriguezauthor=W.+Yangauthor=S.+Wongauthor=A.+Makrisauthor=B.+D.+Lehmannauthor=X.+Chenauthor=I.+Mayerauthor=J.+A.+Pietenpolauthor=Z.+M.+Shaoauthor=W.+F.+Symmansauthor=J.+C.+Chang&title=Identification+of+prognosis-relevant+subgroups+in+patients+with+chemoresistant+triple-negative+breast+cancer&doi=10.1158%2F1078-0432.CCR-12-2986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer</span></div><div class="casAuthors">Yu, Ke-Da; Zhu, Rui; Zhan, Ming; Rodriguez, Angel A.; Yang, Wei; Wong, Stephen; Makris, Andreas; Lehmann, Brian D.; Chen, Xi; Mayer, Ingrid; Pietenpol, Jennifer A.; Shao, Zhi-Ming; Symmans, W. Fraser; Chang, Jenny C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2723-2733</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Patients with triple-neg. breast cancer (TNBC) and residual disease after neoadjuvant chemotherapy generally have worse outcome; however, some patients with residual tumor after neoadjuvant chemotherapy do not relapse.  We hypothesize that there are subgroups of patients with chemoresistant TNBC with different prognosis.  Exptl. Design: Forty-nine chemoresistant cases from 111 patients with TNBC treated with neoadjuvant chemotherapy (M.D. Anderson Cancer Center, Houston, TX) constituted the discovery cohort, and 25 chemoresistant samples from 47 neoadjuvant chemotherapy-treated TNBC (The Methodist Hospital, Houston, TX) were chosen for validation.  Extended validation was carried out in 269 operable TNBC predicted to be chemoresistant by expression pattern from published datasets.  Results: We established a seven-gene prognostic signature using dChip and gene set enrichment analyses.  In the independent validation cohort, the classifier predicted correctly with pos. predictive value of 75.0% and neg. predictive value (i.e., relapse-free survival; RFS) of 76.9% at 3 years.  Those predicted to relapse had a HR of 4.67 [95% confidence interval (CI): 1.27-17.15] for relapse in 3 years.  In extended validation, patients predicted not to relapse exhibited 3-yr RFS of 78.9%, whereas the 3-yr RFS was 48.5% for patients predicted to relapse, with HR of 2.61 (95% CI: 1.52-4.49).  The TNBC subgroup that predicted to have relatively favorable prognosis was characterized by high expression of "luminal-like" genes [androgen-receptor (AR) and GATA3], whereas the subgroup with worse prognosis was characterized by expression of cancer stem-cell markers.  Conclusion: We developed a clin. relevant signature for patients with chemoresistant TNBC.  For these women, new therapeutic strategies like targeting AR activation or cancer stem cells may need to be developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr97SbiyNt-OLVg90H21EOLACvtfcHk0ljvFyoPrAavnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2ktbc%253D&md5=75646315c3e391a9ba7c43125d47bff2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-2986%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%2BD.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DZhan%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DA.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DMakris%26aufirst%3DA.%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMayer%26aufirst%3DI.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26aulast%3DShao%26aufirst%3DZ.%2BM.%26aulast%3DSymmans%26aufirst%3DW.%2BF.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26atitle%3DIdentification%2520of%2520prognosis-relevant%2520subgroups%2520in%2520patients%2520with%2520chemoresistant%2520triple-negative%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D2723%26epage%3D2733%26doi%3D10.1158%2F1078-0432.CCR-12-2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stover, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erwin, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizoguchi, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrener, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkman, F. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufnagle, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagrou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garber, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goltry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolentino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrock-Wadman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brody, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulter, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folger, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larbig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, G. K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reizer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saier, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lory, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, M. V.</span></span> <span> </span><span class="NLM_article-title">Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.1038/35023079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1038%2F35023079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10984043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlKqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=959-964&author=C.+K.+Stoverauthor=X.+Q.+Phamauthor=A.+L.+Erwinauthor=S.+D.+Mizoguchiauthor=P.+Warrenerauthor=M.+J.+Hickeyauthor=F.+S.+L.+Brinkmanauthor=W.+O.+Hufnagleauthor=D.+J.+Kowalikauthor=M.+Lagrouauthor=R.+L.+Garberauthor=L.+Goltryauthor=E.+Tolentinoauthor=S.+Westbrock-Wadmanauthor=Y.+Yuanauthor=L.+L.+Brodyauthor=S.+N.+Coulterauthor=K.+R.+Folgerauthor=A.+Kasauthor=K.+Larbigauthor=R.+Limauthor=K.+Smithauthor=D.+Spencerauthor=G.+K.-S.+Wongauthor=Z.+Wuauthor=I.+T.+Paulsenauthor=J.+Reizerauthor=M.+H.+Saierauthor=R.+E.+W.+Hancockauthor=S.+Loryauthor=M.+V.+Olson&title=Complete+genome+sequence+of+Pseudomonas+aeruginosa+PAO1%2C+an+opportunistic+pathogen&doi=10.1038%2F35023079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Complete genome sequence of Pseudomonas aeruginosa PA01</span></div><div class="casAuthors">Stover, C. K.; Pham, X. Q.; Erwin, A. L.; Mizoguchi, S. D.; Warrener, P.; Hickey, M. J.; Brinkman, F. S. L.; Hufnagle, W. O.; Kowalik, J.; Lagrou, M.; Garber, R. L.; Goltry, L.; Tolentino, E.; Westbrock-Wadman, S.; Yuan, Y.; Brody, L. L.; Coulter, S. N.; Folger, K. R.; Kas, A.; Larbig, K.; Lim, R.; Smith, K.; Spencer, D.; Wong, G. K.-S.; Wu, Z.; Paulsen, I. T.; Reizer, J.; Saier, M. H.; Hancock, R. E. W.; Lory, S.; Olson, M. V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6799</span>),
    <span class="NLM_cas:pages">959-964</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa is a ubiquitous environmental bacterium that is one of the top three causes of opportunistic human infections.  A major factor in its prominence as a pathogen is its intrinsic resistance to antibiotics and disinfectants.  The authors now report the complete sequence of P. aeruginosa strain PA01.  At 6.3 million base pairs, this is the largest bacterial genome sequenced, and the sequence provides insights into the basis of the versatility and intrinsic drug resistance of P. aeruginosa.  Consistent with its larger genome size and environmental adaptability, P. aeruginosa contains the highest proportion of regulatory genes obsd. for a bacterial genome and a large no. of genes involved in the catabolism, transport and efflux of org. compds. as well as four potential chemotaxis systems.  The size and complexity of the P. aeruginosa genome is proposed to reflect an evolutionary adaptation permitting it to thrive in diverse environments and resist the effects of a variety of antimicrobial substances.  The genome and protein sequences are deposited in the GenBank database with Accession No. AE004091, as well at the web site http://www.pseudomonas.com.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFWCFBwqX4gLVg90H21EOLACvtfcHk0lhxdI_GoCIX1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlKqsrY%253D&md5=aaf166751567ffd3a8ea0631e9bd7b9e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2F35023079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35023079%26sid%3Dliteratum%253Aachs%26aulast%3DStover%26aufirst%3DC.%2BK.%26aulast%3DPham%26aufirst%3DX.%2BQ.%26aulast%3DErwin%26aufirst%3DA.%2BL.%26aulast%3DMizoguchi%26aufirst%3DS.%2BD.%26aulast%3DWarrener%26aufirst%3DP.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DBrinkman%26aufirst%3DF.%2BS.%2BL.%26aulast%3DHufnagle%26aufirst%3DW.%2BO.%26aulast%3DKowalik%26aufirst%3DD.%2BJ.%26aulast%3DLagrou%26aufirst%3DM.%26aulast%3DGarber%26aufirst%3DR.%2BL.%26aulast%3DGoltry%26aufirst%3DL.%26aulast%3DTolentino%26aufirst%3DE.%26aulast%3DWestbrock-Wadman%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DBrody%26aufirst%3DL.%2BL.%26aulast%3DCoulter%26aufirst%3DS.%2BN.%26aulast%3DFolger%26aufirst%3DK.%2BR.%26aulast%3DKas%26aufirst%3DA.%26aulast%3DLarbig%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSpencer%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DG.%2BK.-S.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DPaulsen%26aufirst%3DI.%2BT.%26aulast%3DReizer%26aufirst%3DJ.%26aulast%3DSaier%26aufirst%3DM.%2BH.%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26aulast%3DLory%26aufirst%3DS.%26aulast%3DOlson%26aufirst%3DM.%2BV.%26atitle%3DComplete%2520genome%2520sequence%2520of%2520Pseudomonas%2520aeruginosa%2520PAO1%252C%2520an%2520opportunistic%2520pathogen%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D959%26epage%3D964%26doi%3D10.1038%2F35023079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orlandi, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martegani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mat’átková, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paldrychová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, E.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy by diaryl-porphyrins to control the growth of Candida albicans</span>. <i>Cosmetics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">31</span>, <span class="refDoi"> DOI: 10.3390/cosmetics7020031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fcosmetics7020031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFyjtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=31&author=V.+T.+Orlandiauthor=E.+Marteganiauthor=F.+Bologneseauthor=N.+Trivellinauthor=O.+Mat%E2%80%99%C3%A1tkov%C3%A1author=M.+Paldrychov%C3%A1author=A.+Bajauthor=E.+Caruso&title=Photodynamic+therapy+by+diaryl-porphyrins+to+control+the+growth+of+Candida+albicans&doi=10.3390%2Fcosmetics7020031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy by diaryl-porphyrins to control the growth of Candida albicans</span></div><div class="casAuthors">Orlandi, Viviana Teresa; Martegani, Eleonora; Bolognese, Fabrizio; Trivellin, Nicola; Mat'Atkov, Olga; Paldrychova, Martina; Baj, Andreina; Caruso, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Cosmetics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">31</span>CODEN:
                <span class="NLM_cas:coden">COSMCC</span>;
        ISSN:<span class="NLM_cas:issn">2079-9284</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Candida albicans is an opportunistic pathogen that often causes skin infections such as oral thrush, nail fungus, athlete's foot, and diaper rash.  Under particular conditions, C. albicans alters the natural balance of the host microbiota, and as a result, the skin or its accessory structures lose their function and appearance.  Conventional antimycotic drugs are highly toxic to host tissues, and long-lasting drug administration induces the arising of resistant strains that make the antimycotic therapy ineffective.  Among new antimicrobial approaches to combine with traditional drugs, light-based techniques are very promising.  In this study, a panel of dyes was considered for photodynamic therapy (PDT) applications to control the growth of the model strain C. albicans ATCC 14053.  The chosen photosensitizers (PSs) belong to the family of synthetic porphyrins, and in particular, they are diaryl-porphyrins.  Among these, two monocationic PSs were shown to be particularly efficient In killing C. albicans upon irradn. with light at 410 nm, In a light-dose-dependent manner.  The elicited photo-oxidative stress induced the loss of the internal cellular architecture and death.  The photodynamic treatment was also successful In inhibiting the biofilm formation of clin. C. albicans strains.  In conclusion, this study supports the great potential of diaryl-porphyrins In antimicrobial PDT to control the growth of yeasts on body tissues easily reachable by light sources, such as skin and oral cavity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAQSeE1nD4uLVg90H21EOLACvtfcHk0liynG-JmpZRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFyjtLjL&md5=0848ad8f3bdcb7273e86c8ecde992b16</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3390%2Fcosmetics7020031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcosmetics7020031%26sid%3Dliteratum%253Aachs%26aulast%3DOrlandi%26aufirst%3DV.%2BT.%26aulast%3DMartegani%26aufirst%3DE.%26aulast%3DBolognese%26aufirst%3DF.%26aulast%3DTrivellin%26aufirst%3DN.%26aulast%3DMat%25E2%2580%2599%25C3%25A1tkov%25C3%25A1%26aufirst%3DO.%26aulast%3DPaldrychov%25C3%25A1%26aufirst%3DM.%26aulast%3DBaj%26aufirst%3DA.%26aulast%3DCaruso%26aufirst%3DE.%26atitle%3DPhotodynamic%2520therapy%2520by%2520diaryl-porphyrins%2520to%2520control%2520the%2520growth%2520of%2520Candida%2520albicans%26jtitle%3DCosmetics%26date%3D2020%26volume%3D7%26spage%3D31%26doi%3D10.3390%2Fcosmetics7020031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flaberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guven, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashuba, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekely, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, G.</span></span> <span> </span><span class="NLM_article-title">The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">2274</span>– <span class="NLM_lpage">2283</span>, <span class="refDoi"> DOI: 10.1002/ijc.27521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fijc.27521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=22396138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks12gsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=2274-2283&author=E.+Flabergauthor=H.+Guvenauthor=A.+Savchenkoauthor=T.+Pavlovaauthor=V.+Kashubaauthor=L.+Szekelyauthor=G.+Klein&title=The+architecture+of+fibroblast+monolayers+of+different+origin+differentially+influences+tumor+cell+growth&doi=10.1002%2Fijc.27521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth</span></div><div class="casAuthors">Flaberg, Emilie; Guven, Hayrettin; Savchenko, Andrii; Pavlova, Tatiana; Kashuba, Vladimir; Szekely, Laszlo; Klein, George</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2274-2283</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Normal human and murine fibroblasts can inhibit proliferation of tumor cells when co-cultured in vitro.  The inhibitory capacity varies depending on the donor and the site of origin of the fibroblast.  It requires direct cell-to-cell contact and is not transferable with supernatant.  Here, we show that effective inhibition also requires the formation of a morphol. intact fibroblast monolayer before the seeding of the tumor cells.  Interference with the formation of the monolayer impairs the inhibition.  Subclones of TERT-immortalized fibroblasts were selected on the basis of differences in the growth pattern and related inhibitory activity.  Whereas the well-organized "whirly" (WH) growth pattern was assocd. with strong inhibition, the disorganized "crossy" (CR) growth pattern was linked to reduced inhibition.  Time lapse imaging of tumor-fibroblast co-cultures using extended field live cell microscopy revealed that fibroblast monolayers with growth inhibitory capacity also reduced the motility of the tumor cells whereas noninhibitory monolayers had no effect on tumor cell motility.  Gene expression pattern of two isogenic pairs of fibroblasts, WH and CR subclones of the TERT immortalized line (inhibitory, and less inhibitory subsequently) and freshly explanted skin (inhibitory) and hernia (noninhibitory) fibroblasts derived from the same patient, identified a set of genes that co-segregated with the inhibitory phenotype.  This suggests that our model system may reveal mol. mechanisms involved in contact-mediated microenvironmental surveillance that may protect the organism from the outgrowth of disseminated tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67jZ1iKlmx7Vg90H21EOLACvtfcHk0liynG-JmpZRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks12gsrs%253D&md5=f3836fbf47a8ee2d8baeae4a6acd3c3f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fijc.27521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27521%26sid%3Dliteratum%253Aachs%26aulast%3DFlaberg%26aufirst%3DE.%26aulast%3DGuven%26aufirst%3DH.%26aulast%3DSavchenko%26aufirst%3DA.%26aulast%3DPavlova%26aufirst%3DT.%26aulast%3DKashuba%26aufirst%3DV.%26aulast%3DSzekely%26aufirst%3DL.%26aulast%3DKlein%26aufirst%3DG.%26atitle%3DThe%2520architecture%2520of%2520fibroblast%2520monolayers%2520of%2520different%2520origin%2520differentially%2520influences%2520tumor%2520cell%2520growth%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D131%26spage%3D2274%26epage%3D2283%26doi%3D10.1002%2Fijc.27521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonzi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craparotta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span> <span> </span><span class="NLM_article-title">The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.canlet.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=25979228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1egs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2015&pages=156-164&author=M.+B.+Gariboldiauthor=E.+Taianaauthor=M.+C.+Bonziauthor=I.+Craparottaauthor=S.+Giovannardiauthor=M.+Manciniauthor=E.+Monti&title=The+BH3-mimetic+obatoclax+reduces+HIF-1%CE%B1+levels+and+HIF-1+transcriptional+activity+and+sensitizes+hypoxic+colon+adenocarcinoma+cells+to+5-fluorouracil&doi=10.1016%2Fj.canlet.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil</span></div><div class="casAuthors">Gariboldi, Marzia B.; Taiana, Elisa; Bonzi, Maria Chiara; Craparotta, Ilaria; Giovannardi, Stefano; Mancini, Monica; Monti, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-164</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activation of hypoxia-inducible factor (HIF)-1 is a feature of hypoxic solid tumors that has been assocd. with drug resistance, mainly due to disruption of Bcl-2 family dynamics.  Resetting the balance in favor of proapoptotic family members is an attractive therapeutic goal that has been pursued by developing BH3-mimetic compds.  In the present study we evaluated the response of human colon adenocarcinoma cells to the BH3-mimetic obatoclax (OBX), in terms of growth arrest, apoptosis and autophagy, in the presence or absence of HIF-1α-stabilizing conditions; its possible effect on HIF-1α expression and HIF-1 activity; and the possibility to improve the response of colon cancer cells to cytotoxic chemotherapeutics by combining them with OBX.  Colon cancer cell response to the BH3-mimetic was unmodified by HIF-1 activation and OBX induced a decrease in HIF-1α protein levels and HIF-1 transcriptional activity, probably by decreasing HIF-1α synthesis and facilitating a VHL-independent proteasomal degrdn. pathway.  Finally, a chemosensitizing effect of OBX with respect to 5-fluorouracil or oxaliplatin treatment was obsd., highlighting the possibility that patients with hypoxic colon tumors might benefit from combined regimens including OBX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrblJExRQW-IbVg90H21EOLACvtfcHk0lgJD4TCdcyPkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1egs78%253D&md5=18738781bc23f4aeedc73a6a857ba9dc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DGariboldi%26aufirst%3DM.%2BB.%26aulast%3DTaiana%26aufirst%3DE.%26aulast%3DBonzi%26aufirst%3DM.%2BC.%26aulast%3DCraparotta%26aufirst%3DI.%26aulast%3DGiovannardi%26aufirst%3DS.%26aulast%3DMancini%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DE.%26atitle%3DThe%2520BH3-mimetic%2520obatoclax%2520reduces%2520HIF-1%25CE%25B1%2520levels%2520and%2520HIF-1%2520transcriptional%2520activity%2520and%2520sensitizes%2520hypoxic%2520colon%2520adenocarcinoma%2520cells%2520to%25205-fluorouracil%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D364%26spage%3D156%26epage%3D164%26doi%3D10.1016%2Fj.canlet.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koraimann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span> <span> </span><span class="NLM_article-title">Increasing the precision of comparative models with YASARA NOVA—a self-parameterizing force field</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1002/prot.10104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fprot.10104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=11948792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFantbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2002&pages=393-402&author=E.+Kriegerauthor=G.+Koraimannauthor=G.+Vriend&title=Increasing+the+precision+of+comparative+models+with+YASARA+NOVA%E2%80%94a+self-parameterizing+force+field&doi=10.1002%2Fprot.10104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing the precision of comparative models with yasara NOVA-a self-parameterizing force field</span></div><div class="casAuthors">Krieger, Elmar; Koraimann, Gunther; Vriend, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-402</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">One of the conclusions drawn at the CASP4 meeting in Asilomar was that applying various force fields during refinement of template-based models tends to move predictions in the wrong direction, away from the exptl. detd. coordinates.  We have derived an all-atom force field aimed at protein and nucleotide optimization in vacuo (NOVA), which has been specifically designed to avoid this problem.  NOVA resembles common mol. dynamics force fields but has been automatically parameterized with two major goals: (i) not to make high resoln. x-ray structures worse and (ii) to improve homol. models built by WHAT IF.  Force-field parameters were not required to be phys. correct; instead, they were optimized with random Monte Carlo moves in force-field parameter space, each one evaluated by simulated annealing runs of a 50-protein optimization set.  Errors inherent to the approx. force-field equation could thus be canceled by errors in force-field parameters.  Compared with the optimization set, the force field did equally well on an independent validation set and is shown to move in silico models closer to reality.  It can be applied to modeling applications as well as x-ray and NMR structure refinement.  A new method to assign force-field parameters based on mol. trees is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6LW7Vk3vpG7Vg90H21EOLACvtfcHk0liuM-fJsc2Krw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFantbg%253D&md5=0f187e3ef132542e716eaae61df13b2d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fprot.10104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10104%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26aulast%3DKoraimann%26aufirst%3DG.%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DIncreasing%2520the%2520precision%2520of%2520comparative%2520models%2520with%2520YASARA%2520NOVA%25E2%2580%2594a%2520self-parameterizing%2520force%2520field%26jtitle%3DProteins%26date%3D2002%26volume%3D47%26spage%3D393%26epage%3D402%26doi%3D10.1002%2Fprot.10104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patamia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span> <span> </span><span class="NLM_article-title">Computational tools in the discovery of FABP4 Ligands: A statistical and molecular modeling approach</span>. <i>Mar. drugs.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">624</span>, <span class="refDoi"> DOI: 10.3390/md17110624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fmd17110624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpvVCntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=624&author=G.+Florestaauthor=D.+Gentileauthor=G.+Perriniauthor=V.+Patamiaauthor=A.+Rescifina&title=Computational+tools+in+the+discovery+of+FABP4+Ligands%3A+A+statistical+and+molecular+modeling+approach&doi=10.3390%2Fmd17110624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Computational tools in the discovery of FABP4 ligands: a statistical and molecular modeling approach</span></div><div class="casAuthors">Floresta, Giuseppe; Gentile, Dave; Perrini, Giancarlo; Patamia, Vincenzo; Rescifina, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">624</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Small mol. inhibitors of adipocyte fatty-acid binding protein 4 (FABP4) have received interest following the recent publication of their pharmacol. beneficial effects.  Recently, it was revealed that FABP4 is an attractive mol. target for the treatment of type 2 diabetes, other metabolic diseases, and some type of cancers.  In past years, hundreds of effective FABP4 inhibitors have been synthesized and discovered, but, unfortunately, none have reached the clin. research phase.  The field of computer-aided drug design seems to be promising and useful for the identification of FABP4 inhibitors; hence, different structure- and ligand-based computational approaches have been used for their identification.  In this paper, we searched for new potentially active FABP4 ligands in the Marine Natural Products (MNP) database.  We retrieved 14,492 compds. from this database and filtered through them with a statistical and computational filter.  Seven compds. were suggested by our methodol. to possess a potential inhibitory activity upon FABP4 in the range of 97-331 nM.  ADMET property prediction was performed to validate the hypothesis of the interaction with the intended target and to assess the drug-likeness of these derivs.  From these analyses, three mols. that are excellent candidates for becoming new drugs were found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNr8x3uZQgWbVg90H21EOLACvtfcHk0liuM-fJsc2Krw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpvVCntrg%253D&md5=ad4d21185344cc9a9873a48ef53fd80f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3390%2Fmd17110624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd17110624%26sid%3Dliteratum%253Aachs%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DPerrini%26aufirst%3DG.%26aulast%3DPatamia%26aufirst%3DV.%26aulast%3DRescifina%26aufirst%3DA.%26atitle%3DComputational%2520tools%2520in%2520the%2520discovery%2520of%2520FABP4%2520Ligands%253A%2520A%2520statistical%2520and%2520molecular%2520modeling%2520approach%26jtitle%3DMar.%2520drugs.%26date%3D2019%26volume%3D17%26spage%3D624%26doi%3D10.3390%2Fmd17110624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuochi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furneri, P. M.</span></span> <span> </span><span class="NLM_article-title">New anti SARS-Cov-2 targets for quinoline derivatives chloroquine and hydroxychloroquine</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5856</span>, <span class="refDoi"> DOI: 10.3390/ijms21165856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fijms21165856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVChsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=5856&author=D.+Gentileauthor=V.+Fuochiauthor=A.+Rescifinaauthor=P.+M.+Furneri&title=New+anti+SARS-Cov-2+targets+for+quinoline+derivatives+chloroquine+and+hydroxychloroquine&doi=10.3390%2Fijms21165856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">New anti SARS-Cov-2 targets for quinoline derivatives chloroquine and hydroxychloroquine</span></div><div class="casAuthors">Gentile, Davide; Fuochi, Virginia; Rescifina, Antonio; Furneri, Pio Maria</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5856</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a severe global health crisis.  In this paper, we used docking and simulation methods to identify potential targets and the mechanism of action of chloroquine (CQ) and hydroxychloroquine (HCQ) against SARS-CoV-2.  Our results showed that both CQ and HCQ influenced the functionality of the envelope (E) protein, necessary in the maturation processes of the virus, due to interactions that modify the flexibility of the protein structure.  Furthermore, CQ and HCQ also influenced the proofreading and capping of viral RNA in SARS-CoV-2, performed by nsp10/nsp14 and nsp10/nsp16.  In particular, HCQ demonstrated a better energy binding with the examd. targets compared to CQ, probably due to the hydrogen bonding of the hydroxyl group of HCQ with polar amino acid residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzcz7VVeNGWLVg90H21EOLACvtfcHk0ljDsENPH54w5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVChsbnP&md5=7bf89ed990cb0373d53448c773613f78</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3390%2Fijms21165856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21165856%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DFuochi%26aufirst%3DV.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DFurneri%26aufirst%3DP.%2BM.%26atitle%3DNew%2520anti%2520SARS-Cov-2%2520targets%2520for%2520quinoline%2520derivatives%2520chloroquine%2520and%2520hydroxychloroquine%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D5856%26doi%3D10.3390%2Fijms21165856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span> <span> </span><span class="NLM_article-title">A semiempirical free energy force field with charge-based desolvation</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1145</span>– <span class="NLM_lpage">1152</span>, <span class="refDoi"> DOI: 10.1002/jcc.20634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fjcc.20634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=17274016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVSms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=1145-1152&author=R.+Hueyauthor=G.+M.+Morrisauthor=A.+J.+Olsonauthor=D.+S.+Goodsell&title=A+semiempirical+free+energy+force+field+with+charge-based+desolvation&doi=10.1002%2Fjcc.20634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A semiempirical free energy force field with charge-based desolvation</span></div><div class="casAuthors">Huey, Ruth; Morris, Garrett M.; Olson, Arthur J.; Goodsell, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1145-1152</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors describe the development and testing of a semiempirical free energy force field for use in AutoDock4 and similar grid-based docking methods.  The force field is based on a comprehensive thermodn. model that allows incorporation of intramol. energies into the predicted free energy of binding.  It also incorporates a charge-based method for evaluation of desolvation designed to use a typical set of atom types.  The method has been calibrated on a set of 188 diverse protein-ligand complexes of known structure and binding energy, and tested on a set of 100 complexes of ligands with retroviral proteases.  The force field shows improvement in redocking simulations over the previous AutoDock3 force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonvP0et7yst7Vg90H21EOLACvtfcHk0ljDsENPH54w5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVSms78%253D&md5=6fe6ef9bc0bd8149203a2b7351a2f15c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20634%26sid%3Dliteratum%253Aachs%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26atitle%3DA%2520semiempirical%2520free%2520energy%2520force%2520field%2520with%2520charge-based%2520desolvation%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2007%26volume%3D28%26spage%3D1145%26epage%3D1152%26doi%3D10.1002%2Fjcc.20634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J. J. P.</span></span> <span> </span><span class="NLM_article-title">Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements</span>. <i>J. Mol. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1007/s00894-007-0233-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1007%2Fs00894-007-0233-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=17828561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlequr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1173-1213&author=J.+J.+P.+Stewart&title=Optimization+of+parameters+for+semiempirical+methods+V%3A+modification+of+NDDO+approximations+and+application+to+70+elements&doi=10.1007%2Fs00894-007-0233-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements</span></div><div class="casAuthors">Stewart, James J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1173-1213</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Several modifications that have been made to the NDDO core-core interaction term and to the method of parameter optimization are described.  These changes have resulted in a more complete parameter optimization, called PM6, which has, in turn, allowed 70 elements to be parameterized.  The av. unsigned error (AUE) between calcd. and ref. heats of formation for 4,492 species was 8.0 kcal mol-1.  For the subset of 1,373 compds. involving only the elements H, C, N, O, F, P, S, Cl, and Br, the PM6 AUE was 4.4 kcal mol-1.  The equivalent AUE for other methods were: RM1: 5.0, B3LYP 6-31G*: 5.2, PM5: 5.7, PM3: 6.3, HF 6-31G*: 7.4, and AM1: 10.0 kcal mol-1.  Several long-standing faults in AM1 and PM3 have been cor. and significant improvements have been made in the prediction of geometries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl-g7DsFjK8LVg90H21EOLACvtfcHk0lil4F0xjjwD3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlequr7N&md5=7d22928c8e3423f3ca8f2e7c77e6e6c9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs00894-007-0233-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-007-0233-4%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DJ.%2BJ.%2BP.%26atitle%3DOptimization%2520of%2520parameters%2520for%2520semiempirical%2520methods%2520V%253A%2520modification%2520of%2520NDDO%2520approximations%2520and%2520application%2520to%252070%2520elements%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2007%26volume%3D13%26spage%3D1173%26epage%3D1213%26doi%3D10.1007%2Fs00894-007-0233-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span>; <span class="NLM_string-name">Nielsen, J. E.</span>; <span class="NLM_string-name">Spronk, C. A. E. M.</span>; <span class="NLM_string-name">Vriend, G.</span></span> <span> </span><span class="NLM_article-title">Fast empirical pKa prediction by Ewald summation</span>.  <i>Computational Drug Discovery and Design</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2006</span>,  <span class="NLM_volume">25</span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1016/j.jmgm.2006.02.009</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1016%2Fj.jmgm.2006.02.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=481-486&author=E.+Krieger&author=J.+E.+Nielsen&author=C.+A.+E.+M.+Spronk&author=G.+Vriend&title=Computational+Drug+Discovery+and+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2006.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fj.jmgm.2006.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26atitle%3DFast%2520empirical%2520pKa%2520prediction%2520by%2520Ewald%2520summation%26btitle%3DComputational%2520Drug%2520Discovery%2520and%2520Design%26pub%3DSpringer%26date%3D2006%26volume%3D25%26spage%3D481%26epage%3D486%26doi%3D10.1016%2Fj.jmgm.2006.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbrack, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, B.</span></span> <span> </span><span class="NLM_article-title">Assignment of protonation states in proteins and ligands: combining pK<sub>a</sub> prediction with hydrogen bonding network optimization</span>. <i>Methods Mol. Bio.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>819</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1007/978-1-61779-465-0_25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1007%2F978-1-61779-465-0_25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=22183550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSjur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=819&publication_year=2012&pages=405-421&author=E.+Kriegerauthor=R.+Dunbrackauthor=R.+Hooftauthor=B.+Krieger&title=Assignment+of+protonation+states+in+proteins+and+ligands%3A+combining+pKa+prediction+with+hydrogen+bonding+network+optimization&doi=10.1007%2F978-1-61779-465-0_25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Assignment of protonation states in proteins and ligands: combining pKa prediction with hydrogen bonding network optimization</span></div><div class="casAuthors">Krieger, Elmar; Dunbrack, Roland; Hooft, Rob; Krieger, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">819</span>
        (<span class="NLM_cas:issue">Computational Drug Discovery and Design</span>),
    <span class="NLM_cas:pages">405-421</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Among the many applications of mol. modeling, drug design is probably the one with the highest demands on the accuracy of the underlying structures.  During lead optimization, the position of every atom in the binding site should ideally be known with high precision to identify those chem. modifications that are most likely to increase drug affinity.  Unfortunately, X-ray crystallog. at common resoln. yields an electron d. map that is too coarse, since the chem. elements and their protonation states cannot be fully resolved.  This chapter describes the steps required to fill in the missing knowledge, by devising an algorithm that can detect and resolve the ambiguities.  First, the pKa values of acidic and basic groups are predicted.  Second, their potential protonation states are detd., including all permutations (considering for example protons that can jump between the oxygens of a phosphate group).  Third, those groups of atoms are identified that can adopt alternative but indistinguishable conformations with essentially the same electron d.  Fourth, potential hydrogen bond donors and acceptors are located.  Finally, all these data are combined in a single "configuration energy function," whose global min. is found with the SCWRL algorithm, which employs dead-end elimination and graph theory.  As a result, one obtains a complete model of the protein and its bound ligand, with ambiguous groups rotated to the best orientation and with protonation states assigned considering the current pH and the H-bonding network.  An implementation of the algorithm has been available since 2008 as part of the YASARA modeling & simulation program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFpCHVYXJkBrVg90H21EOLACvtfcHk0lil4F0xjjwD3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSjur%252FE&md5=8525f958edc1f737aaf3c305aef34bb1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-465-0_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-465-0_25%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26aulast%3DDunbrack%26aufirst%3DR.%26aulast%3DHooft%26aufirst%3DR.%26aulast%3DKrieger%26aufirst%3DB.%26atitle%3DAssignment%2520of%2520protonation%2520states%2520in%2520proteins%2520and%2520ligands%253A%2520combining%2520pKa%2520prediction%2520with%2520hydrogen%2520bonding%2520network%2520optimization%26jtitle%3DMethods%2520Mol.%2520Bio.%26date%3D2012%26volume%3D819%26spage%3D405%26epage%3D421%26doi%3D10.1007%2F978-1-61779-465-0_25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maier, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasavajhala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span> <span> </span><span class="NLM_article-title">ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3696</span>– <span class="NLM_lpage">3713</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00255</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00255" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3696-3713&author=J.+A.+Maierauthor=C.+Martinezauthor=K.+Kasavajhalaauthor=L.+Wickstromauthor=K.+E.+Hauserauthor=C.+Simmerling&title=ff14SB%3A+Improving+the+accuracy+of+protein+side+chain+and+backbone+parameters+from+ff99SB&doi=10.1021%2Facs.jctc.5b00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</span></div><div class="casAuthors">Maier, James A.; Martinez, Carmenza; Kasavajhala, Koushik; Wickstrom, Lauren; Hauser, Kevin E.; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3696-3713</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. mechanics is powerful for its speed in atomistic simulations, but an accurate force field is required.  The Amber ff99SB force field improved protein secondary structure balance and dynamics from earlier force fields like ff99, but weaknesses in side chain rotamer and backbone secondary structure preferences have been identified.  Here, we performed a complete refit of all amino acid side chain dihedral parameters, which had been carried over from ff94.  The training set of conformations included multidimensional dihedral scans designed to improve transferability of the parameters.  Improvement in all amino acids was obtained as compared to ff99SB.  Parameters were also generated for alternate protonation states of ionizable side chains.  Av. errors in relative energies of pairs of conformations were under 1.0 kcal/mol as compared to QM, reduced 35% from ff99SB.  We also took the opportunity to make empirical adjustments to the protein backbone dihedral parameters as compared to ff99SB.  Multiple small adjustments of φ and ψ parameters were tested against NMR scalar coupling data and secondary structure content for short peptides.  The best results were obtained from a phys. motivated adjustment to the φ rotational profile that compensates for lack of ff99SB QM training data in the β-ppII transition region.  Together, these backbone and side chain modifications (hereafter called ff14SB) not only better reproduced their benchmarks, but also improved secondary structure content in small peptides and reprodn. of NMR χ1 scalar coupling measurements for proteins in soln.  We also discuss the Amber ff12SB parameter set, a preliminary version of ff14SB that includes most of its improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgntnN9ES97rVg90H21EOLACvtfcHk0lh-aEuE4pP-6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN&md5=7b803577b3b6912cc6750cfbd356596e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00255%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DC.%26aulast%3DKasavajhala%26aufirst%3DK.%26aulast%3DWickstrom%26aufirst%3DL.%26aulast%3DHauser%26aufirst%3DK.%2BE.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3Dff14SB%253A%2520Improving%2520the%2520accuracy%2520of%2520protein%2520side%2520chain%2520and%2520backbone%2520parameters%2520from%2520ff99SB%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2015%26volume%3D11%26spage%3D3696%26epage%3D3713%26doi%3D10.1021%2Facs.jctc.5b00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Development and testing of a general amber force field</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1002/jcc.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+amber+force+field&doi=10.1002%2Fjcc.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0lj7jSpEKNLm5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1157%26epage%3D1174%26doi%3D10.1002%2Fjcc.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strockbine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roitberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span> <span> </span><span class="NLM_article-title">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1002/prot.21123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fprot.21123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=16981200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=712-725&author=V.+Hornakauthor=R.+Abelauthor=A.+Okurauthor=B.+Strockbineauthor=A.+Roitbergauthor=C.+Simmerling&title=Comparison+of+multiple+Amber+force+fields+and+development+of+improved+protein+backbone+parameters&doi=10.1002%2Fprot.21123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span></div><div class="casAuthors">Hornak, Viktor; Abel, Robert; Okur, Asim; Strockbine, Bentley; Roitberg, Adrian; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-725</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The ff94 force field that is commonly assocd. with the Amber simulation package is one of the most widely used parameter sets for biomol. simulation.  After a decade of extensive use and testing, limitations in this force field, such as over-stabilization of α-helixes, were reported by the authors and other researchers.  This led to a no. of attempts to improve these parameters, resulting in a variety of "Amber" force fields and significant difficulty in detg. which should be used for a particular application.  The authors show that several of these continue to suffer from inadequate balance between different secondary structure elements.  In addn., the approach used in most of these studies neglected to account for the existence in Amber of two sets of backbone .vphi./ψ dihedral terms.  This led to parameter sets that provide unreasonable conformational preferences for glycine.  The authors report here an effort to improve the .vphi./ψ dihedral terms in the ff99 energy function.  Dihedral term parameters are based on fitting the energies of multiple conformations of glycine and alanine tetrapeptides from high level ab initio quantum mech. calcns.  The new parameters for backbone dihedrals replace those in the existing ff99 force field.  This parameter set, which the authors denote ff99SB, achieves a better balance of secondary structure elements as judged by improved distribution of backbone dihedrals for glycine and alanine with respect to PDB survey data.  It also accomplishes improved agreement with published exptl. data for conformational preferences of short alanine peptides and better accord with exptl. NMR relaxation data of test protein systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoASzza-Gd7Vg90H21EOLACvtfcHk0lj7jSpEKNLm5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM&md5=de683a26eca9e83ae524726e97ac22fa</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fprot.21123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21123%26sid%3Dliteratum%253Aachs%26aulast%3DHornak%26aufirst%3DV.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DOkur%26aufirst%3DA.%26aulast%3DStrockbine%26aufirst%3DB.%26aulast%3DRoitberg%26aufirst%3DA.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3DComparison%2520of%2520multiple%2520Amber%2520force%2520fields%2520and%2520development%2520of%2520improved%2520protein%2520backbone%2520parameters%26jtitle%3DProteins%26date%3D2006%26volume%3D65%26spage%3D712%26epage%3D725%26doi%3D10.1002%2Fprot.21123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Essmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkowitz, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L. G.</span></span> <span> </span><span class="NLM_article-title">A Smooth particle mesh Ewald method</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8577</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1063/1.470117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1063%2F1.470117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8593&author=U.+Essmannauthor=L.+Pereraauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+Smooth+particle+mesh+Ewald+method&doi=10.1063%2F1.470117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A smooth particle mesh Ewald method</span></div><div class="casAuthors">Essmann, Ulrich; Perera, Lalith; Berkowitz, Max L.; Darden, Tom; Lee, Hsing; Pedersen, Lee G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8577-93</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The previously developed particle mesh Ewald method is reformulated in terms of efficient B-spline interpolation of the structure factors.  This reformulation allows a natural extension of the method to potentials of the form 1/rp with p ≥ 1.  Furthermore, efficient calcn. of the virial tensor follows.  Use of B-splines in the place of Lagrange interpolation leads to analytic gradients as well as a significant improvement in the accuracy.  The authors demonstrate that arbitrary accuracy can be achieved, independent of system size N, at a cost that scales as N log(N).  For biomol. systems with many thousands of atoms and this method permits the use of Ewald summation at a computational cost comparable to that of a simple truncation method of 10 Å or less.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Bp1XlSY32LVg90H21EOLACvtfcHk0ljogpa7XIeyVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D&md5=092a679dd3bee08da28df41e302383a7</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssmann%26aufirst%3DU.%26aulast%3DPerera%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520Smooth%2520particle%2520mesh%2520Ewald%2520method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8593%26doi%3D10.1063%2F1.470117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postma, J. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gunsteren, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haak, J. R.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics with coupling to an external bath</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">3684</span>– <span class="NLM_lpage">3690</span>, <span class="refDoi"> DOI: 10.1063/1.448118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1063%2F1.448118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=3684-3690&author=H.+J.+C.+Berendsenauthor=J.+P.+M.+Postmaauthor=W.+F.+van+Gunsterenauthor=A.+DiNolaauthor=J.+R.+Haak&title=Molecular+dynamics+with+coupling+to+an+external+bath&doi=10.1063%2F1.448118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics with coupling to an external bath</span></div><div class="casAuthors">Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; DiNola, A.; Haak, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3684-90</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">In mol. dynamics (MD) simulations, the need often arises to maintain such parameters as temp. or pressure rather than energy and vol., or to impose gradients for studying transport properties in nonequil. MD.  A method is described to realize coupling to an external bath with const. temp. or pressure with adjustable time consts. for the coupling.  The method is easily extendable to other variables and to gradients, and can be applied also to polyat. mols. involving internal constraints.  The influence of coupling time consts. on dynamical variables is evaluated.  A leap-frog algorithm is presented for the general case involving constraints with coupling to both a const. temp. and a const. pressure bath.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecrpUZWkh37Vg90H21EOLACvtfcHk0ljogpa7XIeyVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D&md5=5510dc00297d63b91ee3a7a4ae5aacb1</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1063%2F1.448118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.448118%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DPostma%26aufirst%3DJ.%2BP.%2BM.%26aulast%3Dvan%2BGunsteren%26aufirst%3DW.%2BF.%26aulast%3DDiNola%26aufirst%3DA.%26aulast%3DHaak%26aufirst%3DJ.%2BR.%26atitle%3DMolecular%2520dynamics%2520with%2520coupling%2520to%2520an%2520external%2520bath%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1984%26volume%3D81%26spage%3D3684%26epage%3D3690%26doi%3D10.1063%2F1.448118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span> <span> </span><span class="NLM_article-title">New ways to boost molecular dynamics simulations</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">996</span>– <span class="NLM_lpage">1007</span>, <span class="refDoi"> DOI: 10.1002/jcc.23899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fjcc.23899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=25824339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVOgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=996-1007&author=E.+Kriegerauthor=G.+Vriend&title=New+ways+to+boost+molecular+dynamics+simulations&doi=10.1002%2Fjcc.23899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">New ways to boost molecular dynamics simulations</span></div><div class="casAuthors">Krieger, Elmar; Vriend, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">996-1007</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe a set of algorithms that allow to simulate dihydrofolate reductase (DHFR, a common benchmark) with the AMBER all-atom force field at 160 ns/day on a single Intel Core i7 5960X CPU (no graphics processing unit (GPU), 23,786 atoms, particle mesh Ewald (PME), 8.0 Å cutoff, correct atom masses, reproducible trajectory, CPU with 3.6 GHz, no turbo boost, 8 AVX registers).  The new features include a mixed multiple time-step algorithm (reaching 5 fs), a tuned version of LINCS to constrain bond angles, the fusion of pair list creation and force calcn., pressure coupling with a "densostat," and exploitation of new CPU instruction sets like AVX2.  The impact of Intel's new transactional memory, at. instructions, and sloppy pair lists is also analyzed.  The algorithms map well to GPUs and can automatically handle most Protein Data Bank (PDB) files including ligands.  An implementation is available as part of the YASARA mol. modeling and simulation program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoniH36hOPj37Vg90H21EOLACvtfcHk0ljogpa7XIeyVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVOgsbo%253D&md5=5b3cd97c67fa308b9333d016cf31e0b7</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fjcc.23899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.23899%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DNew%2520ways%2520to%2520boost%2520molecular%2520dynamics%2520simulations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2015%26volume%3D36%26spage%3D996%26epage%3D1007%26doi%3D10.1002%2Fjcc.23899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span> <span> </span><span class="NLM_article-title">Morphing of Ibogaine: A successful attempt into the search for sigma-2 receptor ligands</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">488</span>, <span class="refDoi"> DOI: 10.3390/ijms20030488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.3390%2Fijms20030488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlSrs7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=488&author=G.+Florestaauthor=M.+Dichiaraauthor=D.+Gentileauthor=O.+Prezzaventoauthor=A.+Marrazzoauthor=A.+Rescifinaauthor=E.+Amata&title=Morphing+of+Ibogaine%3A+A+successful+attempt+into+the+search+for+sigma-2+receptor+ligands&doi=10.3390%2Fijms20030488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Morphing of Ibogaine: a successful attempt into the search for sigma-2 receptor ligands</span></div><div class="casAuthors">Floresta, Giuseppe; Dichiara, Maria; Gentile, Davide; Prezzavento, Orazio; Marrazzo, Agostino; Rescifina, Antonio; Amata, Emanuele</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">488</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Ibogaine is a psychoactive indole alkaloid with high affinity for several targets including the σ2 receptor.  Indeed, extensive data support the involvement of the σ2 receptor in neurol. disorders, including Alzheimer's disease, schizophrenia, alc. abuse and pain.  Due to its serious side effects which prevent ibogaine from potential clin. applications, novel ibogaine derivs. endowed with improved σ2 receptor affinity may be particularly beneficial.  With the purpose to facilitate the investigation of iboga alkaloid derivs. which may serve as templates for the design of selective σ2 receptor ligands, here we report a deconstruction study on the ibogaine tricyclic moiety and a successive scaffold-hopping of the indole counterpart.  A 3D-QSAR model has been applied to predict the σ2 pKi values of the new compds., whereas a mol. docking study conducted upon the σ2 receptor built by homol. modeling was used to further validate the best-scored mols.  We eventually evaluated pinoline, a carboline deriv., for σ2 receptor affinity through radioligand binding assay and the results confirmed the predicted high μM range of affinity and good selectivity.  The obtained results could be helpful in the drug design process of new ibogaine simplified analogs with improved σ2 receptor binding capabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxMtynO_4qvbVg90H21EOLACvtfcHk0liPSo50HATv2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlSrs7bM&md5=1cc78e31aebed4cbe1a43aa6f77cc478</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.3390%2Fijms20030488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20030488%26sid%3Dliteratum%253Aachs%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DAmata%26aufirst%3DE.%26atitle%3DMorphing%2520of%2520Ibogaine%253A%2520A%2520successful%2520attempt%2520into%2520the%2520search%2520for%2520sigma-2%2520receptor%2520ligands%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D488%26doi%3D10.3390%2Fijms20030488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patamia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchio, M.</span></span> <span> </span><span class="NLM_article-title">Repurposing of FDA-approved drugs for treating iatrogenic botulism: A paired 3D-QSAR/docking approach<sup>†</sup></span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1002%2Fcmdc.201900594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=31774239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlais7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=256-262&author=G.+Florestaauthor=V.+Patamiaauthor=D.+Gentileauthor=F.+Molteniauthor=A.+Santamatoauthor=A.+Rescifinaauthor=M.+Vecchio&title=Repurposing+of+FDA-approved+drugs+for+treating+iatrogenic+botulism%3A+A+paired+3D-QSAR%2Fdocking+approach%E2%80%A0&doi=10.1002%2Fcmdc.201900594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach†</span></div><div class="casAuthors">Floresta, Giuseppe; Patamia, Vincenzo; Gentile, Davide; Molteni, Franco; Santamato, Andrea; Rescifina, Antonio; Vecchio, Michele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-262</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Botulinum neurotoxin (BoNT) is widely used for the treatment of spasticity, focal dystonia, chronic migraine, facial hemispasm, and facial aesthetic treatments.  Generally, treatment with botulinum toxin is a safe procedure when conducted by clinicians with expertise, and local side effects are rare and transient.  However, occasionally adverse effects can occur due to the spread of the drug to nontargeted muscles and organs, producing dry mouth, fatigue, and flu-like symptoms, up to signs of systemic botulism, which appears to be more frequent in children treated for spasticity than in adults.  In silico 3D-QSAR and mol. docking studies were performed to build a structure-based model on selected potent known botulinum neurotoxin type A inhibitors; this was used to screen the US Food and Drug Administration (FDA) database.  Thirty mols. were identified as possible light-chain BoNT/A inhibitors.  In this study, we applied a well-established ligand- and structure-based methodol. for the identification of hit compds. among a database of FDA-approved drugs.  The identification of budesonide, protirelin, and ciclesonide followed by other compds. can be considered a starting point for investigations of selected compds. that could bypass much of the time and costs involved in the drug approval process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofgLgIX3ZJW7Vg90H21EOLACvtfcHk0liPSo50HATv2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlais7%252FI&md5=1acf0d5493435aca8e9438dc79f71bf5</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900594%26sid%3Dliteratum%253Aachs%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DPatamia%26aufirst%3DV.%26aulast%3DGentile%26aufirst%3DD.%26aulast%3DMolteni%26aufirst%3DF.%26aulast%3DSantamato%26aufirst%3DA.%26aulast%3DRescifina%26aufirst%3DA.%26aulast%3DVecchio%26aufirst%3DM.%26atitle%3DRepurposing%2520of%2520FDA-approved%2520drugs%2520for%2520treating%2520iatrogenic%2520botulism%253A%2520A%2520paired%25203D-QSAR%252Fdocking%2520approach%25E2%2580%25A0%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D256%26epage%3D262%26doi%3D10.1002%2Fcmdc.201900594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahakyan, H.</span></span> <span> </span><span class="NLM_article-title">Improving virtual screening results with MM/GBSA and MM/PBSA rescoring</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1007/s10822-021-00389-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=10.1007%2Fs10822-021-00389-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=33983518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;key=1%3ACAS%3A528%3ADC%252BB3MXhtV2gsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2021&pages=731-736&author=H.+Sahakyan&title=Improving+virtual+screening+results+with+MM%2FGBSA+and+MM%2FPBSA+rescoring&doi=10.1007%2Fs10822-021-00389-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Improving virtual screening results with MM/GBSA and MM/PBSA rescoring</span></div><div class="casAuthors">Sahakyan, Harutyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">731-736</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Virtual screening (VS) based on mol. docking is one of the most useful methods in computer-aided drug design.  By allowing to identify computationally putative ligands binding to the proteins of interest, VS dramatically reduces the time and expense of the development of novel therapeutics.  Among the limitations of the VS approaches is the low accuracy of scoring functions implemented in docking methods for assessing binding affinity.  Many such scoring functions are developed for rapid, high-throughput evaluation of binding energy of multiple conformations generated by a searching algorithm.  The methods for more rigorous calcn. of binding affinity calcn. are generally time-consuming.  Even so, in many studies more accurate methods were used for rescoring of the final poses and false-pos. hits evaluation.  We performed VS for three benchmark sets and used energy minimization with MM/PB(GB)SA methods (mol. mechanics energies combined with the Poisson-Boltzmann or generalized Born and surface area) to rescore binding affinities.  The comparison of the area under the curve (AUC), enrichment factor (EF), and Boltzmann-enhanced discrimination of receiver operating characteristics (BEDROC) showed essential improvements in the binding energy prediction after the rescoring.  Finally, we provide a program for minimization and rescoring VS results based on freely available AmberTools.  The code requires just the final binding poses of the ligand as the input and can be used with any docking program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF1xaf4SHLnrVg90H21EOLACvtfcHk0lj6aPsCR7bmqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXhtV2gsbjF&md5=ea3d72c7ad2434ee3d2cfa370ecf97e5</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1007%2Fs10822-021-00389-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-021-00389-3%26sid%3Dliteratum%253Aachs%26aulast%3DSahakyan%26aufirst%3DH.%26atitle%3DImproving%2520virtual%2520screening%2520results%2520with%2520MM%252FGBSA%2520and%2520MM%252FPBSA%2520rescoring%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2021%26volume%3D35%26spage%3D731%26epage%3D736%26doi%3D10.1007%2Fs10822-021-00389-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Aktulga, H. M.</span>; <span class="NLM_string-name">Belfon, K.</span>; <span class="NLM_string-name">Ben-Shalom, I. Y.</span>; <span class="NLM_string-name">Brozell, S. R.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham, T. E.,  III</span>; <span class="NLM_string-name">Cruzeiro, V. W. D.</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Giambasu, G.</span>; <span class="NLM_string-name">Gilson, M. K.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A.W.</span>; <span class="NLM_string-name">Harris, R.</span>; <span class="NLM_string-name">Izadi, S.</span>; <span class="NLM_string-name">Izmailov, S. A.</span>; <span class="NLM_string-name">Jin, C.</span>; <span class="NLM_string-name">Kasavajhala, K.</span>; <span class="NLM_string-name">Kaymak, M. C.</span>; <span class="NLM_string-name">King, E.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Kurtzman, T.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Lin, C.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Machado, M.</span>; <span class="NLM_string-name">Man, V.</span>; <span class="NLM_string-name">Manathunga, M.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Miao, Y.</span>; <span class="NLM_string-name">Mikhailovskii, O.</span>; <span class="NLM_string-name">Monard, G.</span>; <span class="NLM_string-name">Nguyen, H.</span>; <span class="NLM_string-name">O’Hearn, K. A.</span>; <span class="NLM_string-name">Onufriev, A.</span>; <span class="NLM_string-name">Pan, F.</span>; <span class="NLM_string-name">Pantano, S.</span>; <span class="NLM_string-name">Qi, R.</span>; <span class="NLM_string-name">Rahnamoun, A.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Sagui, C.</span>; <span class="NLM_string-name">Schott-Verdugo, S.</span>; <span class="NLM_string-name">Shen, J.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Skrynnikov, N. R.</span>; <span class="NLM_string-name">Smith, J.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wei, H.</span>; <span class="NLM_string-name">Wolf, R. M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Xue, Y.</span>; <span class="NLM_string-name">York, D. M.</span>; <span class="NLM_string-name">Zhao, S.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> (<span class="NLM_year">2021</span>),  <i>Amber 2021</i>; <span class="NLM_publisher-name">University of California</span>, <span class="NLM_publisher-loc">San Francisco</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=D.+A.+Case&author=H.+M.+Aktulga&author=K.+Belfon&author=I.+Y.+Ben-Shalom&author=S.+R.+Brozell&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=V.+W.+D.+Cruzeiro&author=T.+A.+Darden&author=R.+E.+Duke&author=G.+Giambasu&author=M.+K.+Gilson&author=H.+Gohlke&author=A.W.+Goetz&author=R.+Harris&author=S.+Izadi&author=S.+A.+Izmailov&author=C.+Jin&author=K.+Kasavajhala&author=M.+C.+Kaymak&author=E.+King&author=A.+Kovalenko&author=T.+Kurtzman&author=T.+S.+Lee&author=S.+LeGrand&author=P.+Li&author=C.+Lin&author=J.+Liu&author=T.+Luchko&author=R.+Luo&author=M.+Machado&author=V.+Man&author=M.+Manathunga&author=K.+M.+Merz&author=Y.+Miao&author=O.+Mikhailovskii&author=G.+Monard&author=H.+Nguyen&author=K.+A.+O%E2%80%99Hearn&author=A.+Onufriev&author=F.+Pan&author=S.+Pantano&author=R.+Qi&author=A.+Rahnamoun&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=S.+Schott-Verdugo&author=J.+Shen&author=C.+L.+Simmerling&author=N.+R.+Skrynnikov&author=J.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=H.+Wei&author=R.+M.+Wolf&author=X.+Wu&author=Y.+Xue&author=D.+M.+York&author=S.+Zhao&author=P.+A.+Kollman&title=Amber+2021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26date%3D2021%26btitle%3DAmber%25202021%26pub%3DUniversity%2520of%2520California" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GWK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GWK','PDB','5GWK'); return false;">PDB: 5GWK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XCT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XCT','PDB','2XCT'); return false;">PDB: 2XCT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MS1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MS1','PDB','6MS1'); return false;">PDB: 6MS1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M1S" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M1S','PDB','6M1S'); return false;">PDB: 6M1S</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i52"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00917">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04586"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00917?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00917</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">NMR spectra, fluorescence and absorption spectra, visible spectrum before and after cell binding, and IC<sub>50</sub> values on DU145, PC3, MCF7, MDA-MB231, and HCT116 cell lines of compounds <b>1a</b>, <b>1b</b>, <b>3a</b>, <b>3b</b>, <b>6a</b>–<b>6d</b>, and <b>7a</b>–<b>7d</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_001.pdf">jm1c00917_si_001.pdf (2.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00917/suppl_file/jm1c00917_si_002.csv">jm1c00917_si_002.csv (2.33 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00917&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00917" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00917" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679972e68fbf24f5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
